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Myopia is now being recognized as a significant global public health problem that 
will affect billions of people in the next decades, especially in Asia. Currently, 
pathologic myopia is already a major cause of visual impairment in both Asian and 
Western populations. As the prevalence of myopia and pathological myopia 
increases around the world, there is increasing need for active prevention of myopia 
progression and management of its potential complications.
The purpose of this book is to provide updates on current understanding of myo-
pia, new methods of evaluation of the myopic eye, and a focus on clinical manage-
ment of myopia and its complications. This book will provide a unique perspective 
from the current world experts on the subject, with a focus on clinical aspects of 
understanding, evaluation, and management of myopia.
Chapter 1 provides a concise summary of all the key points from the book for 
busy readers who want a quick overview on clinical myopia. The rest of the book is 
comprehensive and provides updates on almost all aspects with regard to myopia. 
Chapters 2 and 3 describe epidemiology and economic burden; Chaps. 4 and 5 dis-
cuss genetic and pathogenetic mechanisms; Chaps. 6 to 8 describe risk factors and 
ways to prevent myopia development or progression. Next, Chaps. 9 and 10 discuss 
pathological myopia and advances (and challenges) in imaging myopic eyes. 
Finally, Chaps. 11 to 14 provide clinical pearls of managing myopia complications, 
i.e., glaucoma, retina, and choroidal neovascularization in adults.
As new data is constantly emerging, this book was generated with the inputs of 
all authors within 6 months to ensure that the evidence shared is as current as pos-
sible. Thus, it is important to keep updated with online material and literature 
review. Nonetheless, we hope you will find this book as a useful reference for 
optometry students, ophthalmology residents, and eye care professionals to have a 
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1Introduction and Overview on Myopia: A Clinical Perspective
Chee Wai Wong, Noel Brennan, and Marcus Ang
Key Points
• Myopia is a significant global public health and socioeconomic problem.
• Pathologic myopia has become a major cause of blindness or visual impair-
ment in both Asian and Western populations.
• Myopia may be a highly heritable trait, with environmental influences such 
as outdoor activity playing important roles in its development and 
progression.
• Control of myopia in children is important, and various strategies includ-
ing pharmacologic and lens-related interventions have proven efficacy.
• Imaging is important to detect complications of pathologic myopia, and both 
medical and surgical interventions may be useful for their management.
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1.1  Global Epidemiology
Myopia has become a significant global public health and socioeconomic problem 
[1–4]. East Asia, and other parts of the world to a lesser extent, has been faced with an 
increasing prevalence of myopia [5, 6]. The prevalence of myopia and high myopia 
(HM) (the definition of myopia and HM is spherical equivalence (SE) of −0.50 diop-
ters (D) or less and SE −5.00 D or −6.00 D, respectively) in young adults in urban 
areas of East Asian countries has risen to 80–90% and around 20%, respectively [7, 
8]. According to a summary of 145 studies regarding the global prevalence of myopia 
and HM, there are approximately 1950 million with myopia (28.3% of the global pop-
ulation) and 277 million with HM (4.0% of the global population), and these numbers 
are predicted to increase to 4758 million (49.8% of the global population) for myopia, 
and 938 million (9.8% of the global population) for HM by 2050 [9].
The prevalence of childhood myopia is substantially higher in urban East Asian 
countries (49.7–62.0% among 12-year-old children) [7, 10] compared with other 
countries (6.0–20.0% among 12-year-old children) [9]. Similarly, in teenagers and 
young adults, the prevalence of myopia is higher in East Asian countries (65.5–
96.5%) [8] compared with other countries (12.8–35.0%) [9]. However, the geo-
graphic difference of myopia prevalence in older populations is less than that in 
younger populations. The prevalence rates of myopia in adults in urban East Asian 
countries are only slightly higher than in Western countries.
The prevalence of myopia has remained consistently high among Chinese chil-
dren in urban settings, but the evidence does not support the idea that it is caused 
by purely genetic difference [10]. The association of an urbanized setting with high 
myopia rates is likely to be influenced by possible modifiable risk factors such as 
near work and outdoor time.
Despite the relatively low prevalence in the general population, pathologic myo-
pia (PM) is a major cause of blindness or visual impairment in both Asian and 
Western populations. One study has shown that the prevalence of PM was 28.7% 
among high myopes and 65% of those with HM and were over 70 years old had PM 
[11]. Based on the global prediction of HM on 2050, PM may increase to over 200 
million in future [9]. Treatment strategies against PM have not been effective [12].
Generational differences in prevalence are seen with the highest rates in young 
adults (myopia 65.5–96.5% and HM 6.8–21.6%) and the lowest rates in older adults 
(myopia 25.0–40.0% and HM 2.4–8.2%). The disease progression pattern of HM 
and subsequent development of PM may be different between young adults and 
older adults due to generational differences, or changes in the lifestyle factors such 
as the education system, near work, and outdoor time exposure in rapidly develop-
ing urban Asian countries.
1.2  Pathogenesis of Myopia
Ocular Biometric Changes in Human Myopia The axial length of the eye or, 
more precisely, the vitreous chamber depth is the primary individual biometric con-
tributor to refractive error in children, young adults, and the elderly [13–15], with 
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the vitreous chamber depth accounting for over 50% of the observed variation in 
spherical equivalent refractive error (SER), followed by the cornea (~15%) and 
crystalline lens (~1%) [15]. However, the dimensions, curvature, and refractive 
index of each individual ocular structure contribute to the final refractive state. The 
choroid is typically thinner in myopic compared to non-myopic eyes (most pro-
nounced at the fovea [16, 17]) and thins with increasing myopia and axial length in 
both adults [18–25] and children [26–28]. Significant choroidal thinning is also 
observed in eyes with posterior staphyloma [29], and has been associated with the 
presence of lacquer cracks [30], choroidal neovascularization [31], and reduced 
visual acuity [32]. The choroid also appears to be a biomarker of ocular processes 
regulating eye growth given that the central macular choroid thins during the initial 
development and progression of myopia [33–35] and thickens in response to 
imposed peripheral myopic retinal image defocus [36, 37], topical anti-muscarinic 
agents [38, 39], and increased light exposure [40]; clinical interventions associated 
with a slowing of eye growth in children.
Visual Environment, Emmetropization, and Myopia Much of the knowledge on 
vision-dependent changes in ocular growth has emanated from animal experiments 
in which either the quality of image formed on the retina is degraded (known as 
form deprivation [FD]), or the focal point of the image is altered with respect to the 
retinal plane (known as lens defocus). Both FD and lens defocus result in abnormal 
eye growth and development of refractive errors.
Monochromatic Higher-Order Aberrations as a Myopigenic Stimulus Myopia 
may develop due to the eye’s emmetropization response to inherent ocular aberra-
tions that degrade retinal image quality and trigger axial elongation [41]. Evidence 
concerning the relationship between higher order abberation (HOAs) during dis-
tance viewing and refractive error from cross-sectional studies is conflicting [41, 
42]. However, during or following near-work tasks, adult myopic eyes tend to dis-
play a transient increase in corneal and total ocular HOAs, suggesting a potential 
role for near-work-induced retinal image degradation in myopia development [43, 
44]. Longitudinal studies of myopic children also indicate that eyes with greater 
positive spherical aberration demonstrate slower eye growth [45, 46].
Accommodation Given the association between near work and the development 
and progression of childhood myopia [47], numerous studies have compared various 
characteristics of accommodation between refractive error groups. Typically, this 
involves the accuracy of the accommodation response, since lag of accommodation 
(hyperopic retinal defocus) may stimulate axial elongation as observed in some ani-
mal models. The slowing of myopia progression during childhood with progressive 
addition or bifocal lenses, designed to improve accommodation accuracy and mini-
mize lag of accommodation, adds some weight to the role of accommodation in 
myopia development and progression [48, 49]. However, the exact underlying mech-
anism of myopia control with such lenses may be related to imposed peripheral reti-
nal defocus or a reduction in the near vergence demand [50]. Certainly, elevations in 
measured lag observed in myopes arise after rather than before onset [51].
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1.3  Key Environmental Factors on Myopia
Near work and education: Many studies have established a strong link between 
myopia and education [52–57]. Moreover, Mountjoy et al. have shown that expo-
sure to longer duration of education was a causal risk factor for myopia [53]. The 
exact mechanism linking increased education with myopia is unclear. Although it is 
possible that optical [43, 58] or biomechanical [59, 60] ocular changes associated 
with near work could potentially promote myopic eye growth in those with higher 
levels of education (and hence near-work demands), population studies examining 
the link between near-work activities and myopia have been conflicting, with some 
studies suggesting an association between near work and myopia [47, 61], and oth-
ers indicating no significant effects [62]. The relatively inconsistent findings linking 
near work with myopia development suggests a potential role for other factors in the 
association between education and myopia.
Outdoor Activity A number of recent studies report that the time children spend 
engaged in outdoor activities is negatively associated with their risk of myopia [62–68]. 
Both cross-sectional and longitudinal studies indicate that greater time spent outdoors 
is associated with a significantly lower myopia prevalence and reduced risk of myopia 
onset in childhood. Although some studies report significant associations between 
myopia progression and outdoor activity [66, 68], this is not a consistent finding across 
all longitudinal studies [69]. A recent meta-analysis of studies examining the relation-
ship between outdoor time and myopia indicated that there was a 2% reduction in the 
odds of having myopia for each additional hour per week spent outdoors [70].
Duration of Outdoor Activity and Myopia In a large longitudinal study, Jones and 
colleagues [62] reported that children who engaged in outdoor activities for 14 h per 
week or more exhibited the lowest odds of developing myopia. A number of recent 
randomized controlled trials have reported that interventions that increase children’s 
outdoor time (by 40–80 min a day) significantly reduce the onset of myopia in child-
hood [71–73]. In the “Role of outdoor activity in myopia study” [74], children who 
were habitually exposed to low ambient light levels (on average less than 60 min 
exposure to outdoor light per day) had significantly faster axial eye growth compared 
to children habitually exposed to moderate and high light. These findings from 
human studies suggest that children who are exposed to less than 60 min a day of 
bright outdoor light are at an increased risk of more rapid eye growth and myopia 
development, and that approximately 2 h or more of outdoor exposure each day is 
required to provide protection against myopia development in the human eye.
1.4  Genetics of Myopia
Myopia is highly heritable; genes explain up to 80% of the variance in refractive 
error in twin studies. For the last decade, genome-wide association study (GWAS) 
approaches have revealed that myopia is a complex trait, with many genetic variants 
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of small effect influencing retinal signaling, eye growth, and the normal process 
of emmetropization. Particularly notable are genes encoding extracellular matrix- 
related proteins (COL1A1, COL2A1 [75, 76], and MMP1, MMP2, MMP3, MMP9, 
MMP10 [77, 78]). For candidates such as PAX6 and TGFB1, the results were repli-
cated in multiple independent extreme/high myopia studies and validated in a large 
GWAS meta-analysis in 2018, respectively [79, 80]. However, the genetic architec-
ture and its molecular mechanisms are still to be clarified, and while genetic risk 
score prediction models are improving, this knowledge must be expanded to have 
impact on clinical practice.
Gene–environment (GxE) interaction analysis has focused primarily on educa-
tion. An early study in North American samples examined GxE for myopia and 
the matrix metalloproteinases genes (MMP1–MMP10): a subset of single nucleo-
tide polymorphism (SNPs) was only associated with refraction in the lower educa-
tion level [78, 81]. A subsequent study in five Singapore cohorts found variants 
in DNAH9, GJD2, and ZMAT4, which had a larger effect on myopia in a high 
education subset [82]. Subsequent efforts to examine GxE considered the aggregate 
effects of many SNPs together. A study in Europeans found that a genetic risk score 
comprising 26 genetic variants was most strongly associated with myopia in indi-
viduals with a university level education [83]. A study examining GxE in children 
considered near work and time outdoors in association with 39 SNPs and found 
weak evidence for an interaction with near work [83, 84]. Finally, a Consortium 
for Refractive Error and Myopia (CREAM) study was able to identify additional 
myopia risk loci by allowing for a GxE approach [85].
Mendelian randomization (MR) offers a better assessment of causality than that 
available from observational studies [86, 87]. Two MR studies found a causal effect of 
education on the development of myopia [53, 80]. Both found a larger effect through 
MR than that estimated from observational studies suggesting that confounding in 
observational studies may have been obscuring the true relationship [55, 79]. As 
expected, there was little evidence of myopia affecting education (−0.008  years/
diopter, P = 0.6). Another study focused on the causality of low vitamin D on myopia 
found only a small estimated effect on refractive error [88] suggesting that previous 
observational findings were likely confounded by the effects of time spent outdoors.
Due to the high polygenicity of myopia and low explained phenotypic variance 
by genetic factors (7.8%), clinical applications derived from genetic analyses of 
myopia are currently limited. Risk predictions for myopia in children are based 
on family history, education level of the parents, the amount of outdoor exposure, 
and the easily measurable refractive error and axial length. Currently, we are able 
to make a distinction between high myopes and high hyperopes based on the poly-
genic risk scores derived from CREAM studies: persons in the highest decile for 
the polygenic risk score had a 40-fold greater risk of myopia relative to those in 
the lowest decile. A prediction model, including age, sex, and polygenic risk score, 
achieved an area under curve (AUC) of 0.77 (95% CI  =  0.75–0.79) for myopia 
versus hyperopia in adults (Rotterdam Study I–III) [80]. To date, one study has 
assessed both environmental and genetic factors together and showed that modeling 
both genes and environment improved prediction accuracy [89].
1 Introduction and Overview on Myopia: A Clinical Perspective
6
1.5  Prevention of the Onset of Myopia
The vast majority of literature suggests that most cases of myopia develop during 
the school-going age in children. After the age of 6 years, the prevalence of myopia 
starts to rise [90–94]. The highest annual incidence of myopia is reported among 
school children from urban mainland China [92] and Taiwan [95], ranging from 
20% to 30% through ages 7–14 years, with earlier onset of myopia also being iden-
tified [94]. A study in Japan showed that while the prevalence of myopia has been 
increasing from 1984 to 1996, the prevalence among children aged 6 or younger has 
remained unchanged. This suggests that the majority of increased myopia onset is 
secondary to increased educational intensity [94].
Rates of progression increase dramatically with the year of onset and this has 
been suggested by spherical equivalent refraction and axial length [96]. Myopic 
refractions tend to stabilize in late adolescent but can remain progressive until adult-
hood. The mean age at myopia stabilization is 15.6 years but this can vary among 
children of different ethnicities [97].
Several factors have been found to be associated with the development of inci-
dent myopia in school. Asian ethnicity [93, 98], parental history of myopia [62, 
99], reduced time outdoors [62], and level of near-work activity [47, 100] are risk 
factors for incident myopia, although the evidence can be seen as controversial in 
some instances.
Evidence of time spent outdoors as a risk factor for myopia progression was first 
presented in a 3-year follow-up study of myopia in school children, showing that 
those who spent more time outdoors were less likely to progress [64]. Consistent 
results were reported in various studies, such as the Sydney Myopia Study, Orinda 
Study, as well as the Singapore Cohort Study of Risk Factors for Myopia [63, 65, 
101]. This led to the commencement of several clinical trials which confirmed the 
protective effect and indicated a dose-dependent effect, among them, the randomized 
clinical trial in Guangzhou which reported that an additional 40 min of outdoor activ-
ity can reduce the incidence of myopia by 23% [63]. Additionally, the trial in Taiwan 
suggested that an extra 80 min may further reduce incidence by 50% [72, 73].
Near-work activity as a risk factor for myopia has not been entirely consistent. 
A meta-analysis reported a modest, but statistically significant, association between 
time spent performing near work and myopia (odds ratio, 1.14) [47]. Core tech-
niques to implementing interventions of near-work activities include effective mea-
sures of near-work-related parameters, real-time data analyses, and alert systems. 
Wearable devices that possess these techniques have emerged in the last decade.
It has been estimated that without any effective controls or interventions the 
proportion of myopes in the population will reach up to 50% and 10% for high 
myopes by 2050 [9]. Approaches that have produced a reduction of at least 50% 
in incidence, such as time outdoors, lead to delayed onset and have the potential to 
make a significant difference on the impending myopia epidemic.
Another critical issue is the need to balance educational achievement and inter-
ventions to prevent myopia progression in East Asia. This balance can be seen in 
Australia [102], with not only some of the highest educational ranks in the world but 
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also high levels of outdoor activity and light intensity. Preventing the onset of myo-
pia is certainly challenging in the East Asian population and requires a collaborative 
effort among clinics, schools, parents, and the entire society.
1.6  Understanding Pathologic Myopia
Pathologic myopia (PM) is a major cause of blindness in the world, especially in 
East Asian countries [103–107]. The cause of blindness in patients with PM includes 
myopic maculopathy with or without posterior staphyloma, myopic macular reti-
noschisis, and glaucoma or glaucoma-like optic neuropathy. The term “pathologic 
myopia” describes the situation of pathologic consequences of a myopic axial 
elongation. According to a recent consensus article by Ohno-Matsui et al. [108], 
pathologic myopia was defined by a myopic chorioretinal atrophy equal to or more 
serious than diffuse atrophy (by Meta-analysis for pathologic myopia (META-PM) 
study group classification [109]) and/or the presence of posterior staphylomas.
A posterior staphyloma is an outpouching of a circumscribed area of the poste-
rior fundus, where the radius of curvature is less than the curvature radius of the sur-
rounding eye wall [110], and can be associated with, or lead to, vision- threatening 
complications such as myopic maculopathy [109, 111–114] and myopic optic neu-
ropathy/glaucoma [115, 116]. Based upon and modifying Curtin’s [117] classical 
categorization of posterior staphylomas, with types I–V as primary staphylomas 
and types VI–X as compound staphylomas, Ohno-Matsui [118] used 3D-magnetic 
resonance imaging (3D-MRI) and wide-field fundus imaging to re-classify staphy-
lomas into six types: wide macular, narrow macular, peripapillary, nasal, inferior, 
and others.
In the META-PM classification [109], myopic maculopathy lesions have been 
categorized into five categories from “no myopic retinal lesions” (category 0), “tes-
sellated fundus only” (category 1), “diffuse chorioretinal atrophy” (category 2), 
“patchy chorioretinal atrophy” (category 3), to “macular atrophy” (category 4). 
These categories were defined based on long-term clinical observations that showed 
the progression patterns and associated factors of the development of myopic cho-
roidal neovascularization (CNV) for each stage. Three additional features were 
added to these categories and were included as “plus signs”: (1) lacquer cracks, (2) 
fuch spot and (3) myopic CNV.
Myopic CNV is a major sight-threatening complication of pathologic myopia. It 
is the most common cause of CNV in individuals younger than 50 years, and it is the 
second most common cause of CNV overall [119, 120]. Anti-vascular endothelial 
growth factor (anti-VEGF) therapy is the first-line treatment for myopic CNV, as 
shown by the RADIANCE study [121] and the MYRROR study [122].
Panozzo and Mercanti proposed the term “myopic traction maculopathy (MTM)” 
to encompass various findings characterized by a traction as visualized by optical 
coherence tomography (OCT) in highly myopic eyes [123]. A dome-shaped macula 
(DSM) is an inward protrusion of the macula as visualized by OCT [124–126]. 
Imamura, Spaide, and coworkers reported that a DSM was associated with, and 
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caused by, a local thickening of the subfoveal sclera [127]. It was postulated that the 
local thickening of the subfoveal sclera was an adaptive or compensatory response 
to the defocus of the image on the fovea in highly myopic eyes.
1.7  Imaging in Myopia
Imaging the myopic eye can be challenging due to various structural changes 
(abnormal eye elongation, scleral and corneal curvature irregularities, cataracts 
leading to poor clarity; or retinal thinning causing abnormal projections of the final 
image [128, 129]).
Optic disc imaging can also be used to predict the development of glaucoma, 
where visualization of myopic tilting of the optic disc with peripapillary atrophy 
(PPA) and pitting of the optic disc [130] is a possible predisposing factor [131, 132]. 
Serial imaging investigative measures can therefore be utilized for monitoring the 
development of open-angle, normal-tension glaucoma [133]. Features such as optic 
disc tilt, PPA, and abnormally large or small optic discs are the earliest known struc-
tural alterations that potentially predict the development of pathological myopia and 
can be observed even in young highly myopic adults. Unfortunately, these features 
(some also with associations to glaucoma) also interfere with the visualization of 
optic disc margins [134, 135] and are also not easy to discern in highly myopic 
eyes [136]. There is also added difficulty in eyes with myopic maculopathy, where 
visual field defects result in further interference [137]. As such, the answer to these 
challenges may lie in imaging deep optic nerve head structures (such as parapapil-
lary sclera, scleral wall, and lamina cribosa) [138] in highly myopic eyes for more 
precise diagnoses of glaucoma.
The ability to view distinct retinal layers with OCT has enhanced visualization 
of myopic traction maculopathy (MTM). Examples of features that can be seen 
include inner or outer retinal schisis, foveal detachment, lamellar or full-thickness 
macular hole, and/or macular detachment [139, 140]. Non-stereoscopic fundus pho-
tographs are inadequate for detailed studies of posterior staphylomas as the change 
in contour at the staphyloma edge is not always discernible. The OCT overcomes 
this limitation because of its excellent depth resolution [141, 142].
The OCT itself has its shortcomings; the sclera cannot be visualized using the 
OCT. These limitations also extend to the use of OCT angiography (OCTA). There 
is currently no standard protocol for segmentation; the outcome parameters for 
OCTA have not been clearly defined either. Although some authors have tried to 
use analysis of flow voids or signal voids in the choriocapillaris to quantify the 
area taken up by the microvasculature [143, 144], the data pertaining to myopic 
patients are but insufficient [145]. Looking into the future, there is, however, incipi-
ent research suggesting that the comprehension of blood supply and changes in 
vasculature from the anterior to the posterior segment of the myopic eye is crucial 
to the understanding of the disease [146–149].
Photoacoustic imaging has shown promise recently to fill the gaps between OCT 
and ultrasound in terms of penetration depth [150]. This modality has been used 
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before to image the posterior pole of the eye in vitro and in animal models in vivo. 
This can also be used in concurrence with angiography, measuring oxygen satura-
tion and pigment imaging [151]. However, there are some limitations pertaining to 
this modality notwithstanding moderate depth resolution, pure optical absorption 
sensing, need for contact detection with ultrasound sensor, and a relatively long 
acquisition time. In view of these limitations, we are yet to receive tangible results 
from photoacoustic imaging for posterior pole imaging in humans.
1.8  Glaucoma in Myopia
Axial myopization leads to marked changes of the optic nerve head: (1) an enlarge-
ment of all three layers of the optic disc (i.e., optic disc Bruch’s membrane open-
ing, optic disc choroidal opening, optic disc scleral opening) with the development 
of a secondary macrodisc, (2) an enlargement and shallowing of the cup, (3) an 
elongation and thinning of the lamina cribrosa with a secondary reduction in the 
distance between the intraocular space with the intraocular pressure (IOP) and the 
retro- lamina compartment with the orbital cerebrospinal fluid pressure, (4) a direct 
exposure of the peripheral posterior lamina cribrosa surface to the orbital cerebro-
spinal fluid space, (5) an elongation and thinning of the peripapillary scleral flange 
with development and enlargement of the parapapillary gamma zone and delta zone, 
(6) an elongation and thinning of the peripapillary border tissue of the choroid, 
and (7) a rotation of the optic disc around the vertical axis, and less often and to a 
minor degree around the horizontal axis und the sagittal axis. These changes make it 
more difficult to differentiate between myopic changes and (additional) glaucoma- 
associated changes such as a loss of neuroretinal rim and thinning of the retinal 
nerve fiber layer, and these changes may make the optic nerve head more vulner-
able, potentially explaining the increased prevalence of glaucomatous optic neu-
ropathy in highly myopic eyes.
Population-based investigations and hospital-based studies have shown that the 
prevalence of glaucomatous optic neuropathy (GON) was higher in highly myopic 
eyes than in emmetropic eyes [152–166]. A previous study revealed that at a given 
IOP in patients with chronic open-angle glaucoma, the amount of optic nerve dam-
age was more marked in highly myopic eyes with large optic discs than in non- 
highly myopic eyes [165].
Highly myopic glaucomatous eyes as compared with non-highly myopic glau-
comatous eyes may have a markedly lower IOP threshold to develop optic nerve 
damage. It could indicate that an IOP of perhaps lower than 10 mmHg might be 
necessary to prevent the development of GON in these highly myopic eyes, and that 
in highly myopic eyes with axial elongation-associated enlargement and stretching 
of the optic disc and parapapillary region as the main risk factors for GON in high 
myopia a normal IOP may be sufficient to lead to GON [136].
Although it has not yet been firmly proven that GON in high myopia is depen-
dent on IOP, most researchers recommend lowering IOP in highly myopic patients 
with glaucoma. Based on the morphological findings described above, the target 
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pressure in highly myopic glaucoma may be lower than in non-highly myopic glau-
coma. Due to the peculiar anatomy of the optic nerve head in highly myopic eyes, 
most diagnostic procedures fail in precisely assessing the status of the optic nerve 
in highly myopic eyes with glaucoma. It includes factors such as a decreased spa-
tial and color contrast between the neuroretinal rim and the optic cup making a 
delineation of both structures more difficult; a peripapillary retinoschisis leading 
to an incorrect segmentation of the retinal nerve fiber layer upon optical coher-
ence tomography; a large gamma zone (and delta zone) which makes using the end 
of Bruch’s membrane as reference point for the measurement of the neuroretinal 
rim useless; and macular Bruch’s membrane defects and other reasons for non- 
glaucomatous visual field defects which reduces the diagnostic precision of perim-
etry for the detection of presence and progression of GON.
1.9  Management of Myopic Choroidal Neovascularization
Myopic choroidal neovascularization (myopic CNV) is the second most common 
cause of CNV after age-related macular degeneration (AMD) [167, 168]. It is one 
of the most sight-threatening complications of pathological myopia [119, 169] and is 
the most common cause of CNV in those 50 years or younger [167], with significant 
social and economic burden. The prevalence of myopic CNV is between 5.2% and 
11.3% in individuals with pathological myopia [12], with female preponderance seen 
in most studies [167–170]. The long-term outcome of CNV is poor if left untreated. In 
a 10-year follow-up study of 25 patients with myopic CNV, visual acuity deteriorated 
to 20/200 or worse in 89% and 96% of eyes in 5 years and 10 years, respectively [168].
On slit-lamp biomicroscopy, myopic CNV manifests as a small, flat, grayish subret-
inal lesion adjacent to or beneath the fovea [109, 168, 169, 171]. On SD-OCT, myopic 
CNV presents as a hyper-reflective material above the retinal pigment epithelium band 
(type 2 CNV), with variable amount of subretinal fluid. Clinical diagnosis is confirmed 
by fundus fluorescein angiography (FFA). Most myopic CNVs are type 2 neovascular-
ization and present with a “classic” pattern on FA. OCT angiography (OCTA) was able 
to detect flow within myopic CNV vascular complexes and hence delineate vascular 
networks in these myopic neovascular membranes that lie above the retinal pigment 
epithelium (RPE) where flow signals are spared from attenuation [172].
Prior to the advent of anti-VEGF therapy, the main treatment options for myopic 
CNV were limited to thermal laser photocoagulation [173], photodynamic ther-
apy with verteporfin (vPDT) [174, 175]. These treatments had limited efficacy in 
improving vision significantly and have now largely been relegated to the annals of 
history by anti-vascular endothelial growth factor (anti-VEGF) therapy [176]. Once 
active myopic CNV is diagnosed, prompt treatment with intravitreal anti-VEGF 
therapy should be administered as soon as possible [121, 177]. Current evidence 
suggests a pro-re-nata (PRN) regimen without a loading phase can be considered 
in most patients. Patients should be monitored monthly with OCT and treatment 
administered until cessation of disease activity on OCT or visual stabilization.
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1.10  Management of Myopia-Related Retinal Complications
Myopic traction maculopathy (MTM) [123] is estimated to occur in approxi-
mately 8–34% in individuals with high myopia [178–180] and encompasses reti-
nal thickening, macular retinoschisis, foveal detachment, lamellar macular hole 
with or without epiretinal membrane and/or vitreomacular traction [123], and/
or full- thickness macular hole (HM) with or without retinal detachment. Central 
to the pathogenesis of MTM is traction, which was postulated to arise from one 
or more of the following mechanisms [181]: vitreomacular traction associated 
with perifoveal posterior vitreous detachment (PVD) [182–184]; relative incom-
pliance of the internal limiting membrane (ILM) [185–189], epiretinal membrane 
(ERM) [180, 182, 190–192], and cortical vitreous remnant after PVD [193] to the 
outer retina which conforms to the shape of the posterior staphyloma; and traction 
exerted by retinal arterioles [188, 194, 195]. Not all patients with MTM require 
interventions [184, 196, 197]. There are numerous reported interventions for 
MTM. The principles of the treatment are: (1) to relieve traction, mainly achieved 
through pars plana vitrectomy (PPV) with or without ILM peeling; (2) to mini-
mize surgical damage to the weakened macula through technique modifications 
in order to prevent the formation of postoperative MH; and (3) in the presence 
of full-thickness MH, to maximize the chance of hole closure through the use of 
various surgical adjuncts.
1.10.1  Proposed Adjuncts to Improve Outcome of Macular Hole 
Surgery
Inverted Internal Limiting Membrane Flap This technique involves leaving a 
hinge of ILM flap at the edge of MH during ILM peeling. This ILM flap is then 
inverted upside-down to cover or fill the MH [198].
Autologous Internal Limiting Membrane Transplantation In eyes where ILM 
around the macula hole has already been removed, an appropriately sized ILM can 
be peeled off from a distant site and placed as a free flap onto the persistent MH 
[199, 200].
Autologous Blood In order to prevent subretinal migration of dye and the resultant 
retinal toxicity associated with vital stains, it was proposed to use autologous blood 
to cover the MH before injection of brilliant blue dye. It has been demonstrated that 
compared to conventional method, the use of pre-staining autologous blood led to 
better visual acuity outcomes and continuity of ellipsoid zone at all post-operative 
time points [201].
Lens Capsular Flap Transplantation Chen et al. demonstrated a 100% MH clo-
sure rate with anterior capsular transplantation among patients with refractory MH, 
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whereas the complete closure rate of MH after posterior capsular transplantation 
was only 50% and with another 30% enjoyed partial MH closure [202].
Macular Buckle Macular buckles have been used to shorten the axial length of 
myopic eyeballs in conditions such as macular hole retinal detachment (MHRD), 
myopic foveoschisis with or without foveal detachment, and MH with foveoschisis. 
There are many types of macular buckle, including scleral sponge, T-shaped or 
L-shaped buckle, Ando Plombe, wire- strengthened sponge exoplant, and even 
donor sclera and suprachoroidal injectable long-acting hyaluronic acid [203].
Autologous Neurosensory Retinal Transplantation The technique involves 
bimanually harvesting a free flap of neurosensory retina superior to the superotem-
poral arcade, with the harvest site first secured by endolaser barricade and endodia-
thermy. The free flap was translocated in its correct orientation over the macular 
hole and perfluoro-n-octane heavy liquid (PFC) was instilled over it, followed by 
direct PFC–silicone oil exchange [204].
Figure 1.1 presents an overview of the management of myopia-related complica-
tions in adults.
1.11  Management and Control of Myopia in Children
Currently, there are many types of interventions to slow myopia progression in chil-
dren, including spectacle lenses, contact lenses, pharmaceuticals, and environmen-
tal or behavioral modification. However, none of these myopia control methods 
have been proven to stop the development or progression of myopia completely and 
each method has their own limitations.
Fig. 1.1 Summary of the clinical management of pathologic myopia in adults
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Spectacle Lenses Under-correction of myopia in clinical trials has shown con-
flicting results and small, clinically insignificant effect on slowing myopia pro-
gression [205–207]. In view of these conflicting results, there is no convincing 
evidence to indicate that under-correction should be used to slow myopia 
progression.
Bifocal or Multifocal Spectacles Most studies showed that progressive addi-
tion lenses (PALs) have an insignificant effect on slowing myopia progression 
rate (less than 0.2 D per year) overall [48, 208–214]. In contrast, a randomized, 
controlled trial showed that executive bifocal lenses slowed myopia progression 
in Chinese-Canadian children aged 8–13 years by 39% and up to 51% with base-
in prisms incorporated over 3  years [215]. More recently, the Defocus 
Incorporated Multiple Segments (DIMS) spectacle lens enabled clear vision and 
myopic defocus simultaneously for the wearer [216]. Hong Kong Chinese chil-
dren aged 8–13 years wearing DIMS lenses had approximately 60% less myopia 
progression and axial elongation when compared with children wearing single 
vision spectacle lenses over 2  years. Moreover, about 20% of the DIMS lens 
wearers had no myopia progression during the study period.
Peripheral Myopic Defocus Glasses In 2010, Sankaridurg et al. published their 
results of three novel peripheral defocus spectacle lens. Unfortunately, there was no 
significant effect on myopic progression with all three designs [217]. In a recent 
randomized controlled trial (RCT) conducted in Japanese children with peripheral 
defocus lenses, no difference in myopia reduction was found [218].
Rigid Gas Permeable Contact Lenses Two randomized clinical trials [219, 220] 
showed that rigid gas permeable (RGP) contact lenses did not retard axial eye growth. 
However, Walline et al. [219] reported significant slower myopia progression in the 
group of RGP lenses compared with soft contact lenses, despite that no differences 
were found in axial elongation between the groups. The proposed reason for a treat-
ment effect on refraction may be due to the changes in corneal curvature.
Orthokeratology Orthokeratology (Ortho-K) lenses are specially designed RGP 
contact lenses that are worn overnight to reshape the cornea and thereby temporarily 
correct low-to-moderate myopia. Various clinical studies have demonstrated the 
effectiveness of inhibiting myopic progression with Ortho-K. Individual studies and 
meta-analyses have shown a 32–63% reduction in the rate of axial elongation in 
East Asian children initially aged from 7 to 16 years and followed for up to 5 years 
[221–227]. Efficacy may decrease over time [224, 228], with a potential “rebound” 
after discontinuation, especially in children under 14 years [229]. There is also a 
potential non-response rate of 7–12% [223]. Interestingly, a recent study in Japan 
[230] showed that the combination of Ortho-K and low-concentration atropine 
(0.01%) eyedrops was more effective in slowing axial elongation over 12 months 
than Ortho-K treatment alone in myopic children. The risk of infective keratitis 
remains [231].
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Soft Bifocal and Multifocal Contact Lenses These lenses are worn during the 
daytime. Compared to spectacles, contact lenses are more cosmetically acceptable, 
more easily handled, and are more convenient for daily activities of some children, 
especially during sports [232, 233]. For most of eye-care practitioners, the fitting 
procedures of soft bifocal contact lenses are relatively simpler than Ortho-K. Overall, 
soft bifocal and multifocal contact lenses slow the progression of myopia in chil-
dren by an amount comparable to that of Ortho-K lenses. Studies exploring the 
effect of these bifocal soft contact lenses indicate slowing of myopia progression by 
25–50% and axial length by 27–32% in children aged 8–16 of various ethnicities 
over a period of 24 months [234, 235].
Atropine The initial high doses of atropine (i.e., 0.5% or 1.0%) slowed myopia pro-
gression by more than 70% in Asian children aged 6–13 years over 1–2 years [229, 
236–238]. However, lower doses (0.1% or less) can also slow refractive progression by 
30–60% with less side effects (pupil dilation, glare, or blur) [238]. The Atropine 
Treatment of Myopia (ATOM) studies showed that there was a myopic rebound if 
atropine was stopped suddenly, especially at higher doses and in younger children 
[239, 240].
Time Spent Outdoors In the Sydney Myopia Study, exposure to more than 2 h of 
outdoor activity per day decreased the odds of myopia and countered the effects of 
near work [65]. Interventions involving increasing time outdoors appeared to reduce 
the onset of myopia and also its progression in myopic children [71]. A meta- 
analysis has suggested a 2% reduced odds of myopia per additional hour of time 
spent outdoors per week [70].
Environmental Interventions Based on new evidence, the advice has shifted 
from spending at least 2 h per day outdoors in addition to avoiding excessive near 
work. This has changed health and school messaging in many East Asian coun-
tries [71].
Higher Light Intensities and Dopamine Potential reasons why time outdoors 
may be protective include higher light intensities [241], differences in chromatic 
composition [242], the reduction in dioptric accommodative focus and psychomet-
ric influences encountered outdoors [243]. The role of chromaticity (red and blue) 
and ultraviolet (UV) light is still uncertain [244], while that of higher vitamin D 
levels has been debunked [88].
Figure 1.2 presents an overview of the management and prevention of myopia 
in children.
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• The prevalence of myopia in children is high in urban East Asian 
countries.
• The myopia and HM prevalence among young adults is much higher in 
East Asia than in Western countries.
• The burden of HM is huge because HM can cause PM changes and visual 
impairment.
• The prevalence of PM among adults has been relatively low, but it is likely 
to increase in future.




Myopia has become a significant global public health and socioeconomic problem 
[1–4]. Developed countries, especially among East Asia, have been faced with high 
prevalence of myopia and high myopia (HM) and the same trend has been shown in 
other parts of the world with less extent [5, 6]. (The definition of myopia and HM is 
spherical equivalence (SE) of −0.50 diopters (D) or less and SE −5.00 D or −6.00 
D, respectively.) The prevalence of myopia and HM in young adults in urban area 
of East Asian countries has risen to 80–90% and around 20%, respectively [7, 8]. 
According to a summary of 145 studies regarding the global prevalence of myopia 
and HM, there are approximately 1950 million (28.3% of the global population) and 
277 million (4.0% of the global population) cases, and they are predicted to increase 
to 4758 million (49.8% of the global population) for myopia, and 938 million (9.8% 
of the global population) for HM by 2050 [9].
Most cases of myopia are considered as a benign condition because vision is cor-
rected with spectacles, contact lenses, or refractive surgery. However, severe cases 
of myopia are associated with the risk of irreversible vision impairment and blind-
ness due to pathological changes in retina, choroid, and sclera. One study has shown 
that 25% of HM will develop pathologic myopia (PM) and 50% of those with PM 
will have low vision as older adults. Thus, HM and PM are likely to increase drasti-
cally in the older generation. Based on the global prediction of HM on 2050, PM 
may increase to over 200 million in future [9]. Treatment strategies against PM 
have not been effective and costly [10]. Considering the burden of PM in the future, 
it is important to develop public policies and preventive and early interventional 
measures to retard the epidemic myopia. In this chapter, we summarize data on the 
prevalence of myopia and HM in different generations and the prevalence of PM 
from recent epidemiological studies.
2.2  Prevalence of Myopia in Children
In children, cycloplegic refraction is a common procedure to measure refractive 
error because children have a possibility to have an overestimation of myopic 
refraction, due to increased tone of the ciliary muscle and a constant accom-
modative effort during the examination, and makes the refraction overestimated 
approximately over −1 to −2 D [11, 12]. Many population-based studies on chil-
dren have proved that the prevalence of myopia is higher in urbanized East Asian 
countries. In surveys of 12-year-old children, the prevalence of myopia is higher 
in Singapore (62.0%) [13], Hong Kong (53.1%) [14], and Guangzhou, China 
(49.7%) [15] than in the United States (20.0%) [16], Northern Ireland (17.7%) 
[17], Australia (11.9%) [18], urban India (9.7%) [19], Nepal (16.5%) [20], and 
Cambodia (6.0%) [21]. We summarized the prevalence of myopia among chil-
dren in population studies using cycloplegic refraction between Asian countries 
(Table 2.1) and non-Asian countries (Table 2.2).
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2.2.1  Asian Countries
2.2.1.1  East Asian Countries and Singapore
Taiwanese school children have the highest prevalence of myopia among all school 
children worldwide. The prevalence of myopia among 8-year-old children is 36.4% 
in Taiwan [22], followed by 34.7% in Singapore [13], 30.8% in Shanghai [25] and 
14.0% in Malaysia [48]. Lai et al. reported that the prevalence of myopia among 618 
preschool Taiwanese children were also as high as 3.0%, 4.2%, 4.7%, and 12.2% in 
the age groups of 3, 4, 5, and 6 years, respectively [23]. A nationwide myopia sur-
vey in Taiwan showed that the prevalence of myopia among 7-year-olds increased 
from 5.8% in 1983 to 21% in 2000. At the age of 12, the prevalence of myopia was 
36.7% in 1983 increasing to 61% in 2000, corresponding figures for 15-year-olds 
being 64.2% and 81%, respectively [7]. In China, Ma et al. reported that the preva-
lence of myopia in Shanghai was 20.1% among 3-year-old to 10-year-old children. 
They also showed that the prevalence increased dramatically from 5.2% in 6-year- 
old children and 14.3% in 7-year-old children to 52.2% in 10-year-old children [25]. 
In the urban city of Guangzhou, the prevalence of myopia was 7.7% in 7-year-old, 
30.1% in 10-year-old, and 78.4% in 15-year-old children, with an overall prevalence 
of 38.1% among 4364 children aged 5–15 years [15]. In a rural area of Beijing, 
Zhao et al. reported that the prevalence of myopia among school children aged 5–7 
and 14–15 years were 1.2% and 38.8%, respectively, with an overall prevalence of 
14.9% among 5884 children aged 5–15 years [29]. In a suburban area, the preva-
lence of myopia among 3070 school children aged 6, 7, 10, and 14 years was 0.42%, 
1.92%, 9.4%, and 28.8%, respectively [27]. In another rural area of northern China, 
the prevalence of myopia among 1675 school children aged 5–9, 10–14, and 15–18 
years was 0.9%, 4.5%, and 8.2%, respectively, with an overall prevalence rate of 
5.0% [49]. In Hong-Kong, 2 population-based surveys were conducted in children 
aged 3–6 years during 1996–1997 and 2006–2007, which revealed that prevalence 
of myopia increased 2.3–6.3% in a decade [30]. In Singapore, the school-based pop-
ulation study of the Singapore Cohort Study of Risk factors for Myopia (SCORM) 
showed that the prevalence of myopia was 29.0% in 7-year-olds, 34.7% in 8-year-
olds, and 53.1% in 9-year-olds [50]. In younger ages from 6 months to 6 years, the 
Strabismus, Amblyopia, and Refractive Error in Singapore (STARS) Study reported 
that the prevalence of myopia was 11.0% in Chinese children [31].
2.2.1.2  Rest of Asian Countries
On the other hand, the prevalence of myopia is generally lower in other countries in 
Asia. In India, 6447 school children aged 5–15 years had 7.4% of the myopia preva-
lence in an urban population in New Delhi [19]. A population-based cross-sectional 
study was conducted among children in 1 urban and 3 rural areas. It reported that 
the prevalence of myopia among children ≤15 years of age and >15 years of age 
was 3.2% and 20.0%, respectively [32]. In Iran, the prevalence of myopia among 
1854 school children aged 7, 10, and 14 years were 1.7%, 2.4%, and 7.6%, respec-
tively, with an overall prevalence rate of 4.4% among 7-year-old to 15-year-old chil-
dren in Shiraz [33]. In 4282 Nepalese secondary school children aged 10–15 years, 
S. Matsumura et al.
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the myopia prevalence was ranged from 10.9% in 10-year-olds to 27.3% in 15-year-
olds [20]. In Thailand, the prevalence of myopia was 11.1% in 2360 children aged 
6–12 years [37].
2.2.2  Non-Asian Countries
Nowadays, a rise of the myopia prevalence has also been shown in non-East-Asian 
countries that previously were only mildly or moderately affected, such as the UK, 
Australia, and the United States, although the prevalence is still lower than that in 
Asian countries. In the United States, the prevalence of myopia among 6–month-old 
to 6-year-old children was 1.20% and 3.98% in 1501 non-Hispanic White and 1507 
Asian ethnicity children, respectively, as per the Multi-Ethnic Pediatric Eye Disease 
Study [38]. In the Baltimore Eye Study, the prevalence of myopia (SE <−1.00 D) was 
1.2% in Whites, 6.6% in African-Americans among children aged 6 years, and an 
overall prevalence among 6-month-old to 71-month-old children was 0.7% and 5.5% 
in 1030 Whites and 1268 African-Americans, respectively [39]. Although few reports 
have been published on the prevalence of myopia in children in Europe, regional 
differences from country to country were shown even within the same geographi-
cal area. In England, the Aston Eye Study (AES) reported that the prevalence was 
9.4% among children aged 6–7 years, and 29.4% among children aged 12–13 years, 
whereas the prevalence was 2.8% and 17.7% among children in the same age groups 
in Northern Ireland [17, 41]. In the Netherlands, the myopia prevalence rate was as 
low as 2.4% in 5711 children aged 6 years [40]. In Poland, the myopia prevalence 
was lower: 2.0% in 6-year-old, 8.4% in 8-year-old, and 14.7% in 12-year-old chil-
dren [43]. In Australia, the Sydney Myopia Study (SMS) reported that myopia was 
present in 1.43% in 1765 children aged 7 years, with 0.79% in European children 
and 2.73% in other ethnicity children [45]. The Sydney Adolescent Vascular and 
Eye Study (SAVES) reported the myopia prevalence to be 18.9% among 12-year-old 
children, with 52.5% in East Asian, 8.6% in European Caucasian, and 12.0% in other 
ethnicity groups [44]. However, these ethnic differences may not be based solely 
on genetic differences. Studies on migrant populations suggest that the prevalence 
of myopia among Asian children living in non-Asian countries such as Australia is 
not as high as those living in East Asian countries [51]. Finally, in population-based 
studies, the lowest prevalence appears to be in Africa. The prevalence of myopia 
was 3.4% in 12-year-old to 15-year-old children in Ghana and 4.0% in 5-year-old to 
15-year-old children in South Africa [46].
2.2.3  Urban and Rural Areas
Collectively, there are significant differences in the prevalence of myopia between 
urban areas and rural areas. In China, the prevalence of myopia was 38.1% in 
children aged 5–15  years in urban area, Guangzhou, whereas the prevalence of 
myopia was 5.0% in children aged 5–18  years in rural area. In an urban area, 
2 Global Epidemiology of Myopia
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Tehran, the prevalence of myopia was 7.2% in 809 children aged 5–15 years in 
the Tehran Eye Study, while a rural area, Dezful, had a lower prevalence of myo-
pia which was 3.4% in children aged 7–15 years [35, 36]. A recent meta-analysis 
found a 2.6 times higher risk of developing myopia in children of urban residence 
compared with those who lived in rural areas [52]. These differences in the myopia 
prevalence among children may be caused by a rigorous education system which 
children especially living in urbanized are exposed to. Especially in Eastern Asian 
countries, academic success is important, and most children are enrolled in com-
petitive, academically oriented schooling at a very early age [51]. It is influenced 
by enduring patterns of behavior and cultural attitudes that may result in the myo-
pic environmental factors, such as higher levels of more intense near-work and 
lower levels of outdoor activity.
In summary, the prevalence of myopia in children is higher in East Asian coun-
tries (49.7–62.0% among 12-year-old children) compared with non-Asian countries 
and other Asian countries (6.0–20.0%). The prevalence of myopia has remained 
consistently high among Chinese children in urban settings, but the evidence does 
not support the idea that it is caused by purely genetic difference [53]. The associa-
tion of an urbanized setting with high myopia rates is likely to be influenced by 
possible modifiable risk factors such as near-work and outdoor time.
2.3  Prevalence of Myopia and HM in Teenagers and Young 
Adults
2.3.1  East Asian Countries
The prevalence of myopia in young adults is more than 80% in urbanized East Asian 
countries (Table 2.3). A remarkable increase in the myopia and HM prevalence was 
seen in the past decades. In China, Chen et  al. conducted a 15-year population- 
based survey using noncycloplegic autorefraction to investigate trends in the 
prevalence of myopia among 43,858 high school students in Fenghua city, eastern 
China, from 2001 to 2015. The overall prevalence of myopia and HM increased 
from 79.5% to 87.7% and 7.9% to 16.6%, respectively, during the 15-year period 
[54]. In Shandong, another city in eastern China, the prevalence of myopia and HM 
using cycloplegic autorefraction in school children aged 17 years was 84.6% and 
13.9%, respectively [55]. A cross-sectional study among 5083 university students 
in Shanghai showed that 95.5% were myopic and 19.5% were high myopic (SE 
<−6.0 D) [56]. In Korea, the prevalence of myopia and HM (SE <−6.0 D) using 
cycloplegic autorefraction was higher in an urban population (96.5% and 21.6%) 
[8], compared to a rural population (83.3% and 6.8%) [26], among 19-year-old 
males in military conscripts. In Taiwan, the prevalence of myopia and HM (SE 
<−6.0 D) was 86.1% and 21.2%, respectively, in males aged 18–24 years in mili-
tary conscripts [57]. In Singapore, the overall myopia and HM prevalence in 28,906 
young males aged 16–25 years increased from 79.2% and 13.1% in 1996–1997 to 
81.6% and 14.7% in 2009–2010, respectively [58].
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2.3.2  Rest of East Asian Countries
In contrast to the uniformly high prevalence in Eastern Asian countries, the prev-
alence of myopia and HM in young adult populations in other countries varies 
among different ethnicity and geography (Table  2.4). In Israel, a 13-year series 
of population- based prevalence survey was conducted on young adults aged 
16–22 years during the years 1990–2002. The overall prevalence of myopia and HM 
(SE <−6.0 D) using noncycloplegic autorefraction increased from 20.3% and 1.7% 
in 1990 to 28.3% and 2.05% in 2002, respectively [59]. In the Tehran Eye Study, 
the prevalence of myopia using cycloplegic autorefraction was 29.3% among young 
adults aged 16–25 years [36]. In Australia, the prevalence of myopia was 20.4% in a 
population-based cohort using cycloplegic autorefraction in mostly White subjects 
aged 19–22 years [60]. In the Sydney Adolescent Vascular and Eye Study (SAVES), 
myopia was present in 30.8%, with 59.1% in East Asian, 17.7% in European 
Caucasian, and 34.9% in other ethnicity group; and HM (SE <−6.00 D) was present 
in 1.9% among 17-year-old young adults [44]. In Europe, the prevalence of myo-
pia and HM (SE <−6.50 D) among 4681 Danish conscripts was 12.8% and 0.3%, 
respectively [61]. A population-based study in Norway reported that 35.0% were 
myopic among 1248 young adults aged 20–25 years [62]. In the United States, the 
myopic prevalence rate was 27.7% in young adults aged 18–24 years [63].
As shown above, the myopia prevalence among young adults in East Asia is 
much higher than in Western countries. This is most likely reflecting the higher 
myopia prevalence among school children in Eastern Asia and can be further accel-
erated by their education system. This age population usually spend much time 
in study and are expected to achieve high scores for competitive college entrance 
examination, especially in Asia. In one study conducted in China, the prevalence of 
myopia in postgraduates was higher than in undergraduates [56], suggesting that 
associated factors, such as higher school achievement and prolonged near-work and 
less outdoor time, might contribute to the increasing prevalence of myopia [51]. We 
summarized the myopia prevalence in East Asian countries (Table 2.3) and rest of 
East Asian countries (Table 2.4). When comparing the results, we must be cautious 
because some conscript-based studies investigated only men, and conducted eye 
examination without cycloplegic refraction, which may make the refraction overes-
timated approximately over −0.50 D in younger adults [64].
2.4  Prevalence of Myopia and HM in Adults
In adults, the prevalence rates of myopia vary widely with age reflecting the hyper-
opic shift by aging in older generations. According to the results from the Beaver 
Dam Eye Study, the prevalence of myopia was likely to decrease with age among 
individuals aged above 43 years [65]. Wong et al. showed that the highest prevalence 
of myopia was in the age group of 40 years and above 70 years among Chinese-
Singaporean adults aged 40–81 years old [66]. It suggested that the prevalence in 
elderly adults older 70 years could be overestimated due to lens nuclear sclerosis 
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inducing refractive myopia. Population-based data indicate that Asian adult popu-
lation is more susceptible to myopia compared with similarly aged western popu-
lation. However, compared to the prevalence of myopia in children, the regional 
difference is not obvious in adults. We summarized the prevalence of myopia in 
adult population-based studies in the world (Fig. 2.1). It must be noted that there is 
lack of consensus in definitions of myopia and HM, and the definition varies among 
studies and that there is a difference of age population affecting by nuclear cataract, 
thus not directly comparable among different studies.
2.4.1  Asian Countries
2.4.1.1  East Asian Countries
In China, the prevalence of myopia and HM (SE <−6.0 D) was 32.3% and 5.0%, 
respectively, in 1269 adults aged 50 or more years in the Liwan Eye Study [67] 
conducted in an urban city of Guangzhou. In rural areas, 26.7% were myopic and 
1.8% were high myopic in 6491 adults aged 30 or more years in the Handan Eye 
Study [4]. The Beijing Eye Study reported that the myopia and HM (SE <−6.0 
D) prevalence was 22.9% and 2.6%, respectively, in 4319 adults aged 40 or more 
years in urban and rural Chinese populations [68]. However, these data may lead to 
substantial underestimation of the myopia prevalence because refraction data were 
obtained only from those with visual impairment. In Taiwan, the Shinpai Eye Study 
in adults aged over 65 years reported that the prevalence of myopia and HM (SD 
<−6.0 D) was 19.4% and 2.4%, respectively [69]. In Singapore, the prevalence of 
myopia in Singaporean-Chinese, Malay, and Indians was 38.7% [66], 26.2% [70], 
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Fig. 2.1 Reported prevalence of myopia in adult population based on population studies
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respectively. In Japan, the prevalence of myopia and HM in urban areas is relatively 
high, 41.8% and 8.2%, respectively, in 3021 adults above 40 years in the Tajimi 
Study [72]. However, the myopia rates may be overestimated because of the use 
of noncycloplegic refraction for the younger population who may have excessive 
residual accommodation. A latest population-based study from a rural area showed 
that the prevalence of myopia and HM was 29.5% and 1.9%, respectively, among 
adults aged 40 years or older in the Kumejima Study [73]. In this study, the preva-
lence of myopia was nearly the same as those in urban areas of China, while the 
prevalence of HM was similar to that reported in rural areas of other Asian coun-
tries. In South Korea, the prevalence of myopia and HM was 20.5% and 1.0%, 
respectively, among adults above 40 years in the Namil Study [74]. Relatively low 
prevalence in the study was reflected by rural lesions, it was similar to that of rural 
Chinese population.
2.4.1.2  Rest of East Asian Countries
In other Asian developing countries, the prevalence of myopia is slightly lower: 
17.2% among adults aged 40 or more years in Mongolia, and 22.1% among 
adults aged 30 or more years in Bangladesh [75, 76]. Further, the myopia rate in 
the Bangladesh study may be overestimated because of the use of noncyclople-
gic refraction for the younger group aged 30–39 years who may have excessive 
residual accommodation. In a rural area in India, the prevalence of myopia and HM 
was 27.0% and 3.7%, respectively, in 2508 Indian adults aged above 39 years [77]. 
Relatively high prevalence in rural Indian population may be caused by higher rates 
of nuclear cataract. The prevalence of myopia is slightly higher at 36.5% among 
adults aged 30 or more years in Pakistan, and at 30.2% among adults aged 40 or 
more years in Iran [78, 79]. The myopia rate in the Pakistan study may be overesti-
mated because of the cohort effect of younger group aged 30–39 years.
2.4.2  Non-Asian Countries
In the USA, the latest report in the Chinese American study showed the relatively 
high prevalence of myopia and HM, 35.1% and 7.4%, respectively, in 4144 Chinese 
adults aged 50 years or older [80]. This result is similar to or slightly higher than 
same Chinese populations from other studies in urban Asian countries (38.7% in the 
Tanjong Pagar Study, Singapore and 32.3% in the Liwan Eye Study). The Barbados 
Eye Study reported the prevalence of myopia was 21.9% in 4709 African-Americans 
aged 40–84 years [81]. Another population-based study in Latino showed that the 
overall prevalence of myopia (SE <−1.00 D) and HM in the worse eye was 16.8% 
and 2.4%, respectively, among 5927 adults aged 40 years or older [82]. In Europe, 
although the myopia rate varies across the countries, two latest population-based 
studies proved that it was nearly the same as those in urban Asian countries. The 
Gutenburg Health Study in Germany reported that the prevalence of myopia and 
HM was 35.1% and 5.6%, respectively, in 13,959 adults aged 35–74 years. The high 
prevalence of myopia in the study can be explained by the fact that this cohort had 
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younger participants than most other studies [83]. In the Netherlands, the preva-
lence of myopia was 32.5% in a total of 3530 adults aged above 46 years in the 
Rotterdam study [84]. This study may have overestimated the prevalence of myopia 
because the refraction method was subjective refraction. In UK, a population-based 
study showed that 23.0% were myopic among a total of 7444 adults aged above 
48 years [85]. In other European countries, the prevalence of myopia is slightly 
lower: 19.4% among adults aged 38 or more years in Norway, 19.1% among adults 
aged 76 or more years in France, and 14.2% among adults aged 60 or more years 
in Greece [84]. In Australia, the prevalence of myopia was relatively lower, 15.0% 
in 3654 adults aged over 49 years in the Blue Mountain Eye Study in 1999 [86]. 
In the two population-based studies, the lowest prevalence appears to be in Africa. 
In Nigeria, the prevalence of myopia and HM was 16.1% and 2.1%, respectively, 
among 13,599 adults aged over 40  years as per the Nigeria National Blindness 
and Visual Impairment Study [87]. In South Africa, the prevalence of myopia was 
11.4% in 1939 adults aged over 35 years [88]. In the same vein, the prevalence of 
myopia was relatively low 14.4% among adults aged 35–55 years in MIROR Study 
in Colombia [89].
2.4.3  Generational Gap
There is a difference in myopia and HM prevalence among age groups. In gen-
eral, the generational differences of prevalence of myopia and HM are seen with 
the highest rates in young adults and the lowest rates in older adults. We have 
shown the higher prevalence rates of myopia (65.5–96.5%) and HM (14.7–21.6%) 
in East Asian young adults in the previous section [8, 57, 58]. By contrast, the 
lower prevalence rates of myopia (approximately 25–40%) and HM (2.4–8.2%) 
were reported among East Asian middle-aged and elderly adults [69, 72, 90]. 
Particularly, the burden of HM is important because HM is more likely to develop 
PM changes that tend to be visually disabling. Some studies supported the idea of 
two types of HM, one is related to educational parameters such as near-work and 
frequent among young adults, and the other is more likely related to the earlier 
onset of myopia by genetic factors in contrast to environmental factors and occurs 
in older adults [91, 92]. Jonas et al. compared highly myopic young individuals 
and highly myopic adult individuals and assessed the association of the prevalence 
of HM with parameters of education. It revealed that education-related parameters 
did not show a clear association with HM in older generation, while in contrast, 
HM in school children showed a strong association with education [91]. Thus, it 
has been assumed that the development of pathologic myopia (PM) in later life 
may be different depending on two forms of HM with different etiologies. One 
form of HM is caused by mutations of genes responsible to scleral modeling and 
leading to abnormal deformity and thin sclera [93], while the other form caused 
by insufficient outdoor time in younger adults may be driven by reduced release 
of retinal dopamine [1].
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In summary, the higher prevalence rates of myopia were also seen in urban East 
Asian countries (approximately 25–40%) and in Western Europe or the United 
States (approximately 20–35%), compared to other developing Asian countries and 
some countries in Western populations such as Australia (approximately 15–20%). 
Similarly, urban Asian countries have higher prevalence rates of HM (5–9%), com-
pared with other Asian countries (2–5%) or non-Asian countries (2–7%). However, 
the geographic difference of myopia prevalence in older populations is not pro-
nounced compared to that in younger populations. From a viewpoint of ethnic-
ity difference, Chinese have a substantially higher prevalence of myopia compared 
with other racial groups, and a similar pattern of even greater magnitude was seen in 
HM prevalence. The prevalence of myopia and HM in Chinese ethnicity in western 
countries is similar to other studies of Chinese in urban Asian countries [80].
2.5  The Prevalence of PM
Pathologic myopia (PM) has been reported as one of the most common causes of 
blindness worldwide. Studies reported that PM is the major cause of blindness or 
visual impairment (VI) in 7% in Western populations and in 12–27% in Asian popu-
lations [94–99]. According to a review to estimate blindness and VI with myopic 
macular degeneration (MMD), 10.0 million people had VI from MMD (0.13%), 3.3 
million of whom were blind (0.04%) in 2015, and furthermore 55.7 million people 
will have VI from MMD (0.33%), 18.5 million of whom will be blind (0.19%) in 
2050 [100].
Before we discuss the prevalence of PM in detail, it must be noted that the defini-
tion of PM has been inconsistent in previous studies. Avila et al. proposed a defini-
tion of myopic maculopathy that included posterior staphyloma, and it has been 
used most frequently in earlier studies [101]. However, this classification was not 
based on the actual progression pattern. In 2015, the META-analysis for Pathologic 
Myopia (META-PM) study group proposed a new classification system for PM 
for use in future studies [102]. In this classification, myopic macular degeneration 
(MMD) is categorized into 5 categories according to severity: no myopic retinal 
lesions (category 0); tessellated fundus only (category 1); diffuse chorioretinal atro-
phy (category 2); patchy chorioretinal atrophy (category 3); and macula atrophy 
(category 4). And three additional lesions of MMD that cause central vision loss 
were included as plus sign: lacquer cracks, myopic choroidal neovascularization 
(CNV), Fuchs spot. PM is defined if an eye has category 2 or above, or presence 
of plus sign, or the presence of posterior staphyloma. We summarized population-
based studies on PM prevalence in adult populations (Fig. 2.2).
In China, the Beijing Eye Study showed a high PM prevalence, 3.1%, among 
4319 Chinese subjects aged 40 years or older [103]. PM was defined with myopic 
chorioretinal atrophy or staphyloma or lacquer cracks or Fuch’s spot. In the same 
definition, the Handan Eye Study showed that the prevalence of PM and HM was 
0.9% and 2.1%, respectively, among 6603 Chinese subjects aged 30 years or older 
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[104]. The much lower prevalence in this study than Beijing might be due to urban 
and rural differences. Among 1058 Taiwanese subjects aged 65 years or older in 
the Shinpai Eye study, the prevalence of PM and HM was 3% and 4.2%, respec-
tively, with the definition by Avila et al. [105]. The high prevalence was influenced 
by its older population than other population-based studies. The Hisayama study 
reported the prevalence of PM and HM was 1.7% and 5.7%, respectively, among 
1892 Japanese aged 40 years or older with the definition of PM as myopic chorio-
retinal atrophy, lacquer cracks, or Fuch’s spot [106]. However, this study cannot 
exclude the possibility of sampling bias because the response rate was only 44.4%. 
In Western countries, the Blue Mountain Eye Study was performed in 3583 adults 
aged 49 years or older, who were mainly White urban population of Australia, using 
the same PM definition with two studies in China [107]. The prevalence of PM and 
HM was 1.2% and 2.7%, respectively. Using the new META-PM classification, the 
prevalence of PM and HM was 0.2% and 0.5%, respectively, among 4561 Indian 
subjects aged 30 years or older in rural central India [108]. However, the population 
in this study may not be adequately representative of the whole population of India 
because this study was conducted in rural tribal regions.
As shown above, the prevalence of PM among adult populations was relatively 
low in the world. Furthermore, the prevalence of PM among middle-aged and elderly 
adults is higher in urban East Asian populations (1.7–3.1%) than rural Asian popula-
tions (0.2–0.9%) and non-Asian populations (1.2%) [109]. It is consistent with the 
results of higher prevalence of HM in East Asian countries because the risk of PM 
increases with HM [109]. Both the prevalence and severity of PM become higher 
in adult population aged 40 years and with severe high myopia. Compared to the 
PM prevalence in adult populations, adolescents and children have significantly 
lower prevalence [27, 110]. It supports the idea that myopic macular changes are 
time-dependent changes as a result of mechanical stretching of the retina from axial 
elongation. However, a recent report revealed that myopia-related changes of the optic 
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Thus, the disease burden of PM due to high myopia is likely to increase in future, con-
tributed by the aging effect where young adults who have high rates of high myopia 
will grow older.
2.6  Conclusion
In children, the prevalence of myopia is substantially higher in urban East Asian 
countries (49.7–62.0% among 12-year-old children) compared with other countries 
(6.0–20.0% among 12-year-old children). Similarly, in teenagers and young adults, 
the prevalence of myopia is higher in East Asian countries (65.5–96.5%) compared 
with other countries (12.8–35.0%). However, the geographic difference of myopia 
prevalence in older populations is less than that of younger populations. The preva-
lence rates of myopia in adults in urban East Asian countries are only slightly higher 
than in Western countries.
A relationship between myopia prevalence and community development is 
apparent, and most data have shown urban areas have a higher prevalence of myopia 
than rural areas. The association of an urbanized environment with myopia develop-
ment in Asia could be mediated by factors such as intensive education and greater 
levels of near-work and less outdoor time. Overall, the prevalence of myopia in 
child population seems to be strongly related to the region where they grow up and 
the environmental factors such as urbanization, economy, and education.
Generational differences are seen with the highest rates in young adults (myo-
pia 65.5–96.5% and HM 6.8–21.6%) and the lowest rates in older adults (myopia 
25.0–40.0% and HM 2.4–8.2%). The disease progression pattern of HM and subse-
quent development of PM may be different between young adults and older adults due 
to generational differences, or changes in the lifestyle factors such as the education 
system and near-work and outdoor time exposure in rapidly developing urban Asian 
countries.
Current data show a relatively low prevalence of PM among middle-aged and 
elderly adults so far, and PM increases with age over 40 years and severity of myo-
pia. Despite the relatively low prevalence in general population, PM is the major 
cause of blindness or visual impairment in both Asian populations and Western pop-
ulations. According to a previous study, early grades of PM lesions are observed in 
young highly myopic adults in urban Asian population, and these structure changes 
are likely to worsen with age [111]. Considering the increasing prevalence of HM 
among young generations, we must be prepared for the expected increase of disease 
burden of PM in the near future.
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3The Economic and Societal Impact of Myopia and High Myopia
Sharon Yu Lin Chua and Paul J. Foster
Key Points
• The prevalence of myopia has increased rapidly throughout Asia. In urban 
areas, 80–90% of young adults are myopic and 10–20% have high myopia. 
By 2050, it is estimated that five billion people will be myopic. Of these, 
one billion people will be highly myopic. World Health Organization lists 
uncorrected or under-corrected myopia as a major cause of visual 
impairment.
• Myopia may impair many aspects of life including educational and occu-
pational activities. The annual direct cost of myopia correction for Asian 
adults has been estimated at US $328 billion/annum. The cost of care is 
also likely to increase significantly and will be exacerbated by an even 
greater increase in the prevalence of high myopia.
• High myopes have greater risk of developing several vision-threatening 
conditions including myopic macular degeneration, retinal detachment, 
glaucoma, and cataract. Those affected individuals incur costs for special-
ist eye care, or specialist optical aids for patients with visual impairment. 
These costs are in the region of US $250 billion/annum.
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3.1  Introduction
The prevalence of myopia is most pronounced in the industrialized nations of East 
Asia, where rates of 95% among young adults have been recorded [1]. In this con-
text, the impact of myopia is profound and far reaching, and recent study by Naidoo 
et al. [2] suggests that myopia has a global economic impact, with the greatest bur-
den throughout Asia. Its economic impact is very significant. This chapter seeks to 
examine the impact of myopia on individuals and the wider society, both from the 
monetary perspective and also in terms of emotional well-being and quality of life. 
Peer-reviewed data on this subject are comparatively sparse, and in some areas, it is 
necessary to make inferences on the basis of indirect evidence.
The impact of myopia illustrates an interesting dichotomy. The condition 
appears to be an exaggerated adaptive response which has a predilection for the 
most affluent and educated in society. Low myopia [up to around −3 D (diopters)] 
is arguably an ideal state for the older urban professional, in that the frustration of 
presbyopia is avoided, and hence maximum efficiency in an office-based career 
is maintained, and the ability to pursue leisure activities, such as reading, creative 
arts, and many household tasks, is enhanced. Myopes are among the best educated 
and thus highest earning members of any society. Furthermore, they confer on 
their children a range of advantages—they are typically well educated, and in turn 
benefit from higher career prospects and incomes. The offspring are also more 
likely to be myopes [3].
3.2  Economic Impact of Myopia
Myopia is the most common distance refractive error. The global prevalence of 
myopia is expected to increase from 27% of the world’s population in 2010 to 52% 
by 2050 [4]—a 2.6-fold increase. A recent meta-analysis estimated a significant 
• Myopes, especially high myopes, tend to have reduced quality of life due 
to adverse influences from psychological, cosmetic, practical and financial 
factors. Hence, affecting productivity, mobility, and activities of daily 
living.
• Treatments such as under-correction of myopia, gas permeable contact 
lenses, and bifocal or multifocal spectacles have all been proven to be inef-
fective for myopia control. The most effective methods are the use of 
orthokeratology contact lenses, soft bifocal contact lenses, and topical 
pharmaceutical agents, such as low-dose atropine or pirenzepine. These 
will have differing implications for personal finances and quality of life. 
Hence, the best modality should be selected by the eye care practitioner, 
parent or individual, based on the lifestyle of the individual.
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increase in the global prevalence of myopia and high myopia, affecting nearly 
five billion people and one billion people, respectively, by 2050 [4]. The projected 
increases in myopia and high myopia may be due to environmental factors, such as a 
combination of decreased time outdoors and increased near work activities, among 
other factors [5]. Uncorrected distance refractive error was estimated in 2013 to 
affect 108 million people globally, and myopia is the most common refractive error 
[6]. It is the leading cause of moderate and severe vision impairment (VI; 42%) and 
a major cause of blindness (3%) [2]. Uncorrected myopia as low as −1.50 D will 
result in moderate VI, and uncorrected myopia of −4.00 D is sufficient refractive 
error to be classified as blindness [7]. Depending on national legislation, people with 
moderate VI may not be allowed to drive. Moderate VI may also require the use of 
aids and/or accommodations/adaptions for some tasks in the learning environment.
If the increasing prevalence of myopia is not addressed, a similar increase in 
uncorrected refractive error can be expected. These projections are based on con-
servative assumptions and, given the published relationship between level of edu-
cation and myopia, increased provision of education could markedly increase these 
trends. Furthermore, uncorrected distance refractive error has been estimated to 
result in a global loss of productivity of international dollar (I$) 269 billion [8] 
(US $202 billion) annually [9], which will also increase if there is a significant 
increase in uncorrected myopia. International dollar allows comparison of prices 
and currency values between countries after adjustment of currency exchange rate. 
An international dollar has the same purchasing power as the U.S. dollar has in 
the United States [10]. A recent meta-analysis estimated the global potential loss 
associated with VI in 2015 was US $244 billion/annum [95% confidence interval 
(CI) US $49 billion—US $697 billion] from uncorrected myopia and US $6 bil-
lion/annum (95% CI US $2 billion–US $17 billion) from myopic macular degen-
eration [2]. The cost of care is also likely to increase significantly, and will be 
exacerbated by an even greater increase in the prevalence of high myopia, from 
2.8% (190 million people) to 9.7% (924 million people) by 2050 [4], representing 
a 4.9-fold increase in high myopia. In some populations of young adults in Asia, 
the prevalence of high myopia has already reached 38% [11]. The annual direct 
cost of optical correction of myopia for Singaporean adults has been estimated at 
US $755 million. Refractive correction comprising of optometry visits, spectacles, 
and/or contact lenses is the most significant cost domain and it accounts for 65.2% 
of the total costs [12]. In Singapore, the estimates in an adult (SG $587 or US 
$455 per patient per year) is significantly higher than a child aged 7–9 years (SG 
$222 or US $175 per patient per year) [13]. The higher cost could be because of 
the greater likelihood that adults may undergo laser-assisted in situ keratomileusis 
(LASIK), wear contact lens, or develop ocular complications due to high myopia. 
Furthermore, adults tend to have higher spending power compared to a child. It has 
been estimated that if such prevalence rates were extrapolated to all cities in Asia 
in which the prevalence of myopia is approximately equal to the rates in Singapore, 
the estimated direct cost would be US $328 billion/annum. It is estimated that US 
$8.1 billion/annum was spent on vision products including eyeglass frames, lenses, 
and contact lenses in the USA in 1990 [14]. In United States, a cross-sectional 
study demonstrated that 110 million Americans could achieve normal vision with 
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refractive correction and the estimated cost was US $3.8 billion/annum [15]. Of 
this amount, the annual cost of providing distance vision correction for adults older 
than 65  years old was US $780 million. The types of refractive error included 
correction for myopia, hyperopia, and presbyopia. This represents approximately 
US $35 per person or US $13 per capita annually, based on the cost of a pair of 
spectacles and refractive examination. Possible reasons for the difference in direct 
costs of refractive correction are the treatment costs may be borne by the indi-
vidual, who may be willing to pay for other factors such as aesthetics. Whereas 
in some countries (e.g., the United Kingdom), some segments of the population 
are entitled to free eye glasses subsidized by the government. As the prevalence of 
myopia increase in East Asia, the total cost of treating myopia will be high. There 
is likely to be an increase in the demand for optical services as the number of older 
people increases and if, as suggested, the number of younger people with myopia 
increases. It is estimated that partial sight and blindness in adults costs the UK 
economy around £22 billion per year [16].
The cost of spectacles varies, but there may some individuals who may not 
be able to afford a basic pair of spectacles, and hence refractive error may not 
be fully corrected. Health economic analyses in the United States and Australia 
have reported the economic burden of refractive correction associated with 
medical care expenditure, informal care days, and healthy utility is greater than 
age-related macular degeneration, primary open-angle glaucoma, and diabetic 
retinopathy, while it was secondary to the medical cost of age-related cataract 
[17, 18]. As the economic costs of myopia are high, more efforts and resources 
could be directed toward having new strategies to prevent and slow down myo-
pia progression to high myopia and its associated visually disabling ocular 
complications.
3.3  Secondary Impact of Myopia from Other Eye Diseases 
and Sight Loss
High myopia increases the risk of other eye diseases such as cataract, glaucoma, 
retinal detachment, and myopic macular degeneration (MMD), which may lead to 
irreversible vision loss. MMD has been reported to cause 12.1% of VI (approxi-
mately 200,000 people) in Japan [19]. Visual impairment and blindness impact the 
individuals, their families, caregivers, and the community, which lead to a signifi-
cant cost burden. In Australia, visual disorders were ranked seventh among diseases 
in terms of economic burden on the health system, which is ahead of coronary 
heart disease, diabetes, depression, and stroke [20]. Naidoo et  al. estimated the 
potential global economic productivity loss resulting from VI and blindness as a 
result of uncorrected myopia and MMD in 2015 [2]. Their study suggests that the 
greatest burden of VI resulting from uncorrected refractive error is older people in 
rural areas of the least developed countries. The regional productivity loss owing 
to VI resulting from myopia may be reflected in Southeast Asia, South Asia, and 
East Asia as having a percentage gross domestic product (GDP) of 1.35%, 1.3%, 
S. Y. L. Chua and P. J. Foster
57
and 1.27%, respectively. Differences in productivity loss arises from the interplay 
between country-specific variables, such as myopia and high myopia prevalence, 
demographics, Health Development Index (HDI), health expenditure, urbanization, 
labor force participation, employment, GDP, and population. There are other com-
ponents that contribute to the overall burden of myopia, such as cost of eye examina-
tions, refractive corrections, managing pathologic consequences of myopia such as 
MMD, and related opportunity costs. The value of any investment to prevent myo-
pia, slow progression of myopia, improve spectacle correction rates, and improve 
outcomes in MMD depends on a comparison of lost productivity owing to VI result-
ing from myopia with the cost of prevention and management interventions. Fricke 
et al. estimated the global cost of facilities and personnel for establishing refractive 
care services US $20 billion over 5 years [9]. Direct medical costs occur mostly 
due to hospitalization, the use of direct medical services, and medical products. 
Hospitalization and use of medical services around diagnosis and treatment at the 
onset of VI and blindness were the two largest components related to direct medical 
costs. The mean annual expenses per patient to be US$ purchasing power parities 
(PPPs) 12,175–14,029 for moderate VI, US$ PPPs 13,154–16,321 for severe VI, 
and US$ PPPs 14,882–24,180 for blindness [21]. PPPs account for differences in 
price levels between countries, and convert local currencies into international dol-
lars by taking into account the purchasing power of different national currencies and 
eliminates the difference in price levels between countries [22]. Direct nonmedical 
costs include assistive devices and aids, home modifications, and costs for health-
care services such as home-based nursing or nursing home placements. The cost for 
support services and assistive devices increased from US$ PPP 54 for a person with 
visual acuity (VA) 20/20 or better up to US$ PPP 609 for a person with VA 20/80 or 
worse. Indirect costs include productivity losses, changes in employment (employer 
and/or area of work), loss of income, premature mortality, and dead-weight losses 
[21]. Dead-weight losses, also known as excess burden, describe the costs to society 
created by market inefficiency. In the study by Köberlein et al., it is referred to as 
an excess financial burden on society caused by VI and blindness [21]. The annual 
estimates of productivity losses and absenteeism range from US$ PPP 4974 to 5724 
million and a decrease in workforce participation range was estimated to be US$ 
PPP 7.4 billion [21].
Value of the Commercial Optical Good Sector
In the UK in 2017, the optical goods and services industry had total consumer 
spending estimated at £3.1 billion (2.0 billion US$ = @ 0.66 £:$). Growth was 
estimated at 2% for 2017, and forecasts projected further 3.2% growth in 2018. 
Market research suggests this was primarily driven by an aging population. In the 
UK, 70% of consumers are reported to wear some form of prescription eyewear. 
Just 11% of those with vision correction need wear contact lenses, with this sec-
tor characterized by a high rate of premium and daily wear lenses. Contact lenses 
account for 20% of the total spending on optical products, with the sale of con-
tact lens solutions made up an additional 3% of the market, compared to 60% 
market share for spectacle frames and lenses. Only one in six (18%) people have 
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purchased optical products online. Reports suggest that consumers perceive buy-
ing prescriptions eyewear online as harder—49% of people buying prescription 
eyewear saying it is more difficult than buying in-store, although 45% of consum-
ers who said they have not bought optical products online before, would consider 
doing so in the future [23].
3.4  Quality of Life
Quality of life is a multidimensional construct with different domains. The iden-
tified domains related to ophthalmic quality of life include activity limitation, 
mobility, convenience, health concerns, visual symptoms, ocular-comfort symp-
toms, general symptoms, emotional well-being, and social and economic issues 
[24]. Impaired vision will lead to significant reduction in activities associated 
with participation in society and religion, mobility, daily living, and visually 
intensive tasks. This may impact education, employment, child development, 
mental health, and functional capacity in older people, increasing the risk of 
hip fractures and the need for community or family support or nursing home 
placement [25–27]. A cross- sectional study in Germany reported that mild VI 
affected emotional well-being [28]. Depression was considered to cause further 
functional decline in visually impaired patients by reducing motivation, initia-
tive, and resiliency [29–31]. Visual impairment and blindness associated with 
myopic macular degeneration will increase significantly, hence affecting the 
quality of life and causing socioeconomic impact [32]. A cross-sectional study 
reported the functional status in daily life and quality of life of pathologic myo-
pia patients were reduced compared with control subjects [33]. The influence 
of pathologic myopia on a patient’s daily life was primarily the result of three 
major factors: handicap, disability, and support. Wong et al. reported that those 
with VI, measured in terms of presenting vision (i.e., wearing their habitual 
correction), had statistically significantly lower scores for total quality of life 
(−3.8; 95% CI −7.1 to −0.5; P = 0.03), psychosocial functioning (−4.2; 95% CI 
−8.1 to −0.3; P = 0.03), and school functioning (−5.5; 95% CI −10.2 to −0.9; 
P = 0.02) [34]. Another study indicates that correction of refractive errors by 
the provision of spectacles in low socioeconomic areas in China would mark-
edly improve educational outcomes since the major medium of instruction is the 
blackboard [35].
Patients with cataract may experience vision-related problems, such as decreased 
visual acuity, loss of contrast sensitivity, problems under glare conditions, and 
altered color recognition [36]. Studies in Japan and Canada reported a loss of well- 
being as disability adjusted life years (DALYs) and an associated cost of US$ PPP 
51.8 billion/annum and US$ PPP 15.11 billion/annum, respectively [37, 38]. The 
global burden of diseases study 2010 estimated the burden of disease related to 
vision disorders has increased by 47% from 12,858,000 disability adjusted life 
years (DALYs) in 1990 to 18,837,000 DALYs in 2010 [39]. The Melbourne Visual 
Impairment Project (VIP) cohort showed the association between VI and mortality 
to increase linearly from 4.5% in people with a VA of 20/20 or better to 22.2% in 
blind people with VA of 20/200 or worse [40].
S. Y. L. Chua and P. J. Foster
59
3.5  Impact of Myopia Treatments on Quality of Life
Current treatment options for control of myopia progression include optical cor-
rection such as bifocal spectacle lenses, progressive addition spectacle lenses, 
under- correction, orthokeratology, multifocal contact lenses, increased expo-
sure to outdoor activities, and the use of atropine eye drops. Surgical techniques, 
such as LASIK, have become increasingly popular and over a million surgical 
procedures are performed annually in the United States [41]. Choice of refrac-
tive correction leads to various quality-of-life implications. Often, the type of 
refractive correction depends on prescription, lifestyle including occupational and 
recreational needs, economic issues, and personality. If refractive error may be 
corrected through the provision of corrective spectacles, visual acuity, and there-
fore functional vision could be improved. Patient reported outcomes (PROs) have 
been used to assess the outcomes of interventions on people’s lives. A PRO is 
described as a report that comes directly from a patient regarding the impact of 
the condition and outcome of an intervention [42]. The Quality of Life Impact 
of Refractive Correction (QIRC) is useful to detect differences in quality of life 
impact from various refractive corrections (spectacles, contact lenses, and refrac-
tive surgery). Pesudovs et  al. reported that QIRC score was highest in refrac-
tive surgery patients (mean QIRC score of 50.2 ± 6.3), followed by contact lens 
wearers (mean QIRC score 46.7 ± 5.5), and spectacle wears (mean QIRC score 
44.1 ± 5.9) [43]. Orthokeratology (OrthoK) contact lenses (CL) are worn while 
sleeping to reshape the cornea and are used to correct refractive error and slow 
the progression of myopia [44]. Quality of life using the National Eye Institute 
Refractive Error Quality of Life (NEI RQL)-42 questionnaire was evaluated in a 
group of subjects with low to moderate myopia who had undergone four types of 
refractive correction, namely, LASIK, OrthoK, soft contact lens (SCL), and spec-
tacles [45]. Results showed decrease in quality of life for most of the subscales in 
the treatment groups compared to emmetropic subjects. The average decrease in 
quality of life compared with emmetropes were −7.1% (P = 0.021) for LASIK, 
−13.0% (P = 0.001) for OrthoK, −15.8% (P = 0.001) for spectacles, and −17.3% 
(P = 0.001) for SCL. The subscales which were affected in LASIK and OrthoK 
patients compared to emmetropes were as follows: clarity of vision, expectations, 
glare, and worry. This suggests that both types of treatment affected the qual-
ity of life due to high-order aberrations [46]. LASIK and OrthoK are commonly 
associated with experiencing haloes and glare because of the dramatic changes in 
the corneal shape [47]. Spectacle wearers had the worse scores in expectations, 
dependence on correction, worry, and appearance as compared to the other three 
treatment modalities [45]. The primary motivation for undergoing LASIK was a 
desire to improve uncorrected visual acuity, without a need to wear glasses and 
improved ease to pursue sports or recreational activities [48]. Although LASIK 
patients may have excellent vision during day time, they may experience distur-
bances in night vision such as halo and glare disability [49]. An estimated 12–57% 
of patients experience night vision symptoms and 30% have difficulty with night 
driving after undergoing photorefractive keratectomy (PRK) and LASIK [50, 51]. 
In addition, these patients may experience poor vision in low light setting due to 
contrast sensitivity decreasing initially after LASIK [52].
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OrthoK allows patients to enjoy good vision without needing to wear vision cor-
rection during their waking hours. This benefits patients who have an active lifestyle 
as they are more mobile without the need for refractive correction. OrthoK provides 
excellent vision and improves vision related quality of life [45, 53]. Side effects of 
OrthoK include halos secondary to spherical aberration, which may reduce visual 
acuity and contrast sensitivity or discomfort from the lenses [54]. Although the most 
serious complication with CL wear is infection, these occurrences are relatively 
rare [55, 56]. Most common complaints are related to intolerance or limited wear-
ing time due to fluctuations of vision, dryness and discomfort [57]. Atropine has 
been used to control myopia progression [58]. As atropine causes pupil dilation 
and temporary paralysis of accommodation, patients may experience glare, discom-
fort, blurred vision, or allergic/hypersensitivity reactions. Complications of LASIK 
include corneal ectasia [59], dry eyes [60], and night vision disturbances [49].
Cataract surgery is a highly effective, cost-effective health-care intervention [61], 
and results in almost immediate visual rehabilitation. In addition to visual rehabilita-
tion from media opacities, it offers once in a lifetime opportunity for refractive manip-
ulation that benefits the majority of people with a refractive error. Previous studies 
have utilized Visual Functioning Index-14 (VF-14) or similar vision-functioning tools 
and reported the impact of cataract surgery can be translated beyond visual acuity. 
Evidence has shown several fold improvements in other critical daily tasks such as 
read critical daily living tasks such as reading newspapers or books; driving; watching 
TV; cooking; negotiating steps; sewing, knitting, crocheting, or doing handicrafts; 
noticing traffic, information or shop signs; and recognizing people [62]. In addition, 
there are improvements in several psychosocial aspects such as social interaction; 
mental and emotional well-being; psychological distress; adaptation; and coping.
3.6  Summary
Myopia is a major global public health concern due to its high and increasing 
prevalence in Asian countries, where it is a common cause of vision dysfunction. 
Uncorrected myopia is a leading cause of visual impairment. People with high myo-
pia have increased risk of developing myopic pathologies which may lead to blind-
ness. The economic burden of uncorrected distance refractive error, largely caused by 
myopia, is estimated to be US $202 billion annually. Direct cost of refractive correc-
tion comprises of cost from spectacles, contact lenses, and refractive surgeries. Other 
medical costs include those associated with treatment of ocular complications from 
high myopia, such as retinal detachment, myopic macular degeneration, glaucoma 
and cataract, and its associated visual impairment and blindness. This global cost will 
continue to increase as the number of people with myopia rises. Patients with higher 
myopic refractive error tend to have adverse effect on the quality of life and lead to 
lower health, economic, and social outcomes. Effective methods to control or correct 
myopia include the use of optical devices, pharmacological drops, surgical, or outdoor 
exposure. Each treatment method will have various quality of life implications; thus, 
it is important to ensure prescription, lifestyle including occupational and recreational 
needs, and economic issues are discussed. Although a broader societal perspective is 
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useful for informing policy, the patient’s perspective is essential for designing service 
models to improve the social interaction and mental and emotional well-being of these 
individuals. In conclusion, the impact that myopia and its associated visual impair-
ment have on individuals is substantial. Myopia preferentially affects the more highly 
educated and potentially most productive sectors of the population, the individual and 
societal costs involved. Developing appropriate public health policies to prevent and 
reduce myopia progression will benefit the individual and the wider society.
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4Understanding Myopia: Pathogenesis and Mechanisms
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Key Points
• Visual environment (or the quality of the retinal image) modulates the 
refractive development of the eye.
• Ocular response to form-deprivation and lens induced defocus is evident 
across a wide range of animal species, including humans.
• The visual system appears to be more sensitive to myopic than hyperopic 
defocus.
• Evidence suggests that greater time spent outdoors is protective against 
development and progression of myopia in children.
4.1  Emmetropization and Normal Ocular Growth in Human 
Eyes
When incident parallel rays of light from distant objects are brought to a focus upon 
the retina without accommodation, it is known as emmetropia. During postnatal 
eye growth, the precise matching of the axial length (the distance from the anterior 
corneal surface to the retina along the visual axis) and the optical power of the eye 
brings the eye to emmetropia [1, 2]. This active regulatory process that harmonizes 
the expansion of the eye with the optical power of the cornea and the crystalline lens 
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is known as emmetropization [1]. Any disruption to these highly coordinated ocular 
changes results in the development of refractive errors, wherein distant images are 
focused either behind (hyperopia) or in front (myopia) of the retina [1].
Human eyes exhibit a distinctive pattern of eye growth during the early period 
of visual development. The distribution of refractive errors at birth appears to be 
normally distributed [3, 4]. Apart from some exceptions [5], the majority of new-
born infants are moderately hyperopic (~+2.00 to +4.00 D) and this refractive error 
reduces significantly during the first 18 months of life [3, 6–8] (Fig. 4.1). By about 
2–5 years of age, the distribution becomes leptokurtic with a peak around emmetro-
pia to low hyperopia of about +0.50 to +1.00 D [5, 6, 8, 11, 12]. Although studies 
have reported small reductions in hyperopic refraction until the middle to late teen 
years [13, 14], emmetropization is believed to be largely completed by 5–6 years of 
age [5, 6, 8, 14].
Based on the visually guided ocular growth observed in a variety of animal mod-
els [15–17] (see Sect. 4.3), the growth of the human eye is also believed to be modu-
lated by an active visual feedback from the hyperopic refractive error in neonatal 
eyes [18]. Studies have found a strong correlation between the rapid reduction in 
hyperopia and the changes in axial length during early ocular development [18, 
19]. Human eyes are ~17 mm long after birth and grow to about 20 mm after the 
first year [11, 18–20]. This rapid expansion of the eye is largely attributed to the 
Fig. 4.1 Comparison of refractive error distribution among newborns [3] and 6–8-year-old chil-
dren [9]. The distribution of refractive errors narrows between infancy to early childhood during 
the process of emmetropization. Adapted from FitzGerald and Duckman [10]
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expansion of the vitreous chamber [18, 21]. From 2–3 years of age, axial elonga-
tion slows to approximately 0.4 mm/year until preschool age [11]. Consistent with 
changes in ocular refraction, the growth of the eye stabilizes further at 5–6 years, 
and only increases by 1–1.5 mm through the teenage years [11, 20, 21]. Together, 
these studies suggest that axial length is the most influential factor for emmetropiza-
tion in human eyes.
In addition to changes in axial length, there is also a significant reduction in the 
refractive power of the cornea and the crystalline lens that contributes to the overall 
reduction in hyperopia in the first year of life [11, 18, 22]. Mutti et al. [18] reported 
a reduction of 1.07 and 3.62 D in corneal and crystalline lens powers, respectively, 
associated with flattening of the corneal and lens radii in newborn infants, between 
the ages of 3 and 9 months. Studies have also found higher degrees of corneal astig-
matism in newborn infants [23–28], which reduces during the first 4 years of life 
and is associated with corneal flattening [24, 27, 29, 30]. Overall, these studies sug-
gest that emmetropization in human eyes is largely attributed to the changes in axial 
length with minor contributions from corneal and crystalline lens powers.
Refractive errors occur as a result of either variations in (a) axial length with 
respect to the total refractive power of the eye (termed axial myopia or hyperopia) 
or (b) refractive power of the cornea and the crystalline lens with respect to the axial 
length of the eye (termed refractive myopia or hyperopia). This chapter focuses on 
the pathogenesis and potential underlying mechanisms of myopia, and the follow-
ing section discusses the changes in different ocular parameters during myopic eye 
growth.
4.2  Ocular Biometric Changes in Human Myopia
As discussed earlier, the axial length of the eye is the primary biometric determinant 
of refractive error; however, the dimensions, curvature, and refractive index of each 
individual ocular structure contribute to the final refractive state. Ocular biometrics 
vary considerably throughout childhood, during the development and progression 
of myopia, and in response to clinical myopia control interventions.
4.2.1  Cornea
Several cross-sectional analyses have revealed a weak association between increas-
ing corneal power (a steeper radius of curvature) and increasing levels of myopia 
[31–33], while others report no association [34], or the opposite relationship [35]. 
Longitudinal studies indicate that changes in corneal curvature during childhood 
[36–38] and early adulthood [39] are minimal and not associated with the mag-
nitude of myopia progression. However, since the correlation between spherical 
equivalent refraction (SER) and the axial length to corneal radius ratio is typically 
stronger than that of axial length alone (by 15–20%) [40–43], corneal curvature 
does appear to make a modest contribution to the magnitude of myopia. Although 
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corneal thickness does not vary systematically with refractive error [44–47], a 
reduction in corneal hysteresis (an estimate of corneal biomechanical strength or 
viscoelasticity) has been observed with increasing levels of myopia in children [48, 
49] and adults [50–52]. However, the causal nature of this relationship remains 
unclear, or if such corneal metrics correlate with posterior scleral biomechanics.
4.2.2  Crystalline Lens and Anterior Chamber Depth
While the cornea flattens substantially during infancy and then remains relatively 
stable throughout childhood, the crystalline lens continues to thin, flatten, and 
reduce in optical power until approximately 10 years (a 0.25–0.50 D reduction per 
year), concurrent with lens fiber compaction [53–55]. These changes may be part 
of an emmetropization mechanism to compensate for continued axial elongation 
or a mechanical consequence of equatorial eye growth. Across a range of ethnici-
ties, Mutti et al. [56] observed that within 1 year of myopia onset, compensatory 
crystalline lens thinning and flattening abruptly halted compared to children who 
remained emmetropic (Fig. 4.2), suggesting that childhood myopia is not purely 
axial in nature, but involves a decoupling of highly correlated anterior and posterior 
segment eye growth. In Singaporean children, Iribarren et al. [57] reported a tran-
sient acceleration in the reduction of lens power during myopia onset when the rate 
Fig. 4.2 The change in crystalline lens thickness as a function of age in myopes and emmetropes 
during childhood (after Mutti et al. [56]). Shortly after myopia onset (10–12 years), compensatory 
crystalline lens thinning abruptly halted compared to children who remained emmetropic suggest-
ing that myopia development involves a decoupling of anterior and posterior segment eye growth
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of axial growth was high, which was not sustained as myopia progressed (Fig. 4.3). 
Paradoxically, after 10 years of age, the lens continues to thicken and increase in 
curvature with the bedding down of additional fibers, but reduces in optical power, 
most likely due to a steepening of the gradient refractive index [58]. Changes in 
anterior chamber depth throughout childhood are inversely related to changes in 
lens thickness (as the lens thins, the anterior chamber deepens), and the anterior 
chamber is typically deeper in myopes compared to emmetropes and vice versa for 
the crystalline lens [53].
4.2.3  Vitreous Chamber and Axial Length
In contrast to the anterior segment, changes in the posterior segment (particularly, 
the vitreous chamber, choroid, and sclera) are more pronounced in myopic com-
pared to non-myopic eyes (Fig. 4.4). Axial length, or more precisely, the vitreous 
chamber depth is the primary individual biometric contributor to refractive error 
in children, young adults, and the elderly [34, 59, 60], with the vitreous chamber 
depth accounting for over 50% of the observed variation in SER, followed by the 
cornea (~15%) and crystalline lens (~1%) [60]. Modeling of cross-sectional and 
Fig. 4.3 The change in crystalline lens power during childhood (calculated from refraction and 
biometric measurements) in young Singaporean children for a range of refractive error groups 
(after Iribarren et al. [57]) The reduction in lens power increases during myopia onset (to a greater 
extent than other refractive error groups), but is not sustained throughout myopia progression
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longitudinal data from emmetropic children indicates that axial length and vitreous 
chamber depth increase by approximately 0.16 mm per year from age 6–10 years, 
slowing to 0.05 mm per year from 11 to 14 years [61]. In myopic children aged 
between 6 and 11 years (corrected with single vision spectacles or contact lenses) 
average growth rates of approximately 0.30 mm per year have been reported [37, 
62, 63], with greater vitreous chamber and axial elongation observed in younger 
females with myopic parents [37]. A range of myopia control interventions sig-
nificantly slow the rate of eye growth and myopia progression during childhood, in 
some cases by up to 50% [64], and this reduction in axial elongation appears to be 
initially modulated by changes in the choroid underlying the retina.
4.2.4  Choroid
The choroid supplies the outer retina with oxygen and nutrients and regulates intra-
ocular pressure and ocular temperature. The choroid is typically thinner in myopic 
compared to non-myopic eyes (most pronounced at the fovea [65, 66]) and thins 
with increasing myopia and axial length in both adults [67–74] and children [75–
77]. Significant choroidal thinning is also observed in high myopia (<−6.00 D) or 
Fig. 4.4 Optical low coherence reflectometry A-Scan output from two 11-year-old males (one 
myope and one emmetrope). The predominant biometric differences are the deeper vitreous cham-
ber (19.05  mm compared to 15.47  mm) and the longer axial length (25.87  mm compared to 
22.69 mm) in the myopic eye. The anterior chamber depth is slightly shallower in the emmetropic 
eye (by 0.13 mm) while the crystalline lens is thicker (by 0.49 mm) in comparison to the myopic 
eye. The corneal thickness varies by only 0.04 mm
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eyes with posterior staphyloma [78], and has been associated with the presence of 
lacquer cracks [79], choroidal neovascularization [80], and reduced visual acuity 
[81]. The choroid also appears to be a biomarker of ocular processes regulating eye 
growth given that the central macular choroid thins during the initial development 
and progression of myopia [82–84] and thickens in response to imposed peripheral 
myopic retinal image defocus [85, 86], topical anti-muscarinic agents [87, 88], and 
increased light exposure [89] (clinical interventions associated with a slowing of 
eye growth in children).
4.2.5  Sclera
Scleral thinning associated with axial myopia is primarily restricted to the posterior 
pole [90–92], due to scleral tissue redistribution [93]. Scleral thinning may alter the 
tissue strength surrounding the optic nerve head, rendering myopic eyes more sus-
ceptible to glaucomatous damage [94, 95]. Consequently, posterior reinforcement 
surgery using donor scleral tissue has been refined over the years to arrest further 
axial elongation and scleral thinning in highly myopic eyes [96, 97]. Although ante-
rior scleral thickness is similar between myopic and non-myopic eyes [98–100], 
there is growing evidence that the anterior sclera thins slightly during accommoda-
tion, particularly in myopic eyes [101, 102], most likely due to biomechanical forces 
of the ciliary muscle. A greater thinning observed in myopic eyes may be a result of 
a thicker posterior ciliary muscle [103–105] or changes in biomechanical properties 
of the sclera reported in animal models of form-deprivation myopia [106, 107].
4.3  Visual Environment, Emmetropization, and Myopia: 
Evidence from Animal Models
Over the last four decades, numerous animal models have provided valuable insight 
into the mechanisms underlying emmetropization and refractive error development. 
Much of the knowledge on vision-dependent changes in ocular growth has ema-
nated from animal experiments in which either the quality of image formed on the 
retina is degraded (known as form-deprivation [FD]), or the focal point of the image 
is altered with respect to the retinal plane (known as lens induced defocus). Both 
FD and lens induced defocus result in abnormal eye growth and development of 
refractive errors. This section summarizes the attributes of experimental ametropias 
derived from these two visual manipulations, their differences, and significance for 
understanding refractive error development in humans.
4.3.1  Form-Deprivation Myopia
FD is the most commonly used experimental paradigm to model axial myopia in 
animals. Depriving the retina of form or patterned vision through eyelid suture 
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[108–110], or translucent diffusers [2, 15, 111–114] consistently produces axial 
myopia (Fig. 4.5). The use of noncontact translucent diffusers offers a more reliable 
representation of ocular changes with FD since they do not induce corneal changes 
(unlike eyelid fusion techniques). The ocular changes observed in response to FD 
clearly illustrate that degrading retinal image quality can produce robust myopic 
changes. Schaeffel et al. [115] proposed that FD is an open-loop condition, in which 
myopia develops as a result of uncoordinated ocular growth due to reduced retinal 
image contrast (or mid-range spatial frequency vision) [116] and the absence of 
visual feedback related to the effective refractive state of the eye [117].
The myopic response to FD varies among different animals. It is generally great-
est in chickens (−9 D after 5 days of FD) [118], followed by tree shrews (−8 D after 
12 days in young animals) [119] and guinea pigs (−6.6 D after 11 days) [113], and 
is less pronounced and much more variable in marmosets (−8 D after 4.5 weeks) 
[120] and rhesus monkeys (~−5 to −6 D after 17 weeks) [121, 122]. Variations 
observed between individual studies and animal models may be due to differences 
in experimental paradigms, the duration and extent of FD, inherent ocular ana-
tomical variations, and/or differences in susceptibility to environmental myopia. 
Nevertheless, the myopic response to FD is conserved across a wide range of ani-
mal species (including fish, rabbit, mouse, and kestrel) [123]. In all species, axial 
myopia is predominantly caused by a significant elongation of the vitreous cham-
ber, along with thinning of the choroid and the sclera [16, 17, 113, 124–132]. Few 
studies have also reported changes in corneal curvature and lens thickness with FD 
[131, 133–135]. Interestingly, ocular conditions that cause varying degrees of visual 
deprivation in humans such as ptosis [136], congenital cataract [137], corneal opac-
ity [138], and vitreous hemorrhage [139] are associated with myopia, which may 






Fig. 4.5 Ocular 
compensation for 
form-deprivation (FD). (a) 
A diffuser causes 
nondirectional blur and a 
reduction in contrast of the 
retinal image. (b) The 
absence of visual feedback 
related to the effective 
refractive state of the eye 
causes a thinning of the 
posterior choroid and an 
increase in ocular growth, 
resulting in myopia
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FD myopia is a graded phenomenon, where increasing degrees of image degrada-
tion are positively correlated with the magnitude of induced axial myopia [129, 140]. 
In addition, the effects of FD declines with age. Younger chicks [141, 142], macaques 
[143], tree shrews [119], and marmosets [144] show greater ocular changes in response 
to image degradation compared to older animals, potentially due to age-related reduc-
tions in sensory processing of blur stimuli or changes in scleral growth [144].
4.3.2  Lens Defocus Ametropias
Perhaps the strongest evidence of visual regulation of ocular growth comes from 
animal studies that show eyes can actively compensate for artificially induced myo-
pic and hyperopic defocus by adjusting the axial length to the altered focal plane 
(i.e., emmetropization through the treatment lenses) (Fig. 4.6) [145]. Myopic defo-
cus with plus lenses simulates artificial myopia that leads to a thickening of the 
choroid (moving the retina forward) and a reduction in the overall growth of the 
eye, thus, causing a hyperopic refractive error. Conversely, hyperopic defocus with 






Fig. 4.6 (a) Schematic of imposed lens defocus. With no lens (black arrow), incident parallel rays 
of light from distant objects are focused on the retina. A plus lens (green, convex) causes the retinal 
image to focus in front of the retina known as myopic defocus, whereas a minus lens (blue, concave) 
focuses the image behind the retina known as hyperopic defocus. (b) A normal eye with no imposed 
lens defocus (black) exhibits normal ocular growth and choroidal thickness. Myopic defocus with 
plus lenses (green) causes a thickening of the choroid (moving the retina forward) and a reduction 
in the overall growth of the eye, causing a hyperopic refractive error. Hyperopic defocus with minus 
lenses (blue) leads to a thinning of the choroid (moving the retina backward) and an increase in 
ocular growth, resulting in myopia. Adapted from Wallman J and Winawer J, 2004 [1]
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(moving the retina backward) and an increase in ocular growth, resulting in myopia 
to re-establish the optimal refractive state. This phenomenon was first documented 
in chicks [145], and has been extensively studied in chicks [16, 17, 146–148], tree 
shrews [149], rhesus monkeys [15, 150], marmosets [151], guinea pigs [152, 153], 
and mice [154] thereafter, indicating that the mechanisms regulating ocular growth 
can distinguish the sign of the imposed defocus in a wide range of animal species.
Chick eyes can compensate for a remarkable range of +15 to −10 D of imposed 
defocus [16, 147]. However, the operating range of defocus is much smaller for other 
animal species (monkey: −2 to +8 D [15], marmosets: −8 to <+4 D [151], tree shrew: 
−10 to +4 D [155], guinea pig: −7 to +4 D) [152, 156]. Compared to birds, the inabil-
ity of primates to compensate for greater magnitudes of defocus may be due to bigger 
eye size [15, 150], the process of emmetropization [150], differences in the accom-
modative response to defocus stimuli, and/or the degree of independent accommo-
dation between fellow eyes [15, 150, 157]. In all animals, the axial response to lens 
induced defocus is dependent upon the power of the treatment lens [147, 149–152, 
158], and is predominantly attributed to the changes in vitreous chamber depth [16, 
147, 159]. Similar to FD, the ocular response to lens induced defocus decreases with 
age [16]. Recent evidence suggests that the human visual system may also be able to 
detect the sign and magnitude of imposed defocus and make compensatory changes 
in axial length, similar to other animals. A number of studies have reported small 
bidirectional changes in axial length and choroidal thickness in response to 1–2 h of 
myopic and hyperopic defocus in children and young adults [160–165].
Studies have shown that the biological mechanisms underlying alterations in 
ocular growth to myopic and hyperopic defocus may be completely different (and 
not merely opposite to each other), and that the visual system is perhaps more sen-
sitive to myopic defocus [166, 167]. In fact, the ocular response to lens induced 
defocus depends on the frequency and duration of lens wear, and not simply the 
“total duration” per day [166–169]. These findings argue for a nonlinear processing 
of myopic and hyperopic defocus signals across the retina [166, 167].
4.3.3  Comparing Form-Deprivation and Lens Defocus
Although FD and lens induced defocus use different visual stimuli to induce com-
pensatory changes in ocular growth, there are features that are common to both 
visual manipulations. Removal of the visual manipulation triggers “recovery” from 
both FD and lens induced defocus [16, 17, 170]. During this recovery phase, the 
eyes quickly return to emmetropia by reversing the changes in choroidal thickness 
and axial eye growth (mainly by changing the vitreous chamber depth) [16, 17, 119, 
150, 151, 170–173].
Further evidence from animal work suggests that the elimination of accommo-
dation by cycloplegia, ciliary nerve section or damage to the Edinger-Westphal 
nucleus does not prevent the response to imposed FD [145, 174] or lens induced 
defocus [148, 175]. These results suggest that intact accommodation is not essential 
for visually guided growth [176] or there might be another accommodative pathway 
(not through ciliary and iris sphincter muscles) underlying optical defocus induced 
alterations in ocular growth [175].
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Other studies argue that mechanisms underlying the response to FD and 
lens induced defocus may not be the same [177]. Some studies show different 
light paradigms selectively disrupt the response to FD or lens induced defocus 
[178–180]. For instance, high luminance levels inhibit myopia caused by FD in 
monkeys and chicks, but only slow the response to negative lenses [181, 182]. 
Furthermore, dopamine (a strong ocular growth inhibitor, see Sect. 4.4.1) may not 
signal eye growth in a similar manner for these two forms of experimental myopia 
[183]. While most studies indicate that dopamine agonists block increased axial 
elongation [177], one study reported that dopamine agonists inhibit FD, but not 
lens-induced myopia in guinea pigs [184]. More studies are needed to determine 
if these contradictory results are due to different regulatory mechanisms of eye 
growth or other parameters of the experimental paradigm.
4.4  Other Visual Cues for Emmetropization
Whilst the clarity of the retinal image dominates the nature of ocular growth, other 
visual cues may also influence the process of emmetropization. This section exam-
ines some of the important cues that could significantly affect retinal image quality, 
and hence ocular growth in human eyes.
4.4.1  Retinal Physiology
Work from animal models suggests that retinal defocus (or visual blur) initiates a 
signaling cascade that leads to a number of cellular and biochemical changes in 
the retina and the retinal pigment epithelium (RPE), which signal changes to the 
choroid, and eventually the sclera, leading to alterations in the overall growth and 
refractive state of the eye (Fig.  4.7) [16, 17, 185]. The retina is an integral part 
of this visual signaling as it is the first layer of photosensory neurons that detect 
Fig. 4.7 A biochemical signal cascade beginning at the retina and ending at the sclera regulating 
ocular growth and the refractive state. Retinal defocus may initiate a signaling cascade that leads 
to a number of cellular and biochemical changes in the retina and the retinal pigment epithelium 
(RPE), the choroid, and eventually the sclera, leading to alterations in the overall growth and the 
refractive state of the eye
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defocus [186]. Furthermore, ocular compensation for both FD and lens induced 
defocus are largely regulated at the retinal level. Severing the optic nerve in young 
chicks does not prevent the development of refractive errors in response to spec-
tacle lenses [16, 187] or diffusers [130]. In both chicks [17, 188, 189] and primates 
[190], partial diffusers and hemifield spectacle lenses restricted to only half of the 
visual field cause corresponding myopic changes only in the visually deprived part 
of the globe. These studies demonstrate that the visual regulation of ocular growth 
in response to diffusers and lenses primarily occurs within the retina, with minimal 
input from the brain.
Retinal neurons also secrete a number of growth regulatory neurotransmitters 
(such as dopamine [191, 192], retinoic acid [153], nitric oxide [193, 194] and glu-
cagon [195]) that can directly alter ocular growth in mammalian eyes. Dopamine, 
one of the most widely studied neurotransmitters with regard to myopia in animal 
models, has been implicated as a potent stop signal for myopic eye growth [183, 
196]. In both chickens [191, 197] and primates [198], FD myopia is associated 
with lower levels of 3,4-dihydroxyphenylacetate (DOPAC, the primary metabolite 
of dopamine) and dopamine in the retina. Although the protective effects of outdoor 
light exposure on myopia development in children has been hypothesized to be 
mediated by greater dopamine synthesis in the eye (see Sect. 4.5), the exact mecha-
nisms underlying the protective effects of dopamine on myopia are not fully known. 
Together, these studies suggest that alterations in normal retinal physiology and/
or changes in retinal neurotransmitters may lead to the development of refractive 
errors, as shown in chickens [186, 199, 200] and mice [201–206]. Some features 
of retinal abnormalities and refractive errors are evident in humans as well; for 
instance, NYX [207] and GRM6 [208] retinal ON pathway mutations and retinal 
degenerations such as cone-rod dystrophy [209] and retinitis pigmentosa [210] are 
associated with myopia.
4.4.2  Aberrations
A long held belief is that myopia may develop due to the eye’s emmetropization 
response to inherent ocular aberrations that degrade retinal image quality and trigger 
axial elongation [211]. Since there is minimal variation in longitudinal chromatic 
aberration between individuals or refractive error groups in humans [212], most 
investigations have focused on monochromatic higher order aberrations (HOAs) 
as a potential myopigenic stimulus. Evidence concerning the relationship between 
HOAs during distance viewing and refractive error from cross-sectional studies is 
conflicting [211, 213]. However, during or following near work tasks, adult myopic 
eyes tend to display a transient increase in corneal and total ocular HOAs (Figs. 4.8 
and 4.9), suggesting a potential role for near work induced retinal image degrada-
tion in myopia development [214, 215]. Longitudinal studies of myopic children 
also indicate that eyes with greater positive spherical aberration demonstrate slower 
eye growth [63, 216].
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A number of myopia control interventions also alter the HOA and peripheral 
refraction profile. While relative peripheral refraction was initially thought to 
modulate central eye growth, recent longitudinal studies have found no associa-
tion between peripheral refraction and myopia progression in children [217, 218]. 
Multifocal soft contact lenses and orthokeratology significantly increase the magni-
tude of positive spherical aberration [219, 220]. The anticholinergic agent atropine 
may also provide visual feedback that influences eye growth due to an increase in 
positive spherical aberration or horizontal coma associated with cycloplegia and 
pupil mydriasis, respectively [221]. Collectively, these findings suggest that changes 
in HOAs may influence eye growth and refractive development during childhood.
Fig. 4.8 Corneal refractive power difference map following a 10 min reading task at 25° down-
ward gaze. The black circle denotes the pupil outline detected by the video keratoscope. A horizon-
tal band of corneal flattening is observed in the superior aspect of the pupil corresponding to the 
position of the upper eyelid during downward gaze. This refractive change is equivalent to a 0.20 D 
hyperopic shift over the central 4 mm
a b c
Fig. 4.9 Refractive power maps, a graphical representation of total ocular higher order aberra-
tions, during (a) distance fixation (0 D accommodation demand), (b) a 5 D accommodation task, 
and (c) the difference (B minus A) over a 3 mm pupil diameter. A significant increase in negative 
spherical aberration of −0.10 μm is displayed
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4.4.3  Accommodation
Given the association between near work and the development and progression of 
childhood myopia [222], numerous studies have compared various characteristics 
of accommodation between refractive error groups, typically the accuracy of the 
accommodation response, since a lag of accommodation (hyperopic retinal defo-
cus) may stimulate axial elongation as observed in animal models. Using a range 
of experimental approaches, the accommodative response to a 3 D accommodative 
stimulus is ~0.25 to 1.00 D less in myopic adults compared to emmetropes [223–
227]. The slowing of myopia progression during childhood with progressive addi-
tion or bifocal lenses, designed to improve accommodation accuracy and minimize 
a lag of accommodation, adds some weight to the role of accommodation in myopia 
development and progression [62, 228]. However, the exact underlying mechanism 
of myopia control with such lenses may be related to imposed peripheral retinal 
defocus or a reduction in the near vergence demand [229]. In a longitudinal study 
of young infants [230], a significant relationship was observed between the accom-
modative response and the reduction in neonatal refractive error in the first 2 years 
of life, supporting a potential role for accommodation-guided eye growth.
4.4.4  Circadian Rhythms
Like many of the human body’s physiological processes, numerous ocular struc-
tures and functions exhibit cyclic variations over the course of the day. Visual inputs 
such as daily patterns of light exposure are considered critical factors in entraining 
the timing of these circadian rhythms. Findings from animal studies demonstrate 
that normal eye growth exhibits significant circadian variations, with the eye gener-
ally being longest during the day and shorter at night [231]. Choroidal thickness 
also exhibits a circadian rhythm in normal eyes, which is generally in antiphase 
to the rhythms in axial length [172]. Similar patterns of diurnal variation in axial 
length and choroidal thickness have also been documented in normal human eyes 
[232–234].
It has also been suggested that ocular circadian rhythms may play a role in eye 
growth regulation and the development of myopia, since altering the visual inputs 
that drive circadian rhythms (e.g., rearing animals in constant light [235] or constant 
darkness [236], or exposing the eye to bright light at night time [237]) can result in 
alterations in normal eye growth in animal models. Furthermore, when refractive 
errors (both hyperopic and myopic) are induced experimentally in animals, changes 
in the magnitude and phase of the normal circadian rhythms of axial length and 
choroidal thickness also occur, which also supports a potential role of circadian 
rhythms in the development of refractive errors [172, 238]. These findings from 
animal research were paralleled by studies in young adult humans, where changes 
in the normal diurnal rhythms of axial length and choroidal thickness occurred in 
response to short-term (12-h) exposure to monocular myopic [165], and hyperopic 
blur [163]. Although the exact role played by circadian rhythms in the regulation of 
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human eye growth is not fully understood, human studies also indicate that myopes 
exhibit alterations in their systemic melatonin levels [239], and also exhibit altered 
sleep patterns [240] compared to non-myopic individuals.
4.5  Effects of Key Environmental Factors on Myopia
As discussed in Chaps. 1 and 2, myopia represents a “complex” disorder with both 
environmental and genetic origins [241, 242]. This section discusses some of the 
important environmental factors, and their influence on myopia.
4.5.1  Near Work and Education
Since the age when myopia normally develops and progresses coincides with the 
school years, myopia has long been suggested to be connected with increased levels 
of education. Indeed, numerous studies conducted across a range of different popu-
lations have consistently found that higher levels of education are associated with 
a higher prevalence of myopia [243–245]. The exact mechanism linking increased 
education with myopia, however, is less clear. Although it is possible that opti-
cal [214, 224] or biomechanical [246, 247] ocular changes associated with near 
work could potentially promote myopic eye growth in those with higher levels of 
education (and hence near work demands), population studies examining the link 
between near work activities and myopia have been conflicting, with some studies 
suggesting an association between near work and myopia [222, 248], and others 
indicating no significant effects [249]. The relatively inconsistent findings linking 
near work with myopia development suggests a potential role for other factors in the 
association between education and myopia, such as a lack of outdoor light exposure, 
discussed further below.
4.5.2  Urbanization
Aspects of the living environment may also be involved in the development and 
progression of myopia, since population-based studies consistently report a higher 
prevalence of myopia in children living in urban regions, compared to children liv-
ing in rural regions [250, 251]. These associations between the urban environment 
and myopia could at least partially be explained by socioeconomic and educational 
differences between urban and rural regions, which could in turn result in differences 
in near work and outdoor activities. However, a number of recent studies indicate 
that a higher population density is significantly associated with increased myopia 
prevalence in children, independent of near work and outdoor activities [252, 253]. 
This suggests other aspects of the urban environment may potentially impact upon 
eye growth. Studies have also reported associations between housing type and myo-
pia, with children living in smaller homes reported to have a significantly higher 
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prevalence of myopia [253, 254]. Although further research is required to estab-
lish the causative nature and mechanisms underlying these associations, it has been 
hypothesized that a constricted living space may result in an increased exposure to 
hyperopic blur, thus promoting myopia.
4.5.3  Light Exposure
A number of recent studies report that the time children spend engaged in outdoor 
activities is negatively associated with their risk of myopia [241, 249, 255–259]. 
Both cross-sectional and longitudinal studies indicate that greater time spent out-
doors is associated with a significantly lower myopia prevalence and reduced risk 
of myopia onset in childhood. Although some studies report significant associations 
between myopia progression and outdoor activity [257, 259], this is not a consis-
tent finding across all longitudinal studies [260]. A recent meta-analysis of studies 
examining the relationship between outdoor time and myopia indicated that there 
was a 2% reduction in the odds of having myopia for each additional hour per week 
spent outdoors [261].
These associations [241, 255, 256] have prompted recent interest in the potential 
influence of light exposure in the regulation of eye growth and myopia. Since out-
door activity typically involves exposure to high intensity light, it has been hypothe-
sized that increased exposure to bright light may be the important factor underlying 
these protective effects of outdoor activity [256]. Other factors, such as the typical 
pattern of retinal focus experienced in outdoor environments (which is likely to 
involve less near focusing and potentially less exposure to hyperopic blur), may 
also play a role [262].
Light Intensity and Myopia Animal studies indicate that the intensity of daily light 
exposure can influence refractive development. In normal growing young chickens, 
rearing animals under a normal daily light-dark cycle, but with daily bright ambient 
lighting (~10,000 lux) resulted in significantly less myopic refractive errors than 
when animals were reared under dim ambient lighting during the day (50 lux) [263]. 
Bright light exposure also inhibits the development of FD myopia in a range of dif-
ferent animal species [114, 181, 264], with the strength of inhibitory effects corre-
lating significantly with the log of the intensity of ambient light exposure [264]. The 
effects of increased light intensity upon lens induced myopia (through imposing 
hyperopic defocus) in animals however are less consistent, with either a slowing of 
lens compensation (with no change in refractive endpoint) [182], or no significant 
effects on lens compensation reported [265].
Recent observational longitudinal studies in humans utilizing wearable light sen-
sors to assess ambient light exposure have enabled the relationship between light 
exposure and axial eye growth in childhood to be examined [266, 267]. Similar to 
findings in animals, both of these recent studies have reported that slower axial eye 
growth is associated with greater daily ambient light exposure (with a 1-log unit 
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increase in light exposure being associated with ~0.1  mm/year slower axial eye 
growth), with this relationship reaching statistical significance in the study with the 
larger sample size (n = 102) [266], and bordering on significance (p = 0.07, n = 60) 
in the other study [267]. A recent randomized, controlled trial in Taiwan examined 
the effect of increasing outdoor time during the school day (an extra 40  min of 
outdoor time during school recess) upon myopia development and axial eye growth 
over 12 months [268]. In this study, light exposure was also monitored using wear-
able light sensors, and a significant association between greater light exposure and 
slower myopia progression was also documented. Collectively, these studies sug-
gest that increased light exposure is associated with slower axial eye growth in the 
human eye.
Increased light exposure may also underlie some of the differences in myopia 
prevalence found in different geographic locations. A recent study compared the 
habitual ambient light exposure (captured with wearable light sensors) of children 
living in Singapore (a country with some of the highest reported levels of childhood 
myopia prevalence [269]) with children living in Australia (where myopia preva-
lence is generally reported to be relatively low [270]) and found substantially lower 
levels of outdoor light exposure in the children living in Singapore (Fig. 4.10) [271].
Duration of Light Exposure and Myopia Animal studies examining the effects of 
increased light exposure upon myopia development have generally used experimen-
tal paradigms where elevated light levels were applied continuously for the full day. 
Lan et al. [272] examined the influence of different daily durations of bright light 
exposure upon inhibition of myopia in chickens. They found bright light applied for 
Fig. 4.10 Average hourly light exposure of Australian (red lines) and Singaporean (blue lines) chil-
dren assessed during school weekdays using wearable light sensors. Note the substantially greater 
light exposure for the Australian children at a number of periods throughout the day [271]. This lower 
daily exposure to bright outdoor light may be one factor underlying the higher myopia prevalence 
typically observed in Singaporean children. Dashed lines indicate the average school start and finish 
times in Australia (red) and Singapore (blue). Error bars represent the standard error of the mean
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only 1 or 2 h per day did not inhibit myopia, but 5 h of exposure did significantly 
protect against the development of FD myopia. Extending exposure duration further 
to 10 h per day did not appear to offer further protective benefit.
In a large longitudinal study, Jones et al. [249] reported that children who engaged 
in outdoor activities for 14 h per week or more, exhibited the lowest odds of devel-
oping myopia. A number of recent randomized controlled trials have reported that 
interventions that increase children’s outdoor time (by 40–80 min a day) signifi-
cantly reduce the onset of myopia in childhood [268, 273, 274]. In the “Role of out-
door activity in myopia study” [266], children who were habitually exposed to low 
ambient light levels (on average less than 60 min exposure to outdoor light per day) 
had significantly faster axial eye growth compared to children habitually exposed 
to moderate and high light levels. These findings from human studies suggest that 
children who are exposed to less than 60 min a day of bright outdoor light are at an 
increased risk of more rapid eye growth and myopia development, and that approxi-
mately 2 h or more of outdoor exposure each day is required to provide protection 
against myopia development in the human eye.
Spectral Composition of Light and Myopia Since the spectral characteristics of 
outdoor light are significantly different to typical indoor light, it has been suggested 
that the spectral composition of outdoor light may be an additional factor that 
underlies the protective effects of outdoor activity upon myopia development. 
Although some studies in humans suggest exposure to short-wavelength light may 
protect against myopia [275], there has only been limited work in humans examin-
ing the possible impact of the spectral composition of light on myopia.
Animal studies do suggest that the spectral content of light can influence the 
growth of the eye, since altered eye growth is observed in animals reared under nar-
row band spectral lighting conditions. However, the effects of the spectral content 
of light shows substantial interspecies differences [276–279]. In chickens and guin-
eas pigs, raising animals in short-wavelength light appears to slow eye growth and 
reduce myopia development, whereas long-wavelength light appears to increase eye 
growth and lead to myopia development [276, 279]. Conversely long-wavelength 
light appears to slow eye growth and reduce myopia development in tree shrews and 
rhesus monkeys [277, 278]. Further research is required to understand the mecha-
nisms underlying these effects (and interspecies differences) and to establish the 
impact of the spectral composition of light upon human myopia.
4.6  Conclusion
In conclusion, over the last 40 years, remarkable progress has been made in under-
standing the possible mechanisms and pathogenesis of myopia, with a large contri-
bution to this knowledge coming from an extensive body of work in animal models. 
Importantly, laboratory research in animals have shown that the visual environment 
R. Chakraborty et al.
83
(i.e., quality and/or focus of the retinal image) influences ocular growth and refrac-
tive development, which has been a key to our current understanding of the process 
of emmetropization in humans. Similarities in features of defocus induced ocular 
changes in humans and experimental models of myopia, such as the eye’s abil-
ity to detect the sign of retinal defocus and make compensatory changes in axial 
length, suggest that mechanisms of visually guided eye growth and refractive error 
development in animal models may be present in human eyes as well. Alongside 
animal research, a large body of clinical and epidemiological research has identi-
fied a number of other visual cues (e.g., aberrations, accommodation, and circadian 
rhythms) and environmental factors (e.g., light exposure, near work, and education) 
that could affect normal ocular growth and lead to the development of refractive 
errors. Experimental models continue to provide valuable information on cellular 
and biochemical mechanisms of eye growth, enabling the identification of potential 
new therapeutic targets for early diagnosis and treatment of myopia.
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• While the recent global rise of myopia prevalence is primarily attributable 
to environmental changes, within populations inherited factors play a large 
role in explaining why some individuals are affected by myopia while oth-
ers are not.
• Early efforts to identify the specific genes underlying the heritability of 
refractive error used linkage and candidate gene designs to identify up to 
50 loci and genes, although most remain unconfirmed.
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5.1  Introduction
This chapter addresses the scientific exploration of the genetic architecture of myo-
pia. Myopia is the most common eye condition worldwide and its prevalence is 
increasing. Changes in environmental conditions where time spent outdoors has 
reduced relative to previous generations are the main hypothesized culprit. Despite 
these environmental trends, within populations, myopia is highly heritable; genes 
explain up to 80% of the variance in refractive error. Initial attempts to identify 
myopia genes relied on family studies using linkage analysis or candidate gene 
approaches with limited progress. For the last decade, genome-wide association 
study (GWAS) approaches have predominated, ultimately resulting in the identifi-
cation of hundreds of genes for refractive error and myopia, providing new insights 
into its molecular machinery. Thanks to these studies, it was revealed that myopia is 
a complex trait, with many genetic variants of small effect influencing retinal sig-
naling, eye growth and the normal process of emmetropization. However, the 
genetic architecture and its molecular mechanisms are still to be clarified and while 
genetic risk score prediction models are improving, this knowledge must be 
expanded to have impact on clinical practice.
Some sections of this report follow the framework described in a recent 
International Myopia Institute Genetics report by Tedja et al. [1]
5.2  Heritability
The tendency for myopia to run in families has long been noted, suggesting genetic fac-
tors play a role in determining risk [2]. While family studies show familial aggregation, 
twin studies are required to reliably separate the effects of genes and familial environ-
ment [3–6]. Benchmarking of the relative contribution of genetics and environment is 
done by computation of heritability, the proportion of the total trait variance (here, 
spherical equivalent) due to additive genetic factors. Since the contributions of genes 
and environment can vary across human populations, heritabilities are population and 
• As the sample size in genome-wide association studies (GWAS) has 
increased, the number of implicated loci has risen steadily, with 161 vari-
ants reported in the latest meta-analysis.
• Interrogation of loci uncovered by GWAS offers insight into the molecular 
basis of myopia—for example, pathway analysis implicates the light 
induced retina-to-sclera signaling pathway in myopia development.
• Although many loci have been uncovered by GWAS, statistical modelling 
shows there are many more genes to find—identifying these will further 
illuminate the molecular pathways leading to myopia and open up new 
avenues for intervention.
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even time specific [7, 8]. The influence of environmental variance is well illustrated in 
the case of the heritability study in Alaskan Eskimos, where the rapid introduction of the 
American school system dramatically increased the contribution of the environment. As 
a result heritability estimates, computed based on families where the parents are less 
educated relative to their offspring, were very low at this time (10%) [7].
Across most human populations, environment is fairly constant and the estimates 
of spherical equivalent heritability are usually high (~80%) [9–11]. Although the 
aggregate contribution of genetic factors to variation in refractive error is high, ini-
tial studies were unable to determine the genetic architecture of myopia—that is, is 
myopia caused by rare mutations of large effect? Or is most variation driven by 
common variants, each with individually small effect on risk? With the advent of 
genotyping arrays, it became possible to estimate the aggregate effect of all com-
mon variants, with “array heritability” estimates of 35% from the ALSPAC study. 
Such estimates place a lower bound on the proportion of the heritability that is 
attributable to genetic variants which are common in the population. The remaining 
45% (80%–35%) is likely attributable to rare genetic variants, to variants not cov-
ered by genotyping arrays or to non-additive genetic effects.
5.3  Syndromic Myopia
Syndromic myopia is generally monogenic and can occur within a wide spectrum 
of clinical presentations. This type of myopia is usually accompanied by other sys-
temic or ocular disorders. Table 5.1 summarizes all syndromic and ocular condi-
tions that present with myopia [12]. We are able to learn about myopia development 
by investigating these syndromes. For instance, several types of heritable syndromes 
result in extreme axial elongation, due to abnormalities in the development of con-
nective tissue (i.e. Marfan syndrome, OMIM #154700; Stickler syndrome, OMIM 
#,108300 #604841, #614134, #614284 and Ehlers–Danlos syndrome, OMIM 
#225400, #601776). Similarly, inherited retinal dystrophies lead to myopia due to 
defects in photoreceptors, for instance, in X-linked retinitis pigmentosa (mutations 
in RPGR-gene) and congenital stationary night blindness [13].
Interestingly, several syndromic myopia genes were found in association to other 
ocular traits, such as CCT (ADAMTS2, COL4A3, COL5A1, FBN1) [14], and Fuchs’s 
dystrophy (TCF4) [15]. However, the majority of the genes causing syndromic 
myopia have not been linked to common forms of myopia, except for COL2A1 [16, 
17] and FBN1 [18, 19]. Nevertheless, a recent study found an overrepresentation for 
syndromic myopia genes in GWAS studies on refractive error and myopia [20], 
implying their important role in myopia development.
5.4  Linkage Studies
Linkage studies have been successfully applied for many Mendelian disorders, 
although the success has been much more limited in complex traits. The linkage 
approach searches for cosegregation of genetic markers with the trait of interest in 
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Table 5.1 Overview of syndromic forms of myopia
Syndrome
Gene and inheritance 
pattern Ocular phenotype other than myopia
(A) Syndromes associated with myopia and associated ocular phenotype
Acromelic frontonasal 
dysostosis
ZSWIM6 (AD) Telecanthus, ptosis (some patients), corneal 
dermoid cyst (rare), glaucoma (rare), 
segmental optic nerve hypoplasia (rare), 
persistent primary vitreous (rare)
Alagille syndrome JAG1 (AD) Deep-set eyes, hypertelorism, upslanting 
palpebral fissures, posterior embryotoxon, 
anterior chamber anomalies, eccentric or 
ectopic pupils, chorioretinal atrophy, band 
keratopathy, cataracts, retinal pigment 
clumping, Axenfeld anomaly, microcornea, 
choroidal folds, strabismus, anomalous 
optic disc
Alport syndrome COL4A5 (XLD); 
COL4A3 (AR/AD)
Anterior lenticonus, lens opacities, 
cataracts, pigmentary changes (“flecks”) in 
the perimacular region, corneal endothelial 
vesicles, corneal erosions
Angelman syndrome UBE3A (IP); CH Strabismus (most frequently exotropia), 
ocular hypopigmentation, refractive errors 
(astigmatism, hyperopia, myopia)
Bardet–Biedl syndrome ARL6; BBS1; BBS2; 







Rod-cone dystrophy onset by end of 2nd 
decade, retinitis pigmentosa, retinal 
degeneration, strabismus, cataracts
Beals syndrome FBN2 (AD) Ectopia lentis
Beaulieu–Boycott–Innes 
syndrome
THOC6 (AR) Deep-set eyes, short palpebral fissures, 
upslanting palpebral fissures
Bohring–Opitz syndrome ASXL1 (AD) Prominent eyes, hypoplastic orbital ridges, 
hypertelorism, upslanting palpebral 
fissures, strabismus, retinal abnormalities, 
optic nerve abnormalities
Bone fragility and 
contractures; arterial 
rupture and deafness
PLOD3 (AR) Shallow orbits, cataracts
Branchiooculofacial 
syndrome
TFAP2A (AD) Lacrimal sac fistula, orbital dermoid cyst, 
iris pigment epithelial cyst, combined 
hamartoma of the retina and retinal 
pigment epithelium, upslanting palpebral 
fissures, telecanthus, hypertelorism, ptosis, 
lacrimal duct obstruction, iris coloboma, 
retinal coloboma, microphthalmia, 
anophthalmia, cataract, strabismus




Gene and inheritance 
pattern Ocular phenotype other than myopia
Cardiofaciocutaneous 
syndrome
MAP2K2 (AD) Ptosis, nystagmus, strabismus, 
downslanting palpebral fissures, 
hypertelorism, exophthalmos, epicanthal 
folds, optic nerve dysplasia, oculomotor 
apraxia, loss of visual acuity, absence of 
eyebrows, absence of eyelashes
Cohen syndrome VPS13B (AR) Downslanting palpebral fissures, almond- 
shaped eyes, chorioretinal dystrophy, 
decreased visual acuity, optic atrophy




Synophrys, long curly eyelashes, ptosis
Cowden syndrome PTEN (AD) Cataract, angioid streaks
Cranioectodermal 
dysplasia
IFT122 (AR) Telecanthus, hypotelorism, epicanthal 
folds, myopia (1 patient), nystagmus (1 
patient), retinal dystrophy (1 patient)
Cutis laxa ATP6V0A2; 
ALDH18A1 (AR)
Downslanting palpebral fissures, 
strabismus
Danon disease LAMP2 (XLD) Moderate central loss of visual acuity in 
males, normal to near-normal visual acuity 
in carrier females, fine lamellar white 
opacities on slit lamp exam in carrier 
females, near complete loss of peripheral 
retinal pigment in males, peppered 
pigmentary mottling of peripheral retinal 
pigment in carrier females, nonspecific 
changes on electroretinogram in carrier 
females
Deafness and myopia SLITRK6 (AR) High myopia
Desanto–Shinawi 
syndrome
WAC (AD) Hypertelorism, downslanting palpebral 
issues, synophrys, deep-set eyes, 
astigmatism, strabismus




LRP2 (AR) Hypertelorism, high myopia, loss of vision, 
iris coloboma, iris hypoplasia, cataract, 
enlarged globes, downslanting palpebral 
fissures, underorbital skin creases, retinal 
detachment, retinal dystrophy, prominent 
eyes
DOORS TBC1D24 (AR) Optic atrophy, blindness, high myopia, 
cataracts






Blue sclerae, ectopia lentis, epicanthal 
folds
(continued)




Gene and inheritance 
pattern Ocular phenotype other than myopia
Emanuel syndrome CH Hooded eyelids, deep-set eyes, upslanting 
palpebral fissures, strabismus
Fibrochondrogenesis COL11A1 (AR) –
Gyrate atrophy of 
choroid and retina with/
without ornithinemia
OAT (AR) Progressive chorioretinal degeneration, 
night blindness (onset in first decade, 
progressive loss of peripheral vision, 
blindness (onset in fourth or fifth decade), 
posterior subcapsular cataracts (onset in 
second or third decade)
Hamamy syndrome IRX5 (AR) Severe hypertelorism, laterally sparse 
eyebrows, myopia (progressive severe)
Homocystinuria CBS (AR) Ectopia lentis, glaucoma
Joint laxity; short stature; 
myopia
GZF1 (AR) Exophthalmos, severe myopia, retinal 
detachment (some patients), iris coloboma 
(some patients), chorioretinal coloboma 




UBE3B (AR) Blepharophimosis, ptosis, upward-slanting 
palpebral fissures, telecanthus, 
hypertelorism, astigmatism, strabismus, 
mild
Kenny–Caffey syndrome FAM111A (AD) Hyperopia (not myopia), microphthalmia, 
papilledema, corneal and retinal 
calcification, congenital cataracts (rare)
Kniest dysplasia COL2A1 (AD) Retinal detachment, cataracts, prominent 
eyes
Knobloch syndrome COL18A1 (AR) High myopia, vitreoretinal degeneration, 
retinal detachment (childhood), congenital 
cataract, syneresis, vitreous attachment at 
the disc, persistent foetal hyaloid 
vasculature, peripapillary atrophy, phthisis 
bulbi, band keratopathy, macular 
hypoplasia, irregular white dots at the 
vitreoretinal interface, visual loss, 
nystagmus




ERBB3 (AR) High myopia, degenerative 
vitreoretinopathy









Lacrimal duct atresia, nystagmus, 
strabismus
Loeys–Dietz syndrome TGFBR1; TGFBR2 
(AD)
Hypertelorism, exotropia, blue sclerae, 
proptosis




Gene and inheritance 





Marfan syndrome FBN1 (AD) Enophthalmos, ectopia lentis increased 
axial globe length, corneal flatness, retinal 
detachment, iris hypoplasia, early 
glaucoma, early cataracts, downslanting 
palpebral fissures, trabeculodysgenesis, 
primary (some patients), strabismus (some 
patients), exotropia (some patients), 
esotropia (rare), hypertropia (rare)
Marshall syndrome COL11A1 (AD) congenital cataracts, esotropia, retinal 
detachment, glaucoma, lens dislocation, 







KIF11 (AD) Upslanting palpebral fissures, downslanting 
palpebral fissures (some patients), 
epicanthal folds (some patients), 
nystagmus, reduced visual acuity, 
hypermetropia, myopic astigmatism, 
hypermetropic astigmatism, corneal 
opacity, microcornea, microphthalmia, 
cataract, retrolenticular fibrotic mass, 
chorioretinopathy, retinal folds, falciform 
retinal folds, retinal detachment, temporal 
dragging of optic disc, retinal pigment 




TIMM8A (XLR) Photophobia, cortical blindness, decreased 
visual acuity, constricted visual fields, 
abnormal electroretinogram
Mucolipidosis GNPTAG (AR) Fine corneal opacities





Cataracts, strabismus, alacrima (some 
patients)
Nephrotic syndrome LAMB2 (AR) Nystagmus, strabismus, microcoria, 
aplasia/atrophy of the dilatator pupillae 
muscle, hypoplasia of the iris and ciliary 
body, lenticonus posterior, blindness, 
decreased or absent laminin beta-2 
immunoreactivity in tissues of the anterior 
eye
(continued)




Gene and inheritance 
pattern Ocular phenotype other than myopia
Noonan syndrome A2ML1; BRAF; 
CBL; HRAS; KRAS; 
MAP2K1; MAP2K2; 
NRAS; PTPN11; 
RAF1; RIT1; SOS1; 
SHOC2; SPRED1 
(AD)
Ptosis, hypertelorism, downslanting 
palpebral fissures, epicanthal folds, 
blue-green irides
Oculocutaneous albinism TYR (AR) Absent pigment in iris and retina, 
translucent iris, pink irides (childhood), 
blue-gray irides (adult), choroidal vessels 
visible, foveal hypoplasia, decreased visual 
acuity, strabismus, nystagmus, 
photophobia, high refractive errors 
(hyperopia, myopia, with-the-rule 
astigmatism), albinotic optic disc, 
misrouting of the optic nerves at the 
chiasm, absent stereopsis due to anomalous 
decussation at the optic chiasm, positive 
angle kappa (appearance of exotropia but 




GJA1 (AR) Hypoplastic eyebrows, sparse eyelashes, 
telecanthus, short palpebral fissures, 
downslanting palpebral fissures, 




CH Sparse eyebrows, sparse eyelashes, 
upslanting palpebral fissures, 
hypertelorism, ptosis, strabismus, 
epicanthal folds, cataracts, exophthalmos
Papillorenal syndrome PAX2 (AD) Retinal coloboma, optic nerve anomalies 
(coloboma, gliosis, absent optic nerve 
head), optic disc anomalies (dysplasia, 
excavation, hyperplasia, morning glory 
optic disc, hypoplasia), orbital cysts, 
microphthalmia, abnormal retinal pigment 
epithelium, abnormal retinal vessels, 
chorioretinal degeneration, retinal 
detachment (rare). retinal staphyloma 
(rare), retinal edema (rare), macular 
degeneration (rare), papillomacular 
detachment (rare), hyperpigmentation of 
the macula (rare), cystic degeneration of 
the macula (rare), posterior lens luxation 
(rare), lens opacity (rare)




Gene and inheritance 
pattern Ocular phenotype other than myopia
Peters-plus syndrome B3GLCT (AR) Hypertelorism, Peter’s anomaly, anterior 
chamber cleavage disorder, nystagmus, 
ptosis, glaucoma, upslanting palpebral 
fissures, cataract, iris coloboma, retinal 
coloboma




CHMP1A (AR) Astigmatism, esotropia, strabismus, 
hyperopia, nystagmus (some patients), 
cortical visual impairment (some patients), 
poor visual tracking (some patients)
Poretti–Boltshauser 
syndrome
LAMA1 (AR) Strabismus, amblyopia, oculomotor 
apraxia, nystagmus, retinal atrophy, retinal 
dystrophy, retinal dysfunction, macular 
heterotopia
Prader–Willi syndrome NDN (PC); SNRPN 
(IP); CH
Almond-shaped eyes, strabismus, 
upslanting palpebral fissures, hyperopia
Pseudoxanthoma 
elasticum
ABCC6 (AR) Peau d’orange retinal changes (yellow- 
mottled retinal hyperpigmentation), angioid 
streaks of the retina (85% of patients), 
macular degeneration, visual impairment 
(50–70% of patients), central vision loss, 
colloid bodies, retinal haemorrhage, 
choroidal neovascularization, optic head 
drusen (yellowish-white irregularities of 
optic disc), owl’s eyes (paired 
hyperpigmented spots)
Renal hypomagnesemia CLDN16; CLDN19 
(AR)
Strabismus, nystagmus, hyperopia, 
astigmatism
SADDAN FGFR3 (AD) High myopia, exotropia
Schaaf–Yang syndrome MAGEL2 (AD) Esotropia, strabismus, almond-shaped eyes, 
short palpebral fissures, bushy eyebrows
Schimke immunoosseous 
dysplasia
SMARCAL1 (AR) Corneal opacities, astigmatism
Schuurs–Hoeijmakers 
syndrome
PACS1 (AD) Full, arched eyebrows, long eyelashes, 
hypertelorism, downslanting palpebral 
fissures, ptosis, nystagmus, strabismus
Schwartz–Jampel 
syndrome
HSPG2 (AR) Narrow palpebral fissures, 
blepharophimosis, cataract, microcornea, 
long eyelashes in irregular rows, ptosis
Sengers syndrome AGK (AR) Cataracts (infantile), strabismus, glaucoma
Short stature; hearing 
loss; retinitis pigmentosa 
and distinctive facies
EXOSC2 (AR) Deep-set eyes, short palpebral fissures, 
upslanting palpebral fissures, retinitis 
pigmentosa (2 patients), corneal dystrophy 
(2 patients, young-adult onset), glaucoma 
(1 patient), nystagmus (1 patient), 
strabismus (1 patient)
(continued)




Gene and inheritance 
pattern Ocular phenotype other than myopia
Short stature; optic nerve 
atrophy; and Pelger–Huet 
anomaly
NBAS (AR) Thick and bush eyebrows, small orbits, 
bilateral exophthalmos, epicanthus, 
bilateral optic nerve atrophy, non- 
progressive decreased visual acuity, (in)
complete achromatopsia, strabismus (some 
patients), hypertelorism (some patients), 
hypermetropia (rare), pigmented nevus 
(rare)
SHORT syndrome PIK3R1 (AD) Deep-set eyes, Rieger anomaly, 









SKI (AD) Telecanthus, hypertelorism, proptosis, 
strabismus, downslanting palpebral 




Small vessel brain 
disease with/without 
ocular anomalies
COL4A1 (AD) Retinal arteriolar tortuosity, 
hypopigmentation of the fundus, episodic 
scotomas, episodic blurred vision, 
amblyopia (1 family), strabismus (1 
family), high intraocular pressure (1 
family). Reported in some patients: 
astigmatism, hyperopia, congenital 
cataracts, prominent or irregular Schwalbe 
line, iridocorneal synechiae, Axenfeld–
Rieger anomalies, corneal opacities, 
microphthalmia, microcornea, iris 
hypoplasia, corectopia. Rare: decreased 
visual acuity, glaucoma, corneal 
neovascularization, polycoria, 
iridogoniodysgenesis, macular 





Spastic paraplegia and 
psychomotor retardation 
with or without seizures









Retinal detachment, blindness, occasional 
cataracts, glaucoma, membranous (type I) 
vitreous phenotype




Gene and inheritance 
pattern Ocular phenotype other than myopia
Syndromic mental 
retardation




(XLR); SMS (XLR); 
ELOVL4 (AR); 
KDM5C (XLR)
Synophrys, eyebrow abnormalities, 
upslanting and short palpebral fissures, 
epicanthal folds, mild hypertelorism, 




OTX2; BMP4 (AD) Uni- or bilateral microphthalmia, uni- or 
bilateral anophthalmia, coloboma, 
microcornea, cataract, retinal dystrophy, 
optic nerve hypoplasia or agenesis
Temtamy syndrome C12orf57 (AR) Hypertelorism. “key-hole” iris, retina and 
choroid coloboma, dislocated lens 
(upward), downslanting palpebral fissures, 
arched eyebrows
White–Sutton syndrome POGZ (AD) Visual abnormalities, strabismus, 
astigmatism, hyperopia, optic atrophy, 
rod-cone dystrophy, cortical blindness
Zimmermann–Laband 
syndrome
KCNH1 (AD) Thick eyebrows, synophrys, cataracts
AD autosomal dominant, AR autosomal recessive, XLR X linked recessive, XLD X linked domi-
nant, CH chromosomal, IP imprinting defect
Table 5.1A Ocular conditions associated with myopia
Ocular condition Gene and inheritance pattern
Achromatopsia CNGB3 (AR)
Aland Island eye disease GPR143 (XLR)
Anterior segment dysgenesis PITX3 (AD)
Bietti crystalline corneoretinal dystrophy CYP4V2 (AD)
Blue cone monochromacy OPN1LW; OPN1MW (XLR)
Brittle cornea syndrome ZNF469; PRDM5 (AR)
Cataract BFSP2; CRYBA2; EPHA2 (AD)
Colobomatous macrophthalmia with 
microcornea
CH
Cone dystrophy KCNV2 (AD)
Cone rod dystrophy C8orf37 (AR); RAB28 (AR); RPGR (XLR); 
CACNA1F (XLR)
Congenital microcoria CH
Congenital stationary night blindness NYX (XLR); CACNA1F (XLR); GRM6 (AR); 
SLC24A1 (AR); LRIT3 (AR); GNB3 (AR); 
GPR179 (AR)
Ectopia lentis et pupillae ADAMTSL4 (AR)
(continued)
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Leber congenital amaurosis TULP1 (AR)
Microcornea, myopic chorioretinal atrophy, 
and telecanthus
ADAMTS18 (AR)
Microspherophakia and/or megalocornea, 
with ectopia lentis and/or secondary 
glaucoma
LTBP2 (AR)
Ocular albinism OCA2 (AR)
Primary open angle glaucoma MYOC; OPTN (AD)
Retinal cone dystrophy KCNV2 (AR)
Retinal dystrophy C21orf2 (AR); TUB (AR)
Retinitis pigmentosa RP1 (AD); RP2 (XLR); RPGR (XLR); TTC8 
(AR)
Sveinsson chorioretinal atrophy TEAD1 (AD)
Vitreoretinopathy ZNF408 (AD)
Wagner vitreoretinopathy VCAN (AD)
Weill–Marchesani syndrome ADAMTS10 (AR); FBN1(AD); LTBP2 (AR); 
ADAMTS17 (AR)
AD autosomal dominant, AR autosomal recessive, XLR X linked recessive, CH chromosomal
pedigrees [21]. Families with genetic variants which show an autosomal dominant 
inheritance pattern were also most successful for myopia linkage studies. Up to 
now, 20 MYP loci [22–25] and several other loci [26–31] are identified for (high) 
myopia. Fine mapping led to candidate genes, such as the IGF1 gene located in the 
MYP3 locus [32]. Linkage using a complex inheritance design found five additional 
loci [33–37].
Validation of candidate genes often resulted in no association, but other variants 
appeared associated with the non-Mendelian, common form of myopia. This hints 
towards a genetic overlap between Mendelian and common myopia [38]. As the 
GWAS era progressed, linkage studies fell by the wayside. Nevertheless, segrega-
tion analyses combined with linkage and next generation sequencing (i.e. whole 
exome sequencing) of regions in pedigrees with high myopia are, in theory, expected 
to facilitate the discovery of rare variants with large effects; an aspect which cannot 
be distilled from GWAS.
5.5  Candidate Gene Studies
In candidate gene studies the focus is on a gene with suspected biological, physiologi-
cal or functional relevance to myopia, in particular high myopia. Although sometimes 
effective, candidate gene studies are limited by their reliance on this existing knowl-
edge. Table 5.2 summarizes candidate gene studies on (high) myopia. Particularly 
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notable are genes encoding extracellular matrix-related proteins (COL1A1, COL2A1 
[16, 17] and MMP1, MMP2, MMP3, MMP9, MMP10 [59, 60]). For candidates such 
as PAX6 and TGFB1, the results were replicated in multiple independent extreme/high 
myopia studies and validated in a large GWAS meta- analysis in 2018, respectively 
[18, 76]. However in most other cases, the results were not independently validated: 
LUM and IGF1 failed to confirm an association [77, 78]. Interestingly, in a few cases 
the candidates were subsequently implicated in GWAS of other ocular traits: TGFβ2 
and LUM for central corneal thickness (CCT), a glaucoma and keratoconus endophe-
notype [14], PAX6 with optic disc area [79] and HGF [80].
5.6  Genome-Wide Association Studies
Generally, linkage studies are limited to identification of genetic variants with a large 
effect on myopia [81]. Given the limited number of genes identified by linkage, it 
became apparent in the 2000s that identifying large numbers of additional myopia 
genes was more practical with genome-wide association studies (GWASes), since it 
has dramatically higher statistical power. GWASes have greatly enhanced our knowl-
edge of the genetic architecture of (complex) diseases [82]. Most of the variants found 
via GWAS reside in non-exonic regions and their effect sizes are typically small [82, 
83]. For GWAS, 200 k–500 k genetic markers are usually genotyped and a further >10 
million “imputed”, taking advantage of the correlation structure of the genome. This 
approach is most effective for common variants (allele frequencies >0.01 in the popula-
tion, although with larger reference panels, rarer alleles can also be detected).
Initially, GWASes for myopia were performed as a dichotomous outcome (i.e. 
case-control, Table 5.3). Since myopia constitutes a dichotomization of the quantita-
tive trait spherical equivalent, considering the quantitative trait should be more infor-
mative for gene mapping. The first GWASes for spherical equivalent were conducted 
in 2010 [96, 97], with ~4000 individuals required to identify the first loci. The first 
loci to reach the genome-wide significance threshold (P < 5 × 10−8, the threshold 
reflecting the large number of statistical tests conducted genome-wide) were markers 
near the RASGFR1 gene on 15q25.1 (P = 2.70 × 10−9) and markers near GJD2 on 
15q14 (P = 2.21 × 10−14). A subsequent analysis combining five cohorts (N = 7000) 
identified another locus at the RBFOX1 gene on chromosome 16 (P = 3.9 × 10−9) [98].
These early efforts made it clear that individual groups would have difficulty in map-
ping many genes for spherical equivalent, motivating the formation of the Consortium 
for Refractive Error and Myopia (CREAM) in 2010, which included researchers and 
cohorts from the USA, Europe, Asia and Australia. They replicated SNPs in the 15q14 
loci [99], which was further affirmed by other studies on both spherical equivalent and 
axial length alongside with the replication of the 15q25 locus [100, 101].
In 2013, two major GWAS meta-analyses on refractive error traits (spherical 
equivalent and age of spectacle wear) identified 37 novel loci (Table  5.4), with 
robust replication of GJD2, RFBOX1 and RASGFR1 in both meta-analyses. The 
first was the collaborative work of CREAM based on a GWAS meta-analysis on 
spherical equivalent, comprising 35 individual cohorts (NEuropean  =  37,382; 
NSoutheastAsian = 12,332) [108]. 23andMe, a direct-to-consumer genetic testing com-
pany, performed the second major GWAS, replicating 8 of the novel loci found by 
CREAM and identifying another 11 novel loci based on a GWAS survival analysis 
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of age of spectacle wear in 55,177 participants of European ancestry. To the surprise 
of some in the field, the effect sizes and direction of the effects of the loci found by 
these two groups were concordant despite the difference in phenotype definition and 
in scale: dioptres for CREAM and hazard ratios for 23andMe [109]. Subsequently, 
replication studies provided validation for the associated loci and highlighted two 
other suggestive associations. At this point, the implicated loci explained 3% of the 
phenotypic variance in refractive error [108, 110].
The CREAM and 23andMe studies represented a large increase in sample size 
over the initial GWASs. Their meta-analysis approach was very effective in discov-
ering new loci. This motivated joined efforts of CREAM and 23andMe, which 
resulted in a GWAS meta-analysis including 160,420 participants. Moreover, a 
denser imputation reference set was used (1000G phase 1 version 3), enabling bet-
ter characterization of genetic variations. Although CREAM and 23andMe used 
different phenotypes (spherical equivalent and age at first spectacle wear, respec-
tively) again the results were concordant and the new findings were replicated in an 
independent cohort with refractive error available (UK biobank, comprising 95,505 
participants). Overall, this GWAS increased the number of risk loci to 161, explain-
ing 7.8% of the phenotypic variance in refractive error. Very large sample sizes 
(millions) will be required to identify all of the loci contributing to myopia risk.
The genetic correlation was estimated to be 0.78 between European and Asian 
ancestry, suggesting that despite (1) large differences in the rate of myopia between 
these groups and (2) differences in the genetic ancestry of these groups, most of the 
genetic variation is in common. Figure 5.1 provides the chronological discovery of 
all associated loci and Fig. 5.2 shows the effect sizes of the established 161 loci.
Several “endophenotypes” have been considered for myopia: spherical equivalent, 
axial length, corneal curvature and age of diagnosis of myopia. Axial length is a well-
studied “endophenotype” which correlates strongly with refractive error. The first GWAS 
of axial length considered 4944 Asian ancestry individuals and identified a locus at 1q41. 
A subsequent meta-analysis combining data on 12,531 European and 8216 Asian ances-
try individuals uncovered a further eight genome-wide significant loci at RSPO1, 
C3orf26, LAMA2, GJD2, ZNRF3, CD55, MIP, ALPPL2, as well as confirming the 1q41 
locus. Five of the axial length loci were also associated loci for refractive error. GWASs 
performed for corneal curvature [104, 111–114] identified the loci FRAP1, CMPK1, 
RBP3 and PDGFRA; in the case of PDGFRA, associations have also been found with eye 
size. A study in 9804 Japanese individuals and replication in Chinese and European 
ancestry cohorts analysed three myopia-related traits (refractive error, axial length and 
corneal curvature). They replicated the association of GJD2 and refractive error as well 
as the association of SNPs in WNT7B for axial length and corneal curvature [114, 115] 
5.7  Pathway Analysis Approaches
GWAS approaches improve our understanding of the molecular basis of traits by map-
ping individual loci. However, it is possible to place such loci into a broader context by 
applying pathway analysis approaches. In myopia, a retina-to-sclera signaling cascade 
has been postulated, but the specific molecular components were unclear. Recent 
GWASs have uncovered genes which lie along this pathway [108, 110, 116]—genetic 
changes at individual loci only make small changes to phenotype but collectively these 
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Fig. 5.1 Historic overview of myopia gene finding. Overview of myopia gene finding in historic 
perspective. Genes identified using whole exome sequencing are marked as purple. Other loci 
(linkage studies, GWAS) are marked as red
Fig. 5.2 Effect sizes of common and rare variants for myopia and refractive error. Overview of 
SNPs and annotated genes found in the most recent GWAS meta-analysis [18]. X-axis displays the 
minor allele frequency of each SNP; y-axis displays the effect size of per individual SNP. The blue 
dots represent the novel loci discovered by Tedja et al. [18] and the pink dots represent the loci 
found by Verhoeven et al. [108], which now have been replicated
perturbations are responsible for larger changes in the retina-to- sclera signaling cascade, 
ultimately explaining differences in refractive error from individual to individual.
Pathways inferred from the first large-scale CREAM GWAS [108, 110] included 
neurotransmission (GRIA4), ion transport (KCNQ5), retinoic acid metabolism 
(RDH5), extracellular matrix remodelling (LAMA2, BMP2) and eye development 
(SIX6, PRSS56). The 23andMe GWAS identified an overlapping set of pathways: 
neuronal development (KCNMA1, RBFOX1, LRRC4C, NGL-1, DLG2, TJP2), 
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extracellular matrix remodelling (ANTXR2, LAMA2), the visual cycle (RDH5, RGR, 
KCNQ5), eye and body growth (PRSS56, BMP4, ZBTB38, DLX1) and retinal gan-
glion cell (ZIC2, SFRP1) [117]. When considered in the context of known protein–
protein interactions, many genes in these pathways are related to growth and cell 
cycle pathways, such as the TGF-beta/SMAD and MAPK pathways [118].
The most recent meta-analysis combining data from CREAM and 23andMe data 
taken together confirmed previous findings and offered additional insights [18]. In a 
gene-set analysis, several pathways were highlighted including “abnormal photore-
ceptor inner segment morphology” (Mammalian Phenotype Ontology (MP) 0003730); 
“thin retinal outer nuclear layer” (MP 0008515); “nonmotile primary cilium” (Gene 
Ontology (GO) 0031513); “abnormal anterior-eye-segment morphology” (MP 
0005193) and “detection of light stimulus” (GO 0009583). The genes implicated in 
this large-scale GWAS were distributed across all cell types in the retina-to-sclera 
signaling cascade (neurosensory retina, RPE, vascular endothelium and extracellular 
matrix, Fig.  5.3). The larger GWAS also suggested novel mechanisms, including 
angiogenesis, rod-and-cone bipolar synaptic neurotransmission and anterior-segment 
morphology. Interestingly, a novel association was found at the DRD1 gene, support-
ing previous work linking the dopamine pathway to myopia.
5.8  Next Generation Sequencing
GWAS approaches have been highly effective in assessing the role of common vari-
ants in myopia but such methods cannot effectively characterize very rare genomic 
variants. Whole exome sequencing (WES) allows investigation of rare variants in 
exonic regions; due to cost, applications to date have primarily been in family stud-
ies or studies of early onset high myopia.
Fig. 5.3 Schematic overview of known function in retinal cell types of refractive error and syn-
dromic myopia genes according to literature. Bold: genes identified for both common refractive 
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Studies employing WES to date have either focused on family designs (e.g. par-
ticular inheritance patterns such as X-linkage or conditions such as myopic anisome-
tropia) or case-control studies of early onset high myopia [119–122]. The WES-based 
approaches identified several novel mutations in known myopia genes (Table 5.5). 
For instance, Kloss et al. [131] performed WES on 14 families with high myopia, 
identifying 104 genetic variants in both known MYP loci (e.g. AGRN, EME1 and 
HOXA2) and in new loci (e.g. ATL3 and AKAP12) [131]. In the family studies, most 
variants displayed an autosomal dominant mode of inheritance [119, 123, 124, 130] 
although X-linked heterozygous mutations were found in ARR3 [126].
Both retinal dystrophies and ocular development disorders coincide with myo-
pia. Sun et al. [132] investigated if there was a genetic link by evaluating a large 
number of retinal dystrophy genes in early onset high myopia. They examined 298 
unrelated myopia probands and their families, identifying 29 potentially pathogenic 
mutations in COL2A1, COL11A1, PRPH2, FBN1, GNAT1, OPA1, PAX2, GUCY2D, 
TSPAN12, CACNA1F and RPGR with mainly an autosomal dominant pattern.
5.9  Environmental Influences Through Genetics
Although myopia is highly heritable within specific cohorts, dramatic changes in 
environment across many human populations have led to large changes in prevalence 
over time [133–136]. The role of changes in socioeconomic status, time spent out-
doors, education and near-work are now well established as risk factors for myopia, 
based on observational studies [137–139]. Education has proven the most influential 
and consistent factor, with a doubling in myopia prevalence when attending higher 
education compared to finishing only primary education [140–142]. There are two 
main areas where genetic studies can inform our understanding of the role of environ-
ment. Firstly, gene–environment studies can highlight where interactions exist. 
Secondly, observational studies only establish association and not causation—in some 
circumstances genetic data can be used to strengthen the case for an environmental 
risk factor causally (or not) influencing myopia risk (Mendelian randomization).
Gene–environment (GxE) interaction analyses examine whether genes operate 
differently across varying environments. GxE studies in myopia have focused pri-
marily on education. An early study in North American samples examined GxE for 
myopia and the matrix metalloproteinases genes (MMP1-MMP10): a subset of 
SNPs were only associated with refraction in the lower education level [58, 59]. A 
subsequent study in five Singapore cohorts found variants in DNAH9, GJD2 and 
ZMAT4, which had a larger effect on myopia in a high education subset [143]. 
Subsequent efforts to examine GxE considered the aggregate effects of many SNPs 
together. A study in Europeans found that a genetic risk score comprising 26 
genetic variants was most strongly associated with myopia in individuals with a 
university level education [144]. A study examining GxE in children considered 
near work and time outdoors in association with 39 SNPs and found weak evidence 
for an interaction with near work [144, 145]. Finally, a CREAM study was able to 
identify additional myopia risk loci by allowing for a GxE approach [19].
Mendelian randomization (MR) infers whether a risk factor is causally associ-
ated with a disease. MR exploits the fact that germline genotypes are randomly 
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assigned at meiosis, to enable a “natural” randomized controlled trial. Since the 
assigned genotypes are independent of non-genetic confounding and are unmodi-
fied by disease processes, MR offers a better assessment of causality than that avail-
able from observational studies [146, 147].
Two MR studies found a causal effect of education on the development of myopia. 
One of the MR studies tested for causality bi-directionally [148]. Both found a larger 
effect through MR than that estimated from observational studies suggesting that con-
founding in observational studies may have been obscuring the true relationship [149]. 
As expected, there was little evidence of myopia affecting education (−0.008 years/
dioptre, P = 0.6). Another study focused on the causality of low vitamin D on myopia 
due to controversy in the literature [150]. The estimated effects of vitamin D on refrac-
tive error were so small (Caucasians: −0.02 [95% CI −0.09, 0.04] dioptres (D) per 
10 nmol/l increase in vitamin D concentration; Asians: 0.01 [95% CI −0.17, 0.19] D 
per 10 nmol/l increase) that the authors concluded that the true contribution of vitamin 
D levels to degree of myopia is probably zero and that previous observational findings 
were likely confounded by the effects of time spent outdoors.
5.10  Epigenetics
Epigenetics in refractive error and myopia is postulated to be important due to the 
known effects of environmental factors on refractive error and myopia development. 
Nevertheless, this field is still developing and some characteristics of epigenetics ren-
der it a difficult issue to unravel. Epigenetic features can be influenced by environmen-
tal factors and are time dependent and tissue specific. This complicates the study of 
these effects, since myopia and refractive errors develop during childhood and young 
adolescence and obtaining eye tissue, preferably retinal and scleral would be unethical. 
Furthermore, although some epigenetic processes are conserved across species, this is 
not always the case: making animal studies not always translational to humans.
Non-Coding RNAs and Myopia The latest GWAS meta-analysis found 31 of 161 
loci residing in or near regions transcribing (small) noncoding RNAs, thus hinting 
towards the importance of epigenetics [18, 151]. MicroRNAs, or miRNAs, are the 
best-characterized family of small non-coding RNAs. They are approximately 19–24 
nucleotides in length in their mature form. They are able to bind to 3′ UTR regions on 
RNA polymers by sequence-specific post-transcriptional gene silencing; one miRNA 
can regulate the translation of many genes. MiRNAs have been a hot topic in the last 
years due to their potential clinical application: the accessibility of the retina for 
miRNA-based therapeutic delivery has great potential for the prevention and treat-
ment of retinal pathologies [152]. Up to now, there have only been a handful of studies 
on miRNA and its role in myopiagenesis in humans, these are summarized in Table 5.6.
5.11  Implications for Clinical Management
Due to the high polygenicity of myopia and low explained phenotypic variance by 
genetic factors (7.8%), clinical applications derived from genetic analyses of myo-
pia are currently limited. Risk predictions for myopia in children are based on 
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family history, education level of the parents, the amount of outdoor exposure and 
the easily measurable refractive error and axial length.
Currently, we are able to make a distinction between high myopes and high 
hyperopes based on the polygenic risk scores derived from CREAM studies: per-
sons in the highest decile for the polygenic risk score had a 40-fold-greater risk of 
myopia relative to those in the lowest decile.
A prediction model including age, sex and polygenic risk score achieved an AUC 
of 0.77 (95% CI = 0.75–0.79) for myopia versus hyperopia in adults (Rotterdam 
Study I–III) [18]. This AUC is similar to that achieved by modelling environmental 
factors only; the AUC for myopia incidence in a European child cohort was 0.78 
considering parental myopia, 1 or more books read per week, time spent reading, no 
participation in sports, non-European ethnicity, less time spent outdoors and base-
line AL-to-CR ratio [156]. To date, one study has assessed both environmental and 
Table 5.6 Overview of microRNAs associated with myopia







rs662702 High myopia case-control 
study (Ncase = 1083, 
≤−6 D; Ncontrol 1096 
≥−1.5 D)
Down regulation effect on 
PAX6 expression with C 
allele, relative to T allele. 
OR for CC genotype 2.1 
(P = 0.007). This effect 
was significant for 
extreme myopia 






MiR-184 n.a. MiR-184 region sequenced 
in 780 unrelated keratoconus 
patients and 96 unrelated 
Han southern Chinese 
patients with axial myopia 
under the hypothesis that 
axial myopia is associated 
with keratoconus, possibly 
under regulation of 
MiR-184
No miR-184 mutations 






MiR-29a rs157907 High myopia case-control 
study (Ncases = 254, 
≤−6 D; Ncontrols = 300, 
−0.5 to 0.5 D). COL1A1 is 
possibly targeted by 
MiR-29a
The G allele of the 
rs157907 locus was 
significantly associated 
with decreased risk of 
severe myopia (<10 D; 
P = 0.04), compared to 
the A allele. rs157907 
A/G might regulate 
miR-29a expression 
levels, but no functional 
studies have been 






Let-7i rs10877885 High myopia case-control 
study (Ncases = 254, 
≤−6 D; Ncontrols = 300, 
−0.5 to 0.5 D). COL1A1 is 
possibly targeted by Let-7i
No significant association 
with rs10877885 (C/T) 
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genetic factors together and showed that modelling both genes and environment 
improved prediction accuracy [157]. Although these efforts to improve prediction 
are promising, a prediction-based approach will only be beneficial if randomized 
controlled trials of atropine therapy show that children with persistent myopic pro-
gression benefit from an earlier and higher dose of atropine administration. The 
additional costs of genetic testing and potentially invasive regime (collecting blood 
from children) also need to be taken into account.
5.12  Concluding Remarks
The scientific community has discovered more than 200 loci associated with myopia 
and its endophenotypes with a variety of approaches (linkage, candidate gene, GWAS, 
post-GWAS gene-based associations, next generation sequencing approaches, gene 
environment interactions and epigenetic approaches). With the rise of large biobanks, 
such as the UK Biobank [158], further GWAS meta-analyses between large consortia 
and companies will enable identification of many more genes. This will allow full 
elucidation of the molecular mechanism of myopiagenesis. Whole genome sequenc-
ing approaches will replace both GWAS and WES, and will elucidate the genetic 
structure which regulates the function of the myopia risk variants.
To fully understand the underlying mechanisms, the focus should lie on unravel-
ing the genetic and epigenetic architecture of myopia by exploring interactions and 
effects of other “omics” in relevant tissue, i.e. multi-omics. This concept includes 
incorporation of methylomics, transcriptomics, proteomics and metabolomics. 
Future projects should focus on gathering more omics data on eye tissue. Next to the 
multi-omics approach, modelling gene–environment effects will tell us more about 
the genetic key players which are also susceptible to the environment. Furthermore, 
future functional studies interrogating the candidate genes and loci will point us to 
therapeutic solutions for myopia management.
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6Risk Factors for Myopia: Putting Causal Pathways into a Social Context
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Key Points
• Myopia commencing school myopia is found mainly is found mainly in 
developed societies, with only around 1% of any population affected by 
predominantly genetic forms of myopia.
• Exposure to environmental risk factors plays a significant role in the devel-
opment of “school myopia” myopia, both within and between populations.
• Within populations, changes in exposure to environmental risk factors are 
primarily responsible for the emergence of an increasing prevalence of 
myopia.
• The major environmental risk factors identified are educational pressures, 
perhaps best characterized in terms of near work, and limited time out-
doors during daylight hours.
• These risk factors suggest that strategies based on decreases in the amount 
of near work and increases in the amount of time spent outdoors during 
school hours are likely to be useful in the controlling the epidemic of 
myopia.
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It is now generally accepted that there is an environmental epidemic of myopia in 
several parts of East and Southeast Asia, namely Singapore, Japan, South Korea, 
China, including Hong Kong and Macau, as well as in Taiwan [1–8]. In these 
parts of the world, the prevalence of myopia in young adults who have completed 
12 years of schooling, as most do, is now 70–90%, up from 20 to 30% two or three 
generations ago. In addition, the prevalence of high and potentially pathological 
myopia (more than 5 D or 6 D of myopia) is of the order of 10–20% [9–12]. The 
simple argument that the speed at which the prevalence of myopia has increased in 
these locations is not compatible with a predominant role for genetic determination 
of myopia [1, 2] has generally been accepted, even though genetic variation associ-
ated with myopia has been conclusively demonstrated [13]. This emphasizes the 
need to define the environmental exposures responsible for the rapid increases in 
prevalence, in order to design preventive interventions.
The term “an epidemic of myopia” covers two distinct, but related, issues. The 
first is an increase in the prevalence of myopia overall, with a characteristic increase 
in onset of myopia in children in the early school years, leading to a need to provide 
optical correction for a significant proportion of the population from an early age. 
The high prevalence of myopia observed in young adults will gradually become the 
norm for the entire adult population, as younger more myopic generations replace 
those who are older and less myopic.
The second issue is an increase in the prevalence of high myopia, which is asso-
ciated with a higher prevalence of pathological outcomes. The cutoff values used 
to define high myopia are somewhat arbitrary (generally −5  D or −6  D), since 
the prevalence of pathological complications rises steeply with severity of myopia. 
The best cutoff to define high and potentially pathological myopia is one which 
distinguishes, as effectively as possible, between lower and higher risks of pathol-
ogy, but no cutoff will do this perfectly [14]. The increase in more severe levels of 
myopia seems to arise from the fact that myopia has appeared at increasingly early 
ages as the epidemic has developed [11]. With subsequent progression, the myopic 
refractive error will increase toward the cutoff for high myopia, a tendency exacer-
bated by rapid progression in younger children [15]. In these circumstances, slow-
ing the onset of myopia should lead to a disproportionate reduction in high myopia. 
An important question in this area is whether the risk factors for increased preva-
lence of myopia are similar to the risk factors for progression, or in practical terms 
whether increased time outdoors would help to limit progression directly, as well as 
by delaying the onset of myopia. It is certainly possible to slow the development of 
high myopia by clinically slowing progression rates, using optical or pharmaceuti-
cal interventions, and many of these interventions are now available [16].
This chapter reviews the scientific evidence on risk factors in all these areas, and 
relates this evidence to strategies for slowing the onset and progression of myopia. 
We will also mention a number of commonly believed risk factors for myopia that 
may not have a substantial scientific basis. Myopia is such a common condition in 
societies with well-developed education systems that there are many popular beliefs 
about the causes of myopia. These often remain influential, sometimes even when 
the scientific evidence is against them.
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6.1  Key Issues When Studying Risk Factors for Myopia
In assessing the literature on risk factors for myopia, it is essential to be clear about 
a number of fundamental issues.
6.1.1  Myopia Is Etiologically Heterogeneous
It is now generally accepted that environmental factors have a major role to play in 
the development of myopia. Nevertheless, there are 100–200 clearly genetic forms of 
myopia documented in the Online Mendelian Inheritance in Man (OMIM) database 
(https://www.omim.org/, accessed Jan 30, 2019) that clearly run in families [17]. 
These are individually quite rare, but account collectively for myopia in around 1% 
of any population. In a recent detailed analysis, 119 genes were associated specifi-
cally with myopia, generally in association with other clinical features [17]. Most 
of these forms are therefore called syndromic, although in some, myopia seems to 
be the major clinical feature. The latter cases are often called nonsyndromic [18]. 
Environmental factors appear to play a rather limited role in these diseases, but their 
existence does not mean that all forms of myopia are similarly genetic—This issue 
is further discussed in Chapter 5 etc.
In addition to these genetic forms, in modern societies, myopia generally appears 
in association with schooling, as “school myopia.” It is this form that has increased 
in the epidemics of myopia. Genetic variation has some role to play in this form of 
myopia, with the most recent genetic data identifying variants in over 160 genes 
associated with spherical equivalent refraction (SER). Many of these variants are 
associated with the genes involved in the more clearly genetic forms, suggesting 
that mutations in coding regions of the same genes can lead to highly genetic forms 
of myopia, or to more modest effects if the mutations affect regulatory regions [17].
Identified single nucleotide polymorphisms (SNPs) in samples of European 
ancestry account for less than 10% of the variance in refraction [13]. Measured as 
SNP-heritability, they may account for 20–35% of the phenotypic variance [19]. 
These values fall well short of the twin study heritability of 80–90% [20–22]—an 
example of the missing heritability seen with many complex traits [23]. The esti-
mated SNP-heritability in East Asian samples is much lower at around 5% [13], as 
would be expected if the amount of phenotypic variation due to genetic variation 
had remained constant, but that induced by environmental factors had increased 
substantially in populations severely affected by the environmentally induced epi-
demic of myopia. We have recently reviewed this area, and readers can consult these 
reviews for more details [2, 24].
Given this picture, genetic variation may have little, if any, role to play in the 
rapid changes that have produced the current epidemic of myopia, but this does 
not mean that it has no role to play in the determination of variations in refrac-
tive error within a population. In fact, some myopia geneticists have argued that 
environmental factors are important between populations, but within populations, 
genetic factors are the primary determinants [5, 6, 8]. However, this argument does 
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not make sense, because between-population differences have largely emerged due 
to selective changes within populations of the kind seen in East and Southeast Asia 
(Fig. 6.1). The key to understanding lies in the recognition that the balance between 
genetic and environmental factors is population-specific. In the case of myopia, the 
evidence suggests that there is little difference between ethnic groups in the levels 
of SNPs associated with myopia [13], although studies on a wider range of eth-
nic groups are required. However, environmental exposures can differ substantially 
between ethnic groups, and can change rapidly. Environmental factors are therefore 
far more likely to be involved in rapid intergenerational change, or in the rapid 
emergence of differences between societies—both features of the current epidemic.
This has an important implication; key insights into the epidemics are most likely 
to come from comparisons of societies with different prevalence of myopia, rather 
than from detailed studies within populations. Many epidemiologists are wary of 
this ecological approach, because of what is known as the “ecological fallacy”—the 
error that can be made if conclusions are based only upon ecological comparisons. 
But in the case of myopia, this is not an issue, because education and time outdoors 
clearly play a role both within and between populations.
Fig. 6.1 Prevalence of myopia in older and more recent cohorts in older and more recent younger 
cohorts. Data taken from cohorts closest in age to 20 from Breslin et al. [66], French et al. [96], 
Czepita et al. [71] Wang et al. [58], Attebo et al. [59], Wu et al. [12], Koh et al. [10], Jung et al. [9], 
Wong et al. [60]. Xu et al. [198], and He et al. [140]
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6.1.2  Myopia Is a Developmental Condition
Developmental considerations also support the importance of etiological heteroge-
neity. Some forms of myopia appear in children before they start school. These are 
often severe forms, with a strong genetic etiology, and are called early onset myo-
pia. In contrast, “school myopia” results from excessive elongation of the eye dur-
ing the school years. Other ocular components, such as corneal and lens power, are 
within the normal age-specific range. Myopic refractions are also seen in two other 
conditions—keratoconus and cataract-related myopic shifts in older people. These 
conditions are etiologically quite distinct from “school myopia”—the first involving 
abnormal increases in corneal power, generally during the teen-age years, and the 
second involving abnormal increases in lens power in older adults. These forms are 
likely to have a different relationship to pathological myopia than “school myopia,” 
because they do not involve excessive enlargement of the posterior pole of the eye.
Most children are born hyperopic, although premature children have a tendency 
toward more myopic refractions [25]. At birth, the distribution of refractions is close 
to Gaussian, and subsequent development involves clustering of refractions to pro-
duce a tighter distribution, combined with reduction in hyperopic refractions [26–
28]. These changes are often called “emmetropisation” because, as a general rule, 
refractions move from hyperopic toward emmetropic. However, emmetropia is not 
the end point for human refractive development under normal conditions. Rather, 
the preferred end point appears to be a moderate level of hyperopia (1.0–1.3 D), 
provided that cycloplegic refraction is measured [29]. This mildly hyperopic state 
can be maintained even in adults in some environments [30]. However, in popula-
tions where the prevalence of myopia becomes high, the hyperopic clustering of 
refractions disappears.
This part of refractive development is consistent with animal studies on experi-
mental myopia that suggest that hyperopic defocus induces faster axial elongation, 
thus reducing hyperopic refractive error, while myopic defocus can slow axial elon-
gation, and thus might be expected to affect the progression of myopia [31]. Simple 
expectations from the animal models, namely that myopia would be a self-limiting 
condition, or that it would be dangerous to correct myopia since it would reduce 
the error signal, are not consistent with current evidence [32–34]. However, there 
is some evidence that early myopic errors can be cleared [35], and contact lenses 
designed to impose myopic appear to slow the progression of myopia [36]. Thus, 
these mechanisms can come into play in particular circumstances, but what these 
circumstances are is currently unclear.
6.1.3  Cycloplegia and Definitions of Myopia: Important 
Methodological Issues
It is now generally accepted that cycloplegia is the gold standard for studies with 
children, with the use of up to three drops of 1% cyclopentolate as a common prac-
tice, with monitoring of pupil diameter and the light reflex to assess adequacy of 
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cycloplegia [37]. This issue is particularly important in young children, where the 
prevalence of myopia is low, and a small amount of pseudomyopia can significantly 
increase prevalence estimates. It is also important when comparing ethnic groups, 
because it is harder to achieve cycloplegia in children with darkly pigmented irises. 
Without cycloplegia, hyperopia is substantially underestimated, emmetropia may 
be overestimated, with a smaller but significant overestimation of the prevalence of 
myopia. Suboptimal cycloplegia is likely to lead to errors of lesser magnitude, but 
in the same direction.
In contrast to studies on children, cycloplegia has generally not been used in 
studies on adults. Adults over the age of 50 show minimal differences between 
cycloplegic and noncycloplegic refractions [37, 38], consistent with the evidence 
that by this age, accommodative capacity has essentially disappeared, resulting 
in the need for some form of correction for reading. However, in younger adults, 
cycloplegia is required for accurate refraction, yet it generally has not been used in 
the larger studies on adults, even if they included young adults.
This emphasis on cycloplegia poses problems, because gaining informed consent 
for cycloplegia appears to be becoming more difficult. It is worth considering alter-
natives, and biometric variables like axial length and the ratio of the axial length to 
corneal radius of curvature (AL/CR ratio) could be used [39–41]. Both correlate 
highly with myopia [42, 43]. Changes in lens power also play a major role in refrac-
tive development, but they do not correlate highly with refraction and cannot be 
measured directly [44]. The advantage of the first two parameters is that they can be 
measured noninvasively. Their disadvantage is that measurement requires relatively 
expensive modern equipment, and that there is only a very limited set of data for 
comparison. But where repeated measures of cycloplegic refraction are envisaged, 
the highly correlated biometric variables may provide a useful alternative.
It is also important to note that a range of definitions is used in the literature for 
both myopia and high myopia. Cutoff values for myopia range from −0.25 D to 
−1.0 D, with some variation in the use of less than, or less than or equal to. Results 
are sometimes reported in relation to the better eye, worse eye, either eye, or both 
eyes, depending, to some extent, on the aims of the study. The most common standard 
for epidemiology is at least −0.5 D in the right eye. Similarly, the prevalence of high 
myopia is sometimes reported in relation to a cutoff of −5 D or −6 D. Sometimes 
more stringent cutoffs (−8 D, −10 D or −12 D) are used, which is likely to con-
centrate more genetic forms of myopia in the sample. Cumberland et al. [45] have 
therefore called for the development of an approach that “serves research, policy and 
practice,” but made no specific recommendations. However, standard definitions will 
be of little use without standardization of cycloplegia. While awaiting agreement in 
both these areas, if it ever comes, we suggest a pragmatic approach is to publish a 
distribution of refraction in all studies in sufficient detail that others can apply the 
cutoff they think is most relevant. Cumberland et al. [45] also emphasized the sensi-
tivity of risk factor analysis to different definitions of myopia, and where appropriate, 
sensitivity analysis should be used to establish that conclusions are robust [46].
These issues are very relevant to several major studies on risk factors for 
myopia. Studies on childhood and adolescence, the period during which myopia 
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develops, and on young adults, when myopia stabilizes, are particularly impor-
tant, since exposures over this period can be most directly related to the develop-
ment of myopia. In addition, studies on young adults give estimates of prevalence 
that can be most directly compared to assess whether and to what extent there 
is an epidemic of myopia. Table  6.1 lists some of the most important studies 
that used cycloplegia. In general, there is a dearth of systematic evidence on 
the prevalence of myopia in most populations, particularly in the critical period 
Table 6.1 Major studies on childhood refraction that measured cycloplegic refraction
Detailed studies of risk factors for refractive errors in school-aged children using cycloplegic 
refraction
Australia
Study name Sydney Myopia Study (SMS) and Sydney Adolescent Vascular and Eye 
Disease Study (SAVES)
Location Sydney, Australia
Design School based, with stratified randomized selection of schools. Large cohorts 
at baseline in Year 1 (1765, 6–7 year olds) and Year 7 (2353, 12–13 year 
olds), with 4–5 year follow-up
Methodology Cycloplegic refraction (cyclopentolate plus tropicamide). Risk factor 
questionnaire, including near work and time outdoors
Europe
Study name Northern Ireland Childhood Errors of Refraction (NICER)
Location Northern Ireland
Design Stratified, random-cluster design with school-based assessment. Cohorts 
6–7 years old (392) and 12–13 years old (661) at baseline, with 6 year 
follow-up
Methodology Cycloplegic refraction (cyclopentolate). Risk factor questionnaire, not 
including near work and time outdoors
Study name Ireland Eye Study
Location Republic of Ireland
Design School based with stratified randomized selection of schools. Cohorts of 
6–7 year olds (681) and 12–13 year olds (745) at baseline
Methodology Cycloplegic refraction (cyclopentolate). Lifestyle questionnaire
Study name Generation R Study
Location Rotterdam, The Netherlands
Design Birth Cohort Study, with 4734 children examined at the age of 6 and 9
Methodology Cycloplegic refraction (cyclopentolate) introduced for a large subsample at 
age 9. Risk factor questionnaire including near work and time outdoors
United States
Study name Orinda Longitudinal Study of Myopia (OLSM)
Location Orinda, California
Design Volunteer sample of 1246 children from the Orinda Union School District 
followed up longitudinally
Methodology Cycloplegic refraction (tropicamide). Annual parent questionnaire on risk 
factors including education and time outdoors or on sports
(continued)
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up to the emergence of young adults. Large studies have rarely been designed 
to look at refractive errors, and studies reporting on refractive errors from the 
1958 British Birth Cohort Study [47], the Avon Longitudinal Study of Parents 
and Children (ALSPAC) [48–50], the British Twins Early Development Study 
(TEDS) [51], the US-based National Health and Nutrition Evaluation Survey 
(NHANES) [52], the Korean NHANES [53], the Gutenberg Health Survey [54], 
and the UK Biobank Study [55] measured noncycloplegic refractions. Data from 
the European Eye Epidemiology (E3) consortium suffers from the same bias [56, 
Table 6.1 (continued)
Study name Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error 
(CLEERE)
Location Multi-Centre Study, with centers at Orinda (California), Eutaw (Alabama), 
Houston (Texas), Irvine (California), and Tucson (Arizona)
Design Volunteer sample of 2583 with selective recruitment of children of different 
ethnicities from different centers, followed up longitudinally
Methodology Cycloplegic refraction (tropicamide or cyclopentolate plus tropicamide). 
Risk factor questionnaire
Singapore
Study name Singapore Cohort Study of the Risk Factors for Myopia (SCORM)
Location Singapore
Design 1979 children aged 7–9 recruited from three schools in Singapore, with 
longitudinal follow-up
Methodology Cycloplegic refraction (cyclopentolate). Risk factor questionnaire, including 
near work and time outdoors
China
Study name Anyang Childhood Eye Study
Location Anyang City, Hebei Province
Design At baseline, cohorts recruited from Year 1 (2283) and Year 7 (1453), with 
longitudinal follow-up for 5 and 3 years respectively
Methodology Cycloplegic refraction (cyclopentolate). Risk factor questionnaire including 
near work and time outdoors
Study name Guangzhou Twin Eye Study
Location Guangzhou City, Guangdong Province
Design Population-based recruitment of over 1000 twin pairs aged from 7 to 15 at 
baseline from Guangzhou City, with annual longitudinal follow-up
Methodology Cycloplegic refraction (cyclopentolate). Risk factor questionnaire including 
near work and time outdoors
Study name Mojiang Eye Study
Location Mojiang County, Yunnan Province
Design At baseline, cohorts recruited from all students in Year 1 (2432) and Year 7 
(1453), with annual follow-up for 5 and 3 years respectively
Methodology Cycloplegic refraction (cyclopentolate). Risk factor questionnaire including 
near work and time outdoors
Study name Jiading Eye Study
Location Jiading District, Shanghai
Design Cross-sectional study of 8267 students from randomly selected preschools 
and primary schools
Methodology Cycloplegic refraction (cyclopentolate) and risk factor questionnaire
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57]. Major studies of eye diseases, including refractive errors, such as the Beaver 
Dam Eye Study [58], the Blue Mountains Eye Study [59], and the Tanjong Pagar 
Eye Study [60] also measured noncycloplegic refractions. However, the Tehran 
Eye Study measured both cycloplegic and noncycloplegic refractions over a wide 
age range [61].
In general, studies designed to look specifically at refractive errors in school age 
children, such as the pioneering studies from Taiwan [11], the RESC (Refractive 
Error Study in Children) Studies [62], the Singapore Cohort Study of the Risk 
Factors for Myopia (SCORM) Study [63], the Orinda [64] and Collaborative 
Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) [34] 
Studies in the United States, the Sydney Myopia Study and the Sydney Adolescent 
Vascular and Eye Study (SMS and SAVES) [65], the Northern Ireland Childhood 
Errors of Refraction Study [66], the Ireland Eye Study [67], several studies from 
China [12, 58, 68, 69] and Poland [70, 71], have measured cycloplegic refrac-
tions. The Generation R birth cohort study [72] introduced cycloplegic refrac-
tions at an early stage, but after the initial data collection. Studies on pediatric 
and preschool samples are more limited, but cycloplegia has generally been used 
[27, 28, 35, 73–77]. Cycloplegia needs to be carefully controlled in these studies, 
because when the prevalence of myopia is low, even a small amount of pseudo-
myopia may have a significant effect on the apparent prevalence.
6.1.4  Myopia: The Importance of Causal Pathways
The aim of identifying risk factors is to generate preventive interventions. This 
requires identification of modifiable causal risk factors, not just associations. 
Observational epidemiological studies can only establish associations, but far too 
often, papers on cross-sectional associations conclude with a limitation that con-
clusions about causality cannot be drawn. This seems to imply that longitudinal 
data can establish causality, but this is not correct. Parallel longitudinal changes are 
equally ambiguous, and this makes understanding the epidemic of myopia difficult 
since many parameters, such as industrialization, urbanization, pollution, incomes, 
nutrition, and education, have changed over the same period.
Strictly, randomized intervention studies are required to establish causality, 
but often studies of this kind would be regarded as unethical. In many cases, we 
therefore have to rely on the nonrandomized trials that occur as a part of social 
development. For example, it would be unethical to offer differential educational 
opportunities to children in a randomly selected fashion, but social differences often 
lead to differential educational opportunities, and these can be highly informative, 
although they lack randomization. The high prevalence of myopia seen in Jewish 
males who received an intensive religious education, compared to their sisters who 
received a less intensive religious education, as well as boys and girls who received 
a less intensive secular education [78], provides rather compelling evidence of cau-
sality. In some cases, Mendelian randomization analysis can be used. Although 
there are strict limitations on its use [79, 80], it has already been usefully applied to 
the problem of myopia [81–83].
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While the limitations of cross-sectional or longitudinal data are clear, avoiding 
discussing causality misses the point, because whether the association is potentially 
causal is crucial. Causality is therefore an important issue to discuss. Unfortunately, 
journals often discourage speculation, both explicitly and through tight word and 
reference limits. We recognize that wild speculation is not useful—Curtin’s descrip-
tion of the ophthalmologist waking after a sleepless night with “a new and usu-
ally more bizarre” hypothesis often rings true [84]. But evidence-based speculation 
should be encouraged, and subjected to critical review.
A related issue is the distinction between proximal and distal risk factors. 
Proximal risk factors are those closest to having a direct impact on eye growth, 
whereas distal factors will modulate the magnitude of more proximal factors. A 
plausible causal chain leads from education (excessive near work and limited 
time outdoors) to control of dopamine release and changes in axial elongation. 
Parental socioeconomic status, increases in the accessibility to education, and 
social attitudes to education may all increase involvement in education and/or 
result in reduced time outdoors, changing the prevalence of myopia through a 
common pathway that probably involves regulation of dopamine release and cer-
tainly involves regulation of axial elongation.
6.1.5  Statistical Analysis
There are also some associated considerations in relation to statistical analysis. A 
very common approach in analysis of risk factors is to identify significant associa-
tions in univariate analysis, then put the significant associations into multivariate 
regression analysis, labeling those factors that remain significant as “independent” 
risk factors. Often this appears to be done without serious consideration of whether 
the risk factors make sense in terms of causal pathways, whether they are modifi-
able, whether they are accurately measureable, whether they are likely to be collin-
ear, whether they could result from reverse causality, and how complete the list of 
variables is. All these considerations can affect the validity of regression analysis.
Statistical analysis can be used more scientifically to address specific hypoth-
eses about mediation by associated factors [85]. For example, in considering the 
relationship between myopia, education, and socioeconomic status (SES), it is pos-
sible to include SES and then the SES and education to see if there is a reduction 
in the strength of the association. This would be a sign that education mediates the 
influence of SES. In general, stepwise procedures need to be increasingly used in 
analysis. The quality of the variables is also important—whether they are continu-
ous or categorical variables, and whether they can be accurately measured. Even 
if one factor is entirely mediated by another, if either variable is poorly measured, 
adjustment may only reduce rather than largely eliminate the effect of the other vari-
able. Thus, the concept of independent risk factors is somewhat problematic [86].
Some of the variables are intrinsically complex. Education, for example, can 
be assessed in adults as a set of categories (primary school, high school, and uni-
versity completed) or as a continuous variable (years of education). But intensity 
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of education is also important, since children who obtain higher academic grades 
at a given level of schooling are more likely to be myopic. No variable captures 
both duration and intensity effectively. Myopia is associated with both intelligence 
quotient (IQ) [87] and school results [88]. Both are sometimes included in analyses 
to measure “innate” potential. But this approach is problematic since IQ shows 
complex changes over time [89, 90], and like myopia, combines significant twin 
heritability, considerable missing heritability, and social malleability [91]. There 
are both phenotypic and genetic correlations between myopia and IQ [92], as well 
as strong environmental effects. Inclusion of past performance or IQ in analyses as 
indicators of “innate potential,” may, if these measures are influenced by the same 
environmental factors that influence myopia, obscure their role.
Regression analyses that combine variables that are more or less proximal also 
pose a problem. It is well known that axial elongation is the biological basis of 
myopic shifts in refraction, and thus it correlates highly with SER. If axial length is 
included in a regression analysis with more distal factors, it will tend to obscure the 
associations of these more distal factors with refraction.
In summary, there are a number of conceptual and methodological issues that 
need careful consideration in seeking to tease out the risk factors for myopia. 
Further progress in the analysis of risk factors for myopia requires more critical 
approaches in several areas.
6.2  The Main Risk Factors for “School Myopia”: Education 
and Time Outdoors
We have recently reviewed this topic in detail, and these reviews can be consulted 
for more detailed references [1, 2, 4, 24]. In one of them, we distinguish between 
societies where the provision of education is limited and the prevalence of myopia is 
low (operationally, less than 10% myopia in young adults), at an age when 12 years 
of schooling would be the norm in the developed world, societies with western style 
education where the prevalence is between 10 and 60%, and developed countries in 
East and Southeast Asia, where education is intense, time outdoors is low, and the 
prevalence of myopia is high at 70–90%, particularly in urban areas.
It seems likely that the gradual transition from a very low prevalence in societies 
with little formal education to that typical of modern western societies with widespread 
education is predominantly due to the expansion of educational provision to cover all 
children, combined with increases in educational standards. Many of the countries 
in the first group are currently well short of the UN Sustainable Development Goals 
in Education for 2030 (https://sustainabledevelopment.un.org/sdg4, accessed January 
30, 2019). The prevalence of myopia is unlikely to increase in these countries until 
progress is made in achieving these goals. In contrast, the very high prevalence rates 
now typical of developed countries in East and Southeast Asia compared to the much 
more moderate prevalence rates observed in western countries cannot be attributed 
to more years of education, but are probably related to more intense education, early 
onset of high homework loads, and much less time outdoors.
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Because of the common observation in societies with significant educational 
provision that the prevalence of myopia increases with age, there is now a wide-
spread assumption that myopia is affected by chronological age. However, the low 
prevalence of myopia in societies where educational opportunities are limited, sug-
gests that it is not chronological age, but cumulative experience of schooling that is 
important, because without schooling most children do not become myopic. For this 
reason, it is often a useful sampling strategy to obtain a large sample of a given age, 
rather than smaller age-specific samples over a range of ages.
In adults, years of schooling is often used as a variable to look at associations 
with myopia. Consistent with the preceding arguments, those who have completed 
university education are more likely to be myopic than those who have completed 
secondary education, or primary education [55, 93]. Data from the UK Biobank 
dataset was recently used to address the issue of causality in relation to years of 
schooling and myopia [83]. The authors used two sets of genetic data—one on 
SNPs that associated with years of education, the other on SNPs associated with 
myopia. It was found that people with SNPs associated with more years of educa-
tion were more likely to be myopic, whereas those with SNPs associated with more 
myopia did not have more years of education. This provides a clear direction of 
causation from years of education to myopia. It is important to note that this does 
not mean that variables such as years of education or myopia are predominantly 
genetically determined. The percentage of variation in the two parameters explained 
by identified SNPs was low in both cases.
Rapid historical increases in years of schooling cannot be explained by genetic 
change but must depend on more distal social changes that made mass education 
more available, and linked employment and salary to increased skill levels, creat-
ing a strong incentive for parents to extend the education of their children. In the 
west, the expansion of mass education paralleled industrialization and the rise of 
modern capitalism, and later the introduction of new technologies. Data suggesting 
that the prevalence of myopia has increased can in fact be traced back to the early 
years of last century in the United States [94]. In contrast, the rapid economic devel-
opment of countries in East and Southeast Asia has been based on industrializa-
tion supported by rapid development of a skilled work force. This, combined with 
recent experiences of rural poverty and Confucian concepts of familial obligation 
and work ethic, appears to have taken educational intensity to a much higher level, 
producing the epidemic of myopia.
Intensity of schooling shows up in measures of achievements during schooling. 
There is a general association of higher school performance with more myopia, 
for a given number of years of schooling [88], with associations of more myo-
pia with involvement in accelerated learning streams within or between schools 
[95–97], and use of after-school tutoring [98]. These factors seem to be associated 
with the strong international performance of school systems in the countries with 
high prevalence of myopia [99], and may point to possible control measures. For 
example, if involvement in accelerated learning streams starts early, this provides an 
incentive for parents to impose intensive study regimes on children early in life so 
I. G. Morgan et al.
145
that they get into the higher level streams, leading to early onset myopia and rapid 
progression. A possible reform would therefore be to delay the onset of myopia with 
policies designed to control the early introduction of accelerated or elite streams 
within or between schools, while controlling intensive academic streams in private 
schools, private tutorial colleges, or cram schools.
Analysis of the results of the E3 consortium suggested that education was not the 
whole story [56]. This is not surprising, since the role of time outdoors, discussed 
below, has been demonstrated. But the analysis rests on an implicit assumption that 
completion of primary education (defined in this paper as 16 years) posed the same 
educational load across the many decades of development of education systems. 
Putting to one side the rather unusual definition of primary school education, it is very 
unlikely that this is the case. Educational standards at the end of primary school when 
most children completed schooling to work as unskilled laborers or homemakers were 
almost certainly lower than they are today, when most children complete many further 
years of education, and a significant percentage engage in tertiary studies.
Two potentially more proximal factors that may be related to educational inten-
sity have also been considered—reading distance and reading duration without 
breaks [100]. The first has a long history, dating back to Cohn, who supported the 
use of headrests to maintain head position while reading. These were abandoned, 
but it is not clear if that was because they were not effective, or because children 
refused to use with them. Some studies report a strong independent association of 
reading distance with myopia, but it is not clear whether the relationship is causal, 
or whether children decrease their reading distance as they become myopic. The use 
of headrests has been reintroduced in some schools in China, and many products 
are available online to control head position. Longitudinal studies are required to 
establish if close reading positions are adopted prior to, or in parallel with the devel-
opment of myopia, and randomized trials are required to assess whether controlling 
reading position does reduce myopia. Reading without breaks has also often been 
regarded as a risk factor, and the rule of a 10 min break every 30 min forms part of 
myopia prevention in both Taiwan and mainland China. An intervention study is 
also important in this area.
6.2.1  The Search for Causal Mechanisms for Education
While there can be no doubt about the causal relationship between education and 
myopia, the causal pathways are less clear. Near work was generally considered to 
be a likely mediating factor; however, the evidence on near work has been rather 
inconsistent, although meta-analyses indicate that there is a relatively small effect 
[101]. Part of the problem may be that near work is generally estimated from ques-
tionnaire responses which are intrinsically not particularly reliable. It is also dif-
ficult because the slow development of myopia means that near work estimates 
need to cover periods of at least some months if not years to be related to signifi-
cant changes in axial length or refraction. Recent development of instruments for 
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objectively measuring near work may provide better estimates, although consider-
able thought will need to be given to the sampling frames, given the marked daily, 
weekly, and seasonal variations in near work demands.
Initial thinking about the causal connection invoked accommodation as the 
probable driver, but this idea has been increasingly called into question. Some of 
the important negative evidence came from animal experimentation, which showed 
that refractive development was not drastically affected by cutting the ciliary nerve 
[102], and that animals that had no accommodative capacity showed normal pat-
terns of refractive development [103, 104]. The ability of atropine to block axial 
elongation was initially interpreted as supporting the hypothesis, but this judg-
ment had to be reevaluated, since atropine was effective, even in animals such as 
chickens where control of accommodation involves nicotinic rather than musca-
rinic pathways.
Attention therefore shifted to the possibility of control by defocus on the retina, 
given the clear role for defocus signals in controlling axial elongation demonstrated 
in animal models [31]. The link to education was provided by the hypothesis that 
lags in accommodation would result in residual hyperopia, which could stimulate 
axial elongation. Testing this hypothesis has led to inconsistent results, and Mutti 
et al. have shown that accommodative lag may be a consequence rather than a cause 
[105]. There is thus no clear pattern of support for the hypothesis.
It has also been suggested that peripheral rather than central defocus may play 
the dominant role in controlling eye growth [106]. This hypothesis developed from 
evidence that trainee pilots with eye shapes that created peripheral hyperopia were 
more likely to become myopic [107], leading to the idea that peripheral hyperopia 
leads to the development of myopia. Elegant animal experiments then demonstrated 
that eyes could normally regulate eye growth, even if the central retina was ablated 
[108]. However, this hypothesis has not been supported by several lines of evidence. 
The interpretation of the original evidence on development of myopia has been 
questioned [109], and while there is a general trend for eyes to develop from more 
oblate to more prolate, the relationship between eye shape and refraction has been 
quite variable tend to appear [110]. It remains possible that peripheral hyperopic 
defocus might drive myopic progression but attempts to control myopic correction 
by reducing peripheral hyperopic have not been particularly successful. However, 
selective imposition of myopic defocus in the periphery may provide a method for 
controlling myopia [111].
A clear causal mechanism linking education to myopia has therefore not been 
identified, but the causal relationship nevertheless appears to be solid. A recent 
hypothesis is that the problem may be associated with the predominant use of black 
text on white background [112]. This hypothesis proposes that the problem lies in 
the balance of stimulation of ON and OFF visual pathways, with natural scenes 
leading to balanced stimulation, with black text on white heavily overstimulating 
OFF pathways. Given that ON-bipolar pathways stimulate release of dopamine 
from amacrine cells [113], and dopamine agonists can inhibit axial elongation in 
animal models [114, 115], this is a promising link.
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6.2.2  Protection by Time Outdoors
In contrast to the long history of speculation and research about near work, solid 
evidence that time outdoors was an important factor only became available about 
10  years ago. However, since the first presentation of the evidence at the 2006 
ARVO meeting, a large amount of evidence supporting the idea has been accumu-
lated [2, 116], and a recent meta-analysis has confirmed the association [117]. Two 
key pieces of evidence are shown in Figs. 6.2 and 6.3 [118, 119]. The first shows 
that increased time outdoors can override the impact of increased near work, the 
second that increased time outdoors can override the impact of parental myopia. 
There are some reports that have failed to find this association, but these have gen-
erally been in situations where the amount of time spent outdoors is low and may 
be subthreshold for protection. The evidence now includes successful school-based 
intervention trials that have shown that increases in time outdoors of 40–80 min per 
day produced significant reductions in incident myopia [46, 120, 121], consistent 
with expectations from the epidemiological data.
Rose et al. [118] postulated that the mechanism was probably that the brighter 
light outdoors during daylight hours led to more dopamine release, which in turn 
inhibited axial elongation. This hypothesis was confirmed by laboratory experiments 
that demonstrated the inhibitory effects of bright light on myopia, and the protec-
tive effect was shown to involve D2-dopamine receptors [122–126]. The plausible 
possibility that lower vitamin D levels, observed in children who spend less time 
outdoors, played a causal role has not been supported by further analysis [81, 82, 
127]. The hypothesis that the protective effects might be due to a different balance 
of hyperopic and myopia defocus outdoors as compared to indoors [14], while plau-
sible in terms of the results of animal experimentation, also seems unlikely, given 
that increasing light intensity alone blocks experimental myopia.
The question of causality has been settled with the randomized intervention trials 
in children. However, some issues are still unclear. The initial studies were based 
on distinctions between time spent outdoors and indoors, and were later linked to 
an operational definition of outdoors as involving light intensities over 1000 lux. 
Fig. 6.2 Impacts of tertiles 
of near work and time 
outdoors on the odds ratio for 
myopia. Figure reproduced 
from Rose et al. [118]
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Animal studies suggested that light intensities considerably higher, at least 10,000 
lux, might be required to produce significant effects, but there is suggestive evi-
dence that lower light intensities might be effective in humans [120, 128]. One 
intervention trial has even suggested that modest increases in classroom lighting 
strongly inhibit the development of myopia [129], and this study requires urgent 
replication. A school-based intervention trial in Taiwan has reported that more mod-
est outdoor light exposures might also reduce incident myopia and, in fact, some 
research using objective measurements of light suggests that effective exposures of 
over a few thousand lux are rare outdoors, even though light appears to be regulating 
axial elongation. It would not be surprising if animal experimentation overestimated 
the light exposures required for protection, given that the stimulus for eye growth 
is strong and constant, whereas signals in humans may be more intermittent. It 
has also been suggested that the timing of the exposures, or their frequency, and 
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Fig. 6.3 Impact of hours playing sport (and outdoor activity) on the risk of myopia against num-
ber of myopic parents. Figure reproduced with permission from Jones et al. [119]
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parameters such as spectral composition may be important. There is limited and so 
far inconsistent support for these ideas, but the uncertainty around them does not 
matter when the simple intervention, increased time outdoors, is considered. These 
factors may become important if increased time outdoors needs to be supplemented 
or even replaced by artificial light exposures.
There is also controversy over whether increased time outdoors reduces pro-
gression as well as onset of myopia. The initial work did not support this possi-
bility [118, 119, 130], but even at that time, there was considerable evidence that 
there were seasonal differences in progression that suggested that progression rates 
were slower in summer than in winter, suggesting regulation of progression consis-
tent with the documented effects of near work and time outdoors [131–135]. More 
recent reports have provided evidence that more time outdoors may slow progres-
sion [120, 136], but more definitive work in this area is required.
6.3  Other Possible Risk Factors for Myopia
A range of other “independent” risk factors that are less obviously related to educa-
tion have been documented. As well as summarizing the evidence for them, we will 
discuss whether they are likely to be mediated by exposures associated with educa-
tion and time outdoors (Table 6.2).
Table 6.2 Summary of probable mechanisms for risk factors for myopia
Risk factor



















Birth order X X







While the evidence is not conclusive, most of the reported independent risk factors for myopia 
might be mediated by environmental exposure to educational pressures and limited time outdoors. 
Systematic use of mediation analysis is required to test independence
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6.3.1  Use of Computers and Smart Phones
In the last few years, use of computers and smart phones has become a routine 
part of daily life, with digital devices integrated into schooling in advanced coun-
tries. Increased digital screen time is often invoked to explain claimed continuing 
increases in the prevalence and severity of myopia, or at least as explanations for 
the increasingly early onset of myopia. Somewhat in advance of the available evi-
dence, Taiwan has introduced laws controlling the amount of digital screen time that 
children of preschool age are allowed, although how regulations of this kind could 
be enforced is not clear. Dirani et al. [137] have recently asked whether increased 
digital screen time might be “the single modifiable risk factor for myopia,” account-
ing for “increased near-work activity and decreased outdoor activity.”
We suggest that this is unlikely, since the epidemic of myopia appeared well 
before the common use of these electronic devices. The prevalence of myopia was 
already high in Taiwan and Singapore for children born in the early 1960s, whereas 
the internet did not become available to the general public until 1993. Early analysis 
in the Sydney Myopia Study found that use of devices such as Nintendos and Game 
Boys was associated with less myopia, perhaps because they were predominantly 
used by academically underperforming boys. It is certainly possible that digital 
devices have now come to constitute a significant form of near work, and will cor-
relate more closely with education and myopia, and some recent studies have docu-
mented significant associations between myopia and digital screen time [51, 138].
However, the historical perspective is important in considering preventive inter-
ventions. If limits are placed on the use of digital devices, children may simply revert 
to older forms of near work, such as reading books. And if digital devices encourage 
even more time indoors, active steps may need to be taken to get children to break 
with established behavior patterns and spend more time outdoors. We believe over-
emphasis on digital screen time may in fact have negative consequences if it leads to 
neglect of the other important factors. There is currently no evidence that time using 
digital devices is more dangerous than a similar amount of time reading. However, 
digital devices may make near work more pervasive and favor indoor lifestyles.
6.3.2  Sex
Many studies have compared the prevalence of myopia in males and females. Older 
studies have some tendency to report higher prevalence in males, whereas more 
recent studies more commonly report higher prevalence in females. For example, 
the Blue Mountains Eye Study reported that older male adults were more myopic 
than females [59], but the situation was reversed in the Sydney Myopia Study on 
children [42, 43, 96, 139]. Similarly, the Liwan Eye Study reported that sex dif-
ferences in older adults were marginal [140], but in younger cohorts, girls were 
more likely to be myopic than boys [141]. The massive difference between the 
prevalence of myopia in girls and boys in Orthodox Jewish communities in Israel, 
where the boys undergo very intensive education from an early age, provides an 
extreme inverted example of this trend [78]. This variability does not suggest a 
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direct biological link between sex and myopia, but rather suggests that the links 
may be mediated by social factors such as access to education for girls, which have 
changed considerably in many places in recent decades.
6.3.3  Ethnicity
Ethnicity or race has often been proposed as a risk factor for myopia, and indeed as 
evidence for genetic determination of myopia. It is however important to note that 
ethnicity and race covers both genetic differences, which are small in magnitude 
compared to the commonalities that make us human, and cultural differences that 
are often hard to quantify. Epidemiological evidence clearly shows major differ-
ences between ethnic groups in the prevalence of myopia, but more detailed analysis 
shows that these are predominantly due to environmental exposures. For example, 
the prevalence of myopia is high in the three major ethnic groups in Singapore, 
Chinese, Indian, and Malay, but in India and Malaysia, the prevalence is much lower 
[1, 4, 24]. This suggests that it is the environment of Singapore, perhaps most of all 
the education system and the limited time spent outdoors, that is crucial.
6.3.4  Parental Myopia
One of the best documented risk factors for myopia that is not directly linked to 
education is having myopic parents. Although shared attitudes to education are just 
as plausible, it is often assumed that this must be a genetic phenomenon, which is 
clearly true for the very genetic, highly familial forms of myopia. But the impact of 
parental myopia is also seen for “school myopia.” Consistently, studies covering a 
range of different ethnic groups have shown that having one or two myopic parents 
increases the risk of myopia [142–147], although the risk is inevitably lower in 
populations with a high prevalence of myopia. Wu and Edwards have shown the 
impact of parental myopia over three generations in China [148].
The effect of parental myopia is often cited as evidence for a genetic contribution to 
myopia, on the grounds that parents and children share genes. But they also share envi-
ronments, and the possibility that myopic parents provide their children with environ-
ments more conducive for developing myopia, perhaps by placing more emphasis on 
education, has not been excluded, although early analyses did not support this hypoth-
esis. However, recent studies have shown that children with myopic parents do not 
have a significantly greater level of myopia-associated SNPs [149], undermining the 
genetic argument. A more detailed analysis of environmental risk factors with objective 
measures of near work and time outdoors may be required to explain this association.
6.3.5  Intelligence
Higher intelligence or IQ, and some other cognitive measures, are generally associated 
with myopia. However, whether they are factors independent of education and time 
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outdoors is not clear. While there are some genetic influences on these factors, as noted 
previously, like myopia, they are socially malleable, rather than genetically determined 
[89, 90]. In the SCORM Study, both academic grades and IQ scores appear to be inde-
pendently associated with myopia [87, 88], and the same result has been obtained in 
a very large study of Israeli conscripts [150]. But the causal chains are very obscure, 
with a number of questions to be answered. For example, Are the links explained by the 
genetic correlations of the phenotypes? Do people with high IQs do more near work? 
Or is part of their high IQ achieved by more time reading and indoors? Do people with 
higher IQs need less effort to achieve high grades? Whatever the answer to these ques-
tions, reducing intelligence does not provide a route to prevention.
6.3.6  Urban/Rural Differences
Another consistent association of myopia is with urban residence, with children 
growing up in more rural areas generally being less myopic. In general, educational 
outcomes for children from rural areas are lower, and they often report less near 
work and more time outdoors. It is hard to see a direct link between axial elongation 
and postcode, and we suggest that urban/rural differences are likely to be based on 
differences in near work and time outdoors.
Population density has been invoked as one factor [151], but a major study in 
China has found that while there was a positive association of myopia with increased 
population density [152], even in the area with the lowest population density studied, 
the prevalence of myopia was still very high. This suggests other factors were more 
important. Access to green space has also been linked to lower use of spectacles [153].
6.3.7  Pollution
Pollution is one of the factors that has increased markedly since the Second World 
War in parts of East and Southeast Asia. There are many forms of pollution. 
Speculation about this factor has been fueled by the high levels of air pollution 
seem in some parts of China, but in fact, in international terms, Chinese cities rank 
well behind many cities in South Asia and the Middle East, where the prevalence 
of myopia is much lower than in Chinese cities (https://www.who.int/airpollution/
data/cities/en/, accessed Jan 30, 2019). Increased use of spectacles, presumably for 
myopia, has been associated with traffic-related pollution [154], but this may in fact 
be related to the association between urban residence and more myopia, as well as 
links to socioeconomic status, area of residence, and education [153].
6.3.8  Housing
Nature of housing has also been invoked as a factor. However, the results in this area 
are currently quite contradictory. In Singapore, more spacious housing was associ-
ated with more myopia, possibly because of a causal chain involving socioeconomic 
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status and its associations with education [60, 95]. In contrast, in both Sydney [151] 
and Hong Kong [155], small apartment dwelling has been associated with more 
myopia. A causal chain is not as obvious in this case and more complex pathways 
may need to be considered.
6.3.9  Height
Height has often been considered as a potential risk factor for myopia, and indeed, 
there have been substantial increases in height in populations over the last 150 years. 
These increases in height have been generally attributed to more adequate nutri-
tion. It has also been argued that associations between height and myopia might be 
expected, given that taller people have longer axial lengths, but this argument does 
not take into account the “emmetropisation” mechanisms that produce substantial 
convergence of refractive status, despite differences in body stature. While several 
papers have reported that height is a risk factor for myopia [9, 156], the evidence 
on this is very inconsistent. Rosner et al. [157] reported that Israeli male military 
conscripts, who were not myopic, were taller and weighed more than those who 
were not myopic—the reverse of expectations. Another inconsistency lies in the 
difference in prevalence of myopia between males and females, with a higher preva-
lence of myopia being commonly reported in girls in recent studies. If there were a 
tight biological link between height and refraction, a more consistent relationship 
would be expected. Social factors affecting nutrition and education may therefore 
be important. Given the differences in height between the sexes, studies need to be 
carried out with population stratification wherever possible.
Rahi and colleagues reported that maternal height (and age) was associated with 
more myopia [47]. In the United Kingdom, height differs by socioeconomic status, 
with greater heights (and also maternal age) in higher SES groups [158]. Since chil-
dren from higher SES groups are generally more myopic, these associations need to 
be tested for mediation by social factors.
6.3.10  Diet
Diets in East and Southeast Asia have changed significantly since the Second World 
War, and Cordain et al. argued that dietary change could have contributed to the 
increased prevalence of myopia, backed up by a plausible hypothesis linking insulin 
resistance, chronic hyperinsulinemia, increased circulating insulin-like growth fac-
tor (IGF-1), decreased circulating growth hormone, and decreased retinoid receptor 
signaling to increases in scleral growth [159]. But in other ways, this hypothesis has 
gained little support, and expected associations of height, weight, body mass index 
(BMI) and obesity with myopia have not been consistently observed. Improved diet 
is associated with greater height and axial length, but it does not appear to have pro-
duced increased refraction, consistent with the powerful eye growth control mecha-
nisms that have been reported. It is also worth noting that international variations in 
overweight and obesity do not parallel the international distribution of myopia, with 
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none of the countries with a high prevalence of myopia making the list of the top 20 
countries ranked by percentage of obesity (https://www.who.int/gho/ncd/risk_fac-
tors/overweight/en/, accessed Jan 30, 2019) and thus there is little support for a tight 
biological link between diet and myopia.
6.3.11  Sleep
Associations between sleep and myopia have also been reported, but the evidence 
is quite inconsistent [160–162]. It is clear that children who have heavy study loads 
after school are likely to get less sleep, both because there is less time available, 
but also because mental activity close to bed time can disrupt sleep. Lack of sleep 
is more likely to be a problem in the senior years of school, when homework loads 
in many parts of East and Southeast Asia are very high. However, sleep deprivation 
is likely to be less common in the early primary years, when myopia first appears, 
which reduces the likelihood that it is a major risk factor. Kearney et al. [163] have 
recently reported that myopes in the Northern Ireland Childhood Errors of Refraction 
(NICER) Study have lower levels of serum melatonin, which could be linked to dis-
ruption of circadian rhythms, which have sometimes been linked to myopia [164], or 
could be linked to reduced light exposures and dopaminergic function.
6.3.12  Smoking
Maternal smoking was associated with a lower risk of myopia in the SCORM Study 
from Singapore, but there was no association with paternal smoking, and the number 
of mothers who smoked was small [165]. In the subsequent Strabismus, Amblyopia 
and Refractive Error in young Singaporean Children Study (STARS) Study, a stron-
ger negative association with maternal and paternal smoking was reported [166]. 
A similar protective relationship was reported in a sample from a pediatric oph-
thalmology clinic, which largely persisted after adjustment for a range of factors 
including child’s near work activity and parental myopia and education [167]. A 
detailed study from South Korea reported consistent results for exposure to passive 
smoke estimated from urinary cotinine level [168], supporting the suggestion that 
nicotinic pathways are involved in the regulation of eye growth. In contrast, Rahi 
et al. reported a positive association between maternal smoking in early pregnancy 
and more myopia [47]. Although some of the associations reported are substantial, 
given the associations of smoking with SES and education, and lower gestational 
weight, these studies need to be carefully controlled for confounding.
6.3.13  Birth Order
Associations between myopia and birth order were reported with first-born chil-
dren tending to be more myopic [49]. However, in educational studies, it is well 
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documented that first-born children generally get more education [169]. A subse-
quent study on the UK Biobank dataset, adjusted for education, showed that the 
association between myopia and birth order was reduced but not eliminated [170]. 
In addition, in China, children from one child families are also more myopic than 
other children with siblings, and this was attributed to greater parental support for 
their child’s education [171]. However, the sociology of these differences is very 
complex, and more work needs to be done to establish that birth order is an inde-
pendent risk factor.
6.3.14  Season of Birth
Season of birth has also been associated with myopia in several studies, with chil-
dren born in summer tending to be more myopic [51, 172, 173]. No plausible path-
way has been suggested for a direct link. Instead, it has been suggested that children 
born in summer often start school up to a year younger than their peers born in 
spring. This could mean first exposure to education and less time outdoors at an age 
when myopic shifts in refraction, including myopic progression, are larger, result-
ing in more myopia.
6.3.15  Allergic Conjunctivitis: Hay Fever and Kawasaki Disease
In 2011, Herbort et al. proposed a general association of myopia with inflamma-
tory conditions affecting the choriocapillaris [174]. An association between ocu-
lar inflammatory conditions such as uveitis was subsequently demonstrated [175]. 
Later, a higher risk of myopia was associated with allergic conjunctivitis, and less 
so allergic rhinitis, atopic dermatitis, and asthma [176]. A large population-based 
study using the NHANES dataset showed that hay fever was also associated with 
a higher prevalence of high myopia [177]. A recent report has also associated 
increased myopia with Kawasaki disease [178], which has conjunctivitis as one of 
its core diagnostic criteria. This association needs further study.
These studies provide a persuasive case for some link between ocular allergic 
responses and the development of myopia, and using an animal model. Wei et al. 
have proposed a mechanism involving increased tumor necrosis factor (TNF)-
alpha and interleukins. It does not seem likely that a link between ocular inflam-
mation and myopia can explain the epidemic of myopia in East and Southeast 
Asia, since there is no parallel between the international distribution myopia 
and that of allergic rhinoconjunctivitis in children [179]. One possibility is that 
eye rubbing may lead to myopic refractions through corneal changes, as may be 
the case with keratoconus [180], but the US study on hay fever ruled out a role 
for them. The possibility that children with these conditions tend to spend less 
time outside should be examined. It also seems possible that allergic conditions 
might add to the incidence and progression of myopia, without being the primary 
determinant.
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6.3.16  Febrile Diseases
Using data from the UK Biobank, Guggenheim et al. reported associations between 
several childhood diseases and myopia. From a list including pneumonia, enceph-
alitis, meningitis, rheumatic fever, measles, rubella, mumps, diphtheria, and per-
tussis, rubella, mumps and pertussis were associated with myopia, while measles, 
rubella, and pertussis were associated with high myopia [181]. The authors argued 
against a link to educational disruption or limited time outdoors, since not all seri-
ous childhood diseases were linked to myopia, but this link, whatever its causes, 
cannot explain the emergence of the epidemic of myopia. But these findings may 
have clinical implications that need to be explored.
6.3.17  Fertility Treatment
The British TEDS Study has documented a standard range of social variables, with 
level of maternal education, summer birth, hours spent playing computer games sur-
viving full multivariate regression analysis, with associations with socioeconomic 
status, educational attainment, reading enjoyment, and cognitive variables showing 
associations at multiple stages in the life-course analysis. A unique feature of the 
analysis was the protective associations of fertility treatment detected in the final 
analysis [51]. The authors ruled out associations with parental education, and the 
causes are currently obscure.
6.4  Popular Beliefs About the Causes of Myopia
There are many popular beliefs in the causes of myopia around the world, which 
have presumably arisen because the development of myopia and its progression is 
often observed by parents, who naturally seek explanations. In the western world, a 
common belief is that reading in dim light, or under the bed clothes causes vision to 
deteriorate, but this outcome, and these behaviors might indeed be common in those 
who like reading books, and there is some evidence that reading for pleasure is a 
risk factor for myopia. We have not attempted a systematic survey in this area, but in 
China, there seem to be many beliefs of this kind, perhaps because the prevalence of 
myopia has increased so conspicuously. One commonly encountered belief is that 
myopia is associated with reading and writing postures that violate the “foot, fist, 
inch” rule, that is the eyes should be one foot from the book, the chest should be one 
fist from the desk, and the fingers should be 1 inch from the nib of the pen. This is a 
variant on the idea that bad posture while reading leads to the development of myo-
pia, which has widespread currency, but has never been proven. A similar common 
belief is that reading while riding on public transport is dangerous, but again this has 
never been tested. Other, intuitively unlikely ideas include the development of myo-
pia in children who read on their back, or their front, or who read extracurricular 
books with font sizes greater than standard textbooks. These have occasionally been 
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looked at in scientific papers, and associations have sometimes been reported. These 
proposed factors need to be rigorously tested epidemiologically, and if they survive 
that sort of testing, they need to be subjected to standard Randomised Control Trial 
(RCT) testing. Unfortunately, without any positive evidence, two of these have been 
written into China’s National Myopia Prevention Plan.
6.5  Comparing Genetic and Environmental Effects
Comparing the impact of genetic to environmental effects is difficult, because they 
are often quantified in different ways, with genetic effects generally determined in 
relation to variation in refraction, while evidence on the impact of environmental 
effects is generally related to prevalence of myopia. Genetic studies have identified 
myopia-associated SNPs that account for slightly less than 10% of the variance in 
refraction, although these factors are very precisely measured [13]. Compared to 
the possibly misplaced expectations from twin studies with heritability estimates 
in the range of 80–90%, there is obviously a large amount of what has come to be 
called missing heritability, although it is actually the identified genetic variation 
which is missing. Use of the SNP-heritability approach suggests that Genome-Wide 
Association Study (GWAS) has the potential to explain more like 20–35% of the 
variance [19]. It is often suggested that improvements in methodology and increases 
in sample size may help to close the gap, although there is a law of diminishing 
returns with increased sample sizes. There is little evidence that other forms of 
genetic variation such as copy number variations or rare genetic effects of large size 
have a role to play.
In contrast, the measurement of risk factor exposures is much less precise, largely 
involving estimates derived from questionnaires. These questionnaires not only suf-
fer from the general problem of recall bias, but in relation to near work and time 
outdoors, they also ask for a very difficult task to be performed, namely estimating 
average exposures. Not surprisingly, such questionnaires are more accurate when 
estimates of recent exposures over a limited time frame are compared to measure-
ments obtained using objective instruments, but even then, discrepancies are sig-
nificant. We are therefore not yet in a position to calculate individual environmental 
risk factor effect sizes. This may explain why attempts to quantify the associations 
between estimates of near work and time outdoors on the one hand and myopia on 
the other explain only low percentages of the variance [19], despite the evidence 
that changes in them appear to be responsible for the major increases in prevalence 
of myopia seen recently.
We suggest that while awaiting more quantitative data on environmental risk 
exposures, the change in mean SER from the age of 5–6 to the end of school-
ing may be taken to represent the cumulative effect of relevant environmental 
exposures over this time. This assumption seems reasonable, given that children 
exposed to only limited schooling generally develop little myopia. The only 
exception that we have found to this statement is the increase in prevalence of 
myopia in Eskimo and Inuit children after exposure to rudimentary schooling in 
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extreme northern latitudes [182–184]. This may be an exception due to the limited 
light exposures available during winter, combined with reductions in the amount 
of time spent outdoors.
The data from the RESC Study in Nepal, where there is little development of 
myopia and limited schooling, appears to be an average shift of −0.02  D/year 
with minimal schooling [185]. This figure is about −0.16 D/year of schooling in 
the Sydney Myopia Study. East Asian studies suggest a total change that is much 
greater. In the Guangzhou RESC Study, refraction changed by at least −3.00  D 
over 10 years, or a change of −0.3 D/year [141]. In the Shandong Eye Study [12], 
the change was closer to −4.00 D over 10 years, or −0.4 D/year. One limitation of 
this simple analysis is that it assumes linear changes across the years of schooling, 
which may not be the case. These values compare with estimates from the UK 
Biobank Study on refractive shifts associated with years of schooling, which sug-
gest shifts from epidemiological analysis of −0.16  D/year, while the Mendelian 
randomization analysis gives a change of −0.28 D/year [83]. It is encouraging that 
these figures are in the same ballpark when children have been exposed to school-
ing, but it needs to be recognized that these figures are only first approximations.
Accepting these estimates as the best currently available, we can then attempt to 
use them to understand the onset of myopia. Age of onset may be a very significant 
parameter, since it has decreased markedly during the emergence of the myopia 
epidemics [11], appears to have similar genetic associations to the final level of 
myopia in adults [13, 186], and appears to be a good predictor of final myopia [187].
In several studies that have used rigorous cycloplegia, refractions at the age of 
5–7 are concentrated in the range of 1.0–1.3 D. This range has been documented 
for children in East Asia [12, 46, 75, 188] and in western societies [43, 76, 96]. 
The similarity of the values reported for children of East Asian and European back-
grounds is striking, given the massively different prevalence rates that emerge later. 
In other reports, mean SER has been lower, and we suggest that, in many of these 
cases, inadequate cycloplegia may be involved. This means that the challenge is to 
explain how genetic factors and environmental factors can produce myopic shifts of 
1.5 D or more to reach the threshold for myopia of −0.5 D. The steps involved in 
moving from this baseline value to the threshold for myopia and onto final SER at 
the age of 20 are summarized in Fig. 6.4.
In the ALSPAC Study [149] on average, participants carried around 130 risk 
alleles, with most of the distribution fitting within ±15 alleles [149]. If the average 
number of risk alleles corresponds to a mean SER of +1.0 to 1.3 D, with an average 
effect size of −0.1 D/risk allele, few participants would reach the myopia cutoff of 
−0.5 D on purely genetic grounds, and several years of schooling would be required 
to reach the threshold. Modeling by Ghorbani-Mojarrad et al. [149] also suggests 
that additive genetic effects are unlikely to produce “school myopia,” without addi-
tional contributions from environmental factors. In contrast, in East Asian environ-
ments, 2–4 years of schooling would bring many children past the myopia cutoff. 
This is likely to happen more rapidly for those who are already at risk genetically.
This picture is based on a number of assumptions and needs extensive fur-
ther development in relation to the size and linearity of effects, but it provides a 
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framework for understanding one of the distinctive characteristics of the current 
epidemic of “school myopia,” the importance of environmental exposures and the 
modest impact of genetic risk. It also suggests that more work needs to be done on 
the determinants of spherical equivalent at the age of 5–7 years, and determinants of 
the age of onset of myopia, because the latter is a significant predictor of subsequent 
progression and final myopia [187].
Gene–environment interactions also need to be taken into account. It must be 
remembered that simple environmental regulation of gene expression is not an 
example of gene–environment interactions. Gene–environment interactions are 
characterized by situations in which genetic risk and environmental risk com-
bine to produce impacts which are greater or less than expected from their indi-
vidual effects—or in other words that expression of different alleles of a given 
gene are differentially affected by different environments. Verhoeven et al. [189] 
have examined the specific case of the interaction of genetic risk and educational 
risk, reporting major interactions, with the combination of high genetic risk and 
high educational risk producing very high risk greater than the arithmetic sum of 
the individual risks, using the synergy analyses of Rothman [190–192]. Cortina-
Borjas et  al. [193] have argued that this method produces many false cases of 
Fig. 6.4 Environmentally driven axial elongation and myopic shifts in refraction lead to final 
refraction. Rate of axial elongation and myopia shifts in refraction increase prior to the onset of 
myopia, and remain elevated but decline with age [199, 200]. This increase may begin when SER 
reaches the low hyperopic range [201]. The earlier the onset, the greater the progression
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gene–environment interactions, in part because when using odds ratios, risks are 
more likely to be multiplicative. From our analysis of the data in the paper by 
Verhoeven et  al., the interactions in this paper are close to multiplicative, and 
we suggest that a more detailed analysis is required. A search for more specific 
cases has produced some more specific examples of gene–environment interac-
tions [194–197], but the cases reported appear to be rare. More work is clearly 
needed in this complex area.
6.6  Conclusions
Our overview of risk factors for myopia has identified education and limited time 
outdoors as the major risk factors for myopia. We suggest that the evidence on these 
two risk factors is now very strong. These two factors both suggest evidence-based 
approaches to control of myopia, such as increased time outdoors and decreased 
near work time. These two factors then appear to converge to regulate eye growth, 
through cellular and biological pathways that require further definition, but appear 
to involve regulation of the rate of dopamine release as one component, and axial 
elongation as another.
Many other risk factors for myopia have been proposed. Many of them may be 
more distal social factors such as parental and social attitudes to education, provi-
sion of educational opportunities, and organization of school systems and schools, 
and may be mediated by the educational and time outdoor exposures that children 
receive.
We suggest that future studies in this area need to become more rigorous in 
several ways. Cycloplegia needs to the required standard in new studies. Mediation 
analysis needs to become a standard part of risk factor analysis, used to define 
causal pathways. As a minimum, new studies also need to collect data on educa-
tional exposures and time outdoors, increasingly using the new methods for collec-
tion of objective data that are becoming available. These higher standards need to 
be enforced by more rigorous review and publication processes.
While there are many aspects of the risk factors for myopia that require fur-
ther analysis, the picture that we currently have provides important insight into the 
characteristics of the current epidemics. In particular, we can now see why genetic 
effects on “school myopia” are so slight, despite the evidence for a large number of 
SNPs of small effect size associated with myopia.
The evidence for a major role of education and time outdoors has given us insight 
into effective means of control, some of which are currently being implemented in myo-
pia control rather than school myopia programs, such as programs aimed to increase 
time outdoors. Many other interventions at more distal levels also can be envisaged that 
might reduce early competition for privileged places in schools. When these are com-
bined with clinical interventions to control myopia progression, and there are now many 
available, in principle, we now understand how to turn back the epidemic of myopia.
But understanding does not automatically lead to success in prevention; after 
all we have known how to correct refractive errors for some time, but uncorrected 
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refractive error is still a major cause of visual impairment. Research into more effec-
tive means of preventing the onset and progression of myopia needs to, and will 
undoubtedly continue. But the next big challenge may already be to identify and 
overcome the barriers to implementation, so that we can ensure that we achieve what 
increasingly appears to be a realizable goal—the prevention of “school myopia.”
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• Time spent outdoors is well recognized as a factor preventing the develop-
ment of myopia onset, and measures including adding an outdoor class, 
locking classroom doors during class recess, or glassed roof and walls 
incorporated in a classroom have been developed. But promotion to 
increase time spent outdoors as a school-based intervention program 
remains challenging especially in East Asia.
• Near work activity has been suggested as a risk factor for myopia although 
the evidence is not entirely consistent. The total duration of near work 
activity may not be as important as the type of near work activity. Core 
techniques to implementing interventions of near work activities include 
effective measures of near work-related parameters, real-time data analy-
ses, and alert systems.
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7.1  Introduction
Over recent decades, the prevalence of myopia in school-aged children has been 
increasing significantly in East Asia. Up to 80% of junior high school students have 
myopia, of which 20% have high myopia in mainland China [1, 2], Hong Kong [3], 
Taiwan [4], South Korea [5], Japan [6], and Singapore [7]. Longitudinal data sug-
gests that the incidence of myopia is around 10–20% per year among school-aged 
children [8–11]. If the onset of myopia can be delayed, the prevalence of myopia as 
well as high myopia in school-aged children will likely reduce. This chapter focuses 
on the clinical strategy to prevent or delay the onset of myopia among school-aged 
children, summarizing the interventions currently available, and takes a glance at 
future perspectives.
7.2  Onset of Myopia
The vast majority of literature suggests that most cases of myopia develop during 
the school-going age in children. The prevalence of myopia among preschool chil-
dren is relatively low [12–15]; furthermore, a longitudinal study in Shunyi Beijing 
demonstrates that the annual incidence of myopia among 5-year-old children is 
below 5% [16]. After the age of 6 years, the prevalence of myopia starts to rise [6, 
16–19]. The highest annual incidence of myopia is reported among school children 
from urban mainland China [18] and Taiwan [20], ranging from 20% to 30% 
through ages 7–14 years with earlier onset of myopia also being identified [6]. A 
study in Japan showed that while the prevalence of myopia has been increasing 
from 1984 to 1996, the prevalence among children aged 6 or younger has remained 
• School children growing up in myopigenic environments are likely to ben-
efit from optical interventions designed to induce myopic defocus. The 
lens with multiple segments of defocus showed promising effect on slow-
ing progression of myopia.
• The Chinese eye exercises of acupoints advocated in mainland China and 
Taiwan were designed to relieve ocular fatigue and reduce the develop-
ment and progression of myopia. But clinical significance of its efficacy 
has not been established according to available data.
• Maximizing the utility of time outdoors is still the priority in the preven-
tion of myopia onset. The role of screen time in myopia development is 
still ambiguous, the restriction may enable more time for children to go 
outdoors. Other approaches to prevent myopia onset still require further 
investigations, such as imposed myopic defocus, low-dose atropine, or 
some novel pharmacological agents for non-myopes.
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unchanged. This suggests that the majority of increased myopia onset is secondary 
to increased educational intensity and develops when children reach school age 
(Fig. 7.1) [6].
A long-term longitudinal study has demonstrated that there is a steady shift in 
refraction toward myopia, before the actual onset of myopia. Rates of progression 
increase dramatically the year of onset and this has been suggested by spherical 
equivalent refraction and axial length (Fig.  7.2) [21]. After the first detection of 
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Fig. 7.2 Changes in spherical equivalent refractions (a) and axial lengths (b) before and after 
myopia onset. © Xiang et al. [21]
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myopia, this acceleration is reduced (Fig. 7.2) [21, 22]. Myopic refractions tend to 
stabilize in late adolescent but can remain progressive until adulthood. The mean 
age at myopia stabilization is 15.6 years but this can vary among children of differ-
ent ethnicities [23].
Several factors have been found to be associated with the development of inci-
dent myopia in school. Asian ethnicity [19, 24], parental history of myopia [25, 26], 
reduced time outdoors [26], and level of near work activity [27, 28] are risk factors 
for incident myopia, although the evidence can be seen as controversial in some 
instances. Some studies have also suggested that non-myopic children with less 
hyperopic refractions and greater axial length/corneal radius of curvature ratios are 
more predisposed to develop myopia [18, 19]. The impact of gender to the develop-
ment of myopia varies among populations. In Chinese school children, females 
have a greater chance of progressing to myopia [18]; while in multiethnic popula-
tions, gender seems to be less impactful [19, 24, 27].
Attempts have been made to establish tools to identify children at risk of devel-
oping myopia or high myopia. Among numerous associated factors, spherical 
equivalent refraction is the most promising predictor. By using a single measure-
ment of refraction alone, future myopia onset of non-myopic children can be accu-
rately predicted [29]. Moreover, children at risk of developing high myopia in 
adulthood can also be identified, with reasonably good sensitivity and specificity, 
when using an age-specific 5th percentile curve of refraction of the population 
(Fig. 7.3) as a cutoff [30]. Other promising tools for the prediction of future high 
myopia include the age of myopia onset [31] and age-specific annual refraction 
progression of children with myopia (Fig. 7.4) [32]. Information on age of myopia 
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Fig. 7.3 Percentile curves of refractions for urban Chinese boys (a) and girls (b). © Chen et al. [30]
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7.3  Increased Time Outdoors as an Intervention
Time spent outdoors is well recognized as a factor preventing the development of 
myopia onset. Evidence of this was first presented in a three-year follow-up study 
of myopia in school children, showing that those who spent more time outdoors 
were less likely to progress [33]. Consistent results were reported in various stud-
ies, such as the Sydney Myopia Study, Orinda study as well as the Singapore 
Cohort Study of Risk Factors for Myopia [34–36]. This led to the commencement 
of several clinical trials, which confirmed the protective effect against myopia and 
indicated a dose-dependent effect, among them is the randomized clinical trial in 
Guangzhou which reported that an additional 40  min of outdoor activity can 
reduce the incidence of myopia by 23%. Additionally, the trial in Taiwan sug-
gested that an extra 80 min may further reduce incidence by 50% [10, 37].
The mechanism of increased outdoor time as an intervention is not completely 
clear. Spending time outdoors itself, instead of physical activities outdoors, has been 
suggested to be the major protective factor [38]. Results from animal experiments 
indicated that protection due to bright light may be mediated by dopamine [39]. Some 
believe that ultraviolet light also plays an important role [40], with evidence suggest-
ing that there is an association between vitamin D level and myopia [41–43], but data 
from a population-based cohort did not support this idea [44]. Alternatively, patterns 
of defocus on the retina by three-dimensional structures of the environment have also 

























































Fig. 7.4 Age-specific annual progression of refraction in children with myopia. © Sankaridurg et al. [32]
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As an economically feasible intervention, getting children outside the classroom has 
been promoted in many public health programs such as Taiwan’s “Daily 120.” However, 
promotion to increase time spent outdoors as a school-based intervention program 
remains challenging. First, what is an effective amount of time outdoors? Population-
based data suggest that 2–3 h a day would be beneficial [26, 35], however, this is diffi-
cult to achieve in some East Asian countries where the education system is very intensive. 
Some programs recommend adding an outdoor class into the curriculum, while others 
recommend prohibiting being inside during recess by locking classroom doors. Another 
group of researchers proposed a classroom design that incorporates a glassed roof and 
walls that enable maximize light intensity while students study indoors (Fig. 7.5) [46]. 
The protective effect of this bright classroom is now under investigation. Second, what 
is the appropriate location for outdoor activities? The ideal location appears to be in an 
area with bright light more than 10,000 lux, suggested by evidence from animal experi-
ments [47, 48]. But the most recent results from Wu et al.’s study indicated that less 
bright light exposure, 1000- lux or 3000-lux for instance, is sufficient enough to generate 
a protective effect (Fig. 7.6) [49]. These findings seem to suggest that an environment 
such as the shade of a tree or building, the hallway, or playground could still work with 
an advantage to avoid sunburn or other side effects from UV exposure.
Another concern is how do we measure outdoor activities? Traditionally, ques-
tionnaires have been commonly used to measure time outdoors but are less accurate 
due to recall bias. Objective measures can provide more precise real-time data. 
Wearable detectors have been developed to record light intensity and time outdoors, 
and even track the patterns of outdoor activities, including HOBO light meters, 
Nike+ Fuel Band, and others. Other measures have been used to estimate exposure 
to natural light such as conjunctival ultraviolet autofluorescence and skin photo-
damage, but these are more appropriate when measuring the cumulative light dos-
age or UV exposure [50, 51].
If increased time spent outdoors can prevent or delay the onset of myopia, it 
would ultimately reduce the prevalence of myopia or even high myopia among 
Fig. 7.5 Classroom 
constructed with glass in 
China. ©Zhou et al. [46]
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school-aged children. Documentation on the impact of time spent outdoors on the 
prevalence of myopia is of public health importance.
7.4  Reduced Near Work Intensity as an Intervention
Near work activity as a risk factor for myopia has been documented in some studies, 
although the evidence is not entirely consistent. A recent meta-analysis has reported 
a modest, but statistically significant, association between time spent performing 
near work and myopia (odds ratio, 1.14) [28].
It has been argued that the total duration of near work activity may not be as 
important as the type of near work activity. Studies have found that continuous read-
ing of more than 30–45 min is associated with the presence of myopia and greater 
myopic refractive errors [52, 53]. Interestingly, after prolonged continuous reading, 
children are more likely to take up their preferred relaxed postures [54], such as 
close reading distance [53] and head tilt [52], both of which have been reported to 
be associated with the presence of myopia. Other factors that have been proposed to 
potentially contribute to the development of myopia include close nib-to-finger dis-
tance [52], downward angle of gaze [55, 56] and inadequate desk [52], or classroom 
lighting [56].
1. Hallway width outside of 
classroom
4. Hallway/Sidewalk distance from
classroom
7. Playground (2450 lux) 8. Field (>100000 lux) 9. Inside classroom (340 lux)
5. Shade beside a building, measured at
500 CM from classroom door (3140 lux)
2. Hallway, measured at 150 CM
from classroom door (1846 lux)
3. Hallway, measured at 250 CM
from classroom door (7600 lux)




Fig. 7.6 Light intensity of different locations in the school. ©Wu et al. [49]
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Efforts have been dedicated to developing novel devices to detect and correct 
inadequate near work behaviors. In mainland China, pens for myopia prevention 
has been invented. The pens are capable of detecting close reading distances (China 
Invention Patent, 200620010200.6) or nib-to-finger distances (China Invention 
Patent, 201020640746.6). Real-time retraction of the nib will occur when the eyes 
are too close to the reading materials or the nib-to-finger distance is inadequate, 
compelling children to adopt correct postures. The effect of the pens on preventing 
myopia onset is to be examined by future clinical trials.
Core techniques to implementing interventions of near work activities include 
effective measures of near work-related parameters, real-time data analyses, and 
alert systems. Wearable devices that possess these techniques have emerged in the 
last decade. A head-mounted instrument (Fig. 7.7) was built in Hong Kong for con-
tinuous logging of near work distance [57]. Measurements have proved to be accu-
rate and repeatable over a range of distances and angles [57]. The Clouclip (Fig. 7.8) 
is another novel device developed in mainland China, primarily for the use of 
a b
c d
Fig. 7.7 Front view (a) and side view (b) of the near work analyzer for logging near work distance 
and its alignment in a straight-ahead position (c) and reading position (d). © Leung et al. [57]
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myopic children [58]. The device can measure reading distances and ambient illu-
minance, perform real-time data analyses, and feedback to children and parents 
(www.clouclip.com). This group of researchers used Clouclip to track reading dis-
tance and eye-level illuminance of children over a representative period of time 
[59]. Based on these data, they developed a summative index and found that a 
change in the index toward a more myopic behavior was significantly associated 
with increased myopic refractive errors in a preliminary longitudinal study [59]. 
The attempt to generate a simplified, summative index for risk estimation will help 
provide comprehensive information on near work-related behaviors and may help 
improve the efficacy of interventions.
7.5  Optical Interventions
The use of noninvasive optical interventions to prevent myopia is based on findings 
of the powerful STOP signals reported in numerous animal studies. By briefly 
exposing chickens to myopic defocus (the STOP signals), eye growth induced by 
presenting minus lenses can be slowed dramatically (Fig. 7.9) [60, 61]. It is there-
fore suggested that school children growing up in myopigenic environments are 
likely to benefit from routine optical interventions designed to induce myopic defo-
cus [62]. The intervention regimen should combine variables including age, lens 
power, and duration of exposure to achieve an adequate effect on delaying the devel-
opment of myopia [62].
While these optical interventions are an attractive idea, they have not been fully 
explored in human subjects—this will be elaborated further in Chap. 13 (Optical 
interventions for Prevention of Myopia Progression). A recent study has prescribed 
plus lenses to non-myopic children aged 5–8 years who are at risk of developing 
myopia [63]. The plus lenses imposed a 1.0 D myopic defocus and the children 
wore the correction the entire day. No cases of myopia onset have been observed in 
this group of children during the follow-up period (ranging from 3 to 9 years) [63]. 




angular acceleration sensor infrared sensor
and illuminance
sensor
Fig. 7.8 Clouclip to monitor 
near work time. © Wen et al. 
[58]
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The Defocus Incorporated Multiple Segments Lens (DIMS Lens) is a novel 
spectacle lens primarily designed for use in myopic children. The lens is composed 
of a central zone for optical correction of refractive error and an annular peripheral 
zone to induce myopic defocus. Interestingly, the lens peripheral zone contains 
numerous well-arranged small plus lenses, separated by small non-defocus areas. 
By using this design, myopic defocus is induced and visual quality is well reserved 
at the same time (presentation at the 16th International Myopia Conference [IMC]). 
In a pilot study conducted among school children, the DIMS lens slowed progres-
sion of myopia by 59% (presentation at the 16th IMC). The lens may also be prom-
ising for preventing myopia onset if adaptation can be successfully made for 
non-myopic children.
7.6  Eye Exercises of Acupoints
The eye exercises of acupoints are a set of bilateral acupoint self-massages designed 
to relieve ocular fatigue and reduce the development and progression of myopia. 
These eye exercises were introduced by the Chinese National Education Commission 
and have been advocated since the 1960s in mainland China and Taiwan. Children 
in primary and junior middle schools are required to perform the eye exercises twice 
a day. The 5-min exercises include: (1) knead Tianying (Ashi); (2) press and squeeze 
Jingming (BL1); (3) press and knead Sibai (ST2); and (4) press Taiyang (EX-HN5) 
and scrape Cuanzhu (BL2), Yuyao (EX-HN4), Sizhukong (TE23), Tongziliao 

















interrupted by positive lenses

























Fig. 7.9 Changes in refractions and ocular biometric parameters over 3 days of binocular negative 
lens wear interrupted by brief periods of positive lens wear on one eye and plano lens wear on the 
other eye. **P < 0.01; ***P < 0.001. © Zhu et al. [61]
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The efficacy of the Chinese eye exercises is believed to be from the theory of 
Traditional Chinese Medicine. By massaging the acupoints, Chi can be achieved 
and help relieve eye strain and recover ocular functions. Peak systolic velocity in the 
central retinal and ophthalmic arteries is observed after the eye exercises [64], 
which might provide some evidences to support this theory. Accommodative lag 
decreases significantly by 0.1 D after 5 min of performing the eye exercises [65].
Clinical significance has never been established in the published literature thus 
far. Cross-sectional studies have assessed the association between Chinese eye exer-
cises and myopia with varied results [66–69]. The inconsistency can be explained 
by the different settings studied (rural vs. urban), failure to adjust for potential con-
founders (including parental myopia, time outdoors, and near work) and the lack of 
representative populations in some studies. In a recent study, the impact of Chinese 
eye exercises on the development of myopia has been examined using a longitudinal 
design [70]. No association between eye exercises and myopia onset has been found 
[70]. However, due to the limited sample size, low level of intervention time, and 
performance qualities of the exercises in the study, the actual impact is still not 
conclusive and needs to be justified by further studies.
7.7  Future Prospects
It has been estimated that without any effective controls or interventions the propor-
tion of myopes in the population will reach up to 50% and 10% for high myopes by 
2050 [71]. Approaches that have produced a reduction of at least 50% in incidence, 
such as time outdoors, have the potential to make a significant difference on the 
impending myopia epidemic. But the level of impact of the full utility of available 
interventions needs to be evaluated by further studies.
Another critical issue is how to implement both education intensity and outdoor 
time interventions in East Asia. There needs to be a balance between educational 
achievement and interventions delivered, which don’t exacerbate the prevalence of 
myopia in East Asia. This balance can be seen in Australia [72], with some of the 










Fig. 7.10 Schematic diagram demonstrating the positions of acupoints used in Chinese eye exer-
cises. © Lin et al. [67]
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also high levels of outdoor activity and light intensity. Preventing the onset of myo-
pia is certainly challenging in the East Asian population and requires a collaborative 
effort among clinics, schools, parents, and the entire society.
Nonetheless, maximizing the utility of time outdoors is still the priority in the 
prevention of myopia onset. The implementation of outdoor activities in school pro-
grams and daily life necessitates further propagation and feedback from parents and 
children. Novel devices combined with the internet and even social networks are a 
potential direction. An example is FitSight, which was developed by Saw et  al. 
(Fig. 7.11) and comprises of a smartwatch with a light sensor and smartphone app 
that records time outdoors and sends feedback to parents and children [73]. This 
kind of devices needs to be proven to be useful by undertaking field study and deter-
mining wearability. Additionally, the price of the device should be considered in the 
design.
Another behavior control method focuses on limiting the screen time on comput-
ers, tablets, and smart phones. Though the role of screen time in myopia develop-
ment is still ambiguous, the restriction may enable more time for children to go 
outdoors. Applications to provide screen distance and time monitoring, alerts to rest 
eyes, blue light filters, and remote locking capability for parents are available in 
some countries (plano, https://www.plano.co/). The effect of this technology on 
myopia prevention remains to be seen.
Other approaches to prevent myopia onset still require further investigations, 
such as imposed myopic defocus, low-dose atropine, or some novel pharmacologi-
cal agents for non-myopes. They may help to prevent myopia in those who are 
rapidly progressing or have high-risk genetic forms. Thus, a question is raised: how 
do we identify children that have an increased risk of becoming myopic or highly 





Fig. 7.11 FitSight fitness 
tracker to record time 
outdoors. ©Verkicharla 
et al. [73]
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individuals. For children who are non-myopic but at an increased risk of developing 
high myopia in the future, additional outdoor activities and aggressive approaches 
should be introduced with frequent follow-up visits. Tools of myopia prediction 
have been developed as mentioned before, and we expect to see the outcomes of the 
integration of risk prediction and clinical practice in the near future.
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8Clinical Management and Control of Myopia in Children
Audrey Chia and Su Ann Tay
Key Points
• Our understanding of the pathogenesis and etiology of myopia continues 
to evolve, and with it, various interventions that prevent or slow the pro-
gression of myopia.  These include the use of bifocal spectacles, peripheral 
defocus spectacles and contact lenses, orthokeratology contact lenses, 
atropine and environmental interventions.
• With various interventions available for myopia control, understanding the 
effectiveness, safety profile and cost of each intervention can aid the clini-
cian in making collective decisions with patients and their families on the 
most appropriate intervention for each child.
• An atropine-based protocol for the treatment of myopia developed based 
on evidence from studies collected thus far is discussed.  This includes 
assessment of risk factors for myopia progression, factors to consider 
when starting atropine, monitoring response to atropine treatment and fac-
tors to consider before cessation of treatment.
• It is important that there is continued assessment of the long-term effect 




The understanding of the pathogenesis of myopia and various interventions has 
evolved over time. The belief of an association between myopia and near work in the 
1980s [1–5] led to interventions targeting accommodation such as bifocal glasses 
[6–8] and topical atropine [9–12]. The discovery of the importance of the peripheral 
retina [13–15], and how peripheral hyperopic defocus may aggravate eye growth 
and myopia [16–19] resulted in the exploration of peripheral defocus glasses and 
contact lenses as potential interventions in the 2000s. Induced peripheral myopic 
defocus is now thought to be how orthokeratology contact lenses slow myopia [16]. 
Research has moved on to novel contact lens designs, which also induce peripheral 
or dual defocus. More recently, it is hoped that with greater understanding of gene 
and molecular processes involved in eye growth, novel genetic and pharmacological 
treatments may be developed over time to control myopia.
8.2  Near Activity and Accommodation
8.2.1  Bifocal and Progressive Addition Spectacles
Progressive and bifocal glasses were introduced in the 1990s to try and slow myopia. 
However, studies with progressive addition lenses (PALs) showed a small and clini-
cally insignificant or no effect on myopia progression [20–23]. One meta- analysis 
noted small reductions in myopia progression (0.25  D, 95% CI 0.13–0.38; nine 
trials) and axial length (−0.12 mm, 95% CI −0.18 to −0.05; six trials) [24]. This 
effect may be greater for children with a higher myopia (<−3.0 D), accommodative 
lag, or near esophoria [24–28].
In contrast, randomized controlled trials (RCTs) showed that executive bifo-
cal lenses slowed myopia progression by 39% and up to 51% with base-in prisms 
incorporated [29]. It is possible that the larger near segment made it more likely for 
children to use the near add during near work, and may also induce more peripheral 
myopic defocus. However, because of the lack of collaborating evidence, meta-
analysis across trials found data to be limited and inconsistent [20].
8.2.2  Atropine
Atropine is a non-specific muscarinic acetylcholine receptor antagonist and was ini-
tially thought to work by blocking accommodation. This theory has since been dis-
proved in animal studies [30]. Its exact mechanism is still unknown but it is thought 
to work through muscarinic or non-muscarinic pathways either in the retina or in the 
sclera [31, 32]. Atropine has a strong dose-dependent inhibitory effect of myopia 
progression [30]. The initial high doses of atropine (i.e., 0.5% or 1.0%) slowed myo-
pia progression by more than 70% over 1–2 years [33–36]. However, lower doses 
(0.1% or less) can also slow myopia by 30–60%, and may be associated with fewer 
side effects (pupil dilation, glare or blur) [36, 37]. Huang et al. in a review of the data, 
found that high-dose and low-dose atropine slowed spherical equivalent by 0.68 D 
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[0.52–0.84] and 0.53 D [0.21–0.85] respectively, and axial length by −0.21  mm 
[−0.28 to −0.16] and−0.15 mm [−0.25 to −0.05] respectively over 1 year [38].
Washout data from the Atropine Treatment of Myopia (ATOM) studies, how-
ever, showed that there was a myopic rebound if atropine was stopped suddenly, 
especially at higher doses and in younger children [39, 40]. Up to 12% of children 
may exhibit a poor response (i.e., progress >1.0 D over 1 year) even on high-dose 
atropine. A poorer response was associated with younger children, a higher degree 
of myopia at baseline and myopic parents [41]. Similarly, in the ATOM2 study, 
9.3%, 6.4%, and 4.3% of children in the 0.01%, 0.1%, and 0.5% group, respectively, 
progressed by 1.5 D or more in the first 2 years of treatment [42].
More recently, in the Low-Concentration Atropine for Myopia Progression 
(LAMP) study involving children aged 4–12 years, those treated with 0.01%, 
0.02%, and 0.05% atropine showed a reduction of SE progression of 27%, 43%, and 
67%, and axial length growth of 12%, 29%, and 51%, respectively [37]. Overall, the 
effect on spherical equivalent was larger than that of axial length.
8.3  Peripheral Defocus
From animal studies, it is known that eyeball growth (i.e., hyperopia or myopia) 
could be induced by using positive and negative lenses, respectively [43, 44]. These 
studies also showed that peripheral refraction could influence eye growth, indepen-
dent of central vision. Excessive near work could induce hyperopic defocus in the 
peripheral retina and promote eye growth [25, 45–48]. The increased prolate growth 
of the myopic eyeball and use of spherical glasses correcting for central vision may 
aggravate this effect [46, 49–52]. Based on this theory, optical interventions that 
induce a myopic defocus in the periphery should slow myopia.
8.3.1  Peripheral Myopic Defocus Glasses
In 2010, Sankaridurg et al. published their results of three novel spectacle lenses. 
All lenses had a central clear aperture with varying amounts of plus defocus in 
the periphery. Unfortunately, there was no significant effect on myopic progres-
sion with all three designs compared to single vision lenses (SVLs). In a sub-
group of younger children with parental myopia, however, the prototype where 
the central aperture extended into the horizontal and inferior meridians with a 
peripheral power of +1.9 D did result in less myopia progression [53]. However, 
in a recent RCT conducted in Japanese children involving this design, no differ-
ence in myopia reduction was found [54].
8.3.2  Bifocal or Dual-Focus Contact Lenses
Bifocal contact lens designs often include a central distance focus, and peripheral 
rings with near add, creating a peripheral myopic defocus. Studies exploring the 
effect of these bifocal soft contact lenses indicate slowing of myopia progression by 
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30–38% and axial length by 31–51% over a period of 24 months [55–57]. Different 
studies suggest that efficacy may improve with increase in wear time, in children 
with faster rates of progression [58], near esophoria [59], and with designs possess-
ing a higher hyperopic power in the mid-periphery (up to 6 D) [60]. With the myriad 
of lens designs possible, the challenge now is to develop the most effective design 
with the least compromise to visual quality, comfort, and safety [61].
8.3.3  Orthokeratology
Orthokeratology (Ortho-k) lenses optically correct myopia by flattening the central 
cornea, resulting in a relative peripheral myopic defocus [62, 63]. Individual studies 
and meta-analyses have shown a 40–60% reduction in the rate of myopia progres-
sion with ortho-k lenses compared with controls using SVL spectacles [64–69]. In 
a meta-analysis by Sun et al., the combined results showed a mean AL reduction 
of 0.27 mm (95% CI: 0.22, 0.32) after 2 years, corresponding to a 45% reduction 
in myopic progression [69]. Younger children (aged 7–8 years) with faster myopic 
progression (>1.0 D/year) might benefit more [66], and benefits were noted even in 
partially corrected children with high myopia [68]. However, studies show that the 
efficacy may decrease over time, especially after 4–5 years [70–72], and a potential 
“rebound” after discontinuation, especially in children under 14 years [73]. There is 
also a potential non-response rate of 7–12% [74, 75]. The risk of infective keratitis 
remains [76–81]; a recent systemic review suggested an infection rate similar to 
overnight wear of soft contact lenses, which is estimated at 13.9 per 10,000 [82, 83].
8.4  Time Spent Outdoors
While initial strategies were targeted at minimizing near work, it became apparent 
that increasing time spent outdoors could be more important [84, 85]. In the Sydney 
Myopia Study, exposure to more than 2 h of outdoor activity per day decreased the 
odds of myopia and countered the effects of near work [86]. Interventions involving 
increasing time outdoors appeared to reduce the onset of myopia and also its pro-
gression in myopic children [87, 88]. A meta-analysis has suggested a 2% reduced 
odds of myopia per additional hour of time spent outdoors per week [89]. Another 
meta-analysis showed that time outdoors protected children against incident myo-
pia with a risk ratio (RR) of 0.536–0.574 in clinical trials and longitudinal cohort 
studies, and an odds ratio of 0.964 in cross-sectional studies, but had less effect in 
slowing progression in children who were already myopic [90].
8.4.1  Environmental Interventions
Based on new evidence, the advice has shifted from spending at least 2 h/day out-
doors in addition to avoiding excessive near work. This has changed health and 
school messaging in many East Asian countries [88].
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8.4.2  Higher Light Intensities and Dopamine
Potential reasons why time outdoors may be protective include higher light intensi-
ties [91, 92], differences in chromatic composition [93–95], the reduction in dioptric 
accommodative focus and psychometric influences encountered outdoors [96]. Higher 
light intensities increase retina dopamine production, which is believed to retard axial 
length elongation [97]. In animal studies, higher light levels greatly retarded form-
deprivation myopia [91, 92, 98], a reaction which is abolished by dopamine antagonists 
[97]. The role of chromaticity (red and blue) and ultraviolet (UV) light is still uncertain 
[99–102], while that of higher vitamin D levels has been debunked [103, 104].
8.5  Inheritance and Genetics of Myopia
Epidemiology studies suggest that the risk of myopia is doubled if children had one 
myopic parent, and 3–5 times if they had two [105], with a possible additive effect 
with subsequent generations [106]. In addition, monozygous twins have a 75–90% 
chance of having a similar refraction compared to 30% in dizygous twins [107–109].
From pedigree analysis, multiple inheritance patterns (i.e., autosomal dominant, 
autosomal recessive, and X-linked) have been identified. Genome-wide sequencing 
analyses have identified more than 20 myopia and high myopia loci and over 130 
potential genes (MYP1-3, 5–19) in different populations [107, 110]. These loci have 
been linked to neuronal signaling, retinoic acid synthesis, ion transport, channel 
activity, and membrane potential [110], which may influence ocular development, 
differentiation, and growth [111]. It is hoped that by understanding the genetics 
of myopia, it may be possible to predict who may develop high myopia or com-
plications of myopia early, how people may respond to various interventions, and 
uncover novel interventions.
8.6  Application to Clinical Practice
In deciding on treatment regimes, questions on which children would benefit most 
from treatment in terms of age, baseline myopia, rate of progression, and family 
history remain. In addition, the appropriate duration of treatment and the best time 
to start, stop, and restart treatment need to be further studied. With the various inter-
ventions available for myopia control, decisions need to be made in conjunction 
with patients and their families on the most appropriate one, taking into consider-
ation the effectiveness, safety profile, and cost of the each intervention (Table 8.1).
The following is an atropine-based protocol which has been developed, based on 
evidence collected thus far (Table 8.2 and Fig. 8.1). On presentation, the risk of the 
child developing myopia and its potential complications are assessed. Low-risk children 
may be older children (aged >11 years), those with little or no myopia progression in 
the last 1 year, and relatively low myopia. High-risk children may be those who have a 
strong family history of high myopia or myopic complications, are younger (<9 years), 
and with documented rapid progression of myopia over the last year. Parental and child 
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sentiments are also assessed (e.g., overall anxiety, willingness to administer eye drops 
every day, possibly till the child is in his/her mid- teens). Various options are discussed, 
ensuring that parents have realistic expectations of the outcome. The possibility of a 
poor response and need for a higher dose of atropine or alternative treatments are also 
carefully explained. Options would then include starting atropine or waiting another 
6–12 months to monitor the natural progression of refraction.
In this protocol, children are first started on a lower dose of atropine with a plan 
to increase the dose as necessary. However, an alternative would be to start initially 
Table 8.1 Summary of interventions for myopia control efficacy, safety, and accessibility
Effectiveness Safety Accessibility
Time outdoors Decrease onset of myopia 
by 30%; and progression 
of myopia by 18% [87, 
88]
Safe. Requires sun 
protection of eyes 
and skin
Available to all. 
Limited by social 
factors (academic 
expectations), 





progression by 39%; 51% 
with base-in prisms 
incorporated [29]
Safe although may 
result in some visual 
distortion
Moderately expensive
Readily available in 
most spectacle shops




No significant difference 
from SVL [53, 54]
Bifocal or dual 
focus soft contact 
lenses
Decrease myopia 
progression 30–38% over 
24 months [57]
Better effect with near 
esophoria [59]













40–50% reduction in 
myopia progression over 
1–2 years
Effect may wane over 
time
Rebound noted if stopped 
suddenly [69, 70]
Risk of infective 
keratitis similar to 
overnight soft CL 







expertise to ensure 
proper fit
Atropine Dose-related response for 
myopia control with 
70–80% reduction with 
high dose (0.5–1%) 
[33–36] and 30–60% 
with low dose (0.01–
0.05%) [36, 37]
Rebound noted if stopped 
suddenly (esp. in younger 
children and at higher 
doses) [39, 40]
Glare and near blur 
with higher doses 
Allergy 1–4% 
Systemic effects rare
Effect on spherical 
equivalent greater 
than axial length
Can be cost-effective 
if manufactured in 
bulk
Lower doses not 
readily available in 
all communities
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on a higher dose, with an aim to taper medication over time. Once medication is 
started, progression (refraction and/or axial length) is monitored every 6 months, 
with an initial aim to continue children on medication (i.e., atropine 0.01% daily) 
for at least 2 years. Children may respond to treatment in three ways: well (with 
little or no progression); adequately (with acceptable amount of progression, e.g., 
<0.5 D/year); or poorly (>0.5 D/year).
If a good response is obtained, the next question is how long treatment should 
continue for and when treatment should be stopped. From the ATOM 2 study, we 
know that stopping atropine 0.01% between 8 and 10 years resulted in a 60% risk 
of a rebound effect, compared to 30% at age 10–12 years and 8% after the age of 
12 years. In addition, children who did not demonstrate rebound tended to show lit-
tle or no myopic progression within the last year [67]. This suggests that in children 
younger than 12 years who showed no progression in the past year, atropine 0.01% 
may be slowly tapered (e.g., by reducing drop frequency by 1–2 days/week each 
year). However, if children are older than 12 years, then the frequency of eye drops 
could be tapered more quickly (e.g., by 1–2 days/week every 6 months). Using this 
regime, most children will be off medication by about 14–15 years of age.
Table 8.2 An atropine-based protocol for myopia treatment
A.  Starting atropine
  –  Assess child’s risk of myopia
  –  High risk: family history of high myopia or myopic complications, younger age, 
documented rapid progression of myopia, poor life-style profile (outdoor–near work)
  –  Assess parents’ and children’s risk aversion to treatment, willingness to continue on 
treatment till at least teenage years
  –  Age 4–13 years of age with documented progression of myopia of at least >0.5 D in the 
last year
B1:  Not keen on treatment: monitor over next 6–12 months
B2:  Keen on treatment: commence atropine 0.01% daily for at least 2 years
C.  Follow-up on treatment
  –  Review child every 6 months
  –  Monitor for compliance and side effects : near blur, glare, and allergy
  –  Cycloplegic refraction and axial length measurements at least once per year
D1:  Good or acceptable response to treatment (<0.5 D/year)
   Age <12 years old: consider continuing dose or slowly taper if no myopia progression 
noted in the past year
   Age >12 years old: consider taper of medication if no/little progression noted in the past 
year
D2:  Poor response to treatment (>0.5 D/year)
  –  Particularly in younger children (<9 years), with strong family history, with baseline 
high myopia and rapid progression prior to starting atropine
  –  Consider an increased dose (e.g., atropine 0.01% 2× per day, 0.1% daily or 1.0% 2–3× 
per week)
  –  Consider tinted glasses with near add if required
  –  Once stabilization of myopia is achieved, continue at that dose, and taper frequency of 
drops as child reaches teenage years
D3:  Poor response despite maximum atropine dose
  –  Consider stopping and changing or adding different treatment options
E.  Long-term follow-up
  –  Continue to monitor child for at least 1 year after stopping treatment
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In children who progress on low-dose atropine, the frequency of application or 
dose could be increased (e.g., using atropine 0.01% twice a day; or using a higher 
concentration, e.g., 0.1% or 1%). Note that while using higher concentrations, a 
daily dose may not be necessary and children may require tinted glasses with near 
add to cope with any glare or near blur. Once an adequate control of myopia is 
achieved, medication can be continued till the child reaches teenage years and then 
tapered as required. There are some children (10%), however, who may progress 
rapidly even on higher doses of atropine [68]. If this occurs, then the possibility of 
stopping treatment or trying other treatment modalities should be discussed. Even 
after stopping treatment, it may be necessary to monitor children for a further 6–12 
months to ensure that there is no further rebound.
Since our knowledge of how children respond to atropine and other interventions 
continues to increase over time, any protocol developed needs to be evaluated regularly, 
taking full advantage of our knowledge and accessibility to different treatment options.
8.7  Conclusion
Our management of myopia continues to evolve over time with a better under-
standing of the pathogenesis of myopia and its interventions. The challenge 
is to identify which individuals to treat, when to start treatment and which 
Assess child's risk 
of myopia
High Risk (Refer to 
Table 1)
YES




daily (at least 2 years)
Monitor 6 monthly
(Refer to Table 1) 
Good response (≤0.5D/yr) and <12yo
Continue or consider
slow taper
Good response (≤0.5D/yr) and ≥12yo
Consider slow taper
Continue monitoring for at least 1 year 
after cessation of treatment 
Poor response (>0.5D/yr)
Consider increased atropine 
dose (refer Table 1)
NO
Monitor over 6 - 12
months
Commence on atropine 0.01% daily if keen and 
continued rapid progression
NO
Monitor over 6 - 12 months
Fig. 8.1 Flow chart of atropine-based protocol for myopia treatment.
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interventions one should use. There are differences in efficacy, safety, and cost 
which need to be balanced. More work is required to determine how to com-
bine or time treatments to optimize outcome, and when treatments can be safely 
stopped. It is also important that there is continued assessment of the long-term 
effect and value of these treatments in preventing high myopia and its associated 
complications.
References
 1. Parssinen O, Lyyra AL. Myopia and myopic progression among schoolchildren: a three-year 
follow-up study. Invest Ophthalmol Vis Sci. 1993;34:2794–802.
 2. Goss DA. Nearwork and myopia. Lancet. 2000;356:1456–7.
 3. Hepsen IF, Evereklioglu C, Bayramlar H. The effect of reading and near-work on the develop-
ment of myopia in emmetropic boys: a prospective, controlled, three-year follow-up study. Vis 
Res. 2001;41:2511–20.
 4. Saw SM, Chua WH, Hong CY, et al. Nearwork in early-onset myopia. Invest Ophthalmol Vis 
Sci. 2002;43:332–9.
 5. Li SM, Li SY, Kang MT, et al. Near work related parameters and myopia in Chinese children: 
The Anyang Childhood Eye Study. PLoS One. 2015;10:e0134514.
 6. Goss DA. Effect of bifocal lenses on the rate of childhood myopia progression. Am J Optom 
Physiol Optic. 1986;63:135–41.
 7. Parssinen O, Hemminki E, Klemetti A. Effect of spectacle use and accommodation on myopic 
progression: final results of a three-year randomised clinical trial among schoolchildren. Br J 
Ophthalmol. 1989;73:547–51.
 8. Grosvenor T, Perrigin DM, Perrigin J, Maslovitz B. Houston Myopia Control Study: a ran-
domized clinical trial. Part II. Final report by the patient care team. Am J Optom Physiol Optic. 
1987;64:482–98.
 9. Bedrossian RH. The effect of atropine on myopia. Ann Ophthalmol. 1971;3:891–7.
 10. Gimbel HV. The control of myopia with atropine. Can J Ophthalmol. 1973;8:527–32.
 11. Bedrossian RH. The effect of atropine on myopia. Ophthalmology. 1979;86:713–9.
 12. Brodstein RS, Brodstein DE, Olson RJ, et al. The treatment of myopia with atropine and bifo-
cals. A long-term prospective study. Ophthalmology. 1984;91:1373–9.
 13. Wallman J, Gottlieb MD, Rajaram V, et al. Local retinal regions control local eye growth and 
myopia. Science. 1987;237:73–8.
 14. Diether S, Schaeffel F. Local changes in eye growth induced by imposed local refractive error 
despite active accommodation. Vis Res. 1997;37:659–68.
 15. Miles FA, Wallman J. Local ocular compensation for imposed local refractive error. Vis Res. 
1990;30:339–49.
 16. Wallman J, Winawer J.  Homeostasis of eye growth and the question of myopia. Neuron. 
2004;43:447–68.
 17. Smith EL III, Hung LF, Ramamirtham R, et al. Optically imposed hyperopic defocus in the 
periphery can produce central axial myopia in infant monkeys. Invest Ophthalmol Vis Sci. 
2007;48(13):1533.
 18. Smith EL, Hung LF, Huang J. Relative peripheral hyperopic defocus alters central refractive 
development in infant monkeys. Vis Res. 2009;49:2386–92.
 19. Smith EL III, Hung LF, Huang J, et al. Effects of optical defocus on refractive development 
in monkeys: evidence for local, regionally selective mechanisms. Invest Ophthalmol Vis Sci. 
2010;51:3864–73.
 20. Walline JJ, Lindsley K, Vedula SS, et al. Interventions to slow progression of myopia in chil-
dren. Cochrane Database Syst Rev. 2011;12:CD004916.
 21. Gwiazda JE, Hyman L, Everett D, The COMET Group, et al. Five–year results from the cor-
rection of myopia evaluation trial (COMET). Invest Ophthalmol Vis Sci. 2006;47(13):1166.
8 Clinical Management and Control of Myopia in Children
196
 22. Hasebe S, Ohtsuki H, Nonaka T, et al. Effect of progressive addition lenses on myopia progres-
sion in Japanese children: a prospective, randomized, double-masked, crossover trial. Invest 
Ophthalmol Vis Sci. 2008;49(7):2781–9.
 23. Hasebe S, Jun J, Vamas SR, et al. Myopia control with positively aspherised progressive addi-
tional lenses: a 2 year, multicentre, randomized, controlled trial. Invest Ophthalmol Vi Sci. 
2014;55(11):7177–88.
 24. Li SM, Ji YZ, Wu SS, et al. Multifocal versus single vision lenses intervention to slow progres-
sion of myopia in school-age children: a meta-analysis. Surv Ophthalmol. 2011;56:451–60.
 25. Gwiazda JE, Hyman L, Norton TT, COMET Group, et al. Accommodation and related risk 
factors associated with myopia progression and their interaction with treatment in COMET 
children. Invest Ophthalmol Vis Sci. 2004;45(7):2143–51.
 26. Correction of Myopia Evaluation Trial 2 Study Group for the Pediatric Eye Disease Investigator 
Group. Progressive-addition lenses versus single-vision lenses for slowing progression of 
myopia in children with high accommodative lag and near esophoria. Invest Ophthalmol Vis 
Sci. 2011;52:2749–57.
 27. Berntsen DA, Sinnott LT, Mutti DO, Zadnik K. A randomized trial using progressive addition 
lenses to evaluate theories of myopia progression in children with a high lag of accommoda-
tion. Invest Ophthalmol Vis Sci. 2012;53:640–9.
 28. Yang Z, Lan W, Ge J, Liu W, Chen X, Chen L, Yu M. The effectiveness of progressive addi-
tion lenses on the progression of myopia in Chinese children. Ophthalmic Physiol Opt. 
2009;29:41–8.
 29. Cheng D, Woo GC, Drobe B, Schmid KL.  Effect of bifocal and prismatic bifocal spec-
tacles on myopia progression in children: three-year results of a randomized clinical trial. 
Ophthamology. 2014;132:258–64.
 30. McBrien NA, Moghaddam HO, Reeder AP. Atropine reduces experimental myopia and eye 
enlargement via a nonaccommodative mechanism. Invest Ophthalmol Vis Sci. 1993;34:205–15.
 31. McBrien NA, Stell WK, Carr B. How does atropine exert its anti-myopia effects? Ophthalmic 
Physiol Opt. 2013;33(3):373–8.
 32. Lind GJ, Chew SJ, Marzani D, Wallman J.  Muscarinic acetylcholine receptor antagonists 
inhibit chick scleral chondrocytes. Invest Ophthalmol Vis Sci. 1998;39:2217–31.
 33. Yen MY, Liu JH, Kao SC, Shiao CH. Comparison of the effect of atropine and cyclopentolate 
on myopia. Ann Ophthalmol. 1989;21:180–2.
 34. Shih YF, Chen CH, Chou AC, et al. Effects of different concentrations of atropine on control-
ling myopia in myopic children. J Ocul Pharmacol Ther. 1999;15:85–90.
 35. Chua WH, Balakrishnan V, Chan YH, et al. Atropine for the treatment of childhood myopia. 
Ophthalmology. 2006;113(12):2285–91.
 36. Chia A, Chua WH, Cheung YB, et al. Atropine for the treatment of childhood myopia: safety 
and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2). 
Ophthalmology. 2012;119(2):347–54.
 37. Yam JC, Jiang Y, Tang SM, et al. Low-concentration atropine for myopia progression (LAMP) 
study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% 
atropine eye drops in myopia control. Ophthalmology. 2019;126(1):113–24.
 38. Huang J, Wen D, Wang Q, et al. Efficacy comparison of 16 interventions for myopia control in 
children: a network meta-analysis. Ophthalmology. 2016;123(4):697–708.
 39. Tong L, Huang XL, Koh AL, et al. Atropine for the treatment of childhood myopia: effect on 
myopia progression after cessation of atropine. Ophthalmology. 2009;116:572–9.
 40. Chia A, Chua WH, Wen L, et al. Atropine for the treatment of childhood myopia: changes after 
stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol. 2014;157(2):451–457.e1.
 41. Loh KL, Lu Q, Tan D, Chia A. Risk factors for progressive myopia in the atropine therapy for 
myopia study. Am J Ophthalmol. 2015;159:945–9.
 42. Chia A, Lu QS, Tan D. Five-year clinical trial on atropine for the treatment of myopia 2: myo-
pia control with atropine 0.01% eyedrops. Ophthalmology. 2016;123(2):391–9.
 43. Troilo D, Wallman J. The regulation of eye growth and refractive state: an experimental study 
of emmetropization. Vis Res. 1991;31:1237–50.
A. Chia and S. A. Tay
197
 44. Schaeffel F, Troilo D, Wallman J, Howland HC. Developing eyes that lack accommodation 
grow to compensate for imposed defocus. Vis Neurosci. 1990;4:177–83.
 45. Seidemann A, Schaeffel F. An evaluation of the lag of accommodation using photorefraction. 
Vis Res. 2003;43:419–30.
 46. Gwiazda J, Bauer J, Thorn F, et al. A dynamic relationship between myopia and blur-driven 
accommodation in school-aged children. Vis Res. 1995;35:1299–304.
 47. Gwiazda J, Thorn F, Bauer J, et al. Myopic children show insufficient accommodative response 
to blur. Invest Ophthalmol Vis Sci. 1993;34:690–4.
 48. Charman WN.  Near vision, lags of accommodation and myopia. Ophthalmic Physiol Opt. 
1999;19:126–33.
 49. Mutti DO, Sinnott LT, Mitchell GL, CLEERE Study Group, et al. Relative peripheral refrac-
tive error and the risk of onset and progression of myopia in children. Invest Ophthalmol Vis 
Sci. 2011;52(1):199–205.
 50. Atchison DA, Jones CE, Schmid KL, et  al. Eye shape in emmetropia and myopia. Invest 
Ophthalmol Vis Sci. 2004;45(10):3380–6.
 51. Schmid GF. Association between retinal steepness and central myopic shift in children. Optom 
Vis Sci. 2011;88(6):684–90.
 52. Sng CCA, Lin XY, Gus G, et  al. Change in peripheral refraction over time in Singapore 
Chinese children. Invest Ophthalmol Vis Sci. 2011;52(11):7880–7.
 53. Sankaridurg P, Donovan L, Varnas S, et al. Spectacle lenses designed to reduce progression of 
myopia: 12-month results. Optom Vis Sci. 2010;87(9):631–41.
 54. Kanda H, Oshika T, Hiraoka T, et al. Effect of spectacle lenses designed to reduce relative 
peripheral hyperopia on myopia progression in Japanese children: a 2-year multicenter ran-
domized controlled trial. Jpn J Ophthalmol. 2018;62:537–43.
 55. Benavente-Pérez A, Nour A, Troilo D. Axial eye growth and refractive error development can 
be modified by exposing the peripheral retina to relative myopic or hyperopic defocus. Invest 
Ophthalmol Vis Sci. 2014;55(10):6765–73.
 56. Walline JJ. Myopia control: a review. Eye Contact Lens. 2016;42(1):3–8.
 57. Li SM, Kang MT, Wu SS, et al. Studies using concentric ring bifocal and peripheral add mul-
tifocal contact lenses to slow myopia progression in school-aged children: a meta-analysis. 
Ophthalmic Physiol Opt. 2017;37(1):51–9.
 58. Lam CSY, Tang WC, Tse DY-Y, Tang YY, To CH. Defocus incorporated soft contact (DISC) 
lens slows myopia progression in Hong Kong Chinese schoolchildren: a 2-year randomised 
clinical trial. Br J Ophthalmol. 2014;98:40–5.
 59. Aller TA, Liu M, Wildsoet CF. Myopia control with bifocal contact lenses: a randomized clini-
cal trial. Optom Vis Sci. 2016;93(4):344–52.
 60. Paune J, Morales H, Armengol J, et al. Myopia control with a novel peripheral gradient soft 
lens and orthokeratology: a 2-year clinical trial. Biomed Res Int. 2015;2015:507572.
 61. Anstice NS, Phillips JR. Effect of dual-focus soft contact lens wear on axial myopia progres-
sion in children. Ophthalmology. 2011;118:1152–61.
 62. Charman WN, Mountford J, Atchison DA, et  al. Peripheral refraction in orthokeratology 
patients. Optom Vis Sci. 2006;83:641–8.
 63. Queirós A, González-Méijome JM, Jorge J, et al. Peripheral refraction in myopic patients after 
orthokeratology. Optom Vis Sci. 2010;87(5):323–9.
 64. Wen D, Huang J, Chen H, et al. Efficacy and acceptability of orthokeratology for slowing myopic 
progression in children: a systematic review and meta-analysis. J Ophthalmol. 2015;2015:360806.
 65. Si JK, Tang K, Bi HS, et al. Orthokeratology for myopia control: a meta-analysis. Optom Vis 
Sci. 2015;92:252–7.
 66. Cho P, Cheung SW, Edwards M, et al. The longitudinal orthokeratology research in children 
(LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res. 
2005;30:71–80.
 67. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, et al. Myopia control with orthokera-
tology contact lenses in Spain: refractive and biometric changes. Invest Ophthalmol Vis Sci. 
2012;53:5060–5.
8 Clinical Management and Control of Myopia in Children
198
 68. Charm J, Cho P. High myopia partial reduction ortho-k: a 2-year randomized study. Optom Vis 
Sci. 2013;90:530–9.
 69. Sun Y, Xu F, Zhang T, Liu M, Wang D, Chen Y, Liu Q. Orthokeratology to control myopia 
progression: a meta-analysis. PLoS One. 2015;10(4):e0124535.
 70. Hiraoka T, Kakita T, Okamoto F, et al. Long-term effect of overnight orthokeratology on axial 
length elongation in childhood myopia: a 5-year follow-up study. Invest Ophthalmol Vis Sci. 
2012;53:3913–9.
 71. Lee YC, Wang JH, Chiu CJ. Effect of Orthokeratology on myopia progression: twelve-year 
results of a retrospective cohort study. BMC Ophthalmol. 2017;17(1):243.
 72. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R, Sugimoto K. Long-
term efficacy of orthokeratology contact lens wear in controlling the progression of childhood 
myopia. Curr Eye Res. 2017;42(5):713–20.
 73. Cho P, Cheung SW. Discontinuation of orthokeratology on eyeball elongation (DOEE). Cont 
Lens Anterior Eye. 2017;40:82–7.
 74. Cho P, Cheung SW. Retardation of myopia in orthokeratology (ROMIO) study: a 2-year ran-
domized clinical trial. Invest Ophthalmol Vis Sci. 2012;53:7077–85.
 75. Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE Study). 
Invest Ophthalmol Vis Sci. 2013;54(10):6510–7.
 76. Sun X, Zhao H, Deng S, et  al. Infectious keratitis related to orthokeratology. Ophthalmic 
Physiol Opt. 2006;26:133–6.
 77. Yepes N, Lee SB, Hill V, et al. Infectious keratitis after overnight orthokeratology in Canada. 
Cornea. 2005;24:857–60.
 78. Tseng CH, Fong CF, Chen WL, et al. Overnight orthokeratology-associated microbial kerati-
tis. Cornea. 2005;24:778–82.
 79. Young AL, Leung AT, Cheng LL, et al. Orthokeratology lens–related corneal ulcers in chil-
dren: a case series. Ophthalmology. 2004;111:590–5.
 80. Xuguang S, Lin C, Yan Z, et al. Acanthamoeba keratitis as a complication of orthokeratology. 
Am J Ophthalmol. 2003;136:1159–61.
 81. Chan TC, Li EY, Wong VW, Jhanji V. Orthokeratology-associated infectious keratitis in a ter-
tiary care eye hospital in Hong Kong. Am J Ophthalmol. 2014;158:1130–5.
 82. Liu YM, Xie P.  The safety of orthokeratology—a systematic review. Eye Contact Lens. 
2016;42:35–42.
 83. Meter V, Woodford S, et al. Safety of overnight orthokeratology for myopia. Ophthalmology. 
2008;115(12):2301–13.
 84. Guggenheim JA, Northstone K, McMahon G, et al. Time outdoors and physical activity as 
predictors of incident myopia in childhood: a prospective cohort study. Invest Ophthalmol Vis 
Sci. 2012;53(6):2856–65.
 85. Rose KA, Morgan IG, Smith W, Burlutsky G, Mitchell P, Saw SM. Myopia, lifestyle, and 
schooling in students of Chinese ethnicity in Singapore and Sydney. Arch Ophthalmol. 
2008;126(4):527–30.
 86. Rose KA, Morgan IG, Ip J, Kifley A, Huynh S, Smith W, Mitchell P. Outdoor activity reduces 
the prevalence of myopia in children. Ophthalmology. 2008;115(8):1279–85.
 87. He M, Xiang F, Zeng Y, et al. Effect of time spent outdoors at school on the development of 
myopia among children in china a randomized clinical trial. JAMA. 2015;314(11):1142–8.
 88. Wu PC, Chen CT, Lin KK, et al. Myopia prevention and outdoor light intensity in a school- 
based cluster randomized trial. Ophthalmology. 2018;125(8):1239–50.
 89. Sherwin JC, Reacher MH, Keogh RH, et al. The association between time spent outdoors and 
myopia in children and adolescents: a systematic review and meta-analysis. Ophthalmology. 
2012;119:2141–51.
 90. Xiong S, Sankaridurg P, Naduvilath T, Zang J, Zou H, Zhu J, Lv M, He X, Xu X. Time spent in 
outdoor activities in relation to myopia prevention and control: a meta-analysis and systematic 
review. Acta Ophthalmol. 2017;95(6):551–66.
 91. Ashby R, Ohlendorf A, Schaeffel F. The effect of ambient illuminance on the development of 
deprivation myopia in chicks. Invest Ophthalmol Vis Sci. 2009;50:5348–54.
A. Chia and S. A. Tay
199
 92. Karouta C, Ashby RS. Correlation between light levels and the development of deprivation 
myopia. Invest Ophthalmol Vis Sci. 2015;56:299–309.
 93. Rohrer B, Schaeffel F, Zrenner E. Longitudinal chromatic aberration and emmetropization: 
results from the chicken eye. J Physiol. 1992;449:363–76.
 94. Seidemann A, Schaefel F. Effects of longitudinal chromatic aberration on accommodation 
and emmetropization. Vis Res. 2002;42:2409–17.
 95. Rucker FJ, Wallman J. Chick eyes compensate for chromatic simulations of hyperopic and 
myopic defocus: evidence that the eye uses longitudinal chromatic aberration to guide eye 
growth. Vis Res. 2009;49:1775–83.
 96. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia 
aetiology. Prog Retin Eye Res. 2012;31:622–60.
 97. Feldkaemper M, Schaeffel F. An updated view on the role of dopamine in myopia. Exp Eye 
Res. 2013;114:106–19.
 98. Smith EL 3rd, Hung LF, Huang J.  Protective effects of high ambient lighting on the 
development of form-deprivation myopia in rhesus monkeys. Invest Ophthalmol Vis Sci. 
2012;53:421–8.
 99. Prepas SB.  Light, literacy and the absence of ultraviolet radiation in the development of 
myopia. Med Hypotheses. 2008;70:635–7.
 100. Foulds WS, Barathi VA, Luu CD. Progressive myopia or hyperopia can be induced in chicks 
and reversed by manipulation of the chromaticity of ambient light. Invest Ophthalmol Vis 
Sci. 2013;54(13):8004–12.
 101. Smith EL, Hung LF, Arumugam B, et al. Effects of long-wavelength lighting on refractive 
development in infant rhesus monkeys. Invest Ophthalmol Vis Sci. 2015;56(11):6490–500.
 102. Hung LF, Arumugam B, She Z, et  al. Narrow-band, long-wavelength lighting promotes 
hyperopia and retards vision-induced myopia in infant rhesus monkeys. Exp Eye Res. 
2018;4(176):147–60.
 103. Guggenheim JA, Williams C, Northstone K, et  al. Does vitamin D mediate the protec-
tive effects of time outdoors on myopia? Findings from a prospective birth cohort. Invest 
Ophthalmol Vis Sci. 2014;55:8550–8.
 104. Cuellar-Partida G, Williams KM, Yazar S, et al. Genetically low vitamin D concentrations and 
myopic refractive error: a Mendelian randomization study. Int J Epidemiol. 2017;46:1882–90.
 105. Wenbo L, Congxia B, Hui L. Genetic and environmental-genetic interaction rules for the myo-
pia based on a family exposed to risk from a myopic environment. Gene. 2017;626:305–8.
 106. Ahn H, Lyu IS, Rim TH. The influence of parental myopia on children’s myopia in different 
generations of parent-offspring pairs in South Korea. Semin Ophthalmol. 2018;33(3):419–28.
 107. Li J, Zhang Q. Insight into the molecular genetics of myopia. Mol Vis. 2017;23:1048–80.
 108. Chen Y, Zhang J, Morgan IG, He M.  Identifying children at risk of high myopia using 
population centile curves of refraction. PLoS One. 2016;11(12):e0167642.
 109. Guggenheim JA, Ghorbani Mojarrad N, Williams C, et  al. Genetic prediction of myopia: 
prospects and challenges. Ophthalmic Physiol Opt. 2017;37:549–56.
 110. Rong SS, Chen LJ, Pang CP.  Myopia Genetics-The Asia-Pacific Perspective. Asia Pac J 
Ophthalmol. 2016;5(4):236–44.
 111. Flitcroft DI, Loughman J, Wildsoet CF, Williams C, Guggenheim JA, CREAM Consortium. 
Novel myopia genes and pathways identified from syndromic forms of myopia. Invest 
Ophthalmol Vis Sci. 2018;59(1):338–48.
8 Clinical Management and Control of Myopia in Children
200
Open Access This chapter is licensed under the terms of the Creative Commons Attribution 4.0 
International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate 
credit to the original author(s) and the source, provide a link to the Creative Commons license and 
indicate if changes were made.
The images or other third party material in this chapter are included in the chapter's Creative 
Commons license, unless indicated otherwise in a credit line to the material. If material is not 
included in the chapter's Creative Commons license and your intended use is not permitted by 
statutory regulation or exceeds the permitted use, you will need to obtain permission directly from 
the copyright holder.
A. Chia and S. A. Tay
201© The Author(s) 2020
M. Ang, T. Y. Wong (eds.), Updates on Myopia, 
https://doi.org/10.1007/978-981-13-8491-2_9
K. Ohno-Matsui (*) 
Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, 
Tokyo, Japan
e-mail: k.ohno.oph@tmd.ac.jp 
J. B. Jonas 




• Pathologic myopia is defined by the presence of posterior staphylomas 
and/or the presence of myopic chorioretinal atrophy equal to or more seri-
ous than diffuse atrophy.
• Myopic CNV is the most frequent cause of central vision loss.
• Ultra wide-field OCT is a useful tool to detect posterior staphylomas.
• Anti-VEGF therapies have greatly improved the prognosis of myopic 
CNV.
• Vitreoretinal surgeries for myopic macular retinoschisis are useful.
9.1  Introduction
Pathologic myopia (PM) is a major cause of blindness in the world, especially in East 
Asian countries [1–5]. The cause of blindness in patients with PM includes myopic 
maculopathy with or without posterior staphyloma, myopic macular retinoschisis, 
and glaucoma or glaucoma-like optic neuropathy. In this chapter, the lesions of 
myopic fundus complications including posterior staphylomas are described.
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9.2  Definition of Pathologic Myopia
The terms “pathologic myopia,” “high myopia,” and “axial myopia” have long 
been used in a parallel manner in the literature. According to recent discus-
sions, the term “high myopia” simply describes the status of a “high degree of 
myopia” and should be defined by a cut-off value of myopic refractive error. 
The term “axial myopia” may be used to describe the situation with an axial 
elongation as cause for the myopic refractive error. It is in contrast to the term 
refractive myopia, which is used for eyes with an abnormally high refractive 
power of their optical media. The term “pathologic myopia” describes the situ-
ation of pathologic consequences of a myopic axial elongation. According to 
a recent consensus article by Ohno-Matsui et  al. [6], pathologic myopia was 
defined by myopic chorioretinal atrophy equal to or more serious than diffuse 
atrophy (by META-PM study group classification [7]) and/or the presence of 
posterior staphylomas.
9.3  Posterior Staphyloma
Posterior staphyloma has been considered a hallmark lesion of pathologic myopia. 
While axial elongation may primarily start in the equatorial and retro-equatorial 
region with secondary changes taking place at the posterior fundus, posterior staph-
ylomas occur in the posterior segment of the eye and can be associated with, or lead 
to, vision-threatening complications in the macula as part of a myopic maculopathy 
[7–11] and myopic optic neuropathy/glaucoma [12, 13].
9.3.1  Definition of Staphyloma by Spaide (Fig. 9.1)
A posterior staphyloma is an outpouching of a circumscribed area of the posterior 
fundus, where the radius of curvature is less than the curvature radius of the sur-
rounding eye wall [14].
9.3.2  Detection of Posterior Staphyloma
Moriyama et al. recently applied three-dimensional magnetic resonance imaging 
(3D-MRI) to analyze the shape of the entire eye from the corneal surface to the 
posterior pole including even large posterior staphylomas (Fig. 9.2) [15–17]. The 
technique allowed visualizing a staphyloma from any angle. The advantage of 
3D-MRI of visualizing the shape of the whole eye including the anterior ocular 
segment is combined with its disadvantage of not being feasible as a screening 
technique. Instead, a new prototype of a wide-field swept-source optical coher-
ence tomographic (OCT) system has been developed, which uses not only one but 
multiple scan lines and which generates scan maps allowing a three-dimensional 
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reconstruction of posterior staphylomas in a region of interest of 23 × 20 mm with 
a depth of 5 mm. Applying a wide-field OCT (WF-OCT), Shinohara et al. [18] 
showed that WF-OCT could provide tomographic images of posterior staphylomas 
in a resolution and size unachievable up to that time, and that WF-OCT might 
replace 3D-MRI in examining posterior staphylomas. Upon WF-OCT, the edges 
of the staphylomas showed consistent features, consisting of a gradual thinning 
of the choroid from the periphery toward the staphyloma edge and a gradual re-
thickening of the choroid from the staphyloma edge in direction to the posterior 
pole (Fig. 9.3).
a b c
Fig. 9.1 Definition of posterior staphyloma (cited from the textbook Pathologic Myopia [14]). (a) 
Normal eye shape. (b) Axial expansion occurring in the equatorial region that does not induce any 
altered curvature in the posterior aspect of the eye. This eye would have axial myopia but no staphy-
loma. (c) Posterior staphyloma. A second curvature occurs in the posterior portion of the eye, and 
this second curvature has a small radius (r2) than the surrounding eye wall (r1). This secondary curve 
is a staphyloma. (This figure does not take into account changes in scleral thickness)
Fig. 9.2 Three-dimensional magnetic resonance images of eyes with emmetropia and posterior 
staphyloma. The shape of the emmetropic eye (left) is almost spherical and symmetrical, while the 
eye with a posterior staphyloma shows an outpouching of its posterior segment
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An additional advantage of the swept-source WF-OCT technology was the rela-
tively large depth of focus so that structures from the posterior vitreous to the sclera 
could be imaged in the same image. It allowed the analysis of relationships between 
vitreoretinal abnormalities and other lesions in the inner retinal layers, such as myo-
pic macular retinoschisis and posterior staphylomas as reported by Shinohara et al. 
[19] (Fig. 9.4).
9.3.3  Classification (Ohno-Matsui’s Modified Classification, 
Fig. 9.3)
Based upon and modifying Curtin’s [20] classical categorization of posterior 
staphylomas, with Types I–V as primary staphylomas and Types VI–X as com-
pound staphylomas, Ohno-Matsui [17] used 3D-MRI and wide-field fundus 
Fig. 9.3 Swept-source wide-field optical coherence tomographic (OCT) image of a posterior staph-
yloma. (Left) Right fundus shows a wide staphyloma (arrowheads). (Right) The wide-field OCT 
image shows the staphyloma edge (arrow) with a gradual thinning of the choroid from the periphery 
toward the staphyloma edge and a gradual re-thickening of the choroid toward the posterior pole. The 
white arrow indicates the change in the curvature radius of the sclera at the staphyloma edge
Fig. 9.4 Spatial relationship between myopic macular retinoschisis and posterior staphyloma. In 
this swept-source wide-field optical coherence tomographic image, the outer and inner retinoschi-
sis is restricted to the area of the posterior staphyloma. It may suggest that the inner retinal struc-
tures as compared to the outer retinal structures were not flexible enough to follow the elongated 
circumference of Bruch’s membrane and sclera
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imaging to reclassify staphylomas into six types: the wide macular type, the nar-
row macular type, the peripapillary type, the nasal type, the inferior type, and 
others (Fig. 9.5).
9.4  Fundus Complications of Pathologic Myopia
9.4.1  Myopic Chorioretinal Atrophy (META-PM Study, Table 9.1)
In the META-PM classification [7], myopic maculopathy lesions have been categorized 
into five categories from “no myopic retinal lesions” (Category 0), “tessellated fundus 
only” (Category 1; Fig. 9.6a), “diffuse chorioretinal atrophy” (Category 2; Fig. 9.6b), 
“patchy chorioretinal atrophy” (Category 3; Fig. 9.6c), to “macular atrophy” (Category 
4; Fig. 9.6d). These categories were defined based on long-term clinical observations 
that showed the progression patterns and associated factors of the development of 
myopic choroidal neovascularization (CNV) for each stage. Three additional features 
were added to these categories and were included as “plus signs”: (1) lacquer cracks 
(Fig. 9.6e) and (2) myopic CNV (Fig. 9.6f) (Table 9.1). Since a Fuchs’ spot represented 
a scarred form of myopic CNV, Fuchs’ spots were categorized under the term of myo-
pic CNV. The reason for separately listing the “plus signs” was that all three lesions 
have been shown to be strongly associated with central vision loss; however, they did 
not fit into any particular category and might develop from, or coexist, in eyes with any 
wide, macular
Type I Type II Type III Type IV Type V
inferior Othersnarrow, macular peripapillary nasal
Fig. 9.5 Classification staphyloma (cited from [17] with permission). New classification of pos-
terior staphyloma according to its location and extent. The staphyloma type is renamed according 
to its location and distribution. Type I → wide, macular staphyloma, Type II → narrow, macular 
staphyloma, Type III → peripapillary staphyloma, Type IV → nasal staphyloma, Type V → inferior 
staphyloma, others → staphylomas other than Types I–V
Table 9.1 Myopic Chorioretinal Atrophy Classification (META-PM Study)
Plus lesions
Category 0 Normal fundus Myopic CNV lacquer cracks
Category 1 Tesselated fundus
Category 2 Diffuse chorioretinal atrophy
Category 3 Patchy chorioretinal atrophy
Category 4 Macular atrophy





Fig. 9.6 Myopic maculopathy. (a) Fundus tessellation temporal to the optic disc. (b) Diffuse chorio-
retinal atrophy. Ill-defined, yellowish atrophy is seen in the posterior fundus. (c) Patchy chorioretinal 
atrophy. Within the area of diffuse atrophy, multiple areas of well-defined, whitish atrophic lesions 
are seen (arrows); yellow arrows: parapapillary gamma zone; red arrow: parapapillary delta zone. (d) 
Macular atrophy, several years after the formation of myopic choroidal neovascularization (CNV), a 
well-defined atrophic lesion is seen in the macular area. (e) Myopic CNV. Subretinal hemorrhage is 
seen around the CNV (arrow); yellow arrows: parapapillary gamma zone; red arrow: parapapillary 
delta zone. (f) Lacquer cracks. Multiple yellowish linear lesions are seen (arrows)
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of the myopic maculopathy categories described above. Based on this classification, 
pathologic myopia has now been defined as myopic maculopathy Category 2 or above, 
or the presence of “plus” sign or posterior staphyloma [7, 21].
9.4.2  Diffuse Chorioretinal Atrophy (Category 2)
Diffuse chorioretinal atrophy is characterized by a yellowish white appearance of the 
posterior pole. The region of the diffuse atrophy may extend from a restricted area 
around the optic disc and a part of the macula to the entire posterior pole. The atro-
phy generally first appears around the optic disc, often increases with age, and finally 
covers the entire area within a staphyloma if a staphyloma is present. Both older age 
and longer axial length have been described as risk factors for the development of 
diffuse atrophy [9]. Marked thinning of the choroidal layer in the area of diffuse atro-
phy can be detected upon OCT, with occasional large choroidal vessels remaining.
9.4.3  Patchy Chorioretinal Atrophy (Category 3)
Patchy chorioretinal atrophy appears as well-defined, grayish white lesion(s) in the 
macular area or around the optic disc. Upon OCT, the area of patchy atrophy is 
characterized by the absence of the entire choroid and the RPE as well as of the 
outer retina. Hyper-transmission through the underlying sclera can be seen upon 
OCT. Using swept-source OCT, Ohno-Matsui et al. [22] showed that patchy atrophy 
was not simply a chorioretinal atrophy but was combined with a defect in Bruch’s 
membrane (BM).
9.4.4  Lacquer Cracks (Plus Sign)
Lacquer cracks appear as yellowish linear lesions in the macula. Lacquer cracks 
have been considered to represent breaks in BM [9, 23–25]. Progression patterns of 
lacquer cracks include an increased number, elongation, and progression to patchy 
atrophy [8, 26].
Detection of lacquer cracks can sometimes be difficult especially in eyes with 
diffuse atrophy. Assessments of hyper-fluorescence by fluorescein angiography 
and hypo-fluorescence upon indocyanine green angiography have been useful for 
the diagnosis. Other linear lesions due to pathologic myopia with a similar hypo- 
fluorescence upon by indocyanine green angiography, such as myopic stretch lines, 
have to be differentiated [27].
Due to their small width, linear defects in BM as the base of lacquer cracks are 
difficult to be directly detected. Instead, hyper-reflective lines of the choroidal and 
scleral tissue layers on the OCT images indirectly indicate the linear BM defect by 
an optical window effect (Fig. 9.7). The recently developed imaging technique of 
OCT angiography may be useful for detecting a rupture of the choriocapillaris in 
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the area of lacquer cracks, again indirectly indicating a defect in BM [28]. Since a 
subretinal bleeding can often be observed at the onset of the development of lacquer 
cracks [29–31] (Fig. 9.8), it is important to exclude the presence of a myopic CNV 
in cases of subretinal bleeding in the region of lacquer cracks.
9.4.5  Myopic CNV and CNV-Related Macular Atrophy
Myopic CNV is a major sight threatening complication of pathologic myopia. It 
is the most common cause of CNV in individuals younger than 50 years, and it is 
the second most common cause of CNV overall [25, 32]. Myopic CNV is a Type II 
CNV and shows a clear hyper-fluorescence by fluorescein angiography. Anti-VEGF 
therapy is the first-line treatment for myopic CNV, as shown by the RADIANCE 
study [33] and the MYRROR study [34].
a b
c d
Fig. 9.7 Multimodal imaging of lacquer cracks. (a) Left fundus shows lacquer crack as yellowish 
linear lesion (arrow). (b) Fluorescein angiogram shows linear hyper-fluorescence at the site of lac-
quer crack (arrow). (c) Optical coherent tomographic image shows deep penetration of light (arrows) 
at the site of lacquer cracks. (d) OCT angiography shows a defect of choriocapillaris (arrows)
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In the long-term, both in treated eyes and in eyes exposed to the natural course of 
the disorder, macular atrophy develops around the scarred CNV and impairs central 
vision (Fig. 9.9). Swept-source OCT showed that CNV-related macular atrophy was 
not simply a chorioretinal atrophy but was BM hole [35], like patchy chorioretinal 
atrophy.
As shown upon OCT-angiography, the CNV maintains its blood flow even 
when the CNV transforms into the scar phase, including the area of CNV-related 
macular atrophy (Fig. 9.10). Louzada et al. [36] and Giuffre et al. [37] reported 
that blood vessels originating from the sclera were found at the site of myopic 
CNVs. Recently Ishida et  al. [38] reported that the blood vessels of myopic 
CNVs were continuous to scleral branches of short posterior ciliary arteries 
(Fig. 9.11).
Fig. 9.8 Subretinal bleeding due to new lacquer crack formation. Left fundus shows subretinal 
bleeding. There are some projections along the temporal border of the hemorrhage. Optical coher-
ent tomographic image shows subretinal hemorrhage. Serous retinal detachment or macular edema 
is not seen
a b c
Fig. 9.9 Fundus photographs showing various phases of myopic CNV in different eyes. (a) Active 
phase. Subretinal bleeding is observed around the grayish CNV (black arrow). (b) Scar phase with 
pigmented scarred CNV (black arrow). (c) Atrophic phase at about 10 years after the first occur-
rence of a CNV; a well-defined macular atrophy (green arrows) appears as a macular Bruch’s 
membrane defect, merging with a large parapapillary gamma zone (yellow arrows) around a para-
papillary delta zone (red arrows)
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Fig. 9.10 Detection of choroidal neovascularization (CNV) with blood flow in all of the three phases of 
myopic CNV by optical coherent tomographic angiography (OCTA) [38]. (a–d) Active phase. Right 
fundus shows a grayish CNV (arrow in a). Fluorescein angiography (FA) shows hyper-fluorescence at 
the CNV (arrow in b). (c) Type II CNV is observed as subretinal tissue with fuzzy border by OCT. (d) 
OCTA shows newly formed vessels. (e–h) Scar phase. (e) Left fundus shows irregular shape of CNV. (f) 
FA shows tissue staining of irregular shape of CNV. (g) OCT shows subretinal CNV with sharp margins. 
(h) OCTA shows spiky shaped CNV. (i–l) Atrophic phase. CNV-related macular atrophy (margined by 
arrowheads) is seen around the remnants of a CNV (arrow in i). Fundus autofluorescence shows clear 
hypo-fluorescence in the area of the macular atrophy around the CNV (arrow in j). OCT shows subretinal 
CNV (arrow in k) surrounded by a large defect of Bruch’s membrane. The inner retina directly sits on the 
sclera in the area of macular atrophy. The choroid is barely seen in the area of the macular atrophy. (l) 
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9.5  Myopic Macular Retinoschisis
Using optical coherence tomography, Takano and Kishi first demonstrated a 
foveal retinal detachment and retinoschisis in severely myopic eyes with poste-
rior staphylomas [39]. Panozzo and Mercanti proposed the term “myopic traction 
maculopathy (MTM)” to encompass various findings characterized by a traction 
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Fig. 9.11 Continuity between scleral perforating vessels and myopic choroidal neovasculariza-
tion (CNV) in the atrophic phase [38]. (a) Fundus photograph of the right eye shows a sharp- 
margined macular atrophy around a CNV (arrow). Arrows indicate scanned line by OCT. (b, c) 
Swept-source OCT images show subretinal CNV. Cross sections of blood vessels coursing within 
the sclera can be seen (arrows in c) in a section scanned by swept-source OCT (blue arrow in a). 
In a serial OCT section (b, in a section scanned at white arrow in a), this vessel (arrows) is observed 
to be continuous with the CNV through a defect of Bruch’s membrane (between arrowheads). (d, 
e) OCT angiogram shows the intrascleral vessel in Fig. 9.4b begins to be seen at the depth just 
posterior to the CNV (arrows, d). At a deeper slab e, the longer course of this vessel is seen (arrow, 
e). (f, g) Arterial phase of ICG angiogram (6 s after dye injection in f, and 8 s after dye injection in 
g) shows that the intrascleral vessel shown in OCT angiogram and OCT b scans was already filled 
with dye in the arterial phase (arrows). (h) Arterial phase of fluorescein angiogram (10 s after dye 
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also called foveal retinoschisis [39], macular retinoschisis [41], or myopic foveo-
schisis [42], includes the features of schisis-like inner retinal fluid, schisis-like 
outer retina fluid, foveal detachment, lamellar or full-thickness macular hole, 
and/or macular detachment [43]. These features can best be detected by OCT 
as an indispensable tool to diagnose MTM. Additional examination techniques 
are a retro-mode imaging which uses an infrared laser in the confocal scanning 
laser ophthalmoscope and which can produce a pseudo-three-dimensional image 
showing the details of deep retinal structures (Fig. 9.12). Applying retro-mode 
imaging, a characteristic fingerprint and firework pattern at the corresponding 
area of a macular retinoschisis have been detected in the region of a macula 
retinoschisis [44, 45].
Shimada et  al. have classified myopic traction maculopathy according to its 
location and extent from S0 through S4: S0: no retinoschisis; S1: extrafoveal; S2: 
foveal; S3: both foveal and extrafoveal but not the entire macula; and S4: entire 
macula [46].
9.6  Dome-Shaped Macula (DSM)
A dome-shaped macula (DSM) is an inward protrusion of the macula as visual-
ized by OCT (Fig. 9.13) [47–49]. Imamura et al. reported that a DSM was associ-
ated with, and caused by, a local thickening of the subfoveal sclera [50]. It was 
postulated that the local thickening of the subfoveal sclera was an adaptive or 
g h
Fig. 9.11 (continued)
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compensatory response to the defocus of the image on the fovea in highly myopic 
eyes. Fang et al. [51] found the high prevalence of macular BM defects around the 
dome (Figs. 9.14 and 9.15). Ohno-Matsui et al. reported a similar finding [52] as 
peri-dome choroidal deepening. The morphology of the DSM in association with 
macular BM defects may be associated with a focal relaxation of the posterior 
sclera, no longer pushed outward by an expanding BM but allowed to partially 
bulge inward, leading to the formation of a DSM.
a b
Fig. 9.12 Myopic macular retinoschisis. (a) OCT image shows outer and inner retinoschisis. (b) 
Columnar structures are seen within the area of outer retinoschisis (cited from [44]). Retro-mode image 
by F10 (Nidek, Aichi, Japan) showing a fingerprint pattern (black arrowheads) consisting of central 
radiating retinal striae and surrounding multiple dots (arrowhead) and lines (arrow). Many lines appear 
in parallel or in a whorled pattern. The inner lamellar hole appears as a circular defect at the central fovea
a b
c
Fig. 9.13 Various types of Dome-shaped macula (DSM). (a) Serous retinal detachment is seen on 
the top of the dome. The sclera is too thick to allow the visualization of its outer surface. (b) The 
subfoveal sclera is thick; however, the scleral outer surface is visible in the surrounding area. (c) 
The subfoveal sclera is thick; however, the scleral outer surface is visible in all regions
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In evaluating the myopic eye, imaging has been proven vital in assessing disease com-
plications [1] and prognostication for future management. Early identification of these 
changes would help predict the development of future complications, which include 
retinal tears and retinal detachments [2]. Additionally, the possibility of identifying 
subtle changes in the macula (such as macular schisis or early macular holes; Fig. 10.1) 
via high-resolution images of the macula could perchance aid clinicians in predicting 
the development of complications such as macular holes and retinal detachments [3].
Furthermore, imaging may help detect, prognosticate, and guide management of 
other myopia-related eye diseases. This includes the early detection of atrophy and 
defects in the basement membrane, located between retinal pigment epithelium (RPE) 
and Bruch’s membrane (BM), which would help predict the risk of developing cho-
roidal neovascularization (CNV) [4]—a leading cause of low vision and blindness in 
5–17% of eyes in patients with pathological myopia (PM) [5]. In addition, imaging 
is vital for monitoring progression of posterior staphylomas and geographic atrophy, 
both of which can cause visual impairment in older age groups of patients [6].
Optic disc imaging can also be used to predict the development of glaucoma, 
where visualization of myopic tilting of the optic disc with peripapillary atrophy 
and pitting of the optic disc [7], is a possible predisposing factor [8, 9]. Serial imag-
ing investigative measures can therefore be utilized for monitoring the development 
Key Points
• Advances in ocular imaging devices including optical coherence tomogra-
phy, ultrasound, and magnetic resonance imaging have enabled the visual-
ization of pathologic changes due to myopia, identifying microscopic 
changes ranging from the posterior segment (sclera, choroid, retina, and/or 
the optic nerve) to the anterior segment.
• Imaging-derived measures (imaging biomarkers) are potentially useful in 
assessing degenerative changes occurring in the myopic fundus, in evaluat-
ing the early changes preceding myopic macular degeneration, and in pro-
viding objective measures of ocular structures to aid in detecting 
staphyloma formation and progression, myopic macular degeneration- 
tilted disc syndrome, and glaucoma in highly myopic eyes.
• Imaging the highly myopic eye is not straightforward and is associated 
with challenges such as optics-related aberrations, focusing ability of cur-
rent devices, and morphological alterations of the myopic fundus and optic 
nerve.
• An understanding of the imaging of microstructural changes associated 
with pathological myopia, challenges associated with imaging devices, 
and potential usefulness and limitations of imaging devices will better 
inform clinicians of its future potential in the diagnosis and management 
of vision-threatening complications associated with pathological myopia.
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of open-angle, normal-tension glaucoma [10]. With the hope of exploring novel 
developments and prospective future clinical applications in the field of imaging in 
myopia, this chapter thus outlines the significance and challenges of imaging myo-
pic eyes (from the anterior and posterior segments and optic nerve).
10.2  Disease Characteristics of Myopia
To best understand how one should approach imaging eyes with myopia, one needs 
to gear imaging modalities based on the pathophysiology of the disease, which has 
already been outlined in previous chapters. For example, not only does the sclera of 
these extremely elongated eyes show marked scleral thinning [12, 13], some eyes 
thin to the extent that local outpouchings or staphylomas form (Figs. 10.2 and 10.3). 




Fig. 10.1 Optical coherence tomography (OCT) imaging findings of a patient with myopic macular 
degeneration, showing the benefits of using the OCT over color fundus photograph in detecting reti-
noschisis. (a) Color fundus photograph showing tilted disc with large temporal peripapillary atrophy. 
(b, 12 × 12 mm; PLEX Elite, Zeiss) OCT of the fundus showing slight elevation of the retina where 




Fig. 10.2 Optical coherence tomography (OCT) imaging findings of a highly myopic patient, 
showing the benefits of using the OCT over fundus photograph to detect posterior staphyloma. (a, 
12 × 12 mm; PLEX Elite, Zeiss) OCT fundus photograph showing tilted disc with large temporal 
peripapillary atrophy. (b) OCT B-scan showing distinct posterior staphyloma (yellow dotted box)
Fig. 10.3 Fundus photography, swept source optical coherence tomography (SSOCT), and 
3-dimensional magnetic resonance imaging (MRI) of patients with posterior staphyloma. Patient 1 
(a, b, c) was a 58-year-old woman with an axial length of 35.4 mm in the right eye (OD). The right 
fundus shows a deep, circular-shaped posterior staphyloma, with an abrupt change in scleral curva-
ture (arrowheads) apparent on fundus photography (A) and OD MRI volume renderings (B- temporal 
view, C- inferior view). Patient 2 (d, e, f) was a 61-year-old woman with an OD axial length of 33.8 
mm. A posterior staphyloma was present, with an abrupt change in scleral curvature (arrowheads) 
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high myopia (HM) patients [14, 15]. More recent reports noted a severe grade of 
staphyloma being associated with further eye elongation [16] and more severe and 
progressive myopic macular degeneration (MMD; Fig. 10.4) [14, 17, 18]. Given that 
MMD is the leading cause of blindness in Japan [19], and the second leading cause in 
Chinese adults [20], it highlights the importance of closely monitoring patients with a 
severe grade of staphyloma. Risk of vision loss from myopic maculopathy (e.g., from 
splitting of retinal layers (foveoschisis), hole formation, atrophy, and CNV) may cor-
relate with the specific location and conformation [11] of staphylomas [21].
10.3  Key Structures Altered in Myopia  
and Pathological Myopia
10.3.1  Sclera and Collagen
Changes in sclera and collagen structures may underlie axial elongation and staphy-
loma formation and progression. The anatomical changes underlying global eye 
elongation and local staphyloma formation likely occur in the component collagen 
Fig. 10.4 Color fundus photographs showing the worsening levels of myopic macular degenera-





fibers of the sclera. In mammalian models, there is scleral thinning and tissue loss 
during myopia development [11, 22] with a net decrease in scleral collagen (with 
decreased collagen synthesis and increased degradation) evidenced by reduced dry 
weight and hydroxyproline content [23, 24]. Decreased collagen fiber diameter and 
decreased collagen crosslinking (CXL) are seen in both mammalian models and 
HM patients [13, 25]. Specifically, in the guinea pig myopia model, there is scleral 
remodeling, possibly from greater slippage [26] between collagen fibrils and/or 
collagen fiber bundles due to fibroblast deactivation, with decreased expression of 
type I collagen, and α2 and α1 integrin [27, 28]. In the tree shrew mammalian myo-
pia model, blockage of collagen crosslinking with β-aminopropionitrile resulted in 
an increased degree of myopia-induced vitreous elongation and scleral thinning at 
the posterior pole [29]. Moreover, the development of high myopia and pathologic 
myopia may be driven by genes such as the scleral remodeling gene LAMA2, lead-
ing to scleral thinning and staphyloma formation [30].
10.3.2  Choroidal Changes
Choroidal changes in myopia may contribute to atrophy and myopic macular degen-
eration. Morphological change such as the thinning of the choroidal vascular layer 
is closely associated with increasing levels of myopia and MMD (either imme-
diately preceding, concurrent with or immediately following the development of 
MMD) [31–33]. Specifically, Wei et al. reported that subfoveal choroidal thickness 
in their Beijing-based cohort decreased by 15 μm per diopter of increased myopia 
[31]. There are various lesions comprising myopic maculopathy [3, 11, 18, 34, 35] 
that all involve the choroid, namely, diffuse chorioretinal atrophy, patchy chorio-
retinal atrophy, macular atrophy (bare sclera), lacquer cracks, and myopic choroidal 
neovascularization. Diffuse atrophy is a yellowish, ill-defined lesion [34], and is 
characterized by a marked thinning of the choroid as seen on optical coherence 
tomography (OCT), but with relatively preserved outer retina and retinal pigment 
epithelium, allowing for relatively good vision. Patchy chorioretinal atrophy is whit-
ish, well-defined atrophy [34] with complete localized loss of the choroid with only 
the large choroidal vessels sporadically remaining within the atrophic area. Loss of 
the choroid is soon followed by loss of outer retina and retinal pigment epithelium. 
Macular atrophy is similar to patchy atrophy but tends to be centered at the fovea.
10.3.3  Bruch’s Membrane and Retinal Pigment Epithelium 
Changes
The hallmark anatomical changes that occur alongside the development and pro-
gression of MMD are changes in BM and RPE as reflected in increasing degrees 
of atrophy [36]. Moreover, BM changes have been postulated to be the main 
driver of axial elongation overall [37]. Recently, Ohno-Matsui et al. reported the 
use of swept-source OCT (SS-OCT) to demonstrate that patchy atrophy was not 
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simply chorioretinal atrophy, but also included a hole in Bruch’s membrane [38]. 
Angiographically observed vessels within the area of patchy atrophy may include 
large choroidal vessels, intrascleral vessels, and retrobulbar vessels. Lacquer cracks 
are observed as yellowish linear lesions [34, 39, 40], and represent the mechanical 
rupture of BM [41]. Jonas et al. have reported an increase in disc–fovea distance 
due to an increase in the peripapillary gamma zone. Since BM thickness was found 
to be independent of axial length [42], even in the much larger surface area in an 
axially elongated eye in a human histomorphometric study, Jonas et al. inferred that 
the volume of BM increased with longer axial length and BM is actively produced 
during axial length elongation [37]. They postulated that BM was a primary driver 
of axial elongation that led to choroidal thinning through “compression.” If this was 
indeed the mechanism, then the RPE is an ideal target for medical intervention in 
both eyes that are already severely elongated, as well as those undergoing progres-
sion, but still only minimally elongated.
10.4  Existing Imaging Modalities to Evaluate the Myopic Eye
10.4.1  Optical Coherence Tomography
Ophthalmic OCT systems can image the anterior segment as well as the posterior 
segment of the eye such as the retina, BM, RPE, and choroid. Spectral-domain OCT 
(SD-OCT, Spectralis, Heidelberg Eng., Carlsbad, CA) provides an axial resolution 
of 4 μm and a lateral resolution of 14 μm, but only about 1 mm of penetration into 
the retina. The extremely fine resolution of OCT allows better assessment of reti-
nal layers such as photoreceptors, the ganglion cells, plexiform, and nuclear layers 
[43] and vitreous membranes in proximity to the retina. In contrast to the SD-OCT, 
SS-OCT uses a tunable laser with a longer wavelength of 1050 nm, which achieves 
greater penetration of tissue with less signal roll-off, allowing better visualization 
of choroidal anatomy [38, 44, 45] and has specifically been employed to correlate 
defects in BM with the atrophy of MMD [38]. In addition to utilizing choroidal 
thickness as biomarker for myopia progression [31–33], recent developments pro-
vide further insight into the function of the choroid, including the calculation of cho-
roidal vascular index (CVI, the vessel-area-to-stromal-area ratio using a validated 
automated algorithm) [46] and OCTA using the SS-OCT (SS-OCTA, a noninvasive 
method of imaging choroidal vasculature, and specifically the foveal avascular zone 
(FAZ) without the administration of intravenous dye) [47, 48]. Newer UWF-OCT 
systems allow for even wider (100°) scans. Wider scans are likely crucial to accu-
rately depicting staphyloma shape [49].
10.4.2  Ultrasound
Ophthalmic ultrasound can image the entire eye dynamically. Since their introduction 
in 1958, mechanically scanned, single element 10 MHz transducers have largely been 
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the norm for imaging of the eye [50]. UBM systems (Escalon-Sonomed, Quantel, 
Ophthalmic Technologies, among others) have been used for diagnostic imaging and 
biometric characterization [51, 52]. Systems operating at 20 MHz were introduced 
(Quantel Medical, Bozeman, MT) for examination of the posterior segment of the 
eye and the vitreoretinal interface [51, 53]. With an axial resolution of about 75 μm, 
these systems provide superior resolution compared to conventional 10 MHz systems 
as well as the ability to image the retina. They also provide far deeper penetration 
than optical modalities (10 mm vs. 1 mm for OCT). Commercial single-element sys-
tems are designed such that during a contact examination, the geometric focus of the 
transducer falls just anterior to the retina. However, the anterior vitreous and anterior-
segment structures (cornea, iris, ciliary body, and lens) are poorly visualized because 
they fall within the unfocused near field of the transducer which makes current oph-
thalmic systems unsuitable for imaging the entire vitreous. Recent advancements in 
annular-array imaging technology overcome these technical limits [54].
10.4.3  Magnetic Resonance Imaging
MRI allows for imaging of the whole eye (Fig. 10.3). The standard ophthalmology 
imaging modalities of ultrasound and optical coherence tomography are limited by a 
relatively narrow field of view. MRI does allow for imaging of the entire eye globe, but 
visualizing eye wall distortions at standard MR resolutions minimizes effect sizes and 
induces aliasing artifacts that obfuscate distortions. Super-resolution is an established 
MR approach that provides a means of detecting extremely small distortions by increas-
ing signal to noise (with isotropic resolutions down to 50–100 μm), reducing scan time 
(which would allow patients to more readily maintain fixation, thereby reducing eye 
movement artifacts), and minimizing aliasing artifacts that can bias estimates [55, 56].
10.5  Challenges in Imaging of the Myopic Eye
10.5.1  Interaction Between Low- and High-Order Aberrations
Given the presence of two positive lenses (the cornea and the crystalline lens) in 
the eye, any imaging of intraocular structures is contingent on their properties. This 
makes direct visualization and imaging structures in the posterior segment, sec-
ondary to optical imperfections through the cornea and lens, the main challenge 
in imaging a myopic eye. Examples of such would include light diffraction in the 
pupil, intraocular scattering, and optical aberrations. As a result of these imperfec-
tions, imaging of patients with high myopia using any modality (such as fundus 
photography) would have a poorer image quality due to an imbalance of low- and 
high-order aberrations [57, 58]. Other causes to consider include the limitations of 
focusing lenses used by the imaging device. For example, the device may not be 
able to compensate (diopter compensation) sufficiently in patients with very high 
myopia (more than −12.0 D). Pathological myopia is also associated with varying 
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structural changes within the eye (due to the abnormal eye elongation, scleral and 
corneal curvature irregularities, cataracts leading to poor clarity, or retinal thinning 
causing abnormal projections of the final image [58, 59]). Such structural changes 
are demonstrated in altered optic nerve head morphology.
Taking into considerations the challenges faced when imaging the myopic eye, 
current standards of practice for investigations include fundus photography, dye- 
based angiography, ultrasound (including biomicroscopy), and magnetic resonance 
imaging (MRI). The OCT has also become an often-used tool for the characteriza-
tion of ocular tissue structural changes arising from myopia [60]. Swept source 
(SS)-OCT has a higher wavelength of 1050 nm and is hence able to penetrate into 
deeper layers. It is also capable of wide-angle scans, given its speed of capture and 
software engineering. More recently, OCT angiography (OCTA) has enabled visu-
alization of the vasculature of the eye [61–63]. Nonetheless, there still exists room 
for improvement and various constraints. In the case of wide-field OCT (WF-OCT), 
problems with segmentation in the periphery may arise due to inadequate depth 
range to image the complete anterior–posterior extent of the posterior pole. Further 
considerations arise regarding the normative databases of OCT systems, where ref-
erence and patient cohorts should ideally be derived from the same population to 
reflect similar comorbidities [64]. Stratifications normally employed for covariates 
that affect measurements (such as age, ethnicity, and refractive error) are challeng-
ing to derive in myopic eyes—a result of large regional variation in refractive error 
prevalence [65]. In regions with a high prevalence of myopia and pathological myo-
pia, this results in normative databases being poor representations of the existing 
patient population.
10.5.2  Challenges in Imaging the Anterior Segment
In high myopia, while most refractive errors in myopic eyes arise from an axial 
length, alterations in the anterior segment lead to significant optical and high-order 
aberrations [66]. Furthermore, the association between myopia and biomechanical 
changes in the cornea has implications in the assessment of intraocular pressure and 
may have a role in the pathogenesis of myopia [67]. Indeed, existing studies report 
inconsistent results—attributable to different imaging and measurement techniques, 
and the technological limitations in measuring biomechanical changes in the cornea 
associated with increasing myopia [68]. Preoperative clinical evaluation of patients 
with high myopia still necessitates imaging of the cornea and anterior segment, 
given their increasing risk of developing ectasia proportionate to the amount of cor-
neal tissue removed in laser refractive surgeries [69]. Furthermore, as high myopes 
are more likely to require phakic lens implantation [70], accurate anterior segment 
imaging is necessary to ensure adequate safety measures prior to implantation and 
accurate intraocular lens (IOL) implantation. Especially in high myopes, accurate 
formulae, anterior segment imaging, and corneal topography are all necessary to 
prevent refractive surprises [71] and complications postoperatively. Significant 
improvements in IOL calculations and refractive prediction in high myopes [71] 
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have fortunately been accomplished with new developments in biometry incorporat-
ing anterior segment OCT technology [72], coupled with next- generation formulae.
10.5.3  Challenges in Imaging the Retina
Prior to the discovery of modern imaging techniques, there were three main chal-
lenges faced in retinal imaging. First, the diagnosis of myopic foveoschisis was 
challenging based on clinical examination and fundus photography due to the lack 
of contrast between the retinal tissues and underlying choroid. Second, posterior 
staphylomas, a hallmark of pathological myopia [73], could not be identified from 
standalone two-dimensional fundus photography with ease. Finally, it is also chal-
lenging to capture lattice degeneration and retinal breaks in the peripheries on tra-
ditional 50° fundus photographs.
With the OCT, the way clinicians diagnosed and managed retinal complications 
of pathological myopia was transformed—with the ability to examine retinal layers 
in vivo and at high resolution. The ability to view distinct retinal layers has enhanced 
visualization of myopic traction maculopathy (MTM), for which splitting of the reti-
nal layers can be well visualized on cross-sectional OCT scans of the retina. This can 
be taken a step further using retromode fundus imaging [74]. Examples of features 
that can be seen include inner or outer retinal schisis, foveal detachment, lamellar, or 
full thickness macular hole and/or macular detachment [75, 76].
Another aspect in which OCT has advanced the diagnosis and management of 
myopia-related eye diseases is in the characterization of posterior staphylomas, 
which are one of the hallmarks of pathological myopia. Nonstereoscopic fundus 
photographs are inadequate for detailed studies of posterior staphylomas as the 
change in contour at the staphyloma edge is not always discernible. The OCT over-
comes this limitation because of its excellent depth resolution [21, 77]. Comparing 
their capability in visualizing posterior staphylomas, Shinohara et  al. showed no 
significant differences between using WF-OCT and three-dimensional (3D) MRI 
imaging. It is noted, however, that ultrawide-field OCT (UWF-OCT) had the advan-
tage in visualizing the spatial relationship of the staphylomas with the optic nerve 
and macula [78, 79].
Comparing the use of conventional fundus photography to UWF retinal imag-
ing, the former has been shown capable of imaging up to 50° of the retina, while the 
latter covers a wider field of the retina at 200°. Given the high prevalence of lattice 
degeneration and retinal breaks in the peripheral retina in patients with highly myo-
pic eyes, the advantages of UWF retinal imaging can be appreciated.
A potentially blinding complication of high myopia, myopic choroidal neovascu-
larization (mCNV) is not easily diagnosed and monitored solely with clinical exami-
nations. Multimodal imaging thus has a pertinent place in assessing mCNV. Verifying 
the diagnosis of mCNV requires the use of a fundus fluorescein angiography (FFA)—
where leakage is seen as increasing size and intensity of hyperfluorescence with 
time [80]. A feature of pathological myopia, retinal avascularity in the 360° of the 
periphery, can also be revealed using wide-field FFA [81]. Distinguishing the myriad 
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causes of subretinal exudation in high myopes (i.e., simple lacquer crack hemor-
rhage, inflammatory lesions, and mCNV [82, 83]) can be achieved with OCTA, 
which has the ability to identify neovascular membranes noninvasively. However, 
FFA remains the gold standard for mCNV diagnosis, given OCTA’s comparatively 
lower sensitivity [84]. Furthermore, FFA is still necessary for monitoring disease 
activity, as OCTA lacks the ability to discern disease activity—where the flow signal 
may persist in an inactive mCNA [83–85]. Still, OCTA can assist with distinguish-
ing the stages of mCNV via identification of signs of activity. These include ill-
defined margins [86], disruption of the external limiting membrane [87], and variable 
amounts of intraretinal and subretinal fluids. These hyper-reflective lesions coalesce 
and develop a distinct border with appropriate treatment. Previous studies using the 
OCTA have suggested that rupture of the Bruch’s membranes may be the cause of 
macular atrophy developing after mCNV [88]. However, the combination of OCTA 
and SS-OCT in multimodal imaging has given promising results—suggesting that 
mCNV is directly supplied by the short posterior ciliary artery instead of the choroi-
dal vasculature as previously postulated [89].
10.5.4  Challenges in Imaging the Choroid and Sclera
Lying between the sclera and the RPE, the choroid’s anatomical location makes 
imaging a challenge without the use of methods such as indocyanine green (ICG) 
angiography, ultrasonography (US), and OCT. Moreover, the choroid in pathologi-
cal myopia is often extremely thin and thus difficult to measure. The addition of 
other, varied factors that interfere with choroid imaging in the myopic eye further 
complicate the process.
Typical fluorescein angiography has limited use in choroidal visualization since 
melanin impedes most of the spectra emitted from the agent. Imaging is also made 
near impossible with light absorption and scattering produced by the RPE pigment 
and choroidal blood. On the other hand, angiography via ICG has better use for 
the evaluation of various choroidal vasculopathy and inflammatory diseases [90]. 
This can be attributed to ICG’s emitted spectrum being within the near-infrared 
wavelength—which is not disrupted by the RPE pigment or choroidal blood [91]. 
Nonetheless, other modalities such as OCT and autofluorescence imaging are still 
more feasible in the clinical setting and are thus still more often used than ICG 
angiography. Other modes of imaging include OCTA for assessing choroidal vascu-
lature and its structures [46–48], as well as B-scan ultrasound to image the choroid 
with better penetration. However, B-scan images provide poorer resolution than 
those of OCTA—which is subsequently worsened by the thinning of the choroid in 
PM [53]. Yet, despite its flaws, the ultrasound remains useful in detecting staphylo-
mas and globe contours.
With regard to OCT, we find that spectral domain OCT (SD-OCT) instruments with 
enhanced depth imaging can visualize the choroid more readily [92]. Inadequacies 
still exist in OCT images of the choroid, where deeper tissues imaged result in poorer 
sensitivity. The signals obtained in the choroid are also usually weak due to the high 
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attenuation coefficient of the RPE. Nonetheless, ironically due to thinner choroids 
and relative depigmentation, full thickness imaging of the choroid is still attainable in 
high myopes. Yet, OCT image quality may still be compromised by distortions caused 
by the likely presence of staphylomas and abnormal eyewall contours in these same 
patients with high myopia. On the other hand, the extent of decreased sensitivities with 
increased tissue depth is comparatively lower in SS-OCT [93]. Clearly, notwithstand-
ing the technique used, many challenges and limitations still exist in OCT imaging of 
high myopia—arising from the extreme axial length of highly myopic eyes, curvature 
deformity exaggeration on OCT, and the production of imaging artifacts [49].
The inability of OCT to readily distinguish the posterior scleral boundary makes 
scleral imaging a greater challenge than choroid imaging—where the choroid itself 
(unless extremely thin) reduces scleral image quality by disrupting signals. With 
the use of “Reflectivity” software, scleral boundaries may be augmented via adap-
tive compensation based on direct application of pixel intensity exponentiation. 
This would improve the precision of scleral thickness assessment [94, 95]. In ret-
rospect, we conclude that the use of 3D MRI and ultrasound have more favorable 
results in visualizing scleral contours and characterizing staphylomas. Using animal 
experimentations on guinea pigs ex vivo and humans in vivo, we were able to dem-
onstrate that quantitative ultrasound and super-resolution 3D MRI can be used to 
localize areas of scleral weakness and elasticity. These modalities could potentially 
detect scleral weakness preceding staphyloma formation; thereby discerning and 
even predicting which highly myopic eye is destined to develop staphylomas and 
MMD. This is critical in research studies targeted toward scleral reinforcement—
such as macular buckling [96] or scleral collagen crosslinking [97, 98].
10.5.5  Challenges in Imaging the Optic Nerve
Features such as optic disc tilt (Fig. 10.5), peripapillary atrophy (PPA), and abnor-
mally large or small optic discs are the earliest known structural alterations that 
potentially predict the development of pathological myopia, and can be observed 
even in young highly myopic adults. Unfortunately, these features (some also with 
associations to glaucoma) also interfere with the visualization of optic disc margins 
[99, 100], and are also not easy to discern in highly myopic eyes [101]. There is also 
added difficulty in eyes with myopic maculopathy, where visual field defects result in 
further interference [102]. As such, the answer to these challenges may lie in imaging 
deep optic nerve head structures (such as parapapillary sclera, scleral wall, and lam-
ina cribrosa) [103] in highly myopic eyes for more precise diagnoses of glaucoma.
Glaucomatous optic nerve damage may be worsened by obstructed axoplasmic 
flow within the optic nerve head—possibly caused by a disrupted lamina cribrosa 
(LC) arising from optic disc tilt [104]. Imaging performed to evaluate the integrity 
of the lamina cribrosa may, therefore, aid in prognosticating risk for eventual glau-
coma development. Indeed, Sawada et  al. have shown via enhanced depth OCT 
imaging that LC defects in myopic eyes (with and without primary open-angle glau-
coma) are associated with optic disc tilt angle, which can also explain the location 
and severity of glaucomatous visual field defects [104].
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The optic nerve exits the eye at the Bruch’s membrane opening (BMO), which 
can be easily discerned on OCT imaging. Using conventional disc margin-based 
measurements as a standard for comparison, Malik et  al. investigated the util-
ity of the BMO as a possible landmark for neuroretinal rim measurements, and 
has shown the BMO minimum rim width (BMO-MRW) to be markedly more 
sensitive (71% against 30%) than disc margin rim area (DM-RA) in diagnosing 
glaucoma [105].
Meanwhile, Enders et al. further demonstrated that a two-dimensional neuroreti-
nal rim parameter based on BMO—namely, the BMO minimum rim area (BMO- 
MRA), outclassed all other measures (such as BMO-RMW, retinal nerve fiber layer 
thickness, and DM-RA) in diagnosing glaucoma [106]. Unfortunately, the diagnos-
tic performance of this parameter has yet to be validated in myopic eyes.
Fig. 10.5 Color photographs (top panels) and optical coherence tomography (bottom panels) of 






Another deep optic nerve head structure that can be imaged on the enhanced 
depth OCT is the border tissue of Elschnig—a cuff of collagenous tissue arising 
from the sclera and joining the Bruch’s membrane at the optic disc margin [104]. 
Having reviewed the externally oblique border tissue length (EOBT), optic nerve 
head tilt angle and optic canal obliqueness, Han et al. have concluded that tempo-
rally located maximal values for these parameters were both independently associ-
ated with the presence of myopic normal tension glaucoma and consistent with the 
location of retinal nerve fiber layer defects [103].
Macular ganglion cell complex (GCC) thickness has been reported to have com-
parable diagnostic power to circumpapillary retinal nerve fiber layer (cp-RNFL) 
thickness [107–110]—which on its own is strongly suggestive of glaucoma in non-
myopic eyes, but faces limitations in interpretation in high myopes with PPA. Zhang 
et al. have indeed demonstrated that macular GCC parameters are superior to cp- 
RNFL parameters in diagnosing high myopes with glaucoma—with focal loss 
volume (FLV) on RTVue-OCT and minimum ganglion cell-inner plexiform layer 
(GCIPL) on the Cirrus HD OCT having the best diagnostic power among these 
macular parameters [111]. Yet, two obstacles persist in limiting the use of macu-
lar GCC measurements for the diagnosis of glaucoma in high myopes. Namely, 
these are the lack of a normative database in highly myopic eyes, as well as inac-
curate measurements attributable to choroidal atrophy in myopic maculopathy. New 
developments regarding the use of OCTA on the optic nerve have suggested that 
it is a prospective adjunctive tool for evaluating the myopic disc for glaucoma-
tous changes. Suwan et  al. measured the perfused capillary density (PCD) via a 
4.5 × 4.5 mm OCTA scan centered on the optic nerve head and has showed that eyes 
with myopia and open angle glaucoma had the lowest PCD compared to eyes with 
glaucoma alone and control eyes [112].
10.6  Future Developments
The primary aim of imaging in myopia would be to study the tissues involved with 
the pathological elongation of the eye, namely, the sclera as well as the choroid 
that is the regulator of scleral extracellular matrix remodeling [113], and its biome-
chanical properties [114]. As the RPE is highly scattering, it makes imaging of the 
myopic eye highly challenging. To make matters worse, the choroid is highly vascu-
larized and perfused with a high concentration of red blood cells, this also causes a 
significant amount of light scattering making imaging more complicated [115]. One 
way to circumvent this problem would be to use OCT systems with wavelengths 
around 1060 nm to image the choroid [116]; however, the results obtained from 
this mode are less than satisfactory due to its relatively poor resolution capacity 
and inability to visualize the microvasculature and cellular structure of the choroid. 
Due to the complexity of this issue, there is no sensible nomenclature available to 
classify choroidal layers and boundaries, nor a definition of the choroidal–scleral 
interface [116]. As such, to facilitate comparisons and meta-analysis of existing 
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data, there is a desperate need for a standardization for choroidal segmentation and 
OCT-based definition of the choroidal layers.
The OCT itself has its shortcomings: the sclera cannot be visualized using the 
OCT, higher wavelengths (around 1300 nm range) used for anterior segment OCT 
would not be able to be used to image the posterior pole either due to the high 
absorption coefficient of water contained in the vitreous [72]. These limitations 
also extend to the use of OCTA. There is currently no standard protocol for seg-
mentation, the outcome parameters for OCTA have not been clearly defined either. 
Although some authors have tried to use analysis of flow voids or signal voids in 
the choriocapillaris to quantify the area taken up by the microvasculature [117, 
118], the data pertaining to myopic patients are but insufficient [119]. Moreover, 
different authors have used different image analysis methods to quantify signal 
voids, as such, there is no clear common protocol in place to address the underly-
ing issue. Looking into the future, there is however incipient research suggesting 
that the comprehension of blood supply and changes in vasculature from the ante-
rior to the posterior segment of the myopic eye is crucial to the understanding of 
the disease [120–123].
Photoacoustic imaging has shown promise recently to fill the gaps between 
OCT and ultrasound in terms of penetration depth. Ultrasound biomicroscopy 
(higher ultrasound frequencies used) of the anterior segment simply does not 
have enough penetrative depth to image the posterior pole of the eye [124]. 
Photoacoustic imaging detects the waves generated by the absorption of pulsed 
laser light in tissues [125]; meanwhile, other modalities use contrast solely based 
on absorption. This modality has been used before to image the posterior pole of 
the eye in vitro and in animal models in vivo. This can also be used in concur-
rence with angiography, measuring oxygen saturation and pigment imaging [126]. 
However, there are some limitation pertaining to this modality notwithstanding 
moderate depth resolution, pure optical absorption sensing, need for contact 
detection with ultrasound sensor, and a relatively long acquisition time. In view 
of these limitations, we have yet to receive tangible results from photoacoustic 
imaging for posterior pole imaging in humans.
Recently, there has been a shift to elastography approaches to study the biochem-
ical properties of ocular tissues with either OCT [127] or with ultrasound [128], the 
visualization of biochemical properties of the eye coats in vivo would otherwise be 
incredibly challenging This perspective is propelled by several studies proposing 
the measurement of ocular rigidity using noninvasive measures instead [129, 130]. 
However, none of these studies have addressed or included patients with myopia. 
The crux of this technique pertains to using an internal or external force to induce 
movement of tissue that is subsequently picked up using imaging devices, most 
in vivo work would be aimed at biochemical properties of the cornea [131, 132]. In 
vivo imaging using an ocular pulse with an internal excitation source is not yet able 
to produce results of biochemical parameters [133, 134]. Meanwhile, some in vivo 
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• In all highly myopic eyes, glaucomatous optic neuropathy may specifically 
be ruled out, in attempt not to miss the diagnosis
• High axial myopia is a major risk factor for glaucomatous or glaucoma- 
like optic neuropathy, even at a normal intraocular pressure.
• Morphological risk factors for glaucoma in high myopia may be an 
enlarged optic disc and enlarged parapapillary delta zone.
• Histological hallmarks of the highly myopic optic nerve head are an elongated 
and thinned lamina cribrosa, steepened trans-lamina cribrosa pressure gradi-
ent, enlarged optic disc, elongated peripapillary scleral flange (as equivalent of 
parapapillary delta zone), and a shallowing of the physiological optic cup.
11.1  Introduction
Axial myopization leads to marked changes in the morphology of the posterior ocu-
lar segment including the anatomy of the optic nerve head. The changes of the optic 
nerve head include an enlargement of all three layers of the optic disc (i.e., optic 
disc Bruch’s membrane opening, optic disc choroidal opening, and optic disc scleral 
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opening) with the development of a secondary macrodisc, and an enlargement and 
shallowing of the cup. Further morphological changes are an elongation and thin-
ning of the lamina cribrosa with a secondary reduction in the distance between 
the intraocular space with the intraocular pressure (IOP) and the retro-lamina com-
partment with the orbital cerebrospinal fluid pressure, and a direct exposure of the 
peripheral posterior lamina cribrosa surface to the orbital cerebrospinal fluid space. 
In the parapapillary region, an elongation and thinning of the peripapillary scleral 
flange with development and enlargement of the parapapillary gamma zone (defined 
as the parapapillary Bruch’s membrane free region) and delta zone (defined as the 
region between the optic disc border and the merging line of the optic nerve dura 
mater with the posterior sclera) occurs, in addition to an elongation and thinning of 
the peripapillary border tissue of the choroid (Jacoby). The optic rotates around the 
vertical axis, and less often and to a minor degree around the horizontal axis und the 
sagittal axis. These changes make it more difficult to differentiate between myopic 
changes and (additional) glaucoma-associated changes such as a loss of neuroreti-
nal rim and thinning of the retinal nerve fiber layer, and these changes may make the 
optic nerve head more vulnerable potentially explaining the increased prevalence of 
glaucomatous optic neuropathy in highly myopic eyes.
11.2  Anatomy of the Optic Nerve Head in High Myopia
The anatomy of the optic nerve head in primary high myopia is markedly influenced 
by the axial elongation. This process of sagittal enlargement of the myopic globe takes 
place predominantly in the posterior hemisphere of the eye, and the changes are more 
pronounced the closer to the posterior pole [1–5]. Histological studies have shown 
that with longer axial length, the axial elongation-associated thinning of the sclera was 
most pronounced close to the posterior pole, while the scleral thickness in the pars 
plana region did not vary significantly between eyes of various axial length. In a simi-
lar manner, the thinning of the choroid was more marked the closer to the macula [6].
It has been postulated that the main driver for the scleral and choroidal thin-
ning in the process of axial elongation may be a new production and elongation 
of Bruch’s membrane in the equatorial and retroequatorial region of the eye [7]. 
Findings leading to this hypothesis were the following:
• the volume of the scleral and choroid did not markedly increase after the end of the 
second year of life and that both parameters were independent of axial length [3, 5];
• the thickness of Bruch’s membrane was not associated with axial length so that 
its volume increased in the process of axial myopization [8];
• the main determinant of the process of emmetropization (and myopization) is the 
length of the optical axis which ends at the photoreceptor outer segments and not 
at the scleral posterior surface;
• the structure with a minimum of biomechanical strength and being located clos-
est to the photoreceptor outer segments is Bruch’s membrane;
• a biomechanical study revealed that the stiffness of Bruch’s membrane was com-
parable or higher than those of other ocular tissues and that it could sustain a 
relatively high pressure of 80 mmHg or higher before rupture [9];
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• the density of the retinal pigment epithelium cells and the retinal thickness 
decreased in the midperiphery with increasing axial length, while both parameters, 
measured in the macular region, were independent of axial length [10, 11]; and
• the optic disc-fovea distance increased with longer axial length by the develop-
ment and enlargement of parapapillary gamma zone while the length of Bruch’s 
membrane in the macular region was independent of axial length [12–14].
These anatomical findings and the postulated mechanism of Bruch’s mem-
brane enlargement in the midperiphery as the driver for the cylindrical-like sagittal 
enlargement of the globe are associated with typical myopic changes in the anatomy 
of the optic nerve head. These include the following: an enlargement of the optic 
nerve head with the development of a secondary or acquired macrodisc [15, 16]; 
enlargement and shallowing of the optic cup, so that the spatial contrast between 
the height of the neuroretinal rim and the depth of the optic cup is decreased; elon-
gation and thinning of the lamina cribrosa [17, 18]; development and enlargement 
of parapapillary gamma zone and delta zone [19, 20]; and rotation of the optic disc 
mostly around the vertical axis [21, 22].
The enlargement of the optic disc (as defined by the peripapillary ring) affects all 
three optic disc layers: Bruch’s membrane opening; the choroidal opening, in which 
the choroid is separated from the intrapapillary compartment by the peripapillary 
border tissue of the choroid (Jacoby); and the scleral opening which is spanned by 
the lamina cribrosa. The (passive) enlargement of all three optic disc layers may be 
due to the finding that the myopic axial elongation additionally includes a widening 
of the eye in the horizontal and vertical directions [23]. For each millimeter increase 
in axial length, both the horizontal globe diameter and the vertical globe diameter 
increase by approximately 0.2 mm [23]. Since the primary and active enlargement of 
Bruch’s membrane may occur in the equatorial region, an increased tension within 
Bruch’s membrane and within the choroid and the sclera may develop at the poste-
rior pole. It would lead to a stretching of the openings of all three optic disc layers. It 
has been discussed that if the increased tension within Bruch’s membrane is not suf-
ficiently released by the enlargement of the physiological Bruch’s membrane open-
ing in the optic disc, secondary defects in Bruch’s membrane may develop starting 
with the formation of lacquer cracks and ending the formation of macular Bruch’s 
membrane defects [24–27]. If the enlargement of the optic disc Bruch’s membrane 
opening is more marked than the enlargement of the optic disc choroidal opening, 
a part of the parapapillary region will no longer be covered by Bruch’s membrane, 
so that parapapillary gamma zone as Bruch’s membrane-free region develops [19, 
20]. The uneven enlargement of the opening of the various layers of the optic disc 
may thus be one of the reasons for the development of parapapillary gamma zone.
The enlargement of the optic disc in axially elongating eyes leads secondarily to 
an enlargement of the optic cup, while the shape of the neuroretinal rim may still 
follow the so-called ISNT (inferior–superior–nasal–temporal) rule, with the small 
rim part being located usually in the temporal horizontal disc region [28]. Due to the 
stretching and enlargement of the optic disc and cup, the spatial contrast between 
the height of the neuroretinal rim and the depth of the optic cup appears to dimin-
ish, so that it becomes clinically more difficult to delineate the optic cup form the 
neuroretinal rim.
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The enlargement of the opening in the scleral layer of the optic disc is associated 
with a stretching and thinning of the lamina cribrosa [17, 18]. Since the diameter 
of the retrobulbar optic nerve is not directly affected by the process of axial elonga-
tion, the myopic enlargement of the posterior surface of the lamina cribrosa has as 
consequence that a peripheral annular-like region of the lamina is no longer covered 
or buffered by the solid optic nerve but is directly facing the orbital cerebrospinal 
fluid space.
Outside of the optic disc border, parapapillary gamma zone and delta zone 
develop during axial elongation (Fig.  11.1) [19–21, 24, 29–35]. Gamma zone 
has been defined as the Bruch’s membrane-free zone at the optic disc border. It is 
usually larger on the temporal side than on the nasal side. Prevalence and size of 
gamma zone is strongly associated with myopic axial elongation and the amount of 
the optic disc rotation around the vertical axis [21]. Two mechanisms may lead to 
the development of gamma zone. As pointed out above, gamma zone may develop 
if the enlargement of the optic disc Burch’s membrane opening is more marked than 
the enlargement of the optic disc choroidal opening. A second mechanism may be 
connected with a shift of the three optic disc layers during axial elongation. One 
may assume that at birth all three optic disc layers are aligned to each other. If in the 
process of axial elongation Bruch’s membrane is newly formed and enlarged in the 
equatorial region, the optic disc Bruch’s membrane opening may shift in direction 
to the macula. If this movement is less marked for the optic disc choroidal layer 
and scleral layer than it is for the Bruch’s membrane opening, a misalignment of 
the layers will occur, with the Bruch’s membrane opening being located most to 
the macular side and the scleral opening being located most to the nasal side. This 
Fig. 11.1 Optical coherence tomographic image of the optic nerve head, showing parapapillary 
gamma zone (between red arrow and yellow arrow) with Bruch’s membrane being absent, and 
parapapillary delta zone (between yellow arrow and green arrow (optic disc border)) showing an 
elongated peripapillary scleral flange as anterior border of the orbital cerebrospinal fluid space 
(yellow stars) between the optic nerve dura mater (horizontal blue arrow) and the optic nerve with 
its surrounding pia mater (vertical blue arrow)
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phenomenon would explain the overhanging of Bruch’s membrane on the nasal side 
of the optic disc in moderately myopic eyes, and it could be a second mechanism 
for the development of parapapillary gamma zone [36]. It would also explain the 
paradoxical course of the optic nerve through the optic nerve head channel with 
the optic nerve entering the canal from nasal anteriorly and reaching the vitreous 
compartment temporal posteriorly, although the optic nerve arrives at the eye globe 
coming from the posterior part of the orbit.
Parapapillary delta zone is located at the optic disc border within gamma zone 
and has been defined as the region of the elongated and thinned peripapillary scleral 
flange [19, 20]. The peripapillary scleral flange is the continuation of the inner half 
of the posterior sclera and continues into the lamina cribrosa, separated from the 
latter by the peripapillary scleral border tissue of Elschnig [37, 38]. It forms the 
anterior end of the orbital cerebrospinal fluid space. In axially elongated eyes, in 
particular beyond an axial length of 26.5 mm, the peripapillary scleral flange gets 
markedly elongated and thinned [37, 39]. It may change its dimensions from a nor-
mal thickness and length of about 0.5 mm to a length of 5 mm and a thickness of 
less than 100 μm. The ophthalmoscopical delineation between gamma zone and 
delta zone can be facilitated by searching for the peripapillary arterial circle of 
Zinn-Haller which is usually located at the merging line of the optic nerve dura 
mater with the sclera, i.e., at the peripheral end of delta zone [40, 41].
The optic disc shape as perceived upon ophthalmoscopy is normally slightly oval 
[42, 43]. It has to be taken into account that the ophthalmoscopically determined 
optic disc shape is different from the true optic disc shape, since the location of the 
optic disc close to the nasal side leads to perspective distortion, usually resulting in 
a perspective shortening of the horizontal disc diameter [44]. In addition, the optic 
disc undergoes rotational changes in the process of myopic axial elongation [22]. 
These are mainly an optic disc rotation around the vertical axis, and to a minor 
degree a rotation around the horizontal axis and the sagittal axis. A rotation round 
the vertical axis leads to a perspective shortening of the horizontal disc diameter, 
a rotation round the horizontal axis leads to a perspective shortening of the verti-
cal disc diameter, a rotation round the sagittal axis does not change the perspective 
appearance of the disc diameters [44]. The rotation around the vertical axis is asso-
ciated with the development and enlargement of gamma zone at the temporal side, 
and a rotation around the horizontal axis is associated with the development and 
enlargement of gamma zone at the inferior border of the optic disc. These optic disc 
rotations explain the ophthalmoscopical appearance of the markedly vertically oval 
shape of optic discs in highly myopic eyes [15, 16]. The difference between the two- 
dimensional ophthalmoscopical optic disc shape and the optic disc shape as deter-
mined three-dimensionally by optical coherence tomography increases with longer 
axial length, due to the progressing disc rotation around the vertical axis [44]. It has 
remained elusive which forces lead to the disc rotation around the vertical axis in 
progressive axial myopia. One reason could be, as outlined above, the increasing 
misalignment of the three optic disc openings, with the Bruch’s membrane opening 
moving in temporally and the scleral opening staying partially behind. The resulting 
overhanging of Bruch’s membrane into the nasal part of the optic disc channel leads 
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to a shortening of the effective horizontal disc diameter. A second mechanism could 
be a backward strain or pull of the optic nerve dura mater on the peripapillary region 
[45, 46]. In a recent study, Demer and colleagues proposed that the backward pull 
of the optic nerve on the optic nerve head in markedly axially elongated eyes could 
lead to a novel mechanical load on the globe at the optic nerve head in ocular adduc-
tion [ 45]. Since the optic nerve originates in the nasal superior region of the orbit 
and inserts in the posterior nasal region of the eye, adduction of the globe would 
lead in axially elongated eyes to a backward pull of the optic nerve on the temporal 
and temporal inferior side of the optic nerve head. Such a mechanism could explain 
the marked rotation of the optic nerve head mainly around its vertical axis (and a 
slight rotation around its horizontal axis with a backward movement of the inferior 
optic disc pole) in highly elongated eyes. Since the optic nerve dura mater as com-
pared to the pia mater or the neural tissue of the optic nerve may be biomechanically 
the strongest element, one may assume that the traction is forwarded by the optic 
nerve dura mater to its insertion on the globe, i.e., the merging line of the dura mater 
with the posterior sclera or the peripheral end of the peripapillary scleral flange. 
Traction on the merging line could also lead to an elongation of the peripapillary 
scleral flange and indirectly to the development and enlargement of parapapillary 
gamma zone. The study by Demer has been confirmed and extended by investiga-
tions conducted by Wang and colleagues who found that that the optic nerve head 
strains due to the pull by the optic nerve dura mater on the peripapillary sclera dur-
ing a lateral eye movement of 13° were as high as, or higher than, those resulting 
from an IOP of 50 mmHg [46]. Fitting with the notion of a biomechanical role the 
optic nerve may play for the anatomy and physiology of the optic nerve head is the 
finding of peripapillary suprachoroidal cavitations which are located mostly in the 
inferior peripapillary region in about 17% of highly myopic eyes [47–50]. Their 
development may also be explained by a backward pull of the optic nerve dura 
mater on the temporal and inferior peripapillary sclera. Correspondingly, peripapil-
lary suprachoroidal cavitations are associated with an optic disc rotation around the 
vertical disc axis and high axial myopia [50].
The cutoff for the differentiation between moderate myopia and high myopia 
at which the axial elongation associated enlargement of the optic nerve head starts 
has not concisely been assessed so far. According to hospital-based investigations 
and population-based studies, the optic disc and parapapillary gamma zone start to 
increase at about a value of approximately −8.00 diopters or an axial length of about 
26.5 mm [51, 52]. At the same cutoff values, the prevalence of myopic retinopathy 
increases [53–55].
11.3  Increased Prevalence of Glaucoma in High Myopia 
and Associated Factors
Population-based investigations and hospital-based studies have shown that the 
prevalence of glaucomatous optic neuropathy (GON) was higher in highly myo-
pic eyes than in emmetropic eyes [53, 56–69]. To cite an example, in the Beijing 
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Eye Study the prevalence of GON was significantly higher in eyes with a myopic 
refractive error exceeding −6 diopters than in the remaining eyes, while between 
the hyperopic eyes, the emmetropic eyes and the eyes with low to moderate myopia 
(myopic refractive up to −6 diopters or less), the frequency of glaucoma did not 
vary significantly [53]. Since the IOP pressure did not differ significantly between 
the highly myopic eyes and the remaining eyes, it suggested a higher glaucoma 
susceptibility in the highly myopic eyes. In the Blue Mountains Eye Study, the 
glaucoma prevalence was higher in moderate to high myopes (4.4%) than in emme-
tropes (1.5%) [63]. In the Barbados Eye Study, myopia increased the odds of having 
glaucoma while hyperopia reduced it [61]. In the Malmö eye survey on more than 
30,000 individuals, the glaucoma prevalence increased with increasing myopia, and 
the association between myopia and glaucoma was strong at lower IOP levels, and 
weakened gradually with increasing IOP [64, 67]. The reason for a discrepancy 
between studies on an association between myopia and glaucoma may be that not 
all studies differentiated between moderate myopia, which may not be associated 
with an increased glaucoma prevalence, and high myopia with an increased fre-
quency of GON [65]. Accordingly, in the Beijing Eye Study the low to moderate 
myopic group, the emmetropic group and the hyperopic group did not vary signifi-
cantly in the prevalence of glaucoma in the present study [53]. By the same token, 
in non-highly myopic individuals, inter-eye differences in refractive error were not 
significantly correlated with inter-eye differences in neuroretinal rim area and mean 
visual field defect nor were the neuroretinal rim area, the horizontal and vertical 
cup/disk diameter ratios and the mean visual field loss correlated with refractive 
error in an interindividual statistical analysis [65].
A previous study revealed that at a given IOP in patients with chronic open-
angle glaucoma, the amount of optic nerve damage was more marked in highly 
myopic eyes with large optic discs than in non-highly myopic eyes [68]. This 
observation was supported by a hospital-based study in which Nagaoka and col-
leagues examined 172 patients with a mean axial length of 30.1 ± 2.3 mm (range: 
24.7–39.1 mm) and in which the prevalence of GON (overall: 28%) was 3.2 times 
higher (P < 0.001) in large optic discs (>3.79 mm2) than in normal-sized discs or 
small discs (<1.51 mm2) after adjusting for older age. Interestingly, axial length 
was not significantly (P = 0.38) associated with glaucoma prevalence in that model 
[70]. It suggested that the axial elongation-associated enlargement of the optic 
disc as compared to the axial elongation itself was one of the main factors for the 
increased glaucoma susceptibility in the highly myopic eyes. In a following study, 
it was additionally detected that an enlarged parapapillary delta zone, together with 
an enlarged optic disc, was associated with the increased glaucoma prevalence in 
highly myopic eyes, while in the multivariate analysis, parapapillary gamma zone 
was not related with the glaucoma prevalence [71]. In that study on 519 eyes with a 
mean axial length of 29.5 ± 2.2 mm, prevalence of GON increased from 12.2% in 
the group with an axial length of <26.5 mm to 28.5% (24.4, 32.5) in the group with 
an axial length of ≥26.5 mm, to 32.6% in the group with an axial length of ≥28 mm, 
to 36.0% in the group with an axial length of ≥29 mm, and to 42.1% in eyes with 
an axial length of ≥30 mm.
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11.4  Potential Reasons for the Association Between 
Glaucoma and High Myopia
The main factors associated with the increased prevalence of GON in the highly 
myopic eyes were the size of the optic disc and the prevalence and size of para-
papillary delta zone. Histomorphometric studies have revealed that the axial 
elongation- associated enlargement of the optic disc is associated with an elonga-
tion and thinning of the lamina cribrosa. Since the lamina cribrosa is the functional 
border tissue between the intraocular compartment with the IOP and the retrobulbar 
compartment with the orbital cerebrospinal fluid pressure, a thinning of the lamina 
cribrosa leads to a decreased distance between both compartments and to a steepen-
ing of the trans-lamina cribrosa pressure gradient between both compartments [17, 
18]. An elevated the trans-lamina cribrosa pressure difference or a steepening of the 
trans-lamina cribrosa pressure gradient have been discussed to be associated with 
the glaucomatous damage to the retinal ganglion cell axons when passing through 
the lamina cribrosa [72–76]. The thinning of the lamina cribrosa may thus be one of 
the reasons for the association between an enlargement of the optic disc size and a 
higher prevalence of GON. Additional potential reasons for the increased glaucoma 
susceptibility in highly myopic optic disc may be a rearrangement of the lamina 
cribrosa pores and the whole lamina cribrosa architecture by the axial elongation- 
associated stretching of the lamina cribrosa. Theoretically, it may have a similar 
effect as the scarring of the lamina cribrosa due to the glaucomatous process itself, 
what may also lead to increased glaucoma susceptibility at a given IOP [77].
Histological studies have additionally shown that the myopic enlargement of 
the posterior surface of the lamina cribrosa leads to an exposure of a peripheral 
annular- like region of the lamina directly to the orbital cerebrospinal fluid space 
[18]. Since the cerebrospinal fluid in contrast to the solid optic nerve tissue cannot 
resist a local backward bowing of the lamina cribrosa, the exposure of the posterior 
lamina cribrosa surface to the cerebrospinal fluid space may allow the development 
of acquired pits of the optic nerve head which are typically located at the optic disc 
border.
The peripapillary scleral flange is the biomechanical anchor of the lamina cribrosa 
to the posterior sclera, with both tissues being partially separated from each other 
by the peripapillary border tissue of Elschnig the scleral flange [38]. In the process 
of axial elongation, the length of the peripapillary scleral flange can increase by a 
factor of 10×, and its thickness can get reduced to 10% of its original value [19, 
78]. These marked anatomical changes may have an effect on the biomechanical 
properties of the flange as the anchor of the lamina cribrosa and may be one of the 
reasons for the increased glaucoma susceptibility in high myopia. This notion fits 
with the observation that the size of parapapillary gamma zone, after adjusting for 
axial length was not significantly associated with the glaucoma prevalence. Gamma 
is the zone free of Bruch’s membrane, and Bruch’s membrane, connected with the 
lamina cribrosa by the thin peripapillary choroidal border tissue of Jacoby may not 
directly be involved in the biomechanics of the lamina cribrosa in glaucoma.
The lamina cribrosa is nourished by vessels originating from the peripapillary 
arterial circle of Zinn-Haller, which is located approximately at the merging point 
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of the posterior sclera with the dura mater of the optic nerve [40, 41, 79]. The longer 
the peripapillary scleral flange, the larger is the distance between the arterial circle 
and the optic nerve head. The axial elongation-associated elongation of the peripap-
illary scleral flange may thus potentially have importance for the blood supply of 
the lamina cribrosa and be another factor for an increased susceptibility of a highly 
myopic disc for optic nerve damage.
It has remained unclear whether the axial elongation-associated enlargement 
of the optic disc is an independent risk factor for an increased GON susceptibility 
in high myopia. In non-highly myopic eyes, the optic disc size was not associated 
with the prevalence and amount of GON [77, 80, 81]. Since the elongation and 
thinning of the lamina cribrosa and of the peripapillary scleral flange are strongly 
associated with the optic disc enlargement, one may assume that the disc enlarge-
ment is secondarily, and not causally, associated with the increased prevalence of 
GON in high myopia. It has also remained elusive whether the axial elongation-
associated thinning of the peripapillary choroid has an influence on the GON 
susceptibility [82].
11.5  Intraocular Pressure and Glaucoma in High Myopia
In a recent pilot study on 517 eyes with a mean axial length of 29.5 ± 2.2 mm, 
the IOP did not differ significantly (P  =  0.53) between the glaucoma group 
(n  =  141 (27.3%) eyes) and the non-glaucomatous group (n  =  376 (72.7%)) 
(14.5 ± 3.3 mmHg versus 14.7 ± 2.5 mmHg) [83]. Only in the eyes with an axial 
length of equal to or less than 27.4 mm, the prevalence of GON was correlated 
with higher IOP (P  =  0.037; odds ratio (OR): 1.35; 95% confidence interval 
(CI):1.02, 1.80), while in the eyes with a longer axial length, the prevalence 
of GON was not significantly (P = 0.97) associated with IOP in a multivariate 
analysis adjusting for age, axial length, shorter vertical diameter of the temporal 
arterial arcade and longer minimal optic disc diameter. There were major limita-
tions of the study as follows: the diagnosis of GON was based on the ophthalmo-
scopic appearance of the optic nerve head, without taking into account results of 
visual field examinations or findings obtained by optical coherence tomography; 
and the glaucomatous group as compared to the non-glaucomatous group had a 
significantly higher prevalence of anti- glaucomatous therapy. It could suggest 
that the lack of a difference in IOP between both groups was due to the higher 
prevalence of IOP-lowering therapy in the glaucomatous group. In the multivari-
ate analysis with adjustment for the prevalence of anti-glaucomatous treatment 
however, the IOP was not significantly associated with the glaucomatous versus 
non-glaucoma group.
If the results of the study are valid, it may not indicate that there is no association 
between IOP and glaucoma in high myopia, but that highly myopic glaucomatous 
eyes as compared with non-highly myopic glaucomatous eyes may have a markedly 
lower IOP threshold to develop optic nerve damage. It could indicate that an IOP 
of perhaps lower than 10 mmHg might be necessary to prevent the development 
of GON in these highly myopic eyes, and that in highly myopic eyes with axial 
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elongation associated enlargement and stretching of the optic disc and parapapillary 
region as the main risk factors for GON in high myopia a normal IOP may be suf-
ficient to lead to GON.
11.6  Therapy of Glaucoma in High Myopia
Although it has not yet been firmly proven that GON in high myopia is dependent 
on IOP, and although a randomized trial on the effect of lowering of IOP as therapy 
of glaucoma in highly myopic eyes has not been performed yet, most researchers 
recommend lowering IOP in highly myopic patients with glaucoma. Based on the 
morphological findings described above, the target pressure in highly myopic glau-
coma may be lower than in non-highly myopic glaucoma. A factor markedly com-
plicating the clinical situation is the difficulty in detecting the presence of GON and, 
in particular, in detecting the progression of optic nerve damage in highly myopic 
glaucoma. Due to the peculiar anatomy of the optic nerve head in highly myopic 
eyes, most diagnostic procedures fail in precisely assessing the status of the optic 
nerve in highly myopic eyes with glaucoma. It includes factors such as:
• a decreased spatial and color contrast between the neuroretinal rim and the optic 
cup making a delineation of both structures more difficult;
• a peripapillary retinoschisis leading to an incorrect segmentation of the retinal 
nerve fiber layer upon optical coherence tomography;
• a large gamma zone (and delta zone) which makes using the end of Bruch’s 
membrane as reference point for the measurement of the neuroretinal rim 
useless;
• a large gamma zone also markedly further reduces the anyway relatively low 
value of parapapillary beta zone as indicator for GON; and
• macular Bruch’s membrane defects and other reasons for non-glaucomatous 
visual field defects which reduces the diagnostic precision of perimetry for the 
detection of presence and progression of GON.
The mode of therapy of lowering IOP in highly myopic glaucoma is similar 
to the therapy of open-angle glaucoma in non-highly myopic eyes and includes 
topically applied drugs reducing the production of aqueous humor and/or increasing 
the outflow of aqueous humor, laser procedures aimed at the trabecular meshwork 
to increase aqueous humor outflow, and surgical procedures for increase of aque-
ous humor outflow or reduction of aqueous humor production. If fistulating proce-
dures, such as trabeculectomy, are performed, one may have to take into account 
a potentially increased risk of postoperative choroidal swelling and detachment 
and even expulsive hemorrhage. Potential reasons might be the marked thinning 
(compression) of the choroid in highly myopic eyes and an oblique course of the 
short posterior ciliary arteries (and potentially vortex veins) through the sclera in 
highly myopic eyes, while in emmetropic eyes the short posterior ciliary arteries run 
almost perpendicularly through the sclera (Fig. 11.2).
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Key Points
• MTM is an important treatable cause of visual loss among individuals with 
high myopia.
• A certain proportion of cases of MTM do not progress. Treatment should be 
offered to patients with more advanced disease with progressive visual loss.
• Fovea-sparing instead of complete peeling of the ILM and avoidance of gas 
tamponade could prevent the formation of secondary macular hole in MTM.
• Surgical adjuncts should be considered for macular hole especially in 
high-risk cases (persistent macular hole despite initial surgery, large and 
chronic macular hole, atrophic macula, etc.)
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12.1  Introduction
As described in the previous chapter, myopic foveal retinoschisis was first described 
in 1958 [1], then by Takano and Kishi in 1999 through the advent of optical coher-
ence tomography (OCT) [2]. Subsequently, the various pathological effects of trac-
tion on the macula in patients with high myopia were collectively termed myopic 
traction maculopathy (MTM) by Panozzo and Mercanti in 2004 [3]. It was esti-
mated to occur in approximately 8–34% in individuals with high myopia [4–6]. The 
term MTM originally encompassed retinal thickening, macular retinoschisis, foveal 
detachment, and lamellar macular hole with or without epiretinal membrane and/
or vitreomacular traction [3]. The spectrum was extended to include full-thickness 
macular hole (HM) with or without retinal detachment.
Central to the pathogenesis of MTM is traction, which was postulated to arise 
from one or more of the following mechanisms [7]: vitreomacular traction associ-
ated with perifoveal posterior vitreous detachment (PVD) [8–10]; relative incom-
pliance of inner retinal structures (e.g., internal limiting membrane [ILM] [11–15], 
epiretinal membrane [ERM] [6, 8, 16–18], and cortical vitreous remnant after PVD 
[19]) to the outer retina which conforms to the shape of the posterior staphyloma; 
and traction exerted by retinal arterioles [14, 20, 21].
Not all patients with MTM require interventions [10, 22, 23]. A study on the 
natural history of MTM with 207 eyes found that while 12% of cases progressed 
during a mean follow-up period of 36 months, the majority (84%) remained stable 
and a small proportion (4%) even had improvement or complete resolution of the 
disease [24]. The extent of macular retinoschisis was identified as a predictor of pro-
gression, with stage 4 disease (i.e., involving the entire macula) having the higher 
chance of progression than any other stages [24]. It is generally accepted that eyes 
with complications such as foveal detachment or full-thickness MH with or without 
retinal detachment, or eyes with significant progression in the extent of macular 
retinoschisis on OCT should undergo intervention early. On the other hand, an early 
macular retinoschisis involving only a limited area of the macula with preserved 
vision should be monitored with OCT for any progression.
There are numerous reported interventions for MTM. The principles of the treat-
ment are: (1) to relieve traction, mainly achieved through pars plana vitrectomy 
(PPV) with or without ILM peeling; (2) to minimize surgical damage to the weak-
ened macula through technique modifications in order to prevent the formation of 
postoperative MH; and (3) in the presence of full-thickness MH to maximize the 
chance of hole closure through the use of various surgical adjuncts.
12.2  Surgical Procedures
12.2.1  Pars Plana Vitrectomy
PPV serves several purposes in the treatment of MTM.  It allows removal of all 
premacular tractional forces, including posterior vitreous cortex and ERM. It also 
creates a potential space in the posterior segment for gas tamponade to be performed.
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12.2.1.1  Microincision Vitrectomy Surgery
With the advent of microincision vitrectomy system, PPV can be performed with 
small sclerotomy wounds and instruments in the size of 23 gauge, 25 gauge, or 27 
gauge. Small sclerotomy wounds tend to be self-sealing and do not require sutures. 
It has the advantages of reduced ocular trauma, reduced inflammation, less conjunc-
tival scarring, shorter operation time, better patient comfort, and faster postopera-
tive recovery [25]. The design of closer opening near the tip of vitreous cutter probe 
also facilitates engagement and induction of PVD.
12.2.1.2  Induction of Posterior Vitreous Detachment
Since the pathogenesis of MTM involves abnormal vitreoretinal traction at the mac-
ula, induction of PVD is crucial to a successful operation. After core vitrectomy, 
induction of PVD is performed by using an aspiration port, usually the vitreous 
cutter probe, to engage the posterior hyaloid just anterior to optic disc. Once the 
posterior hyaloid is engaged by applying aspiration, the port is lifted upward to 
detach the posterior hyaloid from the retinal surface.
Induction of PVD can be difficult in MTM due to tight vitreoretinal adhesion and 
presence of vitreoschisis. Vitreoschisis refers to splitting of posterior vitreous cortex 
which occurs when there is vitreous gel liquefaction but without dehiscence at the vitreo-
retinal interface [26]. Vitreoschisis is common in MTM and is present in around half of 
the patients with MH [27]. To facilitate induction of PVD, triamcinolone acetonide [28] 
or trypan blue can be injected to stain the posterior hyaloid to improve visualization. If 
PVD cannot be induced by aspiration, intraocular forceps or diamond-dusted membrane 
scraper can be used to lift and assist detachment of the posterior hyaloid [29, 30].
12.2.1.3  Epiretinal Membrane Peeling
It is necessary to remove all ERM if any present on the macula. Removal of ERM 
allows removal of tractional forces on the macula, and allows access and identifica-
tion of the underlying ILM with vital dyes.
Trypan blue is useful to stain the ERM to enhance visualization [31, 32]. Trypan 
blue is often injected after fluid-air exchange [33], or it can be mixed with 10% glucose 
isovolumetrically to create a heavy dye denser than balanced salt solution so that it will 
fall onto the macula with less dispersion in vitreous cavity [34]. There are also products 
combining trypan blue, brilliant blue, and polyethylene glycol with increased molecu-
lar weight so that the dye falls onto the macula to enhance tissue staining.
12.2.1.4  Internal Limiting Membrane Peeling
ILM is the innermost layer of a normal retina. It has significant contribution to 
retinal rigidity [35]. ILM peeling therefore improves retinal compliance and allows 
the retina to restore its normal anatomy [35]. The potential complications of ILM 
peeling include iatrogenic damage to retinal nerve fiber layer, retinal hemorrhage, 
and retinal defect formation, especially at sites of ILM flap creation and grasping 
points [35]. Due to the thinner retina and longer distance required to reach the pos-
terior pole, ILM peeling is more technically challenging in highly myopic eyes than 
normal eyes and complications may be more common.
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ILM is barely visible and requires staining with vital dyes for identification. 
Triamcinolone acetonide and trypan blue do not stain ILM well. The better dyes for 
ILM staining are brilliant blue and indocyanine green (ICG) [31, 32]. ICG adheres 
well to the extracellular matrix of ILM such as collagen type 4 and laminin and 
allows good visualization of ILM [31]. However, there are concerns of potential 
retinal toxicity, especially when ICG is in direct contact with the photoreceptors and 
retinal pigment epithelium through a MH [31]. ICG retinal toxicity has been shown 
with electrophysiology and histological studies in animal models [36, 37]. The risk 
increases with endoillumination light exposure [32]. In comparison, brilliant blue 
is a much safer alternative. A recent meta-analysis showed that postoperative visual 
acuity was better with brilliant blue than ICG in MH surgeries [38].
After ILM staining, an ILM flap can be created at the extrafoveal region using 
intraocular forceps by direct pinch method [35]. Alternatively, a pick, diamond- 
dusted membrane scraper or flexible nitinol loop can be used to create an ILM flap 
by scrapping [11]. The ILM flap is then lifted with intraocular forceps and moved in 
a circular fashion so that the whole ILM is peeled off from the macula.
Full-Thickness Macular Hole
In full-thickness MH, ILM peeling helps to reduce retinal rigidity and improve 
retinal compliance and thus the chance of MH closure [35]. It also helps to reduce 
postoperative ERM formation and risk of MH reopening [35]. A meta-analysis of 
four randomized controlled trials showed that ILM peeling for stages 2, 3, and 4 
full-thickness MH has a significantly higher closure rate than without ILM peeling 
[39]. Another meta-analysis showed that MH reopening rate reduced from 7 to 1% 
when ILM peeling was performed.
Concerning the extent of ILM peeling, there is no consensus on the optimal size 
required [35]. Extended ILM peeling up to arcade is often performed for large MH 
to ensure traction has been sufficiently removed. Extended ILM peeling, however, 
is performed at the expense of longer operation time and higher risk of iatrogenic 
retinal trauma due to repeated ILM grasping [35]. Dissociated optic nerve fiber 
layer (DONFL) and swelling of arcuate retinal nerve fiber layer (SANFL), which 
can be shown on imaging modalities such as OCT scan and infrared fundus photo-
graphs, are two known structural changes secondary to ILM peeling [40, 41]. ILM 
flap initiation techniques might affect the chance of these structural complications, 
with pinch technique shown to be less damaging than diamond dust membrane 
scraping [40].
Myopic Foveoschisis
For myopic foveoschisis, ILM peeling helps to ensure that all tractional forces from 
premacular glial cells and vitreous cortex are completely removed [42]. It increases 
retinal compliance and allows the retina to better conform to the posterior staphy-
loma [42].
Favorable anatomical and visual outcomes have been reported for combined 
PPV, ILM peeling, and gas tamponade. However, development of postoperative 
full-thickness MH is not uncommon and occurs in around 13–28% of patients [43]. 
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Shimada et al. [44] and Ho et al. [45] introduced the technique of fovea-sparing ILM 
peel in 2012. Instead of complete ILM removal, this technique involves removal 
of the perifoveal ILM only and leaving the ILM over the central foveola intact. 
It is believed that preservation of foveolar ILM would preserve foveolar Muller 
cells integrity and therefore reduce the risk of postoperative MH development [46]. 
Although studies suggested this technique might be useful to reduce the risk of MH 
development and foveolar thinning [46], leaving ILM on the fovea could result in 
late ILM contraction and retinal thickening [44]. This technique is also more techni-
cally demanding and requires more tissue manipulation than conventional complete 
ILM peeling.
In view of the risk of secondary macular hole development in foveoschisis 
patients undergone ILM peeling, conservative treatment can be considered in foveo-
schisis patients without foveal detachment.
12.2.1.5  Gas Tamponade
The commonly used gases for tamponade include air, sulfur hexafluoride (SF6), 
and perfluoropropane (C3F8). Gas tamponade is commonly performed for MTM, 
particularly in cases with FTMH. For myopic foveoschisis without FTMH, it is still 
controversial whether gas tamponade is necessary. Gas tamponade may help the 
retina to adhere better to the posterior staphyloma and tamponade against unnotice-
able macular holes [47]. In the presence of outer retinal detachment, the subretinal 
fluid (SRF) could be displaced toward areas with healthier retinal pigment epithelial 
(RPE) cells, which can facilitate SRF absorption [48–50]. More rapid resolution of 
foveoschisis was also reported by a study [51]. However, the study showed that the 
chance of successful resolution was similar between the group with gas tamponade 
and that without gas tamponade [51]. Indeed, a meta-analysis showed that for eyes 
undergoing vitrectomy for myopic foveoschisis, gas tamponade did not have sig-
nificant impact on visual acuity or the rate of resolution of foveoschisis, yet it was 
associated with more complications [42]. Several studies also reported the para-
doxical occurrence of FTHM from the use of gas tamponade, which could squeeze 
SRF within the limited space through the weak point of fovea [52–54]. The use of 
gas tamponade as an adjunct for FTMH would be discussed below.
12.2.2  Additional Measures (Adjuncts) to Improve Outcome 
of Macular Hole Surgery
12.2.2.1  Endotamponade
PPV with endotamponade agents is the most commonly employed technique for 
the management of myopic macular hole with or without retinal detachment. Gas 
tamponade with long-acting gases, commonly SF6 and C3F8, has the advantages 
of high surface tension and buoyancy compared to silicone oil. A study compar-
ing C3F8 and silicone oil as a tamponade agent for myopic MH retinal detachment 
(MHRD) showed higher initial success rate for C3F8 than silicone oil [55]. Due to 
lower buoyancy, silicone oil is less conforming to posterior staphyloma, rendering 
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it less effective for MHRD. However, silicone oil still has advantages over gases 
for longer duration of tamponade, shorter duration of face down posturing, earlier 
visual recovery as well as allowing immediate air travel.
12.2.2.2  Inverted Internal Limiting Membrane Flap
Even with extended ILM peeling, a proportion of large chronic MH remains open 
after operation. Michalewska et al. introduced the inverted ILM flap technique in 
2009 and reported closure rate of large MH reached 98% [56]. Instead of complete 
ILM removal, this technique involves leaving a hinge of ILM flap at the edge of MH 
during ILM peeling. This ILM flap is then inverted upside-down to cover or fill the 
MH. Some surgeons would inject an ophthalmic viscosurgical device on the inverted 
ILM flap in order to keep it in place. It is postulated that this technique facilitates 
MH closure by (1) providing a flap which contains Muller cell fragments to induce 
glial cells proliferation, and (2) providing a scaffold for retinal tissue to approximate 
[56]. Despite an apparently promising closure rate for large or persistent MH, it has 
been reported that the visual recovery and recovery of retinal microstructures such 
as external limiting membrane and the ellipsoid zone are worse among cases man-
aged with inverted ILM flap when compared to conventional complete ILM peeling 
[57]. This can possibly be due to mechanical obstruction of functional recovery of 
retinal layers by the presence of an ILM plug in the MH.
12.2.2.3  Autologous Internal Limiting Membrane Transplantation
Although the inverted ILM flap technique proposed by Michalewska and associ-
ates seems to be a good surgical adjunct for anatomical closure of large MH, this 
method cannot be applied to patients who suffer from persistent macular hole after 
vitrectomy and conventional ILM peeling, since ILM surrounding MH has already 
been removed in the previous procedure. In view of this limitation, Morizane et al. 
introduced a new method of ILM flap, which is the autologous ILM transplantation 
(free ILM flap) [58]. Brilliant Blue G solution is used to stain the remaining ILM 
in those refractory MH cases. Subsequently appropriately sized ILM is peeled off, 
which is supposed to match the size of the macular hole, and is placed as a free flap 
onto the persistent MH. Infusion should be turned off during the procedure in order 
to avoid accidental loss of the ILM flap. In order to stabilize the flap, an ophthalmic 
viscosurgical device is injected on the top of the flap before fluid-air exchange is 
performed. It has been demonstrated that with this method of autologous ILM trans-
plantation, up to 90% of refractory MH (with previous vitrectomy and ILM peeled) 
could achieve MH closure [58, 59].
12.2.2.4  Autologous Blood
In order to prevent subretinal migration of dye and the resultant retinal toxicity asso-
ciated with vital stains, it was proposed to use autologous blood to cover the MH 
before injection of brilliant blue dye. Ghosh et al. collected autologous heparinized 
whole blood from patients’ antecubital vein and injected to MH before injection of 
brilliant blue dye assisted ILM peeling. It has been demonstrated that compared to 
conventional method, the use of prestaining autologous blood led to better visual 
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acuity outcomes and continuity of ellipsoid zone at all postoperative time points; 
and the outer retinal layer is thicker as well [60].
Apart from being used in the prevention of subretinal migration of dye, the thera-
peutic effect of autologous blood in persistent and refractory MH has also been 
investigated. It has been shown that injection of autologous blood or platelet con-
centrate into MH after ILM peeling can improve closure rate of macular hole and 
visual recovery [61–63]; and the efficacy of autologous platelet concentrate might 
even be better than whole blood. In one study in which 75 subjects were included, 
MH closure rate after revitrectomy plus autologous platelet concentrate was 85.2% 
versus 7.1% in the group using autologous whole blood instead [64].
12.2.2.5  Lens Capsular Flap Transplantation
Due to the possible lack of residual accessible ILM in reoperative cases of persistent 
MH, transplantation of lens capsules to MH have been proposed to increase the surgi-
cal success rate. In patients with cataract, phacoemulsification would be performed in 
the same setting and capsular flap would be harvested during continuous curvilinear 
capsulorhexis and stained with indocyanine green solution or brilliant blue solution 
for better visualization. In aphakic or pseudophakic patients with insufficient anterior 
capsule, capsular flap can be harvested from their fellow eyes requiring cataract opera-
tions. Alternatively, posterior capsular flap can be used instead. Since capsular flaps 
are more rigid than ILM flap, it is easier to manipulate during the operation. Moreover, 
due to the higher specific gravity of capsular flap, it will sink in balanced salt solution, 
therefore shall fall nicely onto the preretinal surface, unlike ILM flap that is tended 
to float inside the vitreous cavity. Chen et al. demonstrated a 100% MH closure rate 
with anterior capsular transplantation among patients with refractory MH, whereas the 
complete closure rate of MH after posterior capsular transplantation was only 50% and 
with another 30% enjoyed partial MH closure [65]. Similarly, Peng et al. reported a 
90% MH closure rate after transplantation of anterior capsule to refractory MH [66].
12.2.2.6  Macular Buckle
One of the major etiological factors of MTM is the elongation of axial length of 
the globe leading to tension and traction on retinal layers. The aim of vitrectomy 
is to remove vitreous traction and ILM peeling to reduce the rigidity and improve 
the compliance of retina. Nevertheless, none of these procedures tackle the primary 
pathology, which is the long axial length in high myopes.
Macula buckles have been used to shorten the axial length of myopic eyeballs 
in conditions such as MHRD, myopic foveoschisis with or without foveal detach-
ment and MH with foveoschisis. There are many types of macular buckle, includ-
ing scleral sponge, T-shaped or L-shaped buckle, Ando Plombe, wire-strengthened 
sponge exoplant, and even donor sclera and suprachoroidal injectable long-acting 
hyaluronic acid. Chandelier light is attached to the indenting head of macular buckle 
when necessary for better localization and positioning of the buckle. The purpose of 
all the aforementioned macular buckles is to shape the globe back to normal length 
along the visual axis, thereby reducing the anteroposterior traction on retina and the 
tension within retinal layers [67].
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Studies have been carried out to compare the efficacy of vitrectomy and macular 
buckle in inducing retinal reattachment and MH closure in patients suffering from 
MHRD. Fifty to seventy-nine percent of patients with previous vitrectomy had their 
retina successfully reattached whereas 93.3–100% of the patients managed with mac-
ular buckles enjoyed flattening of the retina [68–70]. The differences in MH closure 
rates between the two treatment modalities are even higher. Similarly, comparing to 
less than 50% MH closure rate by vitrectomy, macular buckle surgeries achieved a 
100% closure rate in patients with MH and concomitant foveoschisis, and more than 
80% of these patients had improvement in final visual acuity [67]. In patients with very 
poor MTM, combined vitrectomy and macular buckle surgeries can be considered.
Despite the high success rate in the latest macular buckle surgeries, these procedures 
are technically demanding and are not without risks. Complications of macular buck-
les include globe perforation, problems with extraocular movement, squint, choroidal 
effusion, changes in retinal pigment epithelium and the need for removal of buckle.
12.2.2.7  Autologous Neurosensory Retinal Transplantation
In 2016, Grewal and Mahmoud reported the technique of autologous neurosensory 
retinal free flap transplantation for the closure of refractory macular hole after initial 
PPV with peeling of ILM [71].
The technique involves bimanually harvesting a free flap of neurosensory ret-
ina superior to the superotemporal arcade, with the harvest site first secured by 
endolaser barricade and endodiathermy. The free flap was translocated in its correct 
orientation over the macular hole and perfluoro-n-octane heavy liquid (PFC) was 
instilled over it, followed by direct PFC-silicone oil exchange.
In order to prevent flap dislocation intraoperatively and postoperatively, the 
intraocular pressure should be lowered to reduce fluid turbulence [72]. The edge of 
the flap could be tucked underneath the edge of MH [72]. A technique combining 
autologous blood and autologous retinal free flap transplantation was described to 
secure the flap with blood clot [72].
There were small case series using similar techniques with good results, in terms 
of both anatomical closure rate and visual recovery [73–75]. The recovery of vision 
was postulated to be in part due to integration of the free flap to the surrounding 
retinal tissue with partial recovery of the ellipsoid zone and external limiting mem-
brane, as observed postoperatively using OCT.  It was hypothesized that the flap 
served more than a scaffold, providing glial cells and growth factors for structural 
and functional restoration. The implications of this observation to other macular 
diseases are yet to be determined.
12.3  Conclusion
The pathological changes associated with high myopia lead to a range of retinal com-
plications, including MTM. An understanding of the pathogenesis and natural history 
of the disease sheds light on its management. Advances in surgical instruments and 
skills have shown promises in the management of this challenging condition.
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13Clinical Management of Myopia in Adults: Treatment of Myopic CNV
Shaun Sim, Chee Wai Wong, and Gemmy C. M. Cheung
13.1  Disease Overview
Myopic choroidal neovascularization (myopic CNV), a subtype of CNV associ-
ated with pathological myopia, is the second most common cause of CNV after 
age- related macular degeneration (AMD) [1, 2]. Compared to CNV secondary 
to AMD, key differences include occurrence in a younger age group, less promi-
nent exudative and hemorrhagic changes, generally smaller choroidal 
Key Points
• The prevalence of myopic choroidal neovascularization (CNV) was 
between 5.2% and 11.3% in individuals with pathological myopia and was 
more common in females.
• Fundus fluorescein angiography (FFA) and optical coherence tomography 
are the imaging modalities of choice to diagnose myopic CNV and assess 
activity.
• Current evidence supports the use of intravitreal anti-vascular endothelial 
growth factor as the gold standard of treatment for myopic CNV, following 
a pro re nata (PRN) treatment regimen without a loading phase.
• Long-term visual outcomes remain less favorable, largely due to the devel-
opment of chorioretinal atrophy around the regressed CNV.
272
neovascular membranes, excellent response to anti-vascular endothelial growth 
factor treatment and better long-term visual prognosis [3–5]. It is one of the 
most sight-threatening complications of pathological myopia [6, 7], with indi-
viduals typically reporting acute loss of central vision. Estimated to develop in 
5–10% of eyes with pathological myopia, myopic CNV is the most common 
cause of CNV in people aged 50 years or younger [1], with significant social and 
economic burden.
13.2  Incidence and Prevalence
Owing to a lack of uniform diagnostic criteria, the reported incidence and the 
prevalence of myopic CNV have varied widely and may be well underestimated. 
A recent systematic review reported that the prevalence of myopic CNV was 
between 5.2% and 11.3% in individuals with pathological myopia [8], with 
female preponderance seen in most studies [1, 2, 6, 9]. Myopic CNV was also 
bilateral in approximately 15% of individuals [1, 9]. Table 13.1 shows the prev-
alence as reported in population- based studies and in individuals with patho-
logical myopia.
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13.3  Natural History
The long-term outcome of CNV is poor if left untreated. In a 10-year follow-up 
study of 25 patients with myopic CNV, visual acuity deteriorated to 20/200 or worse 
in 89% and 96% of eyes in 5 and 10 years respectively [2]. Approximately 35% of 
individuals with myopic CNV in one eye developed CNV in the fellow eye, with a 
mean period of 8 years between eyes [12].
In the late twentieth century, Tokoro et  al. classified myopic CNV into three 
stages; active, scar, and atrophic stages [13]. Several other authors subsequently 
examined longitudinally the natural course of CNV and the three stages associated 
with visual loss [14, 15]. In the active phase, myopic CNV is characterized by hem-
orrhage with or without serous retinal detachment. In the scar phase, there is absorp-
tion of hemorrhage with development of fibrotic scars, some of which can become 
hyperpigmented, known classically as Fuchs’ spots. Finally, in the atrophic phase, 
as the myopic CNV regresses, the development of macular chorioretinal atrophy 
ensues. Recent studies using swept source optical coherence tomography have 
revealed the presence of macular Bruch’s membrane defect associated with myopic 
CNV. The expansion of these defects was found to be related to the enlargement of 
chorioretinal atrophy surrounding a regressed CNV [16]. In a small proportion of 
patients, poor visual outcome might be due to formation of myopic macular hole, 
particularly in eyes where chorioretinal atrophy is greater than one disc area [17].
13.4  Risk Factors
Compared to systemic risk factors, ocular risk factors have a much stronger influ-
ence on the development of myopic CNV. A prospective study found that eyes with 
myopic CNV had higher grade myopic maculopathy (with patchy retinal atrophy or 
worse) than eyes without myopic CNV. In the same series, eyes with higher grade 
myopic maculopathy were also 3.55 times more likely to develop myopic CNV than 
those with lower grade myopic maculopathy [18]. Higher grade lacquer cracks 
defined as crisscrossing lacquer cracks with or without linear cracks were also 
found in a significantly higher proportion of eyes with myopic CNV as compared to 
the fellow uninvolved eye [19, 20]. Choroidal thinning, in particular the subfoveal 
and inferior choroid, was found to be significantly thinner in eyes with myopic CNV 
than in the fellow uninvolved eyes [19, 21]. Furthermore, in patients with newly 
diagnosed myopic CNV, it was reported that the incidence of myopic CNV develop-
ment in the fellow eye was 34.8% compared to 6.1% in those with no previous CNV 
[12]. Other studies have also established an association between highly myopic eyes 
with higher aqueous humor levels of the inflammatory cytokines interleukin 6 and 
8 [22, 23]. Systemic risk factors implicated in the development of myopic CNV 
include higher levels of C-reactive protein and complement factors C3 and CH50 
[24]. Older age (>40 years), subfoveal CNV location, larger baseline lesion size 
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(>400 μm), and lower best corrected visual acuity (BCVA) at baseline have been 
identified as factors leading to poorer visual outcomes [8, 25].
13.5  Pathogenesis
The pathogenesis of myopic CNV has not been clarified although several theories 
have been proposed. The mechanical theory postulates that progressive elongation of 
the anteroposterior axis leads to breaks in the retinal pigment epithelium (RPE)–
Bruch’s membrane–choriocapillaris complex with formation of lacquer cracks, which 
in turn facilitates neovascularization from choriocapillaris [26–28]. Lacquer cracks 
have been more frequently observed in fellow eyes of patients with unilateral myopic 
CNV, hence the suggestion that breaks in Bruch’s membrane as the predisposing fac-
tor for development of CNV in pathological myopia [12]. It has also been reported 
that in vitro, progressive elongation of the posterior pole results in mechanical stress 
of the RPE cell layer, thus upregulating the expression and secretion of angiogenic 
factors [29]. The increased expression of vascular endothelial growth factor (VEGF) 
in aqueous humor of eyes with myopic CNV compared to cataract controls has also 
been reported in a comparative study [22]. Notably, VEGF levels in myopic CNV 
were lower than those in CNV secondary to AMD and can be explained by the smaller 
size of CNV membranes in myopic CNV. It is the imbalance between pro- angiogenic 
and anti-angiogenic factors that results in the development of myopic CNV.
The heredo-degenerative theory has been supported by genetic factors associated 
with myopic CNV based on twin and familial aggregation studies of pathologic 
myopia [30]. In a recent study that analyzed 15 genes associated with age-related 
macular degeneration, it was found that a single nucleotide polymorphism in the 
complement factor I (CFI) gene was significantly associated with myopic CNV 
[31]. Complement factor I is a regulatory protein involved in three complement 
pathways and is expressed by macrophages, lymphocytes, and fibroblasts, suggest-
ing that inflammation via the complement pathway may be involved in the develop-
ment of myopic CNV.
The hemodynamic theory suggests that alterations in choroidal perfusion of 
myopic eyes with choroidal filling delay may result in choroidal ischemia [32]. This 
leads to subsequent upregulation of angiogenic factors and the subsequent develop-
ment of myopic CNV [7]. Doppler ultrasound imaging of the retrobulbar vessels 
revealed significantly higher vascular flow resistance in the posterior ciliary artery 
in eyes with myopic CNV as compared to the fellow eye, thus further implicating 
dysfunction of choroidal circulation in the development of myopic CNV [33].
13.6  Diagnosis and Monitoring
On slit-lamp biomicroscopy, myopic CNV manifests as a small, flat, grayish sub-
retinal lesion adjacent to or beneath the fovea [2, 6, 34, 35]. There may be associ-
ated macular hemorrhage with or without exudation or subretinal fluid. Spectral 
S. Sim et al.
275
domain optical coherence tomography (SD-OCT) is a useful non-invasive screening 
tool that can be performed rapidly. On SD-OCT, myopic CNV presents as a hyper-
reflective material above the RPE band (type 2 CNV), with a variable amount of 
subretinal fluid (Fig.  13.1). OCT appearance is helpful to assess the activity of 





Fig. 13.1 Myopic CNV in a 57-year-old female. (a) Fundus photo shows a spot of subretinal hem-
orrhage (white arrow). (b) Fundus fluorescein angiogram shows early hyperfluorescence (white 
arrow) with a halo of hypofluoresence. (c) Optical coherence tomography (OCT) B scan shows a 
subretinal hyper-reflective lesion with indistinct margins, representing a type 2 CNV. (d) OCT angi-
ography shows flow signals representing the choroidal neovascular membrane in the outer retina 
slab. (e) OCT B scan after treatment with a single intravitreal injection of anti-vascular endothelial 
growth factor. The subretinal hyper-reflective lesion is now inactive and has acquired well-demar-
cated margins. (f) OCT angiography shows persistence of flow signals despite inactivity
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limiting membrane, with a variable amount of intraretinal or subretinal fluid. As the 
lesion becomes inactive, it consolidates and acquires a distinct border.
Clinical diagnosis is confirmed by fundus fluorescein angiography (FFA). 
Most myopic CNVs are type 2 neovascularization and present with a “classic” 
pattern on fluorescein angiography (FA). The amount of leakage may vary, 
depending on the level of the activity, the size of the lesion and the health of 
the RPE. FA has been shown to have higher sensitivity for detecting the activity 
than OCT.  In some eyes, subtle late leakage on FA may be the only sign of 
myopic CNV activity [35]. Myopic CNV with dense macular hemorrhage may 
result in masking of both early hyperfluorescence and late leakage. Indocyanine 
green angiography (ICGA) is useful in these cases to detect CNV. In addition, 
imaging also provides important prognostic indications. The size and location 
of the lesion can be better evaluated on FFA, while lacquer cracks and chorio-
retinal atrophy are best seen with ICGA [3]. ICGA also aids in exclusion of 
polypoidal choroidal vasculopathy (PCV) in those with macular hemorrhage, 
particularly important amongst Asian patients with the higher prevalence of 
PCV [36].
OCT angiography (OCTA) allows non-invasive imaging of the retinal and 
choroidal microvasculature. It is able to detect type 2 CNV with high sensitivity 
and specificity when compared against FFA and ICGA [37]. OCTA is able to 
detect flow within myopic CNV vascular complexes and hence delineates vascu-
lar networks in these myopic neovascular membranes that lie above the RPE 
where flow signals are spared from attenuation [38]. On OCTA, CNV shape 
could be described as circular or irregular, margins could be well defined or 
poorly defined and appearance could be interlacing or tangled/disorganized vas-
cular loops. In eyes with active myopic CNV lesions, the OCTA appearance is 
primarily interlacing, while inactive CNV neovascular networks appear primar-
ily tangled [39–41]. OCTA is also able to clearly visualize the choriocapillaris in 
myopic eyes, with varying loss of choriocapillaris depending on the extent of 
myopic maculopathy and the presence of lacquer cracks [42, 43]. Although sen-
sitivity and specificity compared to FFA as gold standard have not been fully 
evaluated for the diagnosis of myopic CNV, it is felt that OCTA may reduce the 
need for FFA if CNV is clearly visualized on OCTA at the commencement of 
anti-VEGF therapy. However, there remain limitations concerning OCTA: It is 
currently still unable to provide information on the disease activity as flow sig-
nals can persist in an inactive myopic CNV [39–41]. Therefore, activity assess-
ment should be evaluated with clinical examination and multi-modal imaging, 
including structural OCT with or without FA. Motion or image artifacts and seg-
mentation errors may further complicate its interpretation. Therefore, it is still 
recommended to complement SD-OCT and FFA to increase diagnostic accuracy 
and monitoring of the disease activity.
The imaging features of various stages of myopic CNV are summarized in 
Table 13.2.
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13.7  Differential Diagnosis
There are several differential diagnoses that must be excluded from myopic CNV.
13.7.1  Macular Hemorrhage Secondary to Lacquer Cracks (Fig. 13.2)
In individuals with macular hemorrhage, it is critical to differentiate eyes with myo-
pic CNV from those with simple hemorrhage associated with lacquer cracks (Fuch’s 
hemorrhage). Eyes with Fuch’s hemorrhage secondary to lacquer cracks tend to 
have better prognosis than myopic CNV and do not require anti-VEGF therapy [44]. 
In cases with thick blood, the myopic CNV may not be visible even in FA or OCTA 
due to masking. In these cases, late phases of ICGA will be able to visualize the 
myopic CNV if it is present [20].
13.7.2  Inflammatory CNV
Punctate inner choroidopathy (PIC) with or without secondary CNV may present 
with OCT appearance similar to that of myopic CNV. The clinical manifestation 
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of punctate inner choroidopathy differs from myopic CNV, with characteristic 
creamy yellow-white lesions located at the RPE and inner choroid. A prospective 
series revealed that PIC lesions go through a five-stage evolution process with 
differing SD-OCT findings at each stage: choroidal infiltration (stage I: mostly 
normal but can present with hyper-reflective fine spots within the outer nuclear 
layer), formation of sub-RPE nodules (stage II: focal elevation of RPE with cor-
responding ellipsoid zone disruption), chorioretinal nodules (stage III: nodule that 
breaks through the RPE and progresses towards and replaces the photoreceptor 
layer that eventually domes the outer plexiform layer (OPL)), regression (stage 
IV: noted to begin from the apex towards the choroid and with herniation of the 
OPL and inner retina through the RPE break) and retinal herniation (stage V: sag-
ging of the OPL and inner retina with loss of photoreceptor layer and RPE prolif-
eration that relieves the retinal hernia) [45]. Of these various stages, only stage III 
may ostensibly be misdiagnosed as myopic CNV. The use of OCTA and its ability 
to identify vascular network can be particularly useful in this instance to distin-
guish myopic CNV from PIC as inflammatory lesions do not manifest vascular 
flow signals [46]. Unlike myopic CNV, the late phases of ICGA would reveal 




Fig. 13.2 A 51-year-old highly myopic male with lacquer crack hemorrhage. (a) Fundus photo 
shows a red spot suggestive of subretinal hemorrhage (white arrow). (b) Optical coherence tomo-
graphic scan shows a separation between the RPE and the underlying Bruch’s membrane in the 
subfoveal position (white arrow head), with hyper-reflectivity in the subretinal space (white arrow) 
corresponding to the area of subretinal hemorrhage. Optical coherence tomographic angiography 
of the region of interest (c) shows no flow signals suggestive of choroidal neovascularization in the 
outer retinal slab (d) or the choriocapillaris slab (e)
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13.7.3  Dome-Shaped Maculopathy with Serous Detachment
Dome-shaped maculopathy (DSM) is characterized by an inward bulge within the 
chorioretinal posterior concavity of the eye in the macular area [48, 49]. Serous 
foveal detachment is a complication of DSM that has been postulated to be related 
to the abnormal curvature of the macula [50]. On FFA, DSM with serous retinal 
detachment can be distinguished from myopic CNV where it may be associated 
with pinpoint leakage. On ICGA, it presents as punctate hypercyanescent spots 
[51]. The absence of macular hemorrhage, with the characteristic dome- shaped pro-
file of the macula visualized on OCT, and the leakage of dye in later frames help 
differentiate this entity from myopic CNV.
13.8  Management
13.8.1  Anti-Vascular Endothelial Growth Factor Drugs
Prior to the advent of anti-VEGF therapy, the main treatment options for myopic 
CNV were limited to thermal laser photocoagulation [52] and photodynamic ther-
apy with verteporfin (vPDT) [53, 54]. These treatments had limited efficacy in 
improving vision significantly and have now largely been relegated to the annals of 
history by the anti-vascular endothelial growth factor (anti-VEGF) therapy [55].
13.9  Ranibizumab
Ranibizumab is a Fab fragment of humanized monoclonal antibody against all iso-
forms of VEGF-A, and it was the first anti-VEGF agent to be FDA approved for the 
treatment of myopic CNV. The strongest evidence of anti-VEGF use for myopic 
CNV comes from two large multi-centered, double-masked, randomized, controlled 
clinical trials [56, 57]. The RADIANCE study (n = 277) was a 12-month, phase III, 
randomized, double-masked, multicenter study comparing the efficacy and safety of 
intravitreal ranibizumab 0.5 mg versus vPDT in patients with myopic CNV [56]. 
This trial demonstrated the superiority of ranibizumab 0.5 mg, with a mean visual 
acuity gain of 10.5–10.6 letters compared to 2.2 letters with vPDT at 3 months and 
maintained through 12 months. The study further compared two retreatment proto-
cols and showed that the disease activity guided retreatment based on OCT could 
achieve similar visual outcomes with a lower median number of injections (2.0) 
compared to retreatment according to visual acuity stabilization (4.0 injections). 
The RADIANCE study confirmed the results of the REPAIR trial, a phase II pro-
spective, open-label, multicenter study of intravitreal ranibizumab 0.5 mg in myo-
pic CNV in 65 eyes. In this study, a mean visual gain of 13.8 letters was achieved 
with a mean of 3.6 ranibizumab injections over 12  months in a cohort of 
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treatment-naïve patients with myopic CNV [58]. These trials were performed in 
predominantly Caucasian populations. To support the use of ranibizumab for Asian 
patients with myopic CNV, the BRILLIANCE study was conducted with a design 
similar to the RADIANCE study. This was a 12-month, double-masked trial in 
which study participants with myopic CNV were randomized into one of three 
treatment groups: ranibizumab guided by visual acuity stabilization criteria (group 
1, n = 182), ranibizumab guided by disease activity (group 2, n = 184) and vPDT 
followed by ranibizumab/vPDT/both treatments at month 3, guided by the disease 
activity (group 3, n = 91) [55]. Findings from the BRILLIANCE study corroborated 
with those from the RADIANCE study. Both ranibizumab arms experienced signifi-
cantly better visual acuity gains at 3 months compared to the vPDT arm (Group I/
II: +9.5/+9.8 letters vs. Group III: +4.5 letters; both P < 0.001), and ranibizumab 
treatment guided by disease activity was noninferior to treatment guided by visual 
acuity stabilization, achieving similar visual acuity outcomes with a median of three 
and four injections over 12 months, respectively. These results confirmed the effi-
cacy of ranibizumab for the treatment of myopic CNV in Asian patients.
In a large post-marketing surveillance study of ranibizumab for the treatment of 
Japanese patients with myopic CNV (n = 318) over a 12-month observation period, 
ranibizumab was found to be safe (incidence of 0.6% and 0.3% of adverse drug 
reactions and serious adverse events, respectively) and effective with a low number 
of injections needed for the therapeutic effect (median injection number of 1 and 
52.2% requiring only 1 injection) [59].
13.10  Aflibercept
Aflibercept is a recombinant human fusion protein that acts as a soluble decoy 
receptor for VEGF family members VEGF-A, VEGF-B and placental growth factor, 
preventing these ligands from binding to, and activating, their receptors. The 
MYRROR trial was a 48-week, phase III, multicenter, randomized, double-masked, 
sham-controlled study investigating the efficacy and safety of intravitreal afliber-
cept 2 mg for the treatment of myopic CNV [57]. Patients treated with intravitreal 
aflibercept (n = 91) achieved a mean visual gain of 12 letters compared to a 2-letter 
loss in the sham group (n = 31). The mean number of injections was low in this 
study (4.2 injections over 48 weeks). Significant improvement in the quality of life 
(National Eye Institute Visual Function Questionnaire 25 and EuroQol-5 Dimension 
score) was also demonstrated in patients treated with aflibercept.
13.11  Bevacizumab
Bevacizumab was the first angiogenesis inhibitor to be approved for clinical use, 
initially for the treatment of metastatic colorectal cancer. Since then, it has been 
used as an open-label drug and a lower cost option for the treatment of choroidal 
neovascularization, including myopic CNV.  There is a lack of randomized 
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controlled trials assessing the efficacy of bevacizumab in the treatment of myopic 
CNV, but many clinical case series have reported significant visual gains ranging 
from 5 to 20 letters with the open-label use of bevacizumab [60–64]. Long-term 
studies have also demonstrated maintenance of visual gains for up to 4 years after 
the initial treatment [52, 65].
13.12  Conbercept
Conbercept is a recombinant fusion protein containing the second Ig-like domain of 
VEGFR-1, the third and fourth Ig-like domains of VEGFR-2 and a human IgG Fc 
fragment, with binding affinity to VEGF and placental growth factor (PIGF) [66]. 
There are no prospective interventional trials on the use of conbercept for myopic 
CNV.  Yan et  al. performed a retrospective analysis of 42 consecutive eyes with 
myopic CNV treated with three loading doses of conbercept at monthly intervals, 
followed by as-needed injections based on monthly follow-up visits till month 12. 
BCVA improved from 0.67 logMAR at baseline to 0.32 at 12 months, with 71.4% 
achieving three lines or more improvement at final follow- up with a mean of 3.76 
injections [67].
13.13  Factors Related to Treatment Outcomes
As previously mentioned, older age, subfoveal location of CNV, larger lesion size 
and poorer presenting visual acuity are poor prognostic factors for myopic CNV [8, 
25, 68]. In addition, subretinal hemorrhage, duration of CNV and previous photody-
namic therapy were found to confer a poorer prognosis after treatment [68]. 
Similarly, older age, larger CNV size and greater central macular thickness were 
factors associated with the need for retreatment [69–71]. Thinner choroid and lac-
quer cracks were also found to be associated with the need for a higher number of 
intravitreal injections [71].
The presence of vitreomacular abnormalities, in particular epiretinal membrane 
(ERM), is common in high myopes. ERM often coexists with myopic CNV. The 
presence of ERM has been shown to hamper visual gains after treatment of myopic 
CNV with ranibizumab compared to eyes without ERM (visual stabilization from a 
baseline of 0.3–0.4 compared to improvement from 0.3 to 0.1, p = 0.008). The coex-
istence of ERM with myopic CNV neither influenced the median number of injec-
tions (3) nor the reduction in central foveal thickness [72]. As regards the myopic 
macular retinoschisis (MRS), a post hoc analysis of the RADIANCE trial showed 
that eyes with MRS received more injections (5.8 ± 2.1 vs 4.0 ± 2.9; P = 0.0001), 
had slower visual gain at 3 months (+2.8 letters vs +12.3 letters) and poorer visual 
outcomes at 12 months (+7.1 letters vs +14.4 letters) than eyes without MRS [73]. 
Post hoc analysis further evaluated whether baseline myopic macular degeneration 
(MMD) influenced the treatment outcomes in 115 eyes. Change in BCVA from 
baseline to week 48 was not significantly different between eyes with mild MMD 
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(META-PM category 1–2) and eyes with severe MMD (META-PM category 1–2) 
(+13.5 letters vs +12.4 letters, p = 0.83), and were achieved with a similar number 
of injections (3.9 vs 5.4, p = 0.23) [74].
13.14  Recurrence
The recurrence rate of myopic CNV is generally low, with most recurrences occur-
ring during the first year. Yang et al. reported a recurrence rate of 23.3% in a retro-
spective series of 103 eyes of 89 consecutive patients with subfoveal myopic CNV, 
followed over 2 years. 72.7% of recurrences occurred in the first year of treatment. 
Baseline CNV size was found to be a significant prognostic factor for recurrence on 
multivariate analysis [71]. In the post-RADIANCE observation study (12–
48 months), only 10% of eyes experienced a recurrence [75]. These findings rein-
force the importance of monitoring for recurrences in the first year of treatment.
13.15  Treatment Regimen and Follow-Up
Once active myopic CNV is diagnosed, prompt treatment with intravitreal anti- 
VEGF therapy should be administered as soon as possible [56, 58]. Current evi-
dence suggests that a pro re nata (PRN) regimen without a loading phase can be 
considered in most patients. Patients should be monitored monthly with OCT and 
treatment administered until cessation of the disease activity on OCT or visual sta-
bilization. FA may be performed to confirm inactive disease before stopping treat-
ment, especially if there are uncertainties regarding activity based on OCT. Thereafter, 
review can be progressively lengthened on an individualized basis if no further 
activity is observed in the first year to monitor for recurrence or development of 
myopic CNV in the fellow eye. After the first year of treatment, patients without 
recurrence can have their visit interval prolonged to 6 months. Patients should be 
advised to return if vision drops or metamorphopsia recurs [3].
13.16  Long-Term Outcomes
Although anti-VEGF therapy for myopic CNV has demonstrated remarkable 
short- and mid-term efficacy, longer term visual outcomes are generally less 
favorable, with most studies reporting a gradual decline back to baseline visual 
acuity [60, 61, 75–79]. Onishi et al. reported the 5-year outcomes of 51 patients 
who received treatment with ranibizumab for myopic CNV. Mean baseline BCVA 
(0.38 logMAR) was significantly improved at 1 year (0.27 logMAR) but not in the 
subsequent years (0.31, 0.35 and 0.32 logMAR at 2, 4 and 5 years, respectively). 
Sarao et al. reported similar findings in a prospective interventional study with 
mean BCVA improvement of −0.13 at 24 months in 101 eyes with myopic CNV 
treated with bevacizumab and an increase in the area of chorioretinal atrophy in 
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the same period [61]. In contrast, the long-term visual outcomes of 41 patients 
who had completed the RADIANCE trial were shown to be sustained up to 48 
months post initiation of treatment. Mean visual gain from baseline (56.5 ± 12.1 
letters) was significant up to 48 months (+16.3 ± 18.7, n = 16, p = 0.0034). Of the 
16 patients who completed 48 months of follow-up, 63% gained ≥10 letters and 
13% lost ≥10 letters. Over the post-RADIANCE observation period (months 
12–48), 83% of patients required no further treatment and 10% experienced recur-
rences [75].
Similar results were reported in Caucasian patients with myopic CNV (n = 40) 
treated with intravitreal ranibizumab: baseline visual acuity improved from 55.4 
letters to 63.4 letters at 3 years (p = 0.039) and 35% gained 15 letters or more at the 
final follow-up, achieved with a mean of 4.1 injections in the first year, 2.4 in the 
second year and 1.1  in the third year [76]. A longer term follow-up study in 
Caucasian eyes treated with bevacizumab or ranibizumab found that visual gains 
could be maintained at 3 (+9.0 letters, n = 52), 4 (+9.0 letters, n = 28) and 5 years 
(+9.8 letters, n  =  13) [77]. A 5-year outcome study by the PAN-American 
Collaborative Retina Study Group with intravitreal bevacizumab (n = 33) reported 
a significant decline in visual acuity from 0.65 ± 0.33 logMAR at baseline to 
0.73 ± 0.50 logMAR units at final follow-up (p = 0.003) [80].
In the longest follow-up study to date, Pastore et al. reported on the visual out-
comes of 17 eyes with myopic CNV, treated with ranibizumab according to a strict 
pro re nata regimen over 9 years. Mean visual acuity was significantly improved 
from baseline (56.2 ± 13.5 letters) at 1 (69.7 ± 12.2 letters) and 2 years (69.9 ± 12.8 
letters) post treatment initiation, but gradually receded towards baseline at 9 years 
(57.4 ± 17.7 letters). Only 11.8% of eyes lost 3 lines or more, while 17.7% main-
tained 3 lines or more gain in vision at 9 years, achieved with a mean of 1.24 ± 1.70 
injections per year (range 2–25) [78]. Despite a loss of visual gains, these results 
demonstrate a considerably superior visual prognosis for patients with myopic CNV 
than patients with CNV secondary to age-related macular degeneration over the 
long term [81, 82].
Myopic CNV-related chorioretinal atrophy (CRA) is the major culprit for the loss 
of visual gain over the long term. Ohno Matsui et al. found that the macular atrophy 
developing after myopic CNV may be related to rupture of Bruch’s membrane. This 
defect in Bruch’s membrane may continue to expand in spite of adequate treatment 
of myopic CNV, leading to macular atrophy and loss of vision [16]. This point was 
demonstrated in a 5-year outcome study of eyes with myopic CNV treated with intra-
vitreal ranibizumab (n = 51), in which visual stability was achieved (baseline best 
corrected visual acuity 20/49 compared to 20/42) at 5 years, where good visual out-
come was shown to be significantly associated with a lack of enlargement of CNV-
related macular atrophy, in addition to better baseline visual acuity and a lower 
number of injections [79]. These outcomes were achieved with a mean of 1.6 injec-
tions over 5 years, and two-thirds received only 1 injection. Another study by Ohno 
Matsui’s group observed similar findings in patients treated with bevacizumab 
(n = 36). Visual acuity improved significantly from a baseline of 0.5 logMAR to 0.31 
and 0.39 at years 2 and 4, respectively, but not at 6 years (0.45), achieved with a mean 
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of 1.78 injections. Again, visual outcomes at 6 years were correlated with the size of 
CNV-related macular atrophy, as well as baseline visual acuity and CNV size. 
Further, in a long-term (mean follow-up 80.6 ± 28.0 months) retrospective review of 
54 eyes with myopic CNV treated with photodynamic therapy and/or intravitreal 
ranibizumab and eyes with myopic maculopathy alone, the progression of macular 
atrophy was significantly greater in myopic CNV eyes compared to the eyes with 
only myopic maculopathy. The risk of progression was related to age, degree of 
myopia and presence of staphyloma, but not the type of treatment [83].
13.17  Conclusions
Myopic CNV is a sight-threatening complication of pathologic myopia that, fortu-
nately, has an effective treatment in the form of anti-VEGF injections. Early detec-
tion, accurate diagnosis with multimodal imaging, early initiation of treatment, and 
careful post-treatment monitoring are key to achieving good treatment outcomes. 
Although FFA and OCT remain the gold standard for diagnosis, OCTA is emerging 
as a good adjunct imaging modality to screen for the presence of neovascular net-
works in patients with suspected myopic CNV. Anti-VEGF therapy has been shown 
to be efficacious and safe with a low treatment burden. Finally, long-term visual 
outcomes remain less favorable, largely due to the development of chorioretinal 
atrophy around the regressed CNV. Therapeutic strategies to prevent the enlarge-
ment of CNV-related atrophy should form the focus of future research for the treat-
ment of myopic CNV.
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14Optical Interventions for Myopia Control
Wing Chun Tang, Myra Leung, Angel C. K. Wong, 
Chi-ho To, and Carly S. Y. Lam
Key Points
• Optical intervention for myopia control can slow down myopia progres-
sion by 50–60%.
• Simultaneous myopic defocus and refractive error correction have been 
proved to be effective in myopia control.
• Different myopia control methods and their pros and cons aid clinicians to 
select the best treatment for patients.
14.1  Introduction
A variety of clinical methods are currently utilized for retarding myopia progres-
sion. However, none of the methods have been proven to cease the development or 
progression of myopia completely and they may not work for some individuals. As 
described in previous chapters, the main clinical interventions for myopia control 
currently include optical lenses, pharmaceutical agents and outdoor activities. This 
chapter provides an overview of the various types of optical interventions for slow-
ing down myopia progression. The findings of the clinical trials of these methods 
are summarized and the relative effectiveness of these methods in myopia control is 
compared. In general, the optical methods for myopia control in children can be 
summarized into two categories: spectacle lenses and contact lenses.
The original version of this chapter was revised. A correction to this chapter can be found at 
https://doi.org/10.1007/978-981-13-8491-2_15.
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14.2  Spectacle Lenses
14.2.1  Under-Correction of Myopia
Studies using animals, such as chicks and mammals, have shown that the use of 
optical lenses to impose myopic defocus inhibits myopic eye growth in developing 
eyes [1–5]. These studies have led to the hypothesis that under-correction of myo-
pia, that is, prescribing spectacles for distance vision that does not fully correct the 
myopic refraction, may be a viable method for slowing myopia progression in 
humans. As near work and accommodation were proposed as key factors for the 
development and progression of myopia, in theory, under-correction could reduce 
accommodative demand during near viewing, thereby halting the myopia progres-
sion of myopia.
Contrary to the animal studies, two clinical trial studies showed that under- 
correction actually accelerates myopia development and progression in myopic 
humans [6, 7]. In a randomized study by Chung et al. [6], children in the experimen-
tal group were assigned to wear spectacle lenses that were under corrected by 0.50–
0.75 D to achieve distance visual acuity of 6/12, while children in the control group 
were prescribed their full correction. After 2 years, the under-correction group had 
greater myopia progression of −1.00 D as compared to the control group who pro-
gressed by −0.77 D. A retrospective study investigating clinical data from a private 
optometric practice also found that under-correction resulted in greater myopia pro-
gression compared to full correction [7].
One recent study in Beijing reported that children with no spectacle correction 
had slower myopia progression and less axial elongation than those given a full 
spectacle correction over 2 years [8]. In this study, myopia progression decreased 
significantly with an increasing amount of under-correction, but the effect on slow-
ing myopia progression was slowed by only 0.27 D over 2 years, which is not clini-
cally meaningful. In view of these conflicting results, there is no convincing 
evidence to indicate that under-correction should be used for slowing myopia pro-
gression in children.
14.2.2  Bifocal or Multifocal Spectacles
Over the past decades, numerous studies have assessed the effect of bifocal, multi-
focal, and progressive addition lens (PALs) spectacles on myopia progression. 
Table 14.1 summarizes the clinical trials of using the different spectacle lens types. 
Bifocals and PALs allow the wearers to clearly see objects in the distance through 
the upper part of the glasses by providing correction of distance refractive error. The 
bottom part of the lens consists of an addition power that may retard myopia pro-
gression by reducing accommodative effort and lag at near in a similar way as 
under-correction.
The majority of these studies have shown that PALs have an insignificant effect 
on slowing myopia progression rate (less than 0.2 D per year) overall (Table 14.1) 
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[9–14]. Some myopic children with esophoria and accommodative lag may benefit 
from PALs, but the retardation effect is not clinically significant.
For bifocal spectacles, an early randomized trial performed by Fulk et al. [15] 
found that bifocals with +1.5 D add slowed myopia progression by 20% in the chil-
dren with esophoria. The clinical trial by Cheng et al. [16] found that both executive 
top bifocals with and without 3Δ base-in prism have shown a more meaningful 
myopia control effect in a selected group of fast progressing myopic children when 
compared with single vision spectacles. The myopia progression rate was reduced 
by approximately 40–50% over 3  years, with the effect being more prominent 
among those with low accommodative lag. The inclusion of base-in prism in the 
experimental lenses was an attempt to reduce fusional vergence demand to enhance 
the treatment effects of the bifocals. A positive effect of myopia control was exhib-
ited as changes in spherical equivalent refraction in the study. Axial length changes 
were similar between those with and without base-in prism in their bifocals; it is 
rather unclear whether there is a benefit in having base-in prism in the bifocal lens. 
This option may also not be preferable for some children having anisometropia, and 
it results in poor cosmesis.
Another hypothesis is that the correction or reduction of relative peripheral 
hyperopia may have an effect on myopia progression [17, 18]. Sankaridurg et al. 
[17] performed a clinical trial to test this hypothesis by using three custom-
designed spectacle lenses that reduced peripheral hyperopic defocus while main-
taining clear central vision. After 12 months of lens wear, no significant reduction 
in myopia progression was found between the treatment groups and the control 
group. Only one type of the treatment lenses showed 30% reduction of myopia 
progression in a subgroup of the children whose parents were myopes. A similar 
clinical trial in soft contact lens [18], based on the same hypothesis, exhibited 
meaningful effects and will be discussed later in the section on soft multifocal 
contact lenses.
More recently, a specially designed bifocal spectacle lens, called Defocus 
Incorporated Multiple Segments (DIMS) spectacle lens (also known as multiseg-
ment of myopic defocus (MSMD) spectacle lens), has been used for myopia con-
trol in a randomized trial by Lam et al. [19]. DIMS lens design is based on the 
principle of simultaneous vision with myopia defocus for myopia control where it 
comprises a central optical zone for correcting refractive error and multiple seg-
ments of constant myopic defocus (+3.50 D) surrounding the central zone. This 
enables the lens to provide clear vision and myopic defocus simultaneously for 
wearers regardless of whether they are looking at distance, intermediate or near 
objects. The results from the clinical trial showed that the children wearing DIMS 
lenses had 52% less myopia progression and 62% less axial elongation when com-
pared with children wearing single vision spectacle lenses over 2 years. Moreover, 
about 20% of the DIMS lens wearers had no myopia progression during the study 
period. Further studies in other study populations are required to validate these 
promising results.
Figure 14.1 presents a comparison of the percentage myopia progression that 
slowed down from PALs, bifocals, and prismatic bifocals use as well as other types 
of multiple spectacle lenses [9–16].
W. C. Tang et al.
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14.3  Contact Lenses
14.3.1  Rigid Gas Permeable Contact Lenses
Several studies in the later part of the twentieth century investigated whether day-
time wear of rigid gas permeable (RGP) contact lenses slowed myopia progression, 
but all those studies had various limitations in their study designs, such as subject 
criteria outside the expected age of progression, lack of randomization, and unequal 
loss to follow-up [20–22]. Two randomized clinical trials [23, 24] showed that RGP 
contact lenses did not retard axial eye growth. However, Walline et al. [23] reported 
significant slower myopia progression in the group of RGP lenses compared with 
soft contact lenses. Despite that no differences were found in axial elongation 
between the groups. The proposed reason for a treatment effect on the refractions 
may be due to the changes in corneal curvature. As wear of RGP contact lenses is 
likely to induce only temporary changes in corneal curvature, the retardation of 
myopia progression may be transient. Therefore, the authors concluded that RGP 
lens wear does not slow myopia progression.
14.3.2  Orthokeratology
Orthokeratology (Ortho-K) lenses are specially designed RGP contact lenses that 
are worn overnight to reshape the cornea and thereby temporarily correct low to 
Fulk (2000)
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Fig. 14.1 The effect on slowing of myopia progression, in terms of percentage within the study 
period (effect %) and diopter per year (D/year), reported by various controlled clinical studies using 
bifocal or multifocal spectacles. The bars represent effect % using bifocals (gray), progressive addition 
lenses (blue) and other types of multifocal spectacle lenses (yellow). The value of effect % is indicated 
in the bar. The dotted line represents treatment effect in D/year (B bifocals, PB prismatic bifocals)
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moderate myopia. It has become a popular modality for controlling myopia in chil-
dren in the last few decades. In addition to the enhancement of unaided vision at 
daytime, Ortho-K is also able to control myopia progression.
Modern Ortho-K lens designs include four zones, namely the central optic zone, the 
reverse zone, the alignment zone and the peripheral zone [25, 26]. The central optic 
zone helps to flatten the central cornea and is used for refractive correction. The reverse 
zone, which has a steeper curvature than the central zone, enhances the corneal reshap-
ing to maximize the myopic reduction. The alignment zone, usually aspherical or tan-
gent, plays a very important role in optimizing the lens centration, while the peripheral 
curve promotes tear exchange. Apart from spherical designs, toric lenses are also avail-
able commercially and are recommended for use in patients with more than 1.50 D 
astigmatism. Fitting of Ortho-K is simple nowadays with manufacturers providing trial 
lens sets or computer software that directly calculates the most suitable and precise 
parameters based on the corneal topography. Although many different Ortho-K lens 
designs are available on the market, Tahhan et al. [27] found no significant variation on 
the clinical efficacy between the different lens designs.
The main hypothesis of myopia control using Ortho-K is the introduction of 
myopic defocus on the peripheral retina [27]. It is proposed that after Ortho-K treat-
ment, the corneal shape changes to an oblate shape, which results in a peripheral 
refraction that has less hyperopic defocus [28]. Another hypothesis of the mecha-
nism behind the myopia control effect of Ortho-K is that the changes in lag of 
accommodation may be due to increasing positive spherical aberration and changes 
in choroidal thickness [29, 30]. It seems that further investigation is required in 
order to determine the actual mechanism for the efficacy of Ortho-K.
Various clinical studies have demonstrated the effectiveness of inhibiting myopic 
progression with Ortho-K.  Table  14.2 summarizes recent clinical trials using 
Ortho-K for myopia control in children. The effect of slowing axial length elonga-
tion ranges from 32% to 63% [31–38]. The overall treatment effect is around 50%. 
Figure 14.2 shows a comparison of the effect on retarding axial elongation using 
Ortho-K among different studies [31–37].
A recent study by Swabrick et al. [39] used a contralateral eye cross-over study 
design to investigate the effects of Ortho-K on axial length growth over 1 year. The 
results revealed that there were no changes in axial length at each 6-month phase of 
Ortho-K wear, while significant increases in axial length were found in the control 
group who wore daytime gas permeable lenses.
To the best of our knowledge, there is no research investigating the maximum 
power of myopia reduction with overnight Ortho-K, and most studies use −4.00 D 
as the exclusion criteria. Charm et  al. investigated the myopic control effect of 
Ortho-K by partial reduction to the power of −4.00 D as the target in children with 
high myopia (spherical equivalent refraction at least −5.75 D and myopia ≥−5.00 D). 
The remaining refractive error was corrected by single vision spectacles. The myo-
pia control effect was comparable to other studies of Ortho-K in low–moderate 
myopic subjects over 2 years [37]. As the risk of having corneal staining and lens 
decentration increases with the amount of myopia correction [39], partial reduction 
of myopia might be a better option in high myopes instead of the full correction.


































































































Fig. 14.2 Effect on slowing axial elongation reported by various studies using orthokeratology. 
The bar represents the treatment effect within the study period in terms of percentage (%) as com-
pared to controls. The dotted line represents reduction in changes of axial length per year (mm/
year)
Table 14.2 Myopia control studies using Ortho-K lenses
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SV single vision spectacle lens, SVCL single vision soft contact lens
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Although Ortho-K is useful for myopic control in numerous studies, all the 
results were reported as an average value. Lipson et  al [26] evaluated the axial 
length change over 3 years in children receiving Ortho-K treatment. Around 65% of 
the children had 0.5 mm or less axial elongation, while axial eye growth of more 
than 1.0 mm was seen in 15% of the children. Hence, the myopic control effect of 
Ortho-K lenses shows a large variation among individuals. Some researchers 
believed that the age at which Ortho-K is started, baseline myopia, cornea profile, 
and pupil size may be possible factors affecting the effectiveness of myopic control 
among Ortho-K wearers [26, 31, 34, 35, 40].
Interestingly, a recent study in Japan [41] showed that the combination of Ortho-K 
and low-concentration atropine (0.01%) eye drops was more effective in slowing 
axial elongation over 12 months than Ortho-K treatment alone in myopic children. 
More research is needed to show if this effect can be sustained in the longer term.
Although hypoxic reactions are rarely seen with Ortho-K wear due to the use of 
highly oxygen permeable materials, the need to wear contact lenses overnight may 
remain a concern for clinicians, as this type of lens wear pattern is associated with 
a higher risk of infectious keratitis [42–44]. A review of 50 cases of microbial kera-
titis done by Watt and Swarbrick [44] revealed that the majority of microbial kera-
titis cases are related to contamination of lenses due to patient non-compliance, 
such as improper lens handling or cleaning. A detailed systematic review on the 
safety of Ortho-K wear by Liu and Xie [45] also suggested that the training of prac-
titioners and wearers, appropriate fitting procedures, compliance to lens care regi-
mens and follow-up schedule are all factors affecting the incidence of microbial 
keratitis. A recent retrospective study compared the adverse events in Ortho-K 
wearers versus soft contact lens wearers over a 10-year period. The number of cor-
neal complications such as keratitis and infiltrates were found to be significantly 
higher in the Ortho-K group, but no infectious keratitis was reported [46]. Bullimore 
et al. [47] found that there was no significant difference in the risk of getting micro-
bial keratitis with Ortho-K wear compared to other overnight contact lens wear. 
This shows that with appropriate fitting and lens care, Ortho-K is a safe myopic 
control method. However, practitioners should always emphasize the importance of 
patient compliance, especially in lens care and follow-up visits, to reduce the risk of 
microbial keratitis [45].
Corneal staining is the most common complication in Ortho-K treatment. Studies 
confirmed the frequency and severity of staining associated with overnight lens 
wear [44]. Lens binding is one of the causes of creating central staining. Optimizing 
lens fitting, adding fenestration on lens and using artificial tears before lens removal 
could reduce the possibility of lens adhesion. Clinicians should be cautious if per-
sistent or recurrent corneal staining is observed.
14.3.3  Soft Bifocal and Multifocal Contact Lenses
Soft contact lenses in the form of bifocal and multifocal have been designed to slow 
myopia progression in children, and there has been a rising interest in this area over 
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the recent decade. These lenses are worn during the daytime. Compared to specta-
cles, contact lenses are more cosmetically acceptable and are more convenient for 
daily activities of some children, especially during sports activities [48, 49]. Also, 
they are generally able to be competently handled and worn by children [48]. For 
most of eye care practitioners, the fitting procedures of soft bifocal contact lenses 
are relatively simpler than those of Ortho-K.
Table 14.3 and Fig. 14.3 summarize recent clinical trials using soft bifocal con-
tact lenses for myopia control [18, 50–56]. Generally, two main approaches are 
employed for the design of soft contact lenses for myopia control. Both lens designs 
incorporate a central distance zone to correct myopia. One design manipulates the 
peripheral lens curvature in order to lower peripheral hyperopic defocus. The other 
design uses concentric rings of alternating myopia defocus using addition (plus) 
powers and myopia correction powers in the periphery. This design is sometimes 
called ‘dual power or dual focus’ contact lenses in the literature. Both approaches 
allow the lens wearers to have good vision in their daily life and receive therapeutic 
optical defocus at the same time.
Several lens types, with a design to reduce peripheral hyperopia, have been 
reported to be promising in retarding myopia progression. Examples include a lens 
type used in a study by Sankaridurg et al. [18] and a multifocal contact lens used in 
a study by Walline et al. [50]. The former was reported to retard myopia progression 
by 34% over 1 year and the latter by 50% over 2 years. Paune et al. [51] carried out 
a study using ‘soft radial refractive gradient’ (SRRG) contact lens, which corrects 
the central refraction while producing peripheral myopic defocus that increases 
gradually from the central optical axis towards the periphery. After 2 years, children 
wearing the SRRG contact lens had retardation in myopia progression by 43%. 
Cheng et al. [52] developed a soft contact lens for myopia control that included a 
positive spherical aberration (+SA) in the optical design to shift retinal hyperopic 
defocus in the opposite direction, resulting in the reduction of relative peripheral 
hyperopia. The greatest effect of myopia control (56%) was observed during the 
first 6 months, and it decreased greatly to 20% by 12 months. The overall treatment 
effects of these contact lenses were better than ophthalmic lenses that used a similar 
approach [17]. This may be due to the soft contact lenses moving with the eye, and 
hence the optical correction remains centered for all viewing gazes.
Anstice and Phillips [53] investigated the use of a concentric bifocal power (also 
called dual-focus or dual power) soft contact lens with 2D of myopic defocus in 
retarding myopia progression in children. Children participating in their study were 
randomly assigned to wear the treatment lens in one eye and an ordinary single 
vision contact lens in the fellow eye for 10  months. The lens types were then 
switched between the eyes and the lenses were worn for another 10 months. On 
average, the eyes with the bifocal contact lenses showed about 45% less myopia 
progression than the eyes with single vision contact lenses. Several randomized 
clinical trials showed that concentric bifocal contact lenses exhibited meaningful 
effects on myopia control. Lam et  al. [54] reported that the use of Defocus 
Incorporated Soft Contact (DISC) lens for at least 7 hours a day resulted in more 
effective myopia control, reaching nearly 60% reduction in myopia progression and 
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axial length growth. The amount of myopic defocus used in the DISC lens was 
2.50 D. Two more recent studies have indicated that a Dual-Focus 1-Day soft con-
tact lens using 2D of myopic defocus also slows myopia progression in children. 
The multicenter study by Chamberlain et al. [55] has shown that the Dual-Focus 
1-Day soft contact lens slows myopic progression and axial elongation in children 
by 59% and 52%, respectively, over 3  years. However, another study in Spain 
showed less myopia control effect, 39% and 36% in terms of refractive changes and 
axial growth, respectively [56]. A study by Aller et al. [57] reported the most prom-
ising effect of 70% with another type of bifocal soft contact lenses, but this was seen 
only for the children with eso fixation disparities at near.
Among the optical interventions for myopia control, Ortho-K lenses (45%), soft 
bifocal contact lenses (50%), prismatic bifocals (50%) and the very recent DIMS 
spectacle lenses (52%) have shown clinically significant treatment effects. However, 
the treatment effect of these methods is still inferior to that of pharmaceutical eye 
drops. The average reduction in myopia progression using regular dose (1%) of 
atropine is approximately 70% or above [58, 59]. Yet, the associated side effects, 
such as blurring of near vision, light sensitivity and possible allergic reactions and 
post-treatment rebound effects [58, 59], will be obstacles for the widespread appli-
cation of atropine 1% in clinical practice. Lower doses of atropine (such as 0.5%, 
0.02%, 0.01%) have been found to have minimal side effects, but long-term safety 
is unclear [60–62]. Atropine 0.01% has been found to have the least side effects 
with good myopia control and least rebound effects [61, 62]. However, optical treat-
ment regimens are less invasive than those by pharmacological treatment and have 
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Fig. 14.3 Comparison of the treatment effect on slowing myopia progression among the studies 
using soft bifocal and multifocal contact lenses. The bar represents treatment effect within the 
study period in terms of percentage as compared with controls. The dotted line represents reduc-
tion of myopia progression per year (D/year)
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14.4  Others: Outdoor Activities and Violet Light  
Transmitting Lenses
Recent epidemiological studies have found that children who spend more time out-
doors during daytime are less likely to become myopic and have less myopia pro-
gression, regardless of the amount of near work duration and parental history of 
myopia [63–65]. Some evidence for this relationship has been shown in young 
adults [63]. Outdoor time also appears to reduce the risk of myopia development in 
schoolchildren. A longitudinal study conducted in Taiwan found that children in a 
primary school who were encouraged to have outdoor activities during recess (out-
door group) were less likely to have myopia after a year compared to children in 
other schools who continued their normal recess routine (the control group) [64]. 
The proportion of children who had myopia onset after a year was significantly 
higher in the control group (18%) than in the intervention group (8%, p < 0.001).
The mechanism by which the outdoor activity could protect against myopia 
development is still unknown. However, there are a number of theories, such as 
relaxed accommodation for viewing distance receiving more myopic defocus in 
outdoor environments and higher light intensity in outdoor environments [65, 66]. 
The spectral composition of sunlight may also play a role in myopia control. 
Sunlight has a large portion of short-wavelength visible and non-visible light, such 
as blue light and ultraviolet light [67]. Animal studies have demonstrated that blue 
light has a suppressive effect against myopia [68, 69]. Recently, Torri et al. [70] 
proposed that violet light (VL) (which has a shorter wavelength than blue light), 
which is a missing light component in indoor environments, may play a role in the 
inhibition of myopia development and progression. They demonstrated that expo-
sure to VL inhibited myopic shift and axial elongation in chicks. On the basis of the 
animal findings, they conducted a clinical trial in which myopic children were 
assigned to wear VL blocking eyeglasses, partially VL blocking contact lenses or 
VL transmitting contact lenses [70]. The results showed that children who wore VL 
transmitting contact lenses had significantly less axial length elongation compared 
to those wearing the other types of lenses over 1 year. These data provide evidence 
that VL may contribute to the protective effect against myopia progression. Further 
investigation is needed to determine whether VL transmitting lenses could slow 
myopia progression or prevent myopia in children.
14.5  Comparison of the Effectiveness on Myopia Control by 
Different Optical Interventions
Several studies have reviewed and compared the outcomes of the effect on myopia 
control using various treatments and methodologies [71–74]. In a review of nine 
randomized controlled trials that compared the effects of multifocal and single 
vision spectacle lenses, multifocals with add power ranging from +1.50 to +2.00 D 
were associated with a statistically significant decrease in myopia progression in 
school-age children compared with single vision lenses [74]. The effect was more 
prominent in children with a higher degree of myopia at baseline and could be 
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sustained for a period of 24 months or more. Asian children were found to have 
greater benefit from the interventions than Caucasian children. A study compar-
ing the treatment effect of atropine, soft bifocal and Ortho-K contact lens indicated 
that both atropine and Ortho-K showed treatment effects reaching over 75%, while 
soft bifocals had effects up to 48% [71].
In another study, a meta-analysis was performed to determine and compare 16 
interventions for myopia control in children using pharmaceuticals or optical meth-
ods [73]. Among the optical methods, spectacle lens, contact lenses and Ortho-K 
were included. They concluded that atropine, pirenzepine, Ortho-K, soft contact 
lenses with myopia control features and progressive addition spectacle lenses are 
effective at reducing myopia progression in terms of refraction or axial length. For 
the pharmaceutical treatment, the average treatment effects reported in the literature 
are around 50%. For spectacle treatments, the effects range from minimal in the 
PAL trials to moderately effective in a study on executive bifocals. The investigators 
also compare different interventions with single vision spectacle lenses/placebo 
[73]. Atropine was found to be the most effective as it can retard myopia progres-
sion by around 0.50–0.60 D per year.
14.6  Conclusions
In summary, under-correction of myopia is not recommended for myopia control as 
it is likely to speed up myopia progression instead. Among spectacles, PALs and 
multifocal lenses do not yield clinically meaningful effects on slowing myopia pro-
gression in children. One single center study using prismatic bifocals in children 
with rapid progressing myopia showed a moderate treatment effect. Ortho-K, soft 
bifocal contact lenses and the very recent DIMS spectacle lenses have all shown 
clinically significant treatment effects ranging from 45% to 60% reduction in myo-
pia progression. These methods demonstrated that myopic defocus as natural opti-
cal signals can inhibit refractive eye growth and control myopia progression through 
different optical designs. Although the effectiveness of myopia control with atro-
pine is relatively better than those of optical methods, the associated side effects, 
such as sensitivity to light and near blur, hinder its widespread clinical application. 
Optical interventions are less invasive, which will make it likely to become more 
popular compared to pharmaceutical treatments.
Although there are a number of clinical methods currently available for myopia 
control for children, none of them have been proven to definitely halt the develop-
ment or progression of myopia. The treatment effect also varies among individuals. 
Each therapy has its advantages and limitations. The suitable choice of treatment for 
each patient can vary and should be determined by the eye care professionals based 
on age, parental history, myopic progression rate, corneal health and lifestyle of the 
children. More research is needed to enhance the treatment effects of myopia con-
trol, particularly to prevent myopia before its onset through improved designs of 
optical lenses or pharmaceuticals. Several clinical trials are also testing the possibil-
ity of better myopia control with combined treatments, for example, optical lenses 
(soft bifocals, Ortho-K or DIMS spectacle lenses) with ophthalmic pharmaceutical 
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(low-concentration atropine) or with other non-optical modalities (outdoor activi-
ties, intense bright light for near work). Also, there is still room for research on new 
myopia control methods, such as VL transmitting contact lenses or spectacles. When 
there is more evidence in the treatment effect, there is hope to reduce the prevalence 
of myopia and high myopia and its related ocular complications.
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